HERBICIDAL MALONAMIDES

Abstract
The present invention relates to malonamide compounds of the formula (I) where the variables are as defined in the claims and the description, and to compositions comprising these compounds. The invention also relates to the use of said malonamide compounds or the corresponding compositions for controlling unwanted vegetation, and to methods of applying the malonamide compounds or the corresponding compositions.
Description

The present invention relates to specific malonamide compounds and compositions comprising the same. The invention also relates to the use of said malonamide compounds or the corresponding compositions for controlling unwanted vegetation. Furthermore, the invention relates to methods of applying the malonamide compounds or the corresponding compositions.


BACKGROUND OF THE INVENTION

For the purpose of controlling unwanted vegetation, especially in crops, there is an ongoing need for new herbicides that have high activity and selectivity together with a substantial lack of toxicity for humans and animals.


WO 2012/130798, WO 2014/004882, WO 2014/048882, WO 2018/228985, WO 2018/228986, WO 2019/034602, and WO 2019/145245 describe 3-phenylisoxazoline-5-carboxamides and their use as herbicides.


WO 87/05898 describes the use of malonic acid derivatives for retarding plant growth.


Malonic acid derivatives are also described in U.S. Pat. No. 3,072,473 as plant growth regulators.


The prior art compounds often suffer from insufficient herbicidal activity, in particular at low application rates, and/or unsatisfactory selectivity resulting in a low compatibility with crop plants.


Accordingly, it is an object of the present invention to provide further malonamide compounds having a strong herbicidal activity, in particular even at low application rates, a sufficiently low toxicity for humans and animals and/or a high compatibility with crop plants. The malonamide compounds should also show a broad activity spectrum against a large number of different unwanted plants.


These and further objectives are achieved by the compounds of formula (I) defined below including their agriculturally acceptable salts, stereoisomers and tautomers.


SUMMARY OF THE INVENTION

Accordingly, the present invention relates to compounds of formula (I)




embedded image


wherein the substituents have the following meanings:

    • R1 is hydrogen, (C1-C3)-alkyl, (C1-C3)-haloalkyl, (C3-C4)-cycloalkyl, (C2-C3)-alkenyl, (C2-C3)-haloalkenyl, (C2-C3)-alkynyl, (C2-C3)-haloalkynyl, (C1-C3)-alkoxy-(C1-C3)-alkyl, (C1-C3)-alkoxy, (C1-C3)-haloalkoxy or (C1-C3)-alkoxy-(C1-C3)-alkoxy;
    • R2 is hydrogen, halogen, hydroxyl, cyano, (C1-C3)-alkyl, (C1-C3)-haloalkyl, (C1-C3)-alkoxy or (C1-C3)-haloalkoxy;
    • R3 is hydrogen, halogen, nitro, hydroxyl, cyano, (C1-C3)-alkyl, (C1-C3)-haloalkyl, hydroxy-(C1-C3)-alkyl, (C3-C5)-cycloalkyl, (C3-C5)-halocycloalkyl, hydroxy-(C3-C5)-cycloalkyl, (C2-C3)-alkenyl, (C2-C3)-haloalkenyl, (C2-C3)-alkynyl, (C2-C3)-haloalkynyl, (C1-C3)-alkoxy, (C1-C3)-haloalkoxy, (C1-C3)-alkoxycarbonyl, (C1-C3)-haloalkoxycarbonyl, (C1-C3)-alkylthio, (C1-C3)-haloalkylthio, (C1-C3)-alkylsulfinyl, (C1-C3)-haloalkylsulfinyl, (C1-C3)-alkylsulfonyl or (C1-C3)-haloalkylsulfonyl;
    • R4 is hydrogen, halogen, hydroxyl, cyano, (C1-C3)-alkyl, (C1-C3)-haloalkyl, (C3-C4)-cycloalkyl, (C3-C4)-halocycloalkyl, (C1-C3)-alkoxy, (C1-C3)-haloalkoxy, (C2-C3)-alkenyl, (C2-C3)-haloalkenyl, (C2-C3)-alkynyl, (C2-C3)-haloalkynyl or (C1-C3)-alkylthio;
    • R5 is hydrogen, halogen, nitro, hydroxyl, cyano, (C1-C3)-alkyl, (C1-C3)-haloalkyl, hydroxy-(C1-C3)-alkyl, (C3-C5)-cycloalkyl, (C3-C5)-halocycloalkyl, hydroxy-(C3-C5)-cycloalkyl, (C2-C3)-alkenyl, (C2-C3)-haloalkenyl, (C2-C3)-alkynyl, (C2-C3)-haloalkynyl, (C1-C3)-alkoxy, (C1-C3)-haloalkoxy, (C1-C3)-alkoxycarbonyl, ((C1-C3)-haloalkoxycarbonyl, (C1-C3)-alkylthio, (C1-C3)-haloalkylthio, (C1-C3)-alkylsulfinyl, (C1-C3)-haloalkylsulfinyl, (C1-C3)-alkylsulfonyl or (C1-C3)-haloalkylsulfonyl;
    • R6 is hydrogen, halogen, hydroxyl, cyano, (C1-C3)-alkyl, (C1-C3)-haloalkyl, (C1-C3)-alkoxy, or (C1-C3)-haloalkoxy;
    • R7 is (C1-C6)-alkyl, (C3-C6)-cycloalkyl, (C2-C6)-alkenyl or (C2-C6)-alkynyl, where the four last-mention aliphatic and cycloaliphatic radicals are each substituted by m radicals selected from the group consisting of fluorine, chlorine, bromine, iodine, hydroxyl and cyano;
    • R8 is hydrogen, (C1-C6)-alkyl, (C1-C6)-haloalkyl, (C3-C4)-cycloalkyl, (C2-C6)-alkenyl, (C2-C6)-haloalkenyl, (C2-C6)-alkynyl, (C2-C6)-haloalkynyl, (C1-C3)-alkoxy-(C1-C3)-alkyl, (C1-C6)-alkoxy, (C1-C6)-haloalkoxy or (C1-C3)-alkoxy-(C1-C3)-alkoxy;
    • X is a bond (X0) or a divalent unit selected from the group consisting of (X1), (X2), (X3), (X4), (X5), and (X6):




embedded image




    • R10 and R11, independently of each other and independently of each occurrence, are hydrogen, fluorine, chlorine, bromine, iodine, hydroxyl, cyano, CO2Re, CONRbRd, NRbCO2Re, Ra,
      • (C1-C6)-alkyl, (C3-C5)-cycloalkyl, (C2-C6)-alkenyl, (C2-C6)-alkynyl, where the four last-mentioned aliphatic and cycloaliphatic radicals are each substituted by m radicals selected from the group consisting of fluorine, chlorine, bromine, iodine, hydroxyl and cyano;
      • (C1-C6)-alkoxy, (C3-C6)-cycloalkoxy, (C2-C6)-alkenyloxy, (C2-C6)-alkynyloxy, (C1-C3)-alkylthio, (C1-C3)-alkylsulfinyl, or (C1-C3)-alkylsulfonyl, where the aliphatic or cycloaliphatic moieties of the seven last-mentioned radicals are each substituted by m radicals selected from the group consisting of fluorine, chlorine, bromine, iodine, cyano and (C1-C2)-alkoxy;

    • R12 to R15, independently of each other and independently of each occurrence, are hydrogen, fluorine, chlorine, bromine, iodine, hydroxyl, cyano, CO2Re, CONRbRd, NRbCO2Re, Ra,
      • (C1-C6)-alkyl, (C3-C5)-cycloalkyl, (C2-C6)-alkenyl, (C2-C6)-alkynyl, phenyl, imidazolyl, where the six last-mentioned aliphatic, cycloaliphatic, aromatic and heteroaromatic radicals are each substituted by m radicals selected from the group consisting of fluorine, chlorine, bromine, iodine, hydroxyl and cyano;
      • (C1-C6)-alkoxy, (C3-C6)-cycloalkoxy, (C2-C6)-alkenyloxy, (C2-C6)-alkynyloxy, (C1-C3)-alkylthio, (C1-C3)-alkylsulfinyl, or (C1-C3)-alkylsulfonyl, where the aliphatic or cycloaliphatic moieties of the seven last-mentioned radicals are each substituted by m radicals from the group consisting of fluorine, chlorine, bromine, iodine, cyano and (C1-C2)-alkoxy;

    • Y is Z,
      • or is
      • (C1-C12)-alkyl, (C3-C8)-cycloalkyl, (C2-C12)-alkenyl or (C2-C12)-alkynyl, where the four last-mentioned aliphatic and cycloaliphatic radicals are each substituted by m radicals selected from the group consisting of Rb, Rc, Re and Rf; and are further substituted by p radicals selected from the group consisting of CO2Re, CONRbRh, S(O)nRa, SO2NRbRd, SO2NRbCORe, CORb,
      • CONReS(O)Ra, CONReSO2Ra, CONRb1SO2NRb2Rb3, NRbRe, NRbCORe, NRb—CONReRe, NRbCO2Re, NRbSO2Re, NRb1SO2NRb2Rb3, OCONRbRe, OCSNRbRe, PORfRf and C(Rb)═NORe;

    • Z is a three-, four-, five- or six-membered saturated, partly unsaturated, fully unsaturated or aromatic ring, except phenyl, which is formed from r carbon atoms, n nitrogen atoms, n sulfur atoms and n oxygen atoms, and which is substituted by m radicals selected from the group consisting of Rb, Rc, Re and Rf and p radicals from the group consisting of CO2Re, CONRbRh, S(O)nRa, SO2NRbRd, SO2NRbCORe, CORb, CONReS(O)Ra, CONReSO2Ra, CONRb1SO2NRb2Rb3, NRbRe, NRbCORe, NRbCONReRe, NRbCO2Re, NRbSO2Re, NRb1SO2NRb2Rb3, OCONRbRe, OCSNRbRe, PORfRf and C(Rb)═NORe, and where the sulfur and carbon ring atoms bear n oxo groups;

    • each Ra is independently (C1-C6)-alkyl, (C2-C4)-alkynyl or (C3-C6)-cycloalkyl, each of which is substituted by m radicals selected from the group consisting of fluorine, chlorine, bromine, iodine, cyano, hydroxy, and (C1-C3)-alkoxy;

    • Rb, Rb1 and Rb2, independently of each other and independently of each occurrence, are hydrogen or have one of the meanings given for Ra;

    • each Rb3 has independently one of the meanings given for Rd; or

    • Rb2 and Rb3, together with the nitrogen atom they are bound to, form a saturated 3-, 4-, 5-, 6- or 7-membered N-bound heterocyclic ring which may contain one further heteroatom or heteroatom group selected from the group consisting of N, O, S, S(O) and S(O)2 as ring member;

    • each Rc is independently fluorine, chlorine, bromine, iodine, cyano, hydroxyl, S(O)nRa, or (C1-C6)-alkoxy, (C2-C6)-alkenyloxy or (C2-C6)-alkynyloxy, where the aliphatic or cycloaliphatic moieties of the three last-mentioned radicals are each substituted by m radicals selected from the group consisting of fluorine, chlorine, bromine, cyano and (C1-C2)-alkoxy;

    • each Rd is independently hydrogen or (C1-C6)-alkyl, (C2-C4)-alkenyl, (C2-C4)-alkynyl, (C3-C6)-cycloalkyl, (C3-C6)-cycloalkyl-(C1-C3)-alkyl, phenyl-(C1-C3)-alkyl or furanyl-(C1-C3)-alkyl, where each of the seven last-mentioned radicals is substituted by m radicals selected from the group consisting of fluorine, chlorine, bromine, cyano, CO2Ra, CONRbRh, (C1-C2)-alkoxy, (C1-C3)-alkylthio, (C1-C3)-alkylsulfinyl, (C1-C3)-alkylsulfonyl, phenylthio, phenylsulfinyl, and phenylsulfonyl;

    • each Re has independently one of the meanings given for Rd;

    • each Rf is independently (C1-C3)-alkyl or (C1-C3)-alkoxy;

    • each Rh is independently hydrogen or (C1-C6)-alkyl, (C1-C2)-alkoxy, (C3-C6)-cycloalkyl, (C2-C4)-alkenyl, (C1-C6)-alkoxycarbonyl-(C1-C6)-alkyl, or (C2-C4)-alkynyl, where each of the six last-mentioned radicals is substituted by m radicals selected from the group consisting of fluorine, chlorine, bromine, cyano, CO2Ra, and (C1-C2)-alkoxy;

    • each m is independently 0, 1, 2, 3, 4 or 5;

    • each n is independently 0, 1 or 2;

    • each p is independently 1, 2 or 3; and

    • r is 1, 2, 3, 4, 5 or 6;

    • including their agriculturally acceptable salts, stereoisomers and tautomers;

    • except for



  • 2-methyl-N1-phenyl-N3-[1-[(2-phenylacetyl)amino]ethyl]propanediamide,

  • carbamic acid [(2S,3S)-3-hydroxy-2-[[2-methyl-1,3-dioxo-3-[[3-(trifluoromethyl)phenyl]amino]propyl]amino]4-hexynyl]-phenylmethylester,

  • ethyl 2-[[3-(4-bromo-2-fluoro-anilino)-3-oxo-propanoyl]amino]acetate,

  • 2-methyl-N-phenyl-N′-[1-[(2-phenylacetyl)amino]ethyl]propanediamide and

  • {(2S,3S)-3-hydroxy-2-[2-(3-trifluoromethyl-phenylcarbamoyl)-propionylamino]-hex-4-ynyl}-carbamic acid benzyl ester.



The invention also relates to a composition comprising at least one compound of formula (I) and at least one auxiliary which is customary for formulating crop protection compounds.


The present invention also provides combinations comprising at least one compound of formula (I) (component A) and at least one further compound selected from the herbicidal compounds B (component B) and safeners C (component C).


The invention relates moreover to the use of a compound of formula (I) or of said compositions for controlling unwanted vegetation, and to a method for controlling unwanted vegetation which comprises allowing a herbicidally effective amount of at least one compound of formula (I) or of said compositions to act on plants, their seed and/or their habitat.







DETAILED DESCRIPTION OF THE INVENTION
Definitions

Depending on the kind of substituents, the compounds of formula (I) may have one or more centers of chirality, in which case they may be present as mixtures of enantiomers or diastereomers but also in the form of the pure enantiomers or pure diastereomers. The invention provides both the pure enantiomers or pure diastereomers of the compounds of formula I, and their mixtures and the use according to the invention of the pure enantiomers or pure diastereomers of the compound of formula I or its mixtures. Suitable compounds of formula I also include all possible geometrical stereoisomers (cis/trans isomers) as a specific form of diastereomers and mixtures thereof. Cis/trans isomers may be present with respect to an alkene, carbon-nitrogen double-bond, nitrogen-sulfur double bond, amide group or a cyclic, non-aromatic moiety. The term “stereoisomer(s)” encompasses both optical isomers, such as enantiomers or diastereomers existing due to more than one stereogenic center in the molecule, as well as geometrical isomers (cis/trans isomers). Just by way of example, a stereogenic center is the C atom carrying R10 and R11 in X1 to X6, provided of course that R10 and R11 are different. Another example for a stereogenic center is the C atom carrying R7.


If the above-mentioned herbicidal compounds B and/or the safeners C have one or more centres of chirality they may also be present as enantiomers or diastereomers, and it is possible to use both the pure enantiomers and diastereomers or their mixtures.


If the compounds of formula (I), the herbicidal compounds B and/or the safeners C as described herein have ionizable functional groups, they can also be employed in the form of their agriculturally acceptable salts. Suitable are, in general, the salts of those cations and the acid addition salts of those acids whose cations and anions, respectively, have no adverse effect on the activity of the active compounds.


Preferred cations are the ions of the alkali metals, preferably of lithium, sodium and potassium, of the alkaline earth metals, preferably of calcium and magnesium, and of the transition metals, preferably of manganese, copper, zinc and iron, further ammonium and substituted ammonium in which one to four hydrogen atoms are replaced by C1-C4-alkyl, hydroxy-C1-C4-alkyl, C1-C4-alkoxy-C1-C4-alkyl, hydroxy-C1-C4-alkoxy-C1-C4-alkyl, phenyl or benzyl, preferably ammonium, methylammonium, isopropylammonium, dimethylammonium, diethylammonium, diisopropylammonium, trimethylammonium, triethylammonium, tris(isopropyl)ammonium, heptylammonium, dodecylammonium, tetradecylammonium, tetramethylammonium, tetraethylammonium, tetrabutylammonium, 2-hydroxyethylammonium (olamine salt), 2-(2-hydroxyeth-1-oxy)eth-1-ylammonium (diglycolamine salt), di(2-hydroxyeth-1-yl)ammonium (diolamine salt), tris(2-hydroxyethyl)ammonium (trolamine salt), tris(2-hydroxypropyl)ammonium, benzyltrimethylammonium, benzyltriethylammonium, N,N,N-trimethylethanolammonium (choline salt), furthermore phosphonium ions, sulfonium ions, preferably tri(C1-C4-alkyl)sulfonium, such as trimethylsulfonium, and sulfoxonium ions, preferably tri(C1-C4-alkyl)sulfoxonium, and finally the salts of polybasic amines such as N,N-bis-(3-aminopropyl)methylamine and diethylenetriamine.


Anions of useful acid addition salts are primarily chloride, bromide, fluoride, iodide, hydrogensulfate, methylsulfate, sulfate, dihydrogenphosphate, hydrogenphosphate, nitrate, bicarbonate, carbonate, hexafluorosilicate, hexafluorophosphate, benzoate and also the anions of C1-C4-alkanoic acids, preferably formate, acetate, propionate and butyrate.


The compounds (I) may be present in form of different tautomers. For instance, the depicted keto form of the malonamide moiety N(R1)—C(═O)—C(H)(R7)—C(═O)—N(R8) can be in equilibrium with its enol forms N(R1)—C(OH)═C(R7)—C(═O)—N(R8) and N(R1)—C(═O)—C(R7)═C(OH)—N(R8) (keto-enol tautomery).


The same applies if ring Z contains a C(═O) group as ring member neighboured to a CH ring member.


Moreover, if ring Z is a lactam, i.e. contains an amide group as ring member (=unsubstituted, secondary nitrogen ring atom neighboured to a carbon ring atom carrying an oxo group), this ring moiety —N(H)—C(═O)— can be in equilibrium with its tautomeric form —N═C(OH)—.


The same applies to the two mandatorily present amide groups of the malonamide moiety —N(R1)—C(═O)—CH(R7)—C(═O)—N(R8)— if one or both of R1 and R8 are hydrogen:

    • If only R1 is hydrogen, the malonamide moiety can be present as —N(H)—C(═O)—CH(R7)—C(═O)—N(R8)— or as —N═C(OH)—CH(R7)—C(═O)—N(R8)— or as a mixture of the two forms;
    • If only R8 is hydrogen, the malonamide moiety can be present as —N(R1)—C(═O)—CH(R7)—C(═O)—N(H)— or as —N(R1)—C(═O)—CH(R7)—C(OH)═N— or as a mixture of the two forms;
    • If both of R1 and R8 are hydrogen, the malonamide moiety can be present as —N(H)—C(═O)—CH(R7)—C(═O)—N(H)— or as —N═C(OH)—CH(R7)—C(═O)—N(H)— or as —N(H)—C(═O)—CH(R7)—C(OH)═N— or as —N═C(OH)—CH(R7)—C(OH)═N— or as mixture of two, three all four of the above forms.


The amount in which the one or other tautomeric form is present depends on the complete molecular structure and even stronger on the surrounding conditions (presence or absence of solvent, type of solvent, pH, temperature etc.).


The term “undesired vegetation” (“weeds”) is understood to include any vegetation growing in non-crop-areas or at a crop plant site or locus of seeded and otherwise desired crop, where the vegetation is any plant species, including their germinant seeds, emerging seedlings and established vegetation, other than the seeded or desired crop (if any). Weeds, in the broadest sense, are plants considered undesirable in a particular location.


The organic moieties mentioned in the above definitions of the variables are—like the term halogen—collective terms for individual listings of the individual group members. The prefix Cn-Cm indicates in each case the possible number of carbon atoms in the group.


The term “halogen” denotes in each case fluorine, bromine, chlorine or iodine, in particular fluorine, chlorine or bromine.


The term “partially or completely halogenated” will be taken to mean that 1 or more, e.g. 1, 2, 3, 4 or 5 or all of the hydrogen atoms of a given radical have been replaced by a halogen atom, in particular by fluorine or chlorine. A partially or completely halogenated radical is termed below also “halo-radical”. For example, partially or completely halogenated alkyl is also termed haloalkyl.


The term “alkyl” as used herein (and in the alkyl moieties of other groups comprising an alkyl group, e.g. alkoxy, alkylamino, dialkylamino, alkylcarbonyl, alkoxycarbonyl, alkylthio, alkylsulfonyl and alkoxyalkyl) denotes in each case a straight-chain or branched alkyl group having usually from 1 to 12 carbon atoms (=C1-C12-alkyl), frequently from 1 to 6 carbon atoms (=C1-C6-alkyl), in particular 1 to 4 carbon atoms (=C1-C4-alkyl) and especially from 1 to 3 carbon atoms (=C1-C3-alkyl) or 1 or 2 carbon atoms (=C1-C2-alkyl). C1-C2-Alkyl is methyl or ethyl. C1-C3-Alkyl is methyl, ethyl, n-propyl or iso-propyl. Examples of C1-C4-alkyl are methyl, ethyl, n-propyl, iso-propyl, n-butyl, 2-butyl (=sec-butyl), isobutyl and tert-butyl. Examples for C1-C6-alkyl are, in addition to those mentioned for C1-C4-alkyl, n-pentyl, 1-methylbutyl, 2-methylbutyl, 3-methylbutyl, 2,2-dimethylpropyl, 1-ethylpropyl, n-hexyl, 1,1-dimethylpropyl, 1,2-dimethylpropyl, 1-methylpentyl, 2-methylpentyl, 3-methylpentyl, 4-methylpentyl, 1,1-dimethylbutyl, 1,2-dimethylbutyl, 1,3-dimethylbutyl, 2,2-dimethylbutyl, 2,3-dimethylbutyl, 3,3-dimethylbutyl, 1-ethylbutyl, 2-ethylbutyl, 1,1,2-trimethylpropyl, 1,2,2-trimethylpropyl, 1-ethyl-1-methylpropyl and 1-ethyl-2-methylpropyl. Examples for C1-C8-alkyl are, in addition to those mentioned for C1-C6-alkyl, n-heptyl, 1-methylhexyl, 2-methylhexyl, 3-methylhexyl, 4-methylhexyl, 5-methylhexyl, 1-ethylpentyl, 2-ethylpentyl, 3-ethylpentyl, n-octyl, 1-methylheptyl, 2-methylheptyl, 1-ethylhexyl, 2-ethylhexyl, 1,2-dimethylhexyl, 1-propylpentyl and 2-propylpentyl. Examples for C1-C12-alkyl are, apart those mentioned for C1-C8-alkyl, nonyl, decyl, 2-propylheptyl, 3-propylheptyl, undecyl, dodecyl and positional isomers thereof.


The term “haloalkyl” as used herein (and in the haloalkyl moieties of other groups comprising a haloalkyl group, e.g. haloalkoxy, haloalkylthio, haloalkylcarbonyl, haloalkylsulfonyl and haloalkylsulfinyl), which is also expressed as “alkyl which is partially or fully halogenated”, denotes in each case a straight-chain or branched alkyl group having usually from 1 to 6 carbon atoms (=C1-C6-haloalkyl), more frequently 1 to 3 carbon atoms (=C1-C3-haloalkyl), as defined above, wherein the hydrogen atoms of this group are partially or totally replaced with halogen atoms. Preferred haloalkyl moieties are selected from C1-C3-haloalkyl, specifically from C1-C2-haloalkyl, in particular from fluorinated C1-C2-alkyl. Examples for C1-C2-haloalkyl are fluoromethyl, difluoromethyl, trifluoromethyl, chloromethyl, dichloromethyl, trichloromethyl, chlorofluoromethyl, dichloro-fluoromethyl, chlorodifluoromethyl, bromomethyl, 1-fluoroethyl, 2-fluoroethyl, 2,2-difluoroethyl, 2,2,2-trifluoroethyl, pentafluoroethyl, 1-chloroethyl, 2-chloroethyl, 2,2,-dichloroethyl, 2,2,2-trichloroethyl, 2-chloro-2-fluoroethyl, 2-chloro-2,2-difluoroethyl, 2,2-dichloro-2-fluoroethyl, 1-bromoethyl, and the like. Examples for C1-C3-haloalkyl are, in addition to those mentioned for C1-C2-haloalkyl, 1-fluoropropyl, 2-fluoropropyl, 3-fluoropropyl, 3,3-difluoropropyl, 3,3,3-trifluoropropyl, heptafluoropropyl, 1,1,1-trifluoroprop-2-yl, 3-chloropropyl, and the like.


The term “hydroxyalkyl” denotes in each case a straight-chain or branched alkyl group having usually from 1 to 6 carbon atoms (=C1-C6-hydroxyalkyl), more frequently 1 to 3 carbon atoms (=C1-C3-hydroxyalkyl), as defined above, wherein one hydrogen atom of this group is replaced with a hydroxyl group. Examples are hydroxymethyl, 1-hydroxyethyl, 2-hydroxyethyl, 1-hydroxypropyl, 2-hydroxypropyl, 3-hydroxypropyl, 1-hydroxy-2-propyl and the like.


The term “alkenyl” as used herein denotes in each case a monounsaturated straight-chain or branched hydrocarbon radical having usually 2 to 12 (=C2-C12-alkenyl), preferably 2 to 6 carbon atoms (=C2-C6-alkenyl), e.g. 3 to 6 carbon atoms (=C3-C6-alkenyl), in particular 2 to 4 carbon atoms (=C2-C4-alkenyl) or 2 or 3 carbon atoms (=C2-C3-alkenyl), and a double bond in any position, for example C2-C3-alkenyl, such as ethenyl, 1-propenyl, 2-propenyl or 1-methylethenyl; C2-C4-alkenyl, such as ethenyl, 1-propenyl, 2-propenyl, 1-methylethenyl, 1-butenyl, 2-butenyl, 3-butenyl, 1-methyl-1-propenyl, 2-methyl-1-propenyl, 1-methyl-2-propenyl or 2-methyl-2-propenyl; C2-C6-alkenyl, such as ethenyl, 1-propenyl, 2-propenyl, 1-methylethenyl, 1-butenyl, 2-butenyl, 3-butenyl, 1-methyl-1-propenyl, 2-methyl-1-propenyl, 1-methyl-2-propenyl, 2-methyl-2-propenyl, 1-pentenyl, 2-pentenyl, 3-pentenyl, 4-pentenyl, 1-methyl-1-butenyl, 2-methyl-1-butenyl, 3-methyl-1-butenyl, 1-methyl-2-butenyl, 2-methyl-2-butenyl, 3-methyl-2-butenyl, 1-methyl-3-butenyl, 2-methyl-3-butenyl, 3-methyl-3-butenyl, 1,1-dimethyl-2-propenyl, 1,2-dimethyl-1-propenyl, 1,2-dimethyl-2-propenyl, 1-ethyl-1-propenyl, 1-ethyl-2-propenyl, 1-hexenyl, 2-hexenyl, 3-hexenyl, 4-hexenyl, 5-hexenyl, 1-methyl-1-pentenyl, 2-methyl-1-pentenyl, 3-methyl-1-pentenyl, 4-methyl-1-pentenyl, 1-methyl-2-pentenyl, 2-methyl-2-pentenyl, 3-methyl-2-pentenyl, 4-methyl-2-pentenyl, 1-methyl-3-pentenyl, 2-methyl-3-pentenyl, 3-methyl-3-pentenyl, 4-methyl-3-pentenyl, 1-methyl-4-pentenyl, 2-methyl-4-pentenyl, 3-methyl-4-pentenyl, 4-methyl-4-pentenyl, 1,1-dimethyl-2-butenyl, 1,1-dimethyl-3-butenyl, 1,2-dimethyl-1-butenyl, 1,2-dimethyl-2-butenyl, 1,2-dimethyl-3-butenyl, 1,3-dimethyl-1-butenyl, 1,3-dimethyl-2-butenyl, 1,3-dimethyl-3-butenyl, 2,2-dimethyl-3-butenyl, 2,3-dimethyl-1-butenyl, 2,3-dimethyl-2-butenyl, 2,3-dimethyl-3-butenyl, 3,3-dimethyl-1-butenyl, 3,3-dimethyl-2-butenyl, 1-ethyl-1-butenyl, 1-ethyl-2-butenyl, 1-ethyl-3-butenyl, 2-ethyl-1-butenyl, 2-ethyl-2-butenyl, 2-ethyl-3-butenyl, 1,1,2-trimethyl-2-propenyl, 1-ethyl-1-methyl-2-propenyl, 1-ethyl-2-methyl-1-propenyl, 1-ethyl-2-methyl-2-propenyl and the like, or C2-C12-alkenyl, such as the radicals mentioned for C2-C6-alkenyl and additionally 1-heptenyl, 2-heptenyl, 3-heptenyl, 1-octenyl, 2-octenyl, 3-octenyl, 4-octenyl, the nonenyls, decenyls, undecenyls, dodecenyls and the positional isomers thereof.


Examples for C3-C6-alkenyl are those mentioned above for C2-C6-alkenyl, except for ethenyl.


The term “haloalkenyl” as used herein, which may also be expressed as “alkenyl which is substituted by halogen”, and the haloalkenyl moieties in haloalkenyloxy and the like refers to unsaturated straight-chain or branched hydrocarbon radicals having 2 to 6 (=C2-C6-haloalkenyl) or 2 to 4 (=C2-C4-haloalkenyl) or 2 to 3 (=C2-C3-haloalkenyl) carbon atoms and a double bond in any position, where some or all of the hydrogen atoms in these groups are replaced by halogen atoms as mentioned above, in particular fluorine, chlorine and bromine, for example chlorovinyl, chloroallyl and the like.


The term “alkynyl” as used herein denotes unsaturated straight-chain or branched hydrocarbon radicals having usually 2 to 12 (=C2-C12-alkynyl), frequently 2 to 6 (=C2-C6-alkynyl), preferably 2 to 4 carbon atoms (=C2-C4-alkynyl) or 2 to 3 carbon atoms (=C2-C3-alkynyl) and a triple bond in any position, for example C2-C3-alkynyl, such as ethynyl, 1-propynyl or 2-propynyl; C2-C4-alkynyl, such as ethynyl, 1-propynyl or 2-propynyl, 1-butynyl, 2-butynyl, 3-butynyl, 1-methyl-2-propynyl and the like; C2-C6-alkynyl, such as ethynyl, 1-propynyl, 2-propynyl, 1-butynyl, 2-butynyl, 3-butynyl, 1-methyl-2-propynyl, 1-pentynyl, 2-pentynyl, 3-pentynyl, 4-pentynyl, 1-methyl-2-butynyl, 1-methyl-3-butynyl, 2-methyl-3-butynyl, 3-methyl-1-butynyl, 1,1-dimethyl-2-propynyl, 1-ethyl-2-propynyl, 1-hexynyl, 2-hexynyl, 3-hexynyl, 4-hexynyl, 5-hexynyl, 1-methyl-2-pentynyl, 1-methyl-3-pentynyl, 1-methyl-4-pentynyl, 2-methyl-3-pentynyl, 2-methyl-4-pentynyl, 3-methyl-1-pentynyl, 3-methyl-4-pentynyl, 4-methyl-1-pentynyl, 4-methyl-2-pentynyl, 1,1-dimethyl-2-butynyl, 1,1-dimethyl-3-butynyl, 1,2-dimethyl-3-butynyl, 2,2-dimethyl-3-butynyl, 3,3-dimethyl-1-butynyl, 1-ethyl-2-butynyl, 1-ethyl-3-butynyl, 2-ethyl-3-butynyl, 1-ethyl-1-methyl-2-propynyl and the like.


The term “haloalkynyl” as used herein, which is also expressed as “alkynyl which is substituted by halogen”, refers to unsaturated straight-chain or branched hydrocarbon radicals having usually 2 to 6 carbon atoms (=C2-C6-haloalkynyl), preferably 2 to 4 carbon atoms (=C2-C4-haloalkynyl) or 2 or 3 carbon atoms (=C2-C3-haloalkynyl), and a triple bond in any position (as mentioned above), where some or all of the hydrogen atoms in these groups are replaced by halogen atoms as mentioned above, in particular fluorine, chlorine and bromine.


The term “cycloalkyl” as used herein (and in the cycloalkyl moieties of other groups comprising a cycloalkyl group, e.g. cycloalkoxy and cycloalkylalkyl) denotes in each case a mono- or bicyclic, saturated cycloaliphatic radical having usually from 3 to 8 carbon atoms (=C3-C8-cycloalkyl), preferably 3 to 6 carbon atoms (=C3-C6-cycloalkyl), 3 to 5 carbon atoms (=C3-C5-cycloalkyl) or 3 to 4 carbon atoms (=C3-C4-cycloalkyl) as (only) ring members. Examples of monocyclic saturated cycloaliphatic radicals having 3 or 4 carbon atoms comprise cyclopropyl and cyclobutyl. Examples of monocyclic saturated cycloaliphatic radicals having 3 to 5 carbon atoms comprise cyclopropyl, cyclobutyl and cyclopentyl. Examples of monocyclic saturated cycloaliphatic radicals having 3 to 6 carbon atoms comprise cyclopropyl, cyclobutyl, cyclopentyl and cyclohexyl. Examples of monocyclic saturated cycloaliphatic radicals having 3 to 8 carbon atoms comprise cyclopropyl, cyclobutyl, cyclopentyl, cyclohexyl, cycloheptyl and cyclooctyl. C5-C6-Cycloalkyl is cyclopentyl or cyclohexyl. Examples of bicyclic radicals having 6 to 8 carbon atoms comprise bicyclo[2.1.1]hexyl, bicyclo[2.2.1]heptyl, bicyclo[3.1.1]heptyl, bicyclo[2.2.1]heptyl, bicyclo[2.2.2]octyl and bicyclo[3.2.1]octyl.


The term “halocycloalkyl” as used herein (and in the halocycloalkyl moieties of other groups comprising an halocycloalkyl group) denotes in each case a mono- or bicyclic cycloaliphatic radical having usually from 3 to 8 carbon atoms (“C3-C8-halocycloalkyl”), preferably 3 to 5 carbon atoms (“C3-C5-halocycloalkyl”), wherein at least one, e.g. 1, 2, 3, 4 or 5 of the hydrogen atoms are replaced by halogen, in particular by fluorine or chlorine. Examples are 1- and 2-fluorocyclopropyl, 1,2-, 2,2- and 2,3-difluorocyclopropyl, 1,2,2-trifluorocyclopropyl, 2,2,3,3-tetrafluorocyclpropyl, 1- and 2-chlorocyclopropyl, 1,2-, 2,2- and 2,3-dichlorocyclopropyl, 1,2,2-trichlorocyclopropyl, 2,2,3,3-tetrachlorocyclpropyl, 1-, 2- and 3-fluorocyclopentyl, 1,2-, 2,2-, 2,3-, 3,3-, 3,4-, 2,5-difluorocyclopentyl, 1-, 2- and 3-chlorocyclopentyl, 1,2-, 2,2-, 2,3-, 3,3-, 3,4-, 2,5-dichlorocyclopentyl and the like.


The term “hydroxycycloalkyl” denotes in each case a mono- or bicyclic cycloaliphatic radical having usually from 3 to 6 carbon atoms (“hydroxy-(C3-C6)-cycloalkyl”), preferably 3 to 5 carbon atoms (“hydroxy-(C3-C5)-cycloalkyl”), wherein at least one, e.g. 1, 2, 3, 4 or 5 of the hydrogen atoms are replaced by a hydroxyl group. Examples are 1-hydroxycyclopropyl, 2-hydroxycyclopropyl, 1,2-dihydroxycyclopropyl, 2,3-dihydroxycyclopropyl, 1-hydroxycyclobutyl, 2-hydroxycyclobutyl, 3-hydroxycyclobutyl, 1,2-dihydroxycyclobutyl, 1,3-dihydroxycyclobutyl, 2,3-dihydroxycyclobutyl, 1-hydroxycyclopentyl, 2-hydroxycyclopentyl, 3-hydroxycyclopentyl, 1,2-dihydroxycyclopentyl, 1,3-dihydroxycyclopentyl, 2,3-dihydroxycyclopentyl and the like.


The term “alkoxy” as used herein denotes in each case a straight-chain or branched alkyl group usually having from 1 to 6 carbon atoms (=C1-C6-alkoxy), preferably 1 to 3 carbon atoms (=C1-C3-alkoxy), in particular 1 or 2 carbon atoms (=C1-C2-alkoxy), which is bound to the remainder of the molecule via an oxygen atom. C1-C2-Alkoxy is methoxy or ethoxy. C1-C3-Alkoxy is additionally, for example, n-propoxy or 1-methylethoxy (isopropoxy). C1-C6-Alkoxy is additionally, for example, butoxy, 1-methylpropoxy (sec-butoxy), 2-methylpropoxy (isobutoxy) or 1,1-dimethylethoxy (tert-butoxy), pentoxy, 1-methylbutoxy, 2-methylbutoxy, 3-methylbutoxy, 1,1-dimethylpropoxy, 1,2-dimethylpropoxy, 2,2-dimethylpropoxy, 1-ethylpropoxy, hexoxy, 1-methylpentoxy, 2-methylpentoxy, 3-methylpentoxy, 4-methylpentoxy, 1,1-dimethylbutoxy, 1,2-dimethylbutoxy, 1,3-dimethylbutoxy, 2,2-dimethylbutoxy, 2,3-dimethylbutoxy, 3,3-dimethylbutoxy, 1-ethylbutoxy, 2-ethylbutoxy, 1,1,2-trimethylpropoxy, 1,2,2-trimethylpropoxy, 1-ethyl-1-methylpropoxy or 1-ethyl-2-methylpropoxy.


The term “haloalkoxy” as used herein denotes in each case a straight-chain or branched alkoxy group, as defined above, having from 1 to 6 carbon atoms (=C1-C6-haloalkoxy), preferably 1 to 3 carbon atoms (=C1-C3-haloalkoxy), in particular 1 or 2 carbon atoms (=C1-C2-haloalkoxy), wherein the hydrogen atoms of this group are partially or totally replaced with halogen atoms, in particular fluorine atoms (in this case, the radical is also termed fluorinated alkoxy). C1-C2-Haloalkoxy is, for example, OCH2F, OCHF2, OCF3, OCH2Cl, OCHCl2, OCCl3, chlorofluoromethoxy, dichlorofluoromethoxy, chlorodifluoromethoxy, 2-fluoroethoxy, 2-chloroethoxy, 2-bromoethoxy, 2-iodoethoxy, 2,2-difluoroethoxy, 2,2,2-trifluoroethoxy, 2-chloro-2-fluoroethoxy, 2-chloro-2,2-difluoroethoxy, 2,2-dichloro-2-fluoroethoxy, 2,2,2-trichloroethoxy or OC2F5. C1-C3-Haloalkoxy is additionally, for example, 2-fluoropropoxy, 3-fluoropropoxy, 2,2-difluoropropoxy, 2,3-difluoropropoxy, 2-chloropropoxy, 3-chloropropoxy, 2,3-dichloropropoxy, 2-bromopropoxy, 3-bromopropoxy, 3,3,3-trifluoropropoxy, 3,3,3-trichloropropoxy, OCH2—C2F5, OCF2—C2F5, 1-(CH2F)-2-fluoroethoxy, 1-(CH2Cl)-2-chloroethoxy or 1-(CH2Br)-2-bromoethoxy. C1-C6-Haloalkoxy is additionally, for example, 4-fluorobutoxy, 4-chlorobutoxy, 4-bromobutoxy or nonafluorobutoxy, 5-fluoropentoxy, 5-chloropentoxy, 5-brompentoxy, 5-iodopentoxy, undecafluoropentoxy, 6-fluorohexoxy, 6-chlorohexoxy, 6-bromohexoxy, 6-iodohexoxy or dodecafluorohexoxy.


The term “alkenyloxy” denotes an alkenyl group, as defined above, attached via an oxygen atom to the remainder of the molecule. C2-C6-Alkenyloxy is a C2-C6-alkenyl group, as defined above, attached via an oxygen atom to the remainder of the molecule. C3-C6-Alkenyloxy is a C3-C6-alkenyl group, as defined above, attached via an oxygen atom to the remainder of the molecule.


The term “haloalkenyloxy” denotes a haloalkenyl group, as defined above, attached via an oxygen atom to the remainder of the molecule. C2-C6-Haloalkenyloxy is a C2-C6-haloalkenyl group, as defined above, attached via an oxygen atom to the remainder of the molecule. C3-C6-Haloalkenyloxy is a C3-C6-haloalkenyl group, as defined above, attached via an oxygen atom to the remainder of the molecule.


The term “alkynyloxy” denotes an alkynyl group, as defined above, attached via an oxygen atom to the remainder of the molecule. C2-C6-Alkynyloxy is a C2-C6-alkynyl group, as defined above, attached via an oxygen atom to the remainder of the molecule. C3-C6-Alkynyloxy is a C3-C6-alkynyl group, as defined above, attached via an oxygen atom to the remainder of the molecule.


The term “haloalkynyloxy” denotes a haloalkynyl group, as defined above, attached via an oxygen atom to the remainder of the molecule. C2-C6-Haloalkynyloxy is a C2-C6-haloalkynyl group, as defined above, attached via an oxygen atom to the remainder of the molecule. C3-C6-Haloalkynyloxy is a C3-C6-haloalkynyl group, as defined above, attached via an oxygen atom to the remainder of the molecule.


The term “cycloalkoxy” denotes a cycloalkyl group, as defined above, attached via an oxygen atom to the remainder of the molecule. C3-C6-Cycloalkoxy is a C3-C6-cycloalkyl group, as defined above, attached via an oxygen atom to the remainder of the molecule. Examples of C3-C6-cycloalkoxy comprise cyclopropoxy, cyclobutoxy, cyclopentoxy and cyclohexoxy.


The term “alkoxy-alkoxy” as used herein, refers to an alkoxy group, as defined above, where one hydrogen atom is replaced by another alkoxy group, as defined above. The term “C1-C3-alkoxy-C1-C3-alkoxy” as used herein, refers to an alkoxy group having 1 to 3 carbon atoms, as defined above, where one hydrogen atom is replaced by a C1-C3-alkoxy group, as defined above. Examples are methoxymethoxy, ethox-ymethoxy, propoxymethoxy, isopropoxymethoxy, 1-methoxyethoxy, 1-ethoxyethoxy, 1-propoxyethoxy, 1-isopropoxyethoxy, 2-methoxyethoxy, 2-ethoxyethoxy, 2-propoxyethoxy, 2-isopropoxyethoxy, 1-methoxypropoxy, 1-ethoxypropoxy, 1-propoxypropoxy, 1-isopropoxypropoxy, 2-methoxypropoxy, 2-ethoxypropoxy, 2-propoxypropoxy, 2-isopropoxypropoxy, 3-methoxypropoxy, 3-ethoxypropoxy, 3-propoxypropoxy, 3-isopropoxypropoxy, and the like.


The term “alkylthio” (also alkylsulfanyl, “alkyl-S” or “alkyl-S(O)k” (wherein k is 0) as used herein denotes in each case a straight-chain or branched saturated alkyl group as defined above, usually comprising 1 to 6 carbon atoms (=C1-C6-alkylthio), preferably 1 to 3 carbon atoms (=C1-C3-alkylthio), which is attached via a sulfur atom at any position in the alkyl group. C1-C2-Alkylthio is methylthio or ethylthio. C1-C3-Alkylthio is additionally, for example, n-propylthio or 1-methylethylthio (isopropylthio). C1-C6-Alkylthio is additionally, for example, butylthio, 1-methylpropylthio (sec-butylthio), 2-methylpropylthio (isobutylthio), 1,1-dimethylethylthio (tert-butylthio), pentylthio, 1-methylbutylthio, 2-methylbutylthio, 3-methylbutylthio, 1,1-dimethylpropylthio, 1,2-dimethylpropylthio, 2,2-dimethylpropylthio, 1-ethylpropylthio, hexylthio, 1-methylpentylthio, 2-methylpentylthio, 3-methylpentylthio, 4-methylpentylthio, 1,1-dimethylbutylthio, 1,2-dimethylbutylthio, 1,3-dimethylbutylthio, 2,2-dimethylbutylthio, 2,3-dimethylbutylthio, 3,3-dimethylbutylthio, 1-ethylbutylthio, 2-ethylbutylthio, 1,1,2-trimethylpropylthio, 1,2,2-trimethylpropylthio, 1-ethyl-1-methylpropylthio or 1-ethyl-2-methylpropylthio.


The term “haloalkylthio” as used herein refers to an alkylthio group as defined above wherein the hydrogen atoms are partially or completely substituted by fluorine, chlorine, bromine and/or iodine. C1-C2-Haloalkylthio is, for example, SCH2F, SCHF2, SCF3, SCH2Cl, SCHCl2, SCCla, chlorofluoromethylthio, dichlorofluoromethylthio, chlo-rodifluoromethylthio, 2-fluoroethylthio, 2-chloroethylthio, 2-bromoethylthio, 2-iodoethylthio, 2,2-difluoroethylthio, 2,2,2-trifluoroethylthio, 2-chloro-2-fluoroethylthio, 2-chloro-2,2-difluoroethylthio, 2,2-dichloro-2-fluoroethylthio, 2,2,2-trichloroethylthio or SC2F5. C1-C4-Haloalkylthio is additionally, for example, 2-fluoropropylthio, 3-fluoropropylthio, 2,2-difluoropropylthio, 2,3-difluoropropylthio, 2-chloropropylthio, 3-chloropropylthio, 2,3-dichloropropylthio, 2-bromopropylthio, 3-bromopropylthio, 3,3,3-trifluoropropylthio, 3,3,3-trichloropropylthio, SCH2—C2F5, SCF2—C2F5, 1-(CH2F)-2-fluoroethylthio, 1-(CH2Cl)-2-chloroethylthio, 1-(CH2Br)-2-bromoethylthio, 4-fluorobutylthio, 4-chlorobutylthio, 4-bromobutylthio or nonafluorobutylthio. C1-C6-Haloalkylthio is additionally, for example, 5-fluoropentylthio, 5-chloropentylthio, 5-brompentylthio, 5-iodopentylthio, undecafluoropentylthio, 6-fluorohexylthio, 6-chlorohexylthio, 6-bromohexylthio, 6-iodohexylthio or dodecafluorohexylthio.


The term “alkylsulfinyl” denotes an alkyl group, as defined above, attached via a sulfinyl [S(O)] group. For example, the term “C1-C2-alkylsulfinyl” refers to a C1-C2-alkyl group, as defined above, attached via a sulfinyl [S(O)] group. The term “C1-C3-alkylsulfinyl” refers to a C1-C3-alkyl group, as defined above, attached via a sulfinyl [S(O)] group. The term “C1-C6-alkylsulfinyl” refers to a C1-C6-alkyl group, as defined above, attached via a sulfinyl [S(O)] group. C1-C2-alkylsulfinyl is methylsulfinyl or ethyl-sulfinyl. C1-C3-alkylsulfinyl is additionally, for example, n-propylsulfinyl or 1-methylethylsulfinyl (isopropylsulfinyl). C1-C6-alkylsulfinyl is additionally, for example, butylsulfinyl, 1-methylpropylsulfinyl (sec-butylsulfinyl), 2-methylpropylsulfinyl (isobutyl-sulfinyl), 1,1-dimethylethylsulfinyl (tert-butylsulfinyl), pentylsulfinyl, 1-methylbutylsulfinyl, 2-methylbutylsulfinyl, 3-methylbutylsulfinyl, 1,1-dimethylpropylsulfinyl, 1,2-dimethylpropylsulfinyl, 2,2-dimethylpropylsulfinyl, 1-ethylpropylsulfinyl, hexylsulfinyl, 1-methylpentylsulfinyl, 2-methylpentylsulfinyl, 3-methylpentylsulfinyl, 4-methylpentylsulfinyl, 1,1-dimethylbutylsulfinyl, 1,2-dimethylbutylsulfinyl, 1,3-dimethylbutylsulfinyl, 2,2-dimethylbutylsulfinyl, 2,3-dimethylbutylsulfinyl, 3,3-dimethylbutylsulfinyl, 1-ethylbutylsulfinyl, 2-ethylbutylsulfinyl, 1,1,2-trimethylpropylsulfinyl, 1,2,2-trimethylpropylsulfinyl, 1-ethyl-1-methylpropylsulfinyl or 1-ethyl-2-methylpropylsulfinyl.


The term “haloalkylsulfinyl” denotes a haloalkyl group, as defined above, attached via a sulfinyl [S(O)] group to the remainder of the molecule. C1-C2-Haloalkylsulfinyl is, for example, S(O)CH2F, S(O)CHF2, S(O)CF3, S(O)CH2Cl, S(O)CHCl2, S(O)CCl3, chlorofluoromethylsulfinyl, dichlorofluoromethylsulfinyl, chlorodi-fluoromethylsulfinyl, 2-fluoroethylsulfinyl, 2-chloroethylsulfinyl, 2-bromoethylsulfinyl, 2-iodoethylsulfinyl, 2,2-difluoroethylsulfinyl, 2,2,2-trifluoroethylsulfinyl, 2-chloro-2-fluoroethylsulfinyl, 2-chloro-2,2-difluoroethylsulfinyl, 2,2-dichloro-2-fluoroethylsulfinyl, 2,2,2-trichloroethylsulfinyl or S(O)C2F5. C1-C3-Haloalkylsulfinyl is additionally, for example, 2-fluoropropylsulfinyl, 3-fluoropropylsulfinyl, 2,2-difluoropropylsulfinyl, 2,3-difluoropropylsulfinyl, 2-chloropropylsulfinyl, 3-chloropropylsulfinyl, 2,3-dichloropropylsulfinyl, 2-bromopropylsulfinyl, 3-bromopropylsulfinyl, 3,3,3-trifluoropropylsulfinyl, 3,3,3-trichloropropylsulfinyl, S(O)CH2—C2F5, S(O)CF2—C2F5, 1-(CH2F)-2-fluoroethylsulfinyl, 1-(CH2Cl)-2-chloroethylsulfinylor 1-(CH2Br)-2-bromoethylsulfinyl. C1-C4-Haloalkylsulfinyl is additionally, for example, 4-fluorobutylsulfinyl, 4-chlorobutylsulfinyl, 4-bromobutylsulfinyl or nonafluorobutylsulfi-nyl. C1-C6-Haloalkylsulfinyl is additionally, for example, 5-fluoropentylsulfinyl, 5-chloropentylsulfinyl, 5-brompentylsulfinyl, 5-iodopentylsulfinyl, undecafluoropentylsulfi-nyl, 6-fluorohexylsulfinyl, 6-chlorohexylsulfinyl, 6-bromohexylsulfinyl, 6-iodohexylsulfinyl or dodecafluorohexylsulfinyl.


The term “alkylsulfonyl” denotes an alkyl group, as defined above, attached via a sulfonyl [S(O)2] group. The term “C1-C2-alkylsulfonyl” refers to a C1-C2-alkyl group, as defined above, attached via a sulfonyl [S(O)2] group. The term “C1-C3-alkylsulfonyl” refers to a C1-C3-alkyl group, as defined above, attached via a sulfonyl [S(O)2] group.


The term “C1-C6-alkylsulfonyl” refers to a C1-C6-alkyl group, as defined above, attached via a sulfonyl [S(O)2] group. C1-C2-alkylsulfonyl is methylsulfonyl or ethylsulfonyl. C1-C3-alkylsulfonyl is additionally, for example, n-propylsulfonyl or 1-methylethylsulfonyl (iso-propylsulfonyl). C1-C6-alkylsulfonyl is additionally, for example, butylsulfonyl, 1-methylpropylsulfonyl (sec-butylsulfonyl), 2-methylpropylsulfonyl (isobutylsulfonyl), 1,1-dimethylethylsulfonyl (tert-butylsulfonyl), pentylsulfonyl, 1-methylbutylsulfonyl, 2-methylbutylsulfonyl, 3-methylbutylsulfonyl, 1,1-dimethylpropylsulfonyl, 1,2-dimethylpropylsulfonyl, 2,2-dimethylpropylsulfonyl, 1-ethylpropylsulfonyl, hexylsulfonyl, 1-methylpentylsulfonyl, 2-methylpentylsulfonyl, 3-methylpentylsulfonyl, 4-methylpentylsulfonyl, 1,1-dimethylbutylsulfonyl, 1,2-dimethylbutylsulfonyl, 1,3-dimethylbutylsulfonyl, 2,2-dimethylbutylsulfonyl, 2,3-dimethylbutylsulfonyl, 3,3-dimethylbutylsulfonyl, 1-ethylbutylsulfonyl, 2-ethylbutylsulfonyl, 1,1,2-trimethylpropylsulfonyl, 1,2,2-trimethylpropylsulfonyl, 1-ethyl-1-methylpropylsulfonyl or 1-ethyl-2-methylpropylsulfonyl.


The term “haloalkylsulfonyl” denotes a haloalkyl group, as defined above, attached via a sulfonyl [S(O)] group to the remainder of the molecule. C1-C2-Haloalkylsulfonyl is, for example, S(O)2CH2F, S(O)2CHF2, S(O)2CF3, S(O)2CH2Cl, S(O)2CHCl2, S(O)2CCl3, chlorofluoromethylsulfonyl, dichlorofluoromethylsulfonyl, chlo-rodifluoromethylsulfonyl, 2-fluoroethylsulfonyl, 2-chloroethylsulfonyl, 2-bromoethylsulfonyl, 2-iodoethylsulfonyl, 2,2-difluoroethylsulfonyl, 2,2,2-trifluoroethylsulfonyl, 2-chloro-2-fluoroethylsulfonyl, 2-chloro-2,2-difluoroethylsulfonyl, 2,2-dichloro-2-fluoroethylsulfonyl, 2,2,2-trichloroethylsulfonyl or S(O)2C2F5. C1-C3-Haloalkylsulfonyl is additionally, for example, 2-fluoropropylsulfonyl, 3-fluoropropylsulfonyl, 2,2-difluoropropylsulfonyl, 2,3-difluoropropylsulfonyl, 2-chloropropylsulfonyl, 3-chloropropylsulfonyl, 2,3-dichloropropylsulfonyl, 2-bromopropylsulfonyl, 3-bromopropylsulfonyl, 3,3,3-trifluoropropylsulfonyl, 3,3,3-trichloropropylsulfonyl, S(O)2CH2—C2F5, S(O)2CF2—C2F5, 1-(CH2F)-2-fluoroethylsulfonyl, 1-(CH2Cl)-2-chloroethylsulfonylor 1-(CH2Br)-2-bromoethylsulfonyl. C1-C4-Haloalkylsulfonyl is additionally, for example, 4-fluorobutylsulfonyl, 4-chlorobutylsulfonyl, 4-bromobutylsulfonyl or nonafluorobutylsulfonyl. C1-C6-Haloalkylsulfonyl is additionally, for example, 5-fluoropentylsulfonyl, 5-chloropentylsulfonyl, 5-brompentylsulfonyl, 5-iodopentylsulfonyl, undecafluoropen-tylsulfonyl, 6-fluorohexylsulfonyl, 6-chlorohexylsulfonyl, 6-bromohexylsulfonyl, 6-iodohexylsulfonyl or dodecafluorohexylsulfonyl.


The substituent “oxo” replaces a CH2 group by a C(═O) group.


The suffix “-carbonyl” in a group denotes in each case that the group is bound to the remainder of the molecule via a carbonyl C═O group. This is the case e.g. in alkylcarbonyl, haloalkylcarbonyl, aminocarbonyl, alkylaminocarbonyl, dialkylaminocarbonyl, alkoxycarbonyl, haloalkoxycarbonyl.


The term “alkoxycarbonyl” denotes an alkoxy group, as defined above, attached via a carbonyl [C(═O)] group to the remainder of the molecule. C1-C3-Alkoxycarbonyl is a C1-C3-alkoxy group, as defined above, attached via a carbonyl [C(═O)] group to the remainder of the molecule. Examples for C1-C3-alkoxycarbonyl are methoxycarbonyl, ethoxycarbonyl, propoxycarbonyl and isopropoxycarbonyl. C1-C6-Alkoxycarbonyl is a C1-C6-alkoxy group, as defined above, attached via a carbonyl [C(═O)] group to the remainder of the molecule. Examples for C1-C6-alkoxycarbonyl are, in addition to those listed for C1-C3-alkoxycarbonyl, n-butoxycarbonyl, sec-butoxycarbonyl, isobutoxycar-bonyl, tert-butoxycarbonyl, pentoxycarbonyl and hexoxycarbonyl.


The term “haloalkoxycarbonyl” denotes a haloalkoxy group, as defined above, attached via a carbonyl [C(═O)] group to the remainder of the molecule. C1-C3-Halolkoxycarbonyl is a C1-C3-haloalkoxy group, as defined above, attached via a carbonyl [C(═O)] group to the remainder of the molecule. Examples for C1-C3-haloalkoxycarbonyl are —C(O)OCH2F, —C(O)OCHF2, —C(O)OCF3, —C(O)OCH2Cl, —C(O)OCHCl2, —C(O)OCC3, chlorofluoromethoxycarbonyl, dichlorofluoromethoxycar-bonyl, chlorodifluoromethoxycarbonyl, 2-fluoroethoxycarbonyl, 2-chloroethoxycarbonyl, 2-bromoethoxycarbonyl, 2-iodoethoxycarbonyl, 2,2-difluoroethoxycarbonyl, 2,2,2-trifluoroethoxycarbonyl, 2-chloro-2-fluoroethoxycarbonyl, 2-chloro-2,2-difluoroethoxycarbonyl, 2,2-dichloro-2-fluoroethoxycarbonyl, 2,2,2-trichloroethoxycarbonyl, —C(O)OC2F5, 2-fluoropropoxycarbonyl, 3-fluoropropoxycarbonyl, 2,2-difluoropropoxycarbonyl, 2,3-difluoropropoxycarbonyl, 2-chloropropoxycarbonyl, 3-chloropropoxycarbonyl, 2,3-dichloropropoxycarbonyl, 2-bromopropoxycarbonyl, 3-bromopropoxycarbonyl, 3,3,3-trifluoropropoxycarbonyl, 3,3,3-trichloropropoxycarbonyl, —C(O)OCH2—C2F5, —C(O)OCF2—C2F5, 1-(CH2F)-2-fluoroethoxycarbonyl, 1-(CH2Cl)-2-chloroethoxycarbonyl or 1-(CH2Br)-2-bromoethoxycarbonyl.


The term “alkoxycarbonyl-alkyl” denotes an alkyl group, as defined above, in which one hydrogen atom is replaced by an alkoxycarbonyl group, as defined above. C1-C6-Alkoxycarbonyl-C1-C6-alkyl is a C1-C6-alkyl group, as defined above, in which one hydrogen atom is replaced by a C1-C6-alkoxycarbonyl group, as defined above.


Phenyl-(C1-C2)-alkyl is a C1-C2-alkyl group, as defined above, in which one hydrogen atom is replaced by a phenyl ring (i.e. the attachment to the remainder of the molecule is via the alkyl group). Examples are benzyl, 1-phenylethyl and 2-phenylethyl. Phenyl-(C1-C3)-alkyl is a C1-C3-alkyl group, as defined above, in which one hydrogen atom is replaced by a phenyl ring (i.e. the attachment to the remainder of the molecule is via the alkyl group). Examples are benzyl, 1-phenylethyl, 2-phenylethyl, 1-phenylpropyl, 2-phenylpropyl, 3-phenylpropyl or 2-phenyl-2-propyl.


Furanyl-(C1-C3)-alkyl is a C1-C3-alkyl group, as defined above, in which one hydrogen atom is replaced by a 2- or 3-furanyl ring (i.e. the attachment to the remainder of the molecule is via the alkyl group). Examples are furan-2-yl-methyl, furan-3-yl-methyl, 1-(furan-2-yl)-ethyl, 1-(furan-3-yl)-ethyl, 2-(furan-2-yl)-ethyl, 2-(furan-3-yl)-ethyl and the like.


Phenylthio is a phenyl ring attached via an S atom to the remainder of the molecule.


Phenylsulfinyl is a phenyl ring attached via a S(O) group to the remainder of the molecule.


Phenylsulfonyl is a phenyl ring attached via a S(O)2 group to the remainder of the molecule.


Z is a three-, four-, five- or six-membered saturated, partly unsaturated, fully unsaturated or aromatic ring, except phenyl, which is formed from r carbon atoms, n nitrogen atoms, n sulfur atoms and n oxygen atoms. The ring can thus be carbocyclic (i.e. containing only carbon atoms as ring members; r being here 3 to 6 and n being 0) or heterocyclic (i.e. containing also at least one N, O and/or S atom as ring member(s); r being here thus from 1 to 5 and at least one of the n's being 1).


An unsaturated carbocycle contains at least one C—C double bond(s). An unsaturated heterocycle contains at least one C—C and/or C—N and/or N—N double bond(s). Partially unsaturated carbocyclic rings contain less than the maximum number of C—C double bond(s) allowed by the ring size. Partially unsaturated heterocyclic rings contain less than the maximum number of C—C and/or C—N and/or N—N double bond(s) allowed by the ring size. A fully (or maximally) unsaturated carbocyclic ring contains as many conjugated C—C double bonds as allowed by the size(s) of the ring(s). Not encom-passed in the definition of Z is however phenyl. A fully (or maximally) unsaturated heterocycle contains as many conjugated C—C and/or C—N and/or N—N double bonds as allowed by the size(s) of the ring(s). Maximally unsaturated 5- or 6-membered heter-omonocyclic rings are generally aromatic. Exceptions are maximally unsaturated 6-membered rings containing O, S, SO and/or SO2 as ring members, such as pyran and thiopyran, which are not aromatic.


Examples for three-, four-, five- or six-membered saturated, partly unsaturated, fully unsaturated or aromatic carbocyclic rings Z are cyclopropyl, cyclobutyl, cyclopentyl, cyclohexyl, cycloprop-1-enyl, cycloprop-2-enyl, cyclobut-1-enyl, cyclobut-2-enyl, cyclobutadienyl, cyclopent-1-enyl, cyclopent-2-enyl, cyclopent-3-enyl, cyclopenta-1,3-dienyl, cyclopenta-1,4-dienyl, cyclopenta-2,4-dienyl, cyclohex-1-enyl, cyclohex-2-enyl, cyclohex-3-enyl, cyclohexa-1,3-dienyl, cyclohexa-1,4-dienyl, cyclohexa-1,5-dienyl, cy-clohexa-2,4-dienyl, cyclohexa-2,5-dienyl, and the like.


Examples for three-, four-, five- or six-membered saturated, partly unsaturated, fully unsaturated or aromatic heterocyclic rings Z are:

    • 3-, 4-, 5- or 6-membered monocyclic saturated heterocycle: e.g. oxiran-2-yl, thiiran-2-yl, aziridin-1-yl, aziridin-2-yl, oxetan-2-yl, oxetan-3-yl, thietan-2-yl, thietan-3-yl, 1-oxothietan-2-yl, 1-oxothietan-3-yl, 1,1-dioxothietan-2-yl, 1,1-dioxothietan-3-yl, azet-idin-1-yl, azetidin-2-yl, azetidin-3-yl, tetrahydrofuran-2-yl, tetrahydrofuran-3-yl, tetrahy-drothien-2-yl, tetrahydrothien-3-yl, 1-oxotetrahydrothien-2-yl, 1,1-dioxotetrahydrothien-2-yl, 1-oxotetrahydrothien-3-yl, 1,1-dioxotetrahydrothien-3-yl, 1,3-dioxolan-2-yl, 1,3-dioxolan-4-yl, 1,3-ditholan-2-yl, 1,3-ditholan-4-yl, 1,3-oxathiolan-2-yl, 1,3-oxathiolan-4-yl, 1,3-oxathiolan-5-yl, pyrrolidin-1-yl, pyrrolidin-2-yl, pyrrolidin-3-yl, pyrazolidin-1-yl, pyrazolidin-3-yl, pyrazolidin-4-yl, pyrazolidin-5-yl, imidazolidin-1-yl, imidazolidin-2-yl, imidazolidin-4-yl, oxazolidin-2-yl, oxazolidin-3-yl, oxazolidin-4-yl, oxazolidin-5-yl, isoxa-zolidin-2-yl, isoxazolidin-3-yl, isoxazolidin-4-yl, isoxazolidin-5-yl, thiazolidin-2-yl, thiazol-idin-3-yl, thiazolidin-4-yl, thiazolidin-5-yl, isothiazolidin-2-yl, isothiazolidin-3-yl, isothia-zolidin-4-yl, isothiazolidin-5-yl, 1,2,4-oxadiazolidin-3-yl, 1,2,4-oxadiazolidin-5-yl, 1,2,4-thiadiazolidin-3-yl, 1,2,4-thiadiazolidin-5-yl, 1,3,4-oxadiazolidin-2-yl, 1,3,4-thiadiazolidin-2-yl, 2-tetrahydropyranyl, 3-tetrahydropyranyl, 4-tetrahydropyranyl, 1,3-dioxan-2-yl, 1,3-dioxan-4-yl, 1,3-dioxan-5-yl, 1,4-dioxan-2-yl, piperidin-1-yl, piperidin-2-yl, piperidin-3-yl, piperidin-4-yl, hexahydropyridazin-1-yl, hexahydropyridazin-3-yl, hexahydropyridazin-4-yl, hexahydropyrimidin-1-yl, hexahydropyrimidin-2-yl, hexahydropyrimidin-4-yl, hexahy-dropyrimidin-5-yl, piperazin-1-yl, piperazin-2-yl, morpholin-2-yl, morpholin-3-yl, morpho-lin-4-yl, thiomorpholin-2-yl, thiomorpholin-3-yl, thiomorpholin-4-yl, 1-oxothiomorpholin-2-yl, 1 oxothiomorpholin-3-yl, 1-oxothiomorpholin-4-yl, 1,1 dioxothiomorpholin-2-yl, 1,1 dioxothiomorpholin-3-yl, 1,1-dioxothiomorpholin-4-yl, and the like;
    • 5- or 6-membered monocyclic partially unsaturated heterocycles: e.g. 2,3-dihydrofuran-2-yl, 2,3-dihydrofuran-3-yl, 2,5-dihydrofuran-2-yl, 2,5-dihydrofuran-3-yl, 2,3-dihydrothien-2-yl, 2,3-dihydrothien-3-yl, 2,5-dihydrothien-2-yl, 2,5-dihydrothien-3-yl, 2-pyrrolin-2-yl, 2-pyrrolin-3-yl, 3-pyrrolin-2-yl, 3-pyrrolin-3-yl, 2-isoxazolin-3-yl, 3-isoxazolin-3-yl, 4-isoxazolin-3-yl, 2-isoxazolin-4-yl, 3-isoxazolin-4-yl, 4-isoxazolin-4-yl, 2-isoxazolin-5-yl, 3-isoxazolin-5-yl, 4-isoxazolin-5-yl, 2-isothiazolin-3-yl, 3-isothiazolin-3-yl, 4-isothiazolin-3-yl, 2-isothiazolin-4-yl, 3-isothiazolin-4-yl, 4-isothiazolin-4-yl, 2-isothiazolin-5-yl, 3-isothiazolin-5-yl, 4-isothiazolin-5-yl, 2,3-dihydropyrazol-1-yl, 2,3-dihydropyrazol-2-yl, 2,3-dihydropyrazol-3-yl, 2,3-dihydropyrazol-4-yl, 2,3-dihydropyrazol-5-yl, 3,4-dihydropyrazol-1-yl, 3,4-dihydropyrazol-3-yl, 3,4-dihydropyrazol-4-yl, 3,4-dihydropyrazol-5-yl, 4,5-dihydropyrazol-1-yl, 4,5-dihydropyrazol-3-yl, 4,5-dihydropyrazol-4-yl, 4,5-dihydropyrazol-5-yl, 2,3-dihydrooxazol-2-yl, 2,3-dihydrooxazol-3-yl, 2,3-dihydrooxazol-4-yl, 2,3-dihydrooxazol-5-yl, 3,4-dihydrooxazol-2-yl, 3,4-dihydrooxazol-3-yl, 3,4-dihydrooxazol-4-yl, 3,4-dihydrooxazol-5-yl, 3,4-dihydrooxazol-2-yl, 3,4-dihydrooxazol-3-yl, 3,4-dihydrooxazol-4-yl, 3,6-dihydro-2H-pyran-2-, -3-, -4-, -5- or 6-yl, 3,4-dihydro-2H-pyran-2-, -3-, -4-, -5- or 6-yl, 3,6-dihydro-2H-thiopyran-2-, -3-, -4-, -5- or 6-yl, 3,4-dihydro-2H-thiopyran-2-, -3-, -4-, -5- or 6-yl, 2-, 3-, 4-, 5- or 6-di- or tetra-hydropyridinyl, 3-di- or tetrahydropyridazinyl, 4-di- or tetrahydropyridazinyl, 2-di- or tetrahydropyrimidinyl, 4-di- or tetrahydropyrimidinyl, 5-di- or tetrahydropyrimidinyl, di- or tetrahydropyrazinyl;
    • 5- or 6-membered monocyclic fully unsaturated (including aromatic) heterocyclic ring: e.g. 2-furyl, 3-furyl, 2-thienyl, 3-thienyl, 1-pyrrolyl, 2-pyrrolyl, 3-pyrrolyl, 1-pyrazolyl, 3-pyrazolyl, 4-pyrazolyl, 5-pyrazolyl, 2-oxazolyl, 4-oxazolyl, 5-oxazolyl, 2-thiazolyl, 4-thiazolyl, 5-thiazolyl, 1-imidazolyl, 2-imidazolyl, 4-imidazolyl, 5-imidazolyl, 2-pyridinyl, 3-pyridinyl, 4-pyridinyl, 3-pyridazinyl, 4-pyridazinyl, 2-pyrimidinyl, 4-pyrimidinyl, 5-pyrimidinyl and 2-pyrazinyl.


Specifically, Z is a five- or six-membered partly unsaturated carbocyclic ring. Examples therefor are cyclopent-1-en-1-yl, cyclopent-2-en-1-yl, cyclopent-3-en-1-yl, cy-clopenta-1,3-dien-1-yl, cyclopenta-1,4-dien-1-yl, cyclopenta-2,4-dien-1-yl, cyclohex-1-en-1-yl, cyclohex-2-en-1-yl, cyclohex-3-en-1-yl, cyclohexa-1,3-dien-1-yl, cyclohexa-1,4-dien-1-yl, cyclohexa-1,5-dien-1-yl, cyclohexa-2,4-dien-1-yl and cyclohexa-2,5-dien-1-yl.


If two radicals bound on the same nitrogen atom (for example Rb2 and Rb3), together with the nitrogen atom to which they are bound, form a 3-, 4-, 5-, 6- or 7-membered, saturated N-bound heterocyclic ring which may contain as a ring member a further heteroatom or heteroatom group selected from the group consisting of N, O, S, S(O) and S(O)2, this is for example aziridn-1-yl, azetidin-1-yl, pyrrolidin-1-yl, pyrazoli-din-1-yl, imidazolidin-1-yl, oxazolidin-3-yl, thiazolidin-3-yl, isoxazolidin-2-yl, isothiazolin-2-yl, piperidin-1-yl, piperazin-1-yl, morpholin-1-yl, thiomorpholin-1-yl, 1-oxothiomorpholin-1-yl, 1,1-dioxothiomorpholin-1-yl, azepan-1-yl or 1,4-diazepan-1-yl.


If two radicals bound on the same nitrogen atom (for example Rb2 and Rb3), together with the nitrogen atom to which they are bound, form a 5- or 6-membered, saturated N-bound heterocyclic ring, this is pyrrolidin-1-yl or piperidin-1-yl.


The remarks made below as to preferred embodiments of the variables (substituents) of the compounds of formula I are valid on their own as well as preferably in combination with each other, as well as in combination with the stereoisomers, tautomers or salts thereof. The remarks made below concerning preferred embodiments of the variables further are valid on their own as well as preferably in combination with each other concerning the compounds of formulae I, where applicable, as well as concerning the uses and methods according to the invention and the composition according to the invention.


Preferably, R1 is hydrogen or (C1-C3)-alkyl, and is more preferably hydrogen.


Preferably, R8 is hydrogen or (C1-C3)-alkyl, and is more preferably hydrogen.


Preferably, R1 and R8 are both hydrogen.


Preferably, R2 is hydrogen, halogen or (C1-C3)-alkyl. More preferably, R2 is hydrogen or halogen, e.g. H or Cl. In particular, R2 is hydrogen.


Preferably, R6 is hydrogen, halogen or (C1-C3)-alkyl. More preferably, R6 is hydrogen.


Preferably, R2 and R6, independently of each other, are hydrogen, halogen or (C1-C3)-alkyl. More preferably, R2 is hydrogen or halogen, e.g. H or C1, and R6 is hydrogen. In particular, R2 is hydrogen and R6 is hydrogen.


Preferably, R3 is hydrogen, halogen, (C1-C3)-alkyl, (C1-C3)-haloalkyl, (C1-C3)-alkoxy or (C1-C3)-haloalkoxy. More preferably, R3 is hydrogen, halogen, (C1-C2)-alkyl, (C1-C2)-haloalkyl, (C1-C2)-alkoxy or (C1-C2)-haloalkoxy. Specifically, R3 is hydrogen or halogen.


Preferably, R5 is hydrogen, halogen, (C1-C3)-alkyl, (C1-C3)-haloalkyl, (C1-C3)-alkoxy or (C1-C3)-haloalkoxy. More preferably, R5 is hydrogen, halogen or (C1-C2)-alkyl. Specifically, R5 is hydrogen or halogen.


Preferably R3 and R5, independently of each other, are hydrogen, halogen, (C1-C3)-alkyl, (C1-C3)-haloalkyl, (C1-C3)-alkoxy or (C1-C3)-haloalkoxy. More preferably, R3 is hydrogen, halogen, (C1-C3)-alkyl, (C1-C3)-haloalkyl, (C1-C3)-alkoxy or (C1-C3)-haloalkoxy and R5 is hydrogen, halogen or (C1-C2)-alkyl. In particular, R3 and R5, independently of each other, are hydrogen or halogen. More particularly, R3 is halogen and R5 is hydrogen or halogen.


In another preferred embodiment, R3 is hydrogen, halogen, (C1-C3)-alkyl, (C1-C3)-haloalkyl, (C1-C3)-alkoxy or (C1-C3)-haloalkoxy and R5 is hydrogen or halogen. More preferably, R3 is hydrogen, halogen, (C1-C2)-alkyl, (C1-C2)-haloalkyl, (C1-C2)-alkoxy or (C1-C2)-haloalkoxy and R5 is hydrogen or halogen.


Preferably, R4 is hydrogen or halogen. In particular, R4 is hydrogen.


R7 is (C1-C6)-alkyl, (C3-C6)-cycloalkyl, (C2-C6)-alkenyl or (C2-C6)-alkynyl, each substituted by m radicals selected from the group consisting of fluorine, chlorine, bromine, iodine, hydroxyl and cyano. Preferably, m is 0, 1 or 2, more preferably, 0 or 1 and specifically 0. Thus, preferably, R7 is (in each case unsubstituted) (C1-C6)-alkyl, (C3-C6)-cycloalkyl, (C2-C6)-alkenyl or (C2-C6)-alkynyl. Even more preferably, R7 is (C1-C6)-alkyl, (C3-C6)-cycloalkyl or (C2-C6)-alkenyl. In particular, R7 is (C1-C6)-alkyl or (C3-C6)-cycloalkyl; more particularly (C1-C6)-alkyl; even more particularly (C1-C4)-alkyl; and specifically methyl or ethyl.


In the divalent radicals (X1) to (X6), the orientation within the molecule is as depicted, the left arrow representing the bond to the adjacent nitrogen atom and the right arrow representing the bond to Y.


When X is a bond (“X0”), the compound (I) can also be depicted as follows:




embedded image


When X is a divalent radical of the formula (X1), the compound (1) can also be depicted as follows:




embedded image


When X is a divalent radical of the formula (X2), the compound (1) can also be depicted as follows:




embedded image


When X is a divalent radical of the formula (X3), the compound (1) can also be depicted as follows:




embedded image


When X is a divalent radical of the formula (X4), the compound (1) can also be depicted as follows:




embedded image


When X is a divalent radical of the formula (X5), the compound (1) can also be depicted as follows:




embedded image


When X is a divalent radical of the formula (X6), the compound (1) can also be depicted as follows:




embedded image


In the divalent radicals (X1) to (X6), R10-R15, independently of each other and independently of each occurrence, are preferably selected from the group consisting of hydrogen, fluorine, chlorine, bromine, iodine, hydroxyl, cyano, CO2Re, CONRbRd; (C1-C6)-alkyl, (C3-C5)-cycloalkyl, (C2-C6)-alkenyl, where the three last-mentioned aliphatic and cycloaliphatic radicals are each independently substituted by m fluorine atoms; (C1-C6)-alkoxy, (C3-C6)-cycloalkoxy, (C2-C6)-alkenyloxy, (C2-C6)-alkynyloxy, (C1-C3)-alkylsulfinyl, (C1-C3)-alkylsulfonyl and (C1-C3)-alkylthio, where the aliphatic and cycloaliphatic moieties in the 7 last-mentioned radicals are each independently substituted by m fluorine atoms.


More preferably, R10-R15, independently of each other and independently of each occurrence, are selected from the group consisting of hydrogen, fluorine, chlorine, bromine, iodine, hydroxyl, cyano, CO2Re, CONRbRd; (C1-C6)-alkyl, (C3-C5)-cycloalkyl, (C2-C6)-alkenyl, where the three last-mentioned aliphatic and cycloaliphatic radicals are each independently substituted by m fluorine atoms; (C1-C6)-alkoxy, (C3-C6)-cycloalkoxy, (C2-C6)-alkenyloxy or (C2-C6)-alkynyloxy, where the aliphatic and cycloaliphatic moieties in the four last-mentioned radicals are each independently substituted by m fluorine atoms.


In particular, R10-R15, independently of each other and independently of each occurrence, are selected from the group consisting of hydrogen, fluorine, chlorine, CO2Re, CONRbRd, (C1-C6)-alkyl substituted by m fluorine atoms, or (C1-C6)-alkoxy substituted by m fluorine atoms.


In particular, R10-R15, independently of each other and independently of each occurrence, are selected from the group consisting of hydrogen, halogen, (C1-C6)-alkyl, (C1-C3)-alkoxy, and CO2Re. More particularly, R10-R15, independently of each other and independently of each occurrence, are hydrogen or (C1-C6)-alkyl and specifically hydrogen or methyl.


Non-exhaustive examples for suitable divalent radicals (X1) to (X6) are CH2, CH2CH2, CH(CH3), CH2CH2CH2, CH(CH2CH3), CH(CH3)CH2, C(CH3)2, C(CH3)2CH2, C(iPr)CH3, CH(CH2iPr)CH2, CH2CH═CH, C(CH3)2C═C, CH(CF3)CH2, CH(CH3)CH2O, CH2CH2O, CH(cPr)CH2O, CH(CH2OCH3), CH(CH2CH2SCH3), CH(COOH), CH(COOCH3), CH(COOH)CH2, CH(COOCH3)CH2, CH2C(OH)(CF3), CH(CONHCH3), CH(CONHCH3)CH2 and CH2CH2CONHCH2. cPr is cyclopropyl; Pr is isopropyl.


In a preferred embodiment, X is a bond or the divalent unit (X1). In the latter, preferably, R10 and R11, independently of each other, are hydrogen or (C1-C6)-alkyl, and more preferably hydrogen or methyl. In particular, one of R10 and R11 is hydrogen and the other is methyl, X1 thus being in particular CH(CH3).


In a preferred embodiment, Y is Z.


Z is preferably a three-, four-, five- or six-membered saturated, partly unsaturated or fully unsaturated carbocyclic ring, except phenyl, which is substituted by p radicals selected from the group consisting of CO2Re, CONRbRh, S(O)nRa, SO2NRbRd, SO2NRbCORe, CORb, CONReS(O)Ra, CONReSO2Ra, CONRb1SO2NRb2Rb3, NRbRe, NRbCORe, NRbCONReRe, NRbCO2Re, NRbSO2Re, NRb1SO2NRb2Re, OCONRbRe, OCSNRbRe, PORfRf and C(Rb)═NORe, and more preferably by p radicals selected from the group consisting of CO2Re, CONRbRh and CONReS(O)Ra; and where the carbon ring atoms bear n oxo groups. p is in this context preferably 1 or 2, more preferably 1. n is in this context preferably 0 or 1, in particular 0. More preferably, Z is a five- or six-membered saturated or partly unsaturated carbocyclic ring which is substituted by p radicals selected from the group consisting of CO2Re, CONRbRh and CONReS(O)Ra. In particular, Z is a five- or six-membered saturated or partly unsaturated carbocyclic ring which is substituted by p radicals CO2Re. Re is in this context preferably hydrogen, (C1-C6)-alkyl which may carry a cyano group; phenyl-(C1-C2)-alkyl or (C3-C6)-cycloalkyl; specifically hydrogen or (C1-C6)-alkyl, and p is in this context preferably 1 or 2, more preferably 1. Thus, more particularly, Z is a five- or six-membered saturated or partly unsaturated carbocyclic ring which is substituted by p radicals CO2Re, where Re is hydrogen, (C1-C6)-alkyl which may carry a cyano group; phenyl-(C1-C2)-alkyl or (C3-C6)-cycloalkyl; specifically hydrogen or (C1-C6)-alkyl, and p is 1 or 2, preferably 1. Even more particularly, Z is a five- or six-membered partly unsaturated carbocyclic ring which is substituted by p radicals CO2Re, where Re is hydrogen, (C1-C6)-alkyl which may carry a cyano group; phenyl-(C1-C2)-alkyl or (C3-C6)-cycloalkyl; specifically hydrogen or (C1-C6)-alkyl, and p is 1 or 2, preferably 1. Specifically, Z is a five-membered partly unsaturated carbocyclic ring which is substituted by p radicals CO2Re, where Re is hydrogen, (C1-C6)-alkyl which may carry a cyano group; phenyl-(C1-C2)-alkyl or (C3-C6)-cycloalkyl; specifically hydrogen or (C1-C6)-alkyl, and p is 1 or 2, preferably 1.


Examples for five- or six-membered saturated or partly unsaturated carbocyclic rings are listed above. Among these, preference is given to cyclopentyl, cyclopent-1-en-1-yl, cyclopent-2-en-1-yl, cyclopent-3-en-1-yl and cyclohexyl. A specific example is cyclo-pent-2-en-1-yl. In the latter ring, if p is 1, the mandatory substituent (CO2Re etc.) is preferably bound in the 4-position.


In an alternatively preferred embodiment, Z is a three-, four-, five- or six-membered saturated, partly unsaturated or fully unsaturated heterocyclic ring containing one or two oxygen atoms as ring members, where the ring is substituted by p radicals selected from the group consisting of CO2Re, CONRbRh, S(O)nRa, SO2NRbRd, SO2NRbCORe, CORb, CONReS(O)Ra, CONReSO2Ra, CONRb1SO2NRb2Rb3, NRbRe, NRbCORe, NRb—CONReRe, NRbCO2Re, NRbSO2Re, NRb1SO2NRb2Re, OCONRbRe, OCSNRbRe, PORfRf and C(Rb)═NORe, and where the carbon ring atoms bear n oxo groups. p is in this context preferably 1 or 2, more preferably 1. n is in this context preferably 0 or 1, in particular 0. More preferably, Z is a saturated or partly unsaturated five- or six-membered heterocyclic ring containing one oxygen atom as ring member, where the ring is substituted by p radicals CO2Re. Re is in this context preferably hydrogen, (C1-C6)-alkyl or (C3-C6)-cycloalkyl; specifically hydrogen or (C1-C6)-alkyl, and p is in this context preferably 1 or 2, more preferably 1. Thus, more particularly, Z is a saturated or partly unsaturated five- or six-membered heterocyclic ring containing one oxygen atom as ring member, where the ring is substituted by p radicals CO2Re, where Re is hydrogen, (C1-C6)-alkyl or (C3-C6)-cycloalkyl; specifically hydrogen or (C1-C6)-alkyl, and p is 1 or 2, preferably 1. Even more particularly, Z is a saturated or partly unsaturated five-membered heterocyclic ring containing one oxygen atom as ring member, where the ring is substituted by p radicals CO2Re, where Re is hydrogen or (C1-C6)-alkyl, and p is in this context preferably 1 or 2, more preferably 1. Specifically, Z is a saturated or partly unsaturated five-membered heterocyclic ring containing one oxygen atom as ring member, where the ring is substituted by one radical CO2Re, where Re is hydrogen or (C1-C6)-alkyl.


Examples for three-, four-, five- or six-membered saturated, partly unsaturated or fully unsaturated heterocyclic rings containing one or two oxygen atoms as ring members are oxiran-2-yl, oxetan-2-yl, oxetan-3-yl, tetrahydrofuran-2-yl, tetrahydrofuran-3-yl, 1,3-dioxolan-2-yl, 1,3-dioxolan-4-yl, tetrahydropyran-2-yl, tetrahydropyran-3-yl, tetrahydro-pyran-4-yl, 1,3-dioxan-2-yl, 1,3-dioxan-4-yl, 1,3-dioxan-5-yl, 1,4-dioxan-2-yl, 2,3-dihydrofuran-2-yl, 2,3-dihydrofuran-3-yl, 2,5-dihydrofuran-2-yl, 2,5-dihydrofuran-3-yl, 3,6-dihydro-2H-pyran-2-yl, 3,6-dihydro-2H-pyran-3-yl, 3,6-dihydro-2H-pyran-4-yl, 3,6-dihydro-2H-pyran-5-yl, 3,6-dihydro-2H-pyran-6-yl, 3,4-dihydro-2H-pyran-2-yl, 3,4-dihydro-2H-pyran-3-yl, 3,4-dihydro-2H-pyran-4-yl, 3,4-dihydro-2H-pyran-5-yl or 3,4-dihydro-2H-pyran-6-yl.


Examples for saturated or partly unsaturated five- or six-membered heterocyclic rings containing one oxygen atom as ring member are tetrahydrofuran-2-yl, tetrahydrofuran-3-yl, tetrahydropyran-2-yl, tetrahydropyran-3-yl, tetrahydropyran-4-yl, 2,3-dihydrofuran-2-yl, 2,3-dihydrofuran-3-yl, 2,5-dihydrofuran-2-yl, 2,5-dihydrofuran-3-yl, 3,6-dihydro-2H-pyran-2-yl, 3,6-dihydro-2H-pyran-3-yl, 3,6-dihydro-2H-pyran-4-yl, 3,6-dihydro-2H-pyran-5-yl, 3,6-dihydro-2H-pyran-6-yl, 3,4-dihydro-2H-pyran-2-yl, 3,4-dihydro-2H-pyran-3-yl, 3,4-dihydro-2H-pyran-4-yl, 3,4-dihydro-2H-pyran-5-yl or 3,4-dihydro-2H-pyran-6-yl.


Examples for saturated or partly unsaturated five-membered heterocyclic rings containing one oxygen atom as ring member are tetrahydrofuran-2-yl, tetrahydrofuran-3-yl, 2,3-dihydrofuran-2-yl, 2,3-dihydrofuran-3-yl, 2,5-dihydrofuran-2-yl, or 2,5-dihydrofuran-3-yl.


Preferably, however, ring Z is carbocyclic.


In another preferred embodiment, Y is (C1-C8)-alkyl which is substituted by p radicals selected from the group consisting of CO2Re, CONRbRh, S(O)nRa, SO2NRbRd, SO2NRbCORe, CORb, CONReS(O)Ra, CONReSO2Ra, CONRb1SO2NRb2Rb3, NRbRe, NRbCORe, NRbCONReRe, NRbCO2Re, NRbSO2Re, NRb1SO2NRb2Re, OCONRbRe, OCSNRbRe, PORfRf and C(Rb)═NORe. p is in this context preferably 1 or 2, more preferably 1.


More preferably, Y is (C1-C4)-alkyl which is substituted by p radicals selected from the group consisting of CO2Re, CONRbRh, CONReS(O)Ra, CONReSO2Ra and CONRb1SO2NRb2Rb3, where Ra, Rb, Rb1, Rb2, Rb3, Re and Rh are as defined above, where however in particular:

    • Re in CO2Re is hydrogen, (C1-C6)-alkyl which may carry a cyano substituent; (C3-C6)-cycloalkyl; (C2-C4)-alkynyl; or phenyl-(C1-C3)-alkyl; preferably hydrogen, (C1-C6)-alkyl, (C1-C2)-alkyl which carries a cyano group; benzyl, (C2-C4)-alkynyl or (C3-C6)-cycloalkyl; more preferably hydrogen, (C1-C6)-alkyl, (C1-C2)-alkyl which carries a cyano group; benzyl or (C2-C4)-alkynyl; specifically (C1-C6)-alkyl;
    • Rb in CONRbRh is hydrogen or (C1-C3)-alkyl;
    • Rh in CONRbRh is (C1-C3)-alkoxy;
    • Re in CONReS(O)Ra is hydrogen or (C1-C3)-alkyl;
    • Ra in CONReS(O)Ra is (C1-C6)-alkyl or (C1-C3)-haloalkyl;
    • Re in CONReSO2Ra is hydrogen or (C1-C3)-alkyl;
    • Ra in CONReSO2Ra is (C1-C6)-alkyl or (C1-C3)-haloalkyl;
    • Rb1 in CONRb1SO2NRb2Rb3 is hydrogen or (C1-C3)-alkyl;
    • Rb2 in CONRb1SO2NRb2Rb3 is hydrogen or (C1-C3)-alkyl;
    • Rb3 in CONRb1SO2NRb2Rb3 is (C1-C6)-alkyl; or
    • Rb2 and Rb3, together with the nitrogen atom they are bound to, form a saturated 5- or 6-membered N-bound heterocyclic ring; and
    • p is 1 or 2, preferably 1.


In a preferred embodiment, X is a bond and Y is Z, where Z has one of the above general or preferred meanings.


Preferably, Z is a three-, four-, five- or six-membered saturated, partly unsaturated or fully unsaturated carbocyclic ring, except phenyl, which is substituted by p radicals selected from the group consisting of CO2Re, CONRbRh, S(O)nRa, SO2NRbRd, SO2NRbCORe, CORb, CONReS(O)Ra, CONReSO2Ra, CONRb1SO2NRb2Rb3, NRbRe, NRbCORe, NRbCONReRe, NRbCO2Re, NRbSO2Re, NRb1SO2NRb2Re, OCONRbRe, OCSNRbRe, PORfRf and C(Rb)═NORe, and more preferably by p radicals selected from the group consisting of CO2Re, CONRbRh and CONReS(O)Ra; and where the carbon ring atoms bear n oxo groups. p is in this context preferably 1 or 2, more preferably 1. n is in this context preferably 0 or 1, in particular 0. More preferably, Z is a five- or six-membered saturated or partly unsaturated carbocyclic ring which is substituted by p radicals selected from the group consisting of CO2Re, CONRbRh and CONReS(O)Ra. In particular, Z is a five- or six-membered saturated or partly unsaturated carbocyclic ring which is substituted by p radicals CO2Re. Re is in this context preferably hydrogen, (C1-C6)-alkyl which may carry a cyano group; phenyl-(C1-C2)-alkyl or (C3-C6)-cycloalkyl; specifically hydrogen or (C1-C6)-alkyl, and p is in this context preferably 1 or 2, more preferably 1. Thus, more particularly, Z is a five- or six-membered saturated or partly unsaturated carbocyclic ring which is substituted by p radicals CO2Re, where Re is hydrogen, (C1-C6)-alkyl which may carry a cyano group; phenyl-(C1-C2)-alkyl or (C3-C6)-cycloalkyl; specifically hydrogen or (C1-C6)-alkyl, and p is 1 or 2, preferably 1. Even more particularly, Z is a five- or six-membered partly unsaturated carbocyclic ring which is substituted by p radicals CO2Re, where Re is hydrogen, (C1-C6)-alkyl which may carry a cyano group; phenyl-(C1-C2)-alkyl or (C3-C6)-cycloalkyl; specifically hydrogen or (C1-C6)-alkyl, and p is 1 or 2, preferably 1. Specifically, Z is a five-membered partly unsaturated carbocyclic ring which is substituted by p radicals CO2Re, where Re is hydrogen, (C1-C6)-alkyl, (C1-C2)-alkyl which carries a cyano group; phenyl-(C1-C2)-alkyl or (C3-C6)-cycloalkyl; specifically hydrogen or (C1-C6)-alkyl, very specifically (C1-C4)-alkyl, and p is 1 or 2, preferably 1.


In an alternatively preferred embodiment, Z is a three-, four-, five- or six-membered saturated, partly unsaturated or fully unsaturated heterocyclic ring containing one or two oxygen atoms as ring members, where the ring is substituted by p radicals selected from the group consisting of CO2Re, CONRbRh, S(O)nRa, SO2NRbRd, SO2NRbCORe, CORb, CONReS(O)Ra, CONReSO2Ra, CONRb1SO2NRb2Rb3, NRbRe, NRbCORe, NRb—CONReRe, NRbCO2Re, NRbSO2Re, NRb1SO2NRb2Re, OCONRbRe, OCSNRbRe, PORfRf and C(Rb)═NORe, and where the carbon ring atoms bear n oxo groups. p is in this context preferably 1 or 2, more preferably 1. n is in this context preferably 0 or 1, in particular 0.


More preferably, Z is a saturated or partly unsaturated five- or six-membered heterocyclic ring containing one oxygen atom as ring member, where the ring is substituted by p radicals CO2Re. Re is in this context preferably hydrogen, (C1-C6)-alkyl or (C3-C6)-cycloalkyl; specifically hydrogen or (C1-C6)-alkyl, and p is in this context preferably 1 or 2, more preferably 1. Thus, particularly, Z is a saturated or partly unsaturated five- or six-membered heterocyclic ring containing one oxygen atom as ring member, where the ring is substituted by p radicals CO2Re, where Re is hydrogen, (C1-C6)-alkyl or (C3-C6)-cycloalkyl; specifically hydrogen or (C1-C6)-alkyl, and p is 1 or 2, preferably 1. More particularly, Z is a saturated or partly unsaturated five-membered heterocyclic ring containing one oxygen atom as ring member, where the ring is substituted by p radicals CO2Re, where Re is hydrogen or (C1-C6)-alkyl and p is 1 or 2, preferably 1.


Preferably, however, ring Z is carbocyclic.


In another preferred embodiment,

    • X is a divalent unit (X1), where R10 and R11 are as defined above and are in particular independently hydrogen or (C1-C6)-alkyl; and
    • Y is (C1-C8)-alkyl which is substituted by p radicals selected from the group consisting of CO2Re, CONRbRh, S(O)nRa, SO2NRbRd, SO2NRbCORe, CORb, CONReS(O)Ra, CONReSO2Ra, CONRb1SO2NRb2Rb3, NRbRe, NRbCORe, NRbCONReRe, NRbCO2Re, NRbSO2Re, NRb1SO2NRb2Re, OCONRbRe, OCSNRbRe, PORfRf and C(Rb)═NORe.


In an alternative preferred embodiment,

    • X is a bond; and
    • Y is (C1-C8)-alkyl which is substituted by p radicals selected from the group consisting of CO2Re, CONRbRh, S(O)nRa, SO2NRbRd, SO2NRbCORe, CORb, CON—ReS(O)Ra, CONReSO2Ra, CONRb1SO2NRb2Rb3, NRbRe, NRbCORe, NRbCONReRe, NRbCO2Re, NRbSO2Re, NRb1SO2NRb2Re, OCONRbRe, OCSNRbRe, PORfRf and C(Rb)═NORe.


More preferably,

    • X is a divalent unit (X1), where R10 and R11 are independently hydrogen or methyl; where however preferably one of R10 and R11 is hydrogen and the other is methyl; and
    • Y is (C1-C4)-alkyl which is substituted by p radicals selected from the group consisting of CO2Re, CONRbRh, CONReS(O)Ra, CONReSO2Ra and CONRb1SO2NRb2Rb3, where Ra, Rb, Rb1, Rb2, Rb3, Re and Rh have one of the above general or preferred meanings.


In an alternative more preferred embodiment,

    • X is a bond; and
    • Y is (C1-C6)-alkyl (preferably (C2-C6)-alkyl) which is substituted by p radicals selected from the group consisting of CO2Re, CONRbRh, CONReS(O)Ra, CONReSO2Ra and CONRb1SO2NRb2Rb3, where Ra, Rb, Rbi, Rb2, Rb3, Re and Rh have one of the above general or preferred meanings.


In this latter alternative more preferred embodiment, (C1-C6)-alkyl in Y is preferably a group —C(R101)(R111)—C1-C4-alkyl which is substituted by p radicals selected from the group consisting of CO2Re, CONRbRh, CONReS(O)Ra, CONReSO2Ra and CONRb1SO2NRb2Rb3, where Ra, Rb, Rb1, Rb2, Rb3, Re and Rh have one of the above general or preferred meanings and R101 and R111 are independently hydrogen or methyl, where however preferably one of R101 and R111 is hydrogen and the other is methyl.


Even more preferably,

    • X is a divalent unit (X1), where R10 and R11 are independently hydrogen or methyl; where however preferably one of R10 and R11 is hydrogen and the other is methyl; and
    • Y is (C1-C4)-alkyl which is substituted by p radicals selected from the group consisting of CO2Re, CONRbRh, CONReS(O)Ra, CONReSO2Ra and CONRb1SO2NRb2Rb3, where
      • Re in CO2Re is hydrogen, (C1-C6)-alkyl which may carry a cyano substituent; (C3-C6)-cycloalkyl; (C2-C4)-alkynyl or phenyl-(C1-C3)-alkyl; preferably hydrogen, (C1-C6)-alkyl, (C1-C2)-alkyl which carries a cyano group; benzyl, (C2-C4)-alkynyl or (C3-C6)-cycloalkyl; more preferably hydrogen, (C1-C6)-alkyl, (C1-C2)-alkyl which carries a cyano group; benzyl or (C2-C4)-alkynyl; specifically (C1-C6)-alkyl;
      • Rb in CONRbRh is hydrogen or (C1-C3)-alkyl;
      • Rh in CONRbRh is (C1-C3)-alkoxy;
      • Re in CONReS(O)Ra is hydrogen or (C1-C3)-alkyl;
      • Ra in CONReS(O)Ra is (C1-C6)-alkyl or (C1-C3)-haloalkyl;
      • Re in CONReSO2Ra is hydrogen or (C1-C3)-alkyl;
      • Ra in CONReSO2Ra is (C1-C6)-alkyl or (C1-C3)-haloalkyl;
      • Rb1 in CONRb1SO2NRb2Rb3 is hydrogen or (C1-C3)-alkyl;
      • Rb2 in CONRb1SO2NRb2Rb3 is hydrogen or (C1-C3)-alkyl;
      • Rb3 in CONRb1SO2NRb2Rb3 is (C1-C6)-alkyl; or
      • Rb2 and Rb3, together with the nitrogen atom they are bound to, form a saturated 5- or 6-membered N-bound heterocyclic ring; and
      • p is 1 or 2, preferably 1.


In an alternative even more preferred embodiment,

    • X is a bond; and
    • Y is (C1-C6)-alkyl (preferably (C2-C6)-alkyl) which is substituted by p radicals selected from the group consisting of CO2Re, CONRbRh, CONReS(O)Ra, CONReSO2Ra and CONRb1SO2NRb2Rb3, where
      • Re in CO2Re is hydrogen, (C1-C6)-alkyl which may carry a cyano substituent; (C3-C6)-cycloalkyl; (C2-C4)-alkynyl or phenyl-(C1-C3)-alkyl; preferably hydrogen, (C1-C6)-alkyl, (C1-C2)-alkyl which carries a cyano group; benzyl, (C2-C4)-alkynyl or (C3-C6)-cycloalkyl; more preferably hydrogen, (C1-C6)-alkyl, (C1-C2)-alkyl which carries a cyano group; benzyl or (C2-C4)-alkynyl; specifically (C1-C6)-alkyl;
      • Rb in CONRbRh is hydrogen or (C1-C3)-alkyl;
      • Rh in CONRbRh is (C1-C3)-alkoxy;
      • Re in CONReS(O)Ra is hydrogen or (C1-C3)-alkyl;
      • Ra in CONReS(O)Ra is (C1-C6)-alkyl or (C1-C3)-haloalkyl;
      • Re in CONReSO2Ra is hydrogen or (C1-C3)-alkyl;
      • Ra in CONReSO2Ra is (C1-C6)-alkyl or (C1-C3)-haloalkyl;
      • Rb1 in CONRb1SO2NRb2Rb3 is hydrogen or (C1-C3)-alkyl;
      • Rb2 in CONRb1SO2NRb2Rb3 is hydrogen or (C1-C3)-alkyl;
      • Rb3 in CONRb1SO2NRb2Rb3 is (C1-C6)-alkyl; or
      • Rb2 and Rb3, together with the nitrogen atom they are bound to, form a saturated 5- or 6-membered N-bound heterocyclic ring; and
    • p is 1 or 2, preferably 1.


In this latter alternative even more preferred embodiment, (C1-C6)-alkyl in Y is preferably a group —C(R101)(R111)—C1-C4-alkyl which is substituted by p radicals selected from the group consisting of CO2Re, CONRbRh, CONReS(O)Ra, CONReSO2Ra and CONRb1SO2NRb2Rb3, where Ra, Rb, Rb1, Rb2, Rb3, Re and Rh have one of the above general or preferred meanings and R101 and R111 are independently hydrogen or methyl, where however preferably one of R101 and R111 is hydrogen and the other is methyl.


Specifically,

    • X is CH(CH3); and
    • Y is (C1-C4)-alkyl which is substituted by p radicals selected from the group consisting of CO2Re, CONRbRh, CONReS(O)Ra, CONReSO2Ra and CONRb1SO2NRb2Rb3, where
      • Re in CO2Re is hydrogen, (C1-C6)-alkyl, (C1-C2)-alkyl which carries a cyano group; benzyl or (C2-C4)-alkynyl; specifically (C1-C6)-alkyl;
      • Rb in CONRbRh is hydrogen or (C1-C3)-alkyl;
      • Rh in CONRbRh is (C1-C3)-alkoxy;
      • Re in CONReS(O)Ra is hydrogen or (C1-C3)-alkyl;
      • Ra in CONReS(O)Ra is (C1-C6)-alkyl or (C1-C3)-haloalkyl;
      • Re in CONReSO2Ra is hydrogen or (C1-C3)-alkyl;
      • Ra in CONReSO2Ra is (C1-C6)-alkyl or (C1-C3)-haloalkyl;
      • Rb1 in CONRb1SO2NRb2Rb3 is hydrogen or (C1-C3)-alkyl;
      • Rb2 in CONRb1SO2NRb2Rb3 is hydrogen or (C1-C3)-alkyl;
      • Rb3 in CONRb1SO2NRb2Rb3 is (C1-C6)-alkyl; or
      • Rb2 and Rb3, together with the nitrogen atom they are bound to, form a saturated 5- or 6-membered N-bound heterocyclic ring; and
      • p is 1 or 2, preferably 1.


In an alternative specific embodiment,

    • X is a bond; and
    • Y is CH(CH3)—(C1-C4)-alkyl which is substituted by p radicals selected from the group consisting of CO2Re, CONRbRh, CONReS(O)Ra, CONReSO2Ra and CONRb1SO2NRb2Rb3, where
      • Re in CO2Re is hydrogen, (C1-C6)-alkyl, (C1-C2)-alkyl which carries a cyano group; benzyl or (C2-C4)-alkynyl; specifically (C1-C6)-alkyl;
      • Rb in CONRbRh is hydrogen or (C1-C3)-alkyl;
      • Rh in CONRbRh is (C1-C3)-alkoxy;
      • Re in CONReS(O)Ra is hydrogen or (C1-C3)-alkyl;
      • Ra in CONReS(O)Ra is (C1-C6)-alkyl or (C1-C3)-haloalkyl;
      • Re in CONReSO2Ra is hydrogen or (C1-C3)-alkyl;
      • Ra in CONReSO2Ra is (C1-C6)-alkyl or (C1-C3)-haloalkyl;
      • Rb1 in CONRb1SO2NRb2Rb3 is hydrogen or (C1-C3)-alkyl;
      • Rb2 in CONRb1SO2NRb2Rb3 is hydrogen or (C1-C3)-alkyl;
      • Rb3 in CONRb1SO2NRb2Rb3 is (C1-C6)-alkyl; or
      • Rb2 and Rb3, together with the nitrogen atom they are bound to, form a saturated 5- or 6-membered N-bound heterocyclic ring; and
    • p is 1 or 2, preferably 1


More specifically,

    • X is CH(CH3); and
    • Y is (C1-C4)-alkyl which is substituted by p radicals selected from the group consisting of CO2Re, CONRbRh, CONReSO2Ra and CONRb1SO2NRb2Rb3, where
      • Re in CO2Re is hydrogen, (C1-C6)-alkyl, (C1-C2)-alkyl which carries a cyano group; benzyl or (C2-C4)-alkynyl; specifically (C1-C6)-alkyl;
      • Rb in CONRbRh is hydrogen;
      • Rh in CONRbRh is (C1-C3)-alkoxy;
      • Re in CONReS(O)Ra is hydrogen;
      • Ra in CONReS(O)Ra is (C1-C6)-alkyl;
      • Re in CONReSO2Ra is hydrogen;
      • Ra in CONReSO2Ra is (C1-C6)-alkyl or (C1-C3)-haloalkyl;
      • Rb1 in CONRb1SO2NRb2Rb3 is hydrogen or (C1-C3)-alkyl;
      • Rb2 in CONRb1SO2NRb2Rb3 is (C1-C3)-alkyl;
      • Rb3 in CONRb1SO2NRb2Rb3 is (C1-C6)-alkyl; or
      • Rb2 and Rb3, together with the nitrogen atom they are bound to, form a saturated 6-membered N-bound heterocyclic ring (=piperidin-1-yl); and
      • p is 1.


In an alternatively preferred embodiment, —X—Y form together a group of the formula (XY1) or (XY2)




embedded image




    • where

    • # designates the attachment point to NR8;

    • RA, RB, RC, RD, RE and RF, independently of each other, have one of the meanings given for R10 and R11; or

    • RA and RC, together with the carbon atoms they are bound to, form a 3-, 4-, 5- or 6-membered saturated or partially unsaturated carbocyclic ring; or

    • RC and RE, together with the carbon atoms they are bound to, form a 3-, 4-, 5- or 6-membered saturated or partially unsaturated carbocyclic ring; or

    • RA and RE, together with the carbon atoms they are bound to, form a 3-, 4-, 5- or 6-membered saturated or partially unsaturated carbocyclic ring.





Re in groups (XY1) and (XY2) is preferably hydrogen, (C1-C6)-alkyl which may carry a cyano substituent; (C3-C6)-cycloalkyl; (C2-C4)-alkynyl or phenyl-(C1-C3)-alkyl; in particular hydrogen, (C1-C6)-alkyl or (C3-C6)-cycloalkyl; more particularly hydrogen or (C1-C6)-alkyl; and specifically (C1-C6)-alkyl.


More preferably,

    • in group of the formula (XY1)
    • RA is hydrogen or methyl; and
    • RB, RC and RD are hydrogen; and
    • in group of the formula (XY2)
    • RA is hydrogen or methyl; and
    • RB, RC, RD, RE and RF are hydrogen; or
    • RA and RE, together with the carbon atoms they are bound to, form a 5- or 6-membered saturated or partly unsaturated carbocyclic ring; and form preferably a 5-membered partly unsaturated carbocyclic ring; and
    • RB, RC, RD and RF are hydrogen;
    • and
    • Re is hydrogen, (C1-C6)-alkyl which may carry a cyano substituent; (C3-C6)-cycloalkyl; (C2-C4)-alkynyl or phenyl-(C1-C3)-alkyl, preferably hydrogen, (C1-C6)-alkyl, (C1-C2)-alkyl which carries a CN substituent, benzyl, (C2-C4)-alkynyl or (C3-C6)-cycloalkyl; and is in particular (C1-C4)-alkyl.


Even more preferably, in XY1

    • RA is methyl; and
    • RB, RC and RD are hydrogen;
    • in XY2
    • RA is methyl; and
    • RB, RC, RD, RE and RF are hydrogen; or
    • in XY2
    • RA and RE, together with the carbon atoms they are bound to, form a 5-membered partly unsaturated carbocyclic ring; and
    • RB, RC, RD and RF are hydrogen;
    • and
    • Re is hydrogen, (C1-C6)-alkyl, (C1-C2)-alkyl which carries a CN substituent, benzyl, (C2-C4)-alkynyl or (C3-C6)-cycloalkyl; and is in particular (C1-C4)-alkyl.


In an alternatively preferred embodiment, —X—Y form together a group of the formula (XY1) or (XY2)




embedded image




    • where

    • # designates the attachment point to NR8;

    • RA and RC, together with the carbon atoms they are bound to, form a 3-, 4-, 5- or 6-membered saturated or partially unsaturated heterocyclic ring containing 1 or 2 oxygen atoms as ring members; or

    • RC and RE, together with the carbon atoms they are bound to, form a 3-, 4-, 5- or 6-membered saturated or partially unsaturated heterocyclic ring containing 1 or 2 oxygen atoms as ring members; or

    • RA and RE, together with the carbon atoms they are bound to, form a 3-, 4-, 5- or 6-membered saturated or partially unsaturated heterocyclic ring containing 1 or 2 oxygen atoms as ring members.





Re in this context is preferably hydrogen, (C1-C6)-alkyl which may carry a cyano substituent; (C3-C6)-cycloalkyl; (C2-C4)-alkynyl or phenyl-(C1-C3)-alkyl; in particular hydrogen, (C1-C6)-alkyl or (C3-C6)-cycloalkyl; more particularly hydrogen or (C1-C6)-alkyl and specifically (C1-C6)-alkyl.


More preferably,

    • RA and RE, together with the carbon atoms they are bound to, form a 5- or 6-membered saturated or partly unsaturated heterocyclic ring containing one oxygen atom as ring member; and form even more preferably a 5-membered saturated or partly unsaturated heterocyclic ring containing one oxygen atom as ring member; and
    • RB, RC, RD and RF are hydrogen;
      • and
    • Re is (C1-C4)-alkyl.


In a particular embodiment, in the compounds of formula (I), the substituents have the following meanings:

    • R1 is hydrogen;
    • R2 is hydrogen or halogen;
    • R3 is hydrogen, halogen, (C1-C3)-alkyl, (C1-C3)-haloalkyl, (C1-C3)-alkoxy or (C1-C3)-haloalkoxy;
    • R4 is hydrogen or halogen;
    • R5 is hydrogen, halogen, (C1-C3)-alkyl, (C1-C3)-haloalkyl, (C1-C3)-alkoxy or (C1-C3)-haloalkoxy;
    • R6 is hydrogen;
    • R7 is (C1-C6)-alkyl or (C3-C6)-cycloalkyl;
    • R8 is hydrogen;
    • X is a bond; and Y is Z; where Z is a five- or six-membered saturated or partly unsaturated carbocyclic ring which is substituted by p radicals CO2Re, where Re is hydrogen, (C1-C6)-alkyl, (C1-C6)-alkyl which carries a cyano group, phenyl-(C1-C2)-alkyl or (C3-C6)-cycloalkyl, preferably hydrogen or (C1-C6)-alkyl; or
    • X is a bond; and Y is Z; where Z is a five- or six-membered saturated or partly unsaturated heterocyclic ring containing one oxygen atom as ring member, where the ring is substituted by p radicals CO2Re, where Re is hydrogen, (C1-C6)-alkyl or (C3-C6)-cycloalkyl, preferably hydrogen or (C1-C6)-alkyl; or
    • X is a divalent unit (X1), where R10 and R11 are independently of each other hydrogen or (C1-C6)-alkyl; and Y is (C1-C4)-alkyl which is substituted by p radicals selected from the group consisting of CO2Re, CONRbRh, CONReS(O)Ra, CONRe—SO2Ra and CONRb1SO2NRb2Rb3, where
      • Re in CO2Re is hydrogen, (C1-C6)-alkyl which may carry a cyano substituent; (C3-C6)-cycloalkyl; (C2-C4)-alkynyl or phenyl-(C1-C3)-alkyl; preferably hydrogen, (C1-C6)-alkyl, (C1-C2)-alkyl which carries a cyano group, phenyl-(C1-C2)-alkyl or (C3-C6)-cycloalkyl; specifically (C1-C6)-alkyl;
      • Rb in CONRbRh is hydrogen or (C1-C3)-alkyl;
      • Rh in CONRbRh is (C1-C3)-alkoxy;
      • Re in CONReS(O)Ra is hydrogen or (C1-C3)-alkyl;
      • Ra in CONReS(O)Ra is (C1-C6)-alkyl or (C1-C3)-haloalkyl;
      • Re in CONReSO2Ra is hydrogen or (C1-C3)-alkyl;
      • Ra in CONReSO2Ra is (C1-C6)-alkyl or (C1-C3)-haloalkyl;
      • Rb1 in CONRb1SO2NRb2Rb3 is hydrogen or (C1-C3)-alkyl;
      • Rb2 in CONRb1SO2NRb2Rb3 is hydrogen or (C1-C3)-alkyl;
      • Rb3 in CONRb1SO2NRb2Rb3 is (C1-C6)-alkyl; or
      • Rb2 and Rb3, together with the nitrogen atom they are bound to, form a saturated 5- or 6-membered N-bound heterocyclic ring; and
    • p is 1 or 2, preferably 1.


In a more particular embodiment, in the compounds of formula (I), the substituents have the following meanings:

    • R1 is hydrogen;
    • R2 is hydrogen or halogen;
    • R3 is hydrogen, halogen, (C1-C3)-alkyl, (C1-C3)-haloalkyl, (C1-C3)-alkoxy or (C1-C3)-haloalkoxy;
    • R4 is hydrogen or halogen;
    • R5 is hydrogen, halogen, (C1-C3)-alkyl, (C1-C3)-haloalkyl, (C1-C3)-alkoxy or (C1-C3)-haloalkoxy;
    • R6 is hydrogen;
    • R7 is (C1-C6)-alkyl or (C3-C6)-cycloalkyl;
    • R8 is hydrogen;
    • X is a bond; and Y is Z; where Z is a five- or six-membered saturated or partly unsaturated carbocyclic ring (preferably a five-membered partly unsaturated carbocyclic ring) which is substituted by p radicals CO2Re, where Re is hydrogen, (C1-C6)-alkyl, (C1-C6)-alkyl which carries a cyano group, phenyl-(C1-C2)-alkyl or (C3-C6)-cycloalkyl; or
    • X is a divalent unit (X1), where R10 and R11 are independently of each other hydrogen or (C1-C6)-alkyl; and Y is (C1-C4)-alkyl which is substituted by p radicals selected from the group consisting of CO2Re, CONRbRh, CONReS(O)Ra, CONRe—SO2Ra and CONRb1SO2NRb2Rb3, where
      • Re in CO2Re is hydrogen, (C1-C6)-alkyl which may carry a cyano substituent;
      • (C3-C6)-cycloalkyl; (C2-C4)-alkynyl or phenyl-(C1-C3)-alkyl; preferably hydrogen, (C1-C6)-alkyl, (C1-C2)-alkyl which carries a cyano group, (C2-C4)-alkynyl, phenyl-(C1-C2)-alkyl or (C3-C6)-cycloalkyl; more preferably hydrogen, (C1-C6)-alkyl, (C1-C2)-alkyl which carries a cyano group, (C2-C4)-alkynyl or phenyl-(C1-C2)-alkyl; specifically (C1-C6)-alkyl;
      • Rb in CONRbRh is hydrogen or (C1-C3)-alkyl;
      • Rh in CONRbRh is (C1-C3)-alkoxy;
      • Re in CONReS(O)Ra is hydrogen or (C1-C3)-alkyl;
      • Ra in CONReS(O)Ra is (C1-C6)-alkyl or (C1-C3)-haloalkyl;
      • Re in CONReSO2Ra is hydrogen or (C1-C3)-alkyl;
      • Ra in CONReSO2Ra is (C1-C6)-alkyl or (C1-C3)-haloalkyl;
      • Rb1 in CONRb1SO2NRb2Rb3 is hydrogen or (C1-C3)-alkyl;
      • Rb2 in CONRb1SO2NRb2Rb3 is hydrogen or (C1-C3)-alkyl;
      • Rb3 in CONRb1SO2NRb2Rb3 is (C1-C6)-alkyl; or
      • Rb2 and Rb3, together with the nitrogen atom they are bound to, form a saturated 5- or 6-membered N-bound heterocyclic ring; and
    • p is 1 or 2, preferably 1.


In an even more particular embodiment, in the compounds of formula (I), the substituents have the following meanings:

    • R1 is hydrogen;
    • R2 is hydrogen or halogen;
    • R3 is hydrogen, halogen, (C1-C3)-alkyl, (C1-C3)-haloalkyl, (C1-C3)-alkoxy or (C1-C3)-haloalkoxy;
    • R4 is hydrogen or halogen;
    • R5 is hydrogen or halogen;
    • R6 is hydrogen;
    • R7 is (C1-C6)-alkyl or (C3-C6)-cycloalkyl;
    • R8 is hydrogen;
    • X is a bond; and Y is Z; where Z is a five- or six-membered saturated or partly unsaturated carbocyclic ring (preferably a five-membered partly unsaturated carbocyclic ring) which is substituted by p radicals CO2Re, where Re is hydrogen (C1-C6)-alkyl, (C1-C6)-alkyl which carries a cyano group, phenyl-(C1-C2)-alkyl or (C3-C6)-cycloalkyl; or
    • X is a divalent unit (X1), where R10 and R11 are independently of each other hydrogen or (C1-C6)-alkyl; and Y is (C1-C4)-alkyl which is substituted by p radicals selected from the group consisting of CO2Re, CONRbRh, CONReS(O)Ra, CONRe—SO2Ra and CONRb1SO2NRb2Rb3, where
      • Re in CO2Re is hydrogen, (C1-C6)-alkyl which may carry a cyano substituent;
      • (C3-C6)-cycloalkyl; (C2-C4)-alkynyl or phenyl-(C1-C3)-alkyl; preferably hydrogen, (C1-C6)-alkyl, (C1-C2)-alkyl which carries a cyano group, (C2-C4)-alkynyl, phenyl-(C1-C2)-alkyl or (C3-C6)-cycloalkyl; more preferably hydrogen, (C1-C6)-alkyl, (C1-C2)-alkyl which carries a cyano group, (C2-C4)-alkynyl or phenyl-(C1-C2)-alkyl; specifically (C1-C6)-alkyl;
      • Rb in CONRbRh is hydrogen or (C1-C3)-alkyl;
      • Rh in CONRbRh is (C1-C3)-alkoxy;
      • Re in CONReS(O)Ra is hydrogen or (C1-C3)-alkyl;
      • Ra in CONReS(O)Ra is (C1-C6)-alkyl or (C1-C3)-haloalkyl;
      • Re in CONReSO2Ra is hydrogen or (C1-C3)-alkyl;
      • Ra in CONReSO2Ra is (C1-C6)-alkyl or (C1-C3)-haloalkyl;
      • Rb1 in CONRb1SO2NRb2Rb3 is hydrogen or (C1-C3)-alkyl;
      • Rb2 in CONRb1SO2NRb2Rb3 is hydrogen or (C1-C3)-alkyl;
      • Rb3 in CONRb1SO2NRb2Rb3 is (C1-C6)-alkyl; or
      • Rb2 and Rb3, together with the nitrogen atom they are bound to, form a saturated 5- or 6-membered N-bound heterocyclic ring; and
    • p is 1 or 2, preferably 1.


In a specific embodiment, in the compounds of formula (I), the substituents have the following meanings:

    • R1 is hydrogen;
    • R2 is hydrogen or halogen;
    • R3 is hydrogen, halogen, (C1-C3)-alkyl, (C1-C3)-haloalkyl, (C1-C3)-alkoxy or (C1-C3)-haloalkoxy;
    • R4 is hydrogen or halogen;
    • R5 is hydrogen or halogen;
    • R6 is hydrogen;
    • R7 is (C1-C6)-alkyl or (C3-C6)-cycloalkyl;
    • R8 is hydrogen;
    • X is a bond; and Y is Z; where Z is a five- or six-membered saturated or partly unsaturated carbocyclic ring (preferably a five-membered partly unsaturated carbocyclic ring) which is substituted by p radicals CO2Re, where Re is hydrogen, (C1-C6)-alkyl, (C1-C6)-alkyl which carries a cyano group, phenyl-(C1-C2)-alkyl or (C3-C6)-cycloalkyl; specifically hydrogen or (C1-C6)-alkyl; or
    • X is a divalent unit (X1), where R10 and R11 are independently of each other hydrogen or (C1-C6)-alkyl; and Y is (C1-C4)-alkyl which is substituted by p radicals selected from the group consisting of CO2Re, CONRbRh, CONReS(O)Ra, CONReSO2Ra and CONRb1SO2NRb2Rb3, where
      • Re in CO2Re is hydrogen, (C1-C6)-alkyl which may carry a cyano substituent; (C3-C6)-cycloalkyl; (C2-C4)-alkynyl or phenyl-(C1-C3)-alkyl; preferably hydrogen, (C1-C6)-alkyl, (C1-C2)-alkyl which carries a cyano group, (C2-C4)-alkynyl, phenyl-(C1-C2)-alkyl or (C3-C6)-cycloalkyl; more preferably hydrogen, (C1-C6)-alkyl, (C1-C2)-alkyl which carries a cyano group, (C2-C4)-alkynyl or phenyl-(C1-C2)-alkyl; specifically (C1-C6)-alkyl;
      • Rb in CONRbRh is hydrogen or (C1-C3)-alkyl;
      • Rh in CONRbRh is (C1-C3)-alkoxy;
      • Re in CONReS(O)Ra is hydrogen or (C1-C3)-alkyl;
      • Ra in CONReS(O)Ra is (C1-C6)-alkyl or (C1-C3)-haloalkyl;
      • Re in CONReSO2Ra is hydrogen or (C1-C3)-alkyl;
      • Ra in CONReSO2Ra is (C1-C6)-alkyl or (C1-C3)-haloalkyl;
      • Rb1 in CONRb1SO2NRb2Rb3 is hydrogen or (C1-C3)-alkyl;
      • Rb2 in CONRb1SO2NRb2Rb3 is hydrogen or (C1-C3)-alkyl;
      • Rb3 in CONRb1SO2NRb2Rb3 is (C1-C6)-alkyl; or
      • Rb2 and Rb3, together with the nitrogen atom they are bound to, form a saturated 5- or 6-membered N-bound heterocyclic ring; and
    • p is 1 or 2, preferably 1.


In a more specific embodiment, in the compounds of formula (I), the substituents have the following meanings:

    • R1 is hydrogen;
    • R2 is hydrogen or halogen;
    • R3 is hydrogen, halogen, (C1-C3)-alkyl, (C1-C3)-haloalkyl, (C1-C3)-alkoxy or (C1-C3)-haloalkoxy;
    • R4 is hydrogen or halogen;
    • R5 is hydrogen or halogen;
    • R6 is hydrogen;
    • R7 is (C1-C6)-alkyl or (C3-C6)-cycloalkyl;
    • R8 is hydrogen;
    • X is a bond; and Y is Z; where Z is a five-membered partly unsaturated carbocyclic ring which is substituted by p radicals CO2Re, where Re is hydrogen, (C1-C6)-alkyl, (C1-C2)-alkyl which carries a cyano group, phenyl-(C1-C2)-alkyl or (C3-C6)-cycloalkyl; or
    • X is a divalent unit (X1), where one of R10 and R11 is hydrogen and the other is methyl; and Y is (C1-C4)-alkyl which is substituted by p radicals selected from the group consisting of CO2Re, CONRbRh, CONReS(O)Ra, CONReSO2Ra and CONRb1SO2NRb2Rb3, where
      • Re in CO2Re is hydrogen, (C1-C6)-alkyl which may carry a cyano substituent; (C2-C4)-alkynyl or phenyl-(C1-C3)-alkyl; preferably hydrogen, (C1-C6)-alkyl, (C1-C2)-alkyl which carries a cyano group, (C2-C4)-alkynyl or phenyl-(C1-C2)-alkyl; specifically (C1-C6)-alkyl;
      • Rb in CONRbRh is hydrogen or (C1-C3)-alkyl;
      • Rh in CONRbRh is (C1-C3)-alkoxy;
      • Re in CONReS(O)Ra is hydrogen or (C1-C3)-alkyl;
      • Ra in CONReS(O)Ra is (C1-C6)-alkyl or (C1-C3)-haloalkyl;
      • Re in CONReSO2Ra is hydrogen or (C1-C3)-alkyl;
      • Ra in CONReSO2Ra is (C1-C6)-alkyl or (C1-C3)-haloalkyl;
      • Rb1 in CONRb1SO2NRb2Rb3 is hydrogen or (C1-C3)-alkyl;
      • Rb2 in CONRb1SO2NRb2Rb3 is hydrogen or (C1-C3)-alkyl;
      • Rb3 in CONRb1SO2NRb2Rb3 is (C1-C6)-alkyl; or
      • Rb2 and Rb3, together with the nitrogen atom they are bound to, form a saturated 5- or 6-membered N-bound heterocyclic ring; and
    • p is 1.


In a very specific embodiment,

    • R1 is hydrogen;
    • R2 is hydrogen;
    • R3 is hydrogen, halogen, (C1-C3)-alkyl, (C1-C3)-haloalkyl, (C1-C3)-alkoxy or (C1-C3)-haloalkoxy;
    • R4 is hydrogen or halogen;
    • R5 is hydrogen or halogen;
    • R6 is hydrogen;
    • R7 is (C1-C4)-alkyl or (C3-C4)-cycloalkyl;
    • R8 hydrogen; and
    • X is a bond; and Y is Z; where Z is a five-membered partly unsaturated carbocyclic ring which is substituted by p radicals CO2Re, where Re is hydrogen, (C1-C6)-alkyl, (C1-C2)-alkyl which carries a cyano group, benzyl or (C3-C6)-cycloalkyl; or
    • X is a divalent unit (X1), where R10 is hydrogen and R11 is methyl; and Y is (C1-C4)-alkyl which is substituted by p radicals selected from the group consisting of CO2Re, CONRbRh, CONReSO2Ra and CONRb1SO2NRb2Rb3, where
      • Re in CO2Re is hydrogen, (C1-C6)-alkyl, (C1-C2)-alkyl which carries a cyano group, benzyl or (C2-C4)-alkynyl; and is specifically (C1-C6)-alkyl;
      • Rb in CONRbRh is hydrogen;
      • Rh in CONRbRh is (C1-C3)-alkoxy;
      • Re in CONReSO2Ra is hydrogen;
      • Ra in CONReSO2Ra is (C1-C6)-alkyl;
      • Rb1 in CONRb1SO2NRb2Rb3 is hydrogen;
      • Rb2 in CONRb1SO2NRb2Rb3 is hydrogen or (C1-C3)-alkyl;
      • Rb3 in CONRb1SO2NRb2Rb3 is (C1-C6)-alkyl; or
      • Rb2 and Rb3, together with the nitrogen atom they are bound to, form a saturated 6-membered N-bound heterocyclic ring; and
    • p is 1.


In an alternative particular embodiment, in the compounds of formula (I), the substituents have the following meanings:

    • R1 is hydrogen;
    • R2 is hydrogen or halogen;
    • R3 is hydrogen, halogen, (C1-C3)-alkyl, (C1-C3)-haloalkyl, (C1-C3)-alkoxy or (C1-C3)-haloalkoxy;
    • R4 is hydrogen or halogen;
    • R5 is hydrogen, halogen, (C1-C3)-alkyl, (C1-C3)-haloalkyl, (C1-C3)-alkoxy or (C1-C3)-haloalkoxy;
    • R6 is hydrogen;
    • R7 is (C1-C6)-alkyl or (C3-C6)-cycloalkyl;
    • R8 is hydrogen;
    • X is a bond;
    • Y is Z; where Z is a five- or six-membered saturated or partly unsaturated carbocyclic ring which is substituted by p radicals CO2Re, where Re is hydrogen, (C1-C6)-alkyl, (C1-C6)-alkyl which carries a cyano group, phenyl-(C1-C2)-alkyl or (C3-C6)-cycloalkyl, preferably hydrogen or (C1-C6)-alkyl; or
      • Z is a five- or six-membered saturated or partly unsaturated heterocyclic ring containing one oxygen atom as ring member, where the ring is substituted by p radicals CO2Re, where Re is hydrogen, (C1-C6)-alkyl or (C3-C6)-cycloalkyl, preferably hydrogen or (C1-C6)-alkyl; or
      • Y is (C1-C6)-alkyl which is substituted by p radicals selected from the group consisting of CO2Re, CONRbRh, CONReS(O)Ra, CONReSO2Ra and CONRb1SO2NRb2Rb3, where
      • Re in CO2Re is hydrogen, (C1-C6)-alkyl which may carry a cyano substituent;
      • (C3-C6)-cycloalkyl; (C2-C4)-alkynyl or phenyl-(C1-C3)-alkyl; preferably hydrogen, (C1-C6)-alkyl, (C1-C2)-alkyl which carries a cyano group, (C2-C4)-alkynyl, phenyl-(C1-C2)-alkyl or (C3-C6)-cycloalkyl; more preferably hydrogen, (C1-C6)-alkyl, (C1-C2)-alkyl which carries a cyano group, (C2-C4)-alkynyl or phenyl-(C1-C2)-alkyl; specifically (C1-C6)-alkyl;
      • Rb in CONRbRh is hydrogen or (C1-C3)-alkyl;
      • Rh in CONRbRh is (C1-C3)-alkoxy;
      • Re in CONReS(O)Ra is hydrogen or (C1-C3)-alkyl;
      • Ra in CONReS(O)Ra is (C1-C6)-alkyl or (C1-C3)-haloalkyl;
      • Re in CONReSO2Ra is hydrogen or (C1-C3)-alkyl;
      • Ra in CONReSO2Ra is (C1-C6)-alkyl or (C1-C3)-haloalkyl;
      • Rb1 in CONRb1SO2NRb2Rb3 is hydrogen or (C1-C3)-alkyl;
      • Rb2 in CONRb1SO2NRb2Rb3 is hydrogen or (C1-C3)-alkyl;
      • Rb3 in CONRb1SO2NRb2Rb3 is (C1-C6)-alkyl; or
      • Rb2 and Rb3, together with the nitrogen atom they are bound to, form a saturated 5- or 6-membered N-bound heterocyclic ring; and
    • p is 1 or 2, preferably 1.


In an alternative more particular embodiment, in the compounds of formula (I), the substituents have the following meanings:

    • R1 is hydrogen;
    • R2 is hydrogen or halogen;
    • R3 is hydrogen, halogen, (C1-C3)-alkyl, (C1-C3)-haloalkyl, (C1-C3)-alkoxy or (C1-C3)-haloalkoxy;
    • R4 is hydrogen or halogen;
    • R5 is hydrogen, halogen, (C1-C3)-alkyl, (C1-C3)-haloalkyl, (C1-C3)-alkoxy or (C1-C3)-haloalkoxy;
    • R6 is hydrogen;
    • R7 is (C1-C6)-alkyl or (C3-C6)-cycloalkyl;
    • R8 is hydrogen;
    • X is a bond;
    • Y is Z; where Z is a five- or six-membered saturated or partly unsaturated carbocyclic ring (preferably a five-membered partly unsaturated carbocyclic ring) which is substituted by p radicals CO2Re, where Re is hydrogen, (C1-C6)-alkyl, (C1-C6)-alkyl which carries a cyano group, phenyl-(C1-C2)-alkyl or (C3-C6)-cycloalkyl; or
      • Y is (C1-C6)-alkyl which is substituted by p radicals selected from the group consisting of CO2Re, CONRbRh, CONReS(O)Ra, CONReSO2Ra and CONRb1SO2NRb2Rb3, where
      • Re in CO2Re is hydrogen, (C1-C6)-alkyl which may carry a cyano substituent; (C3-C6)-cycloalkyl; (C2-C4)-alkynyl or phenyl-(C1-C3)-alkyl; preferably hydrogen, (C1-C6)-alkyl, (C1-C2)-alkyl which carries a cyano group, (C2-C4)-alkynyl, phenyl-(C1-C2)-alkyl or (C3-C6)-cycloalkyl; more preferably hydrogen, (C1-C6)-alkyl, (C1-C2)-alkyl which carries a cyano group, (C2-C4)-alkynyl or phenyl-(C1-C2)-alkyl; specifically (C1-C6)-alkyl;
      • Rb in CONRbRh is hydrogen or (C1-C3)-alkyl;
      • Rh in CONRbRh is (C1-C3)-alkoxy;
      • Re in CONReS(O)Ra is hydrogen or (C1-C3)-alkyl;
      • Ra in CONReS(O)Ra is (C1-C6)-alkyl or (C1-C3)-haloalkyl;
      • Re in CONReSO2Ra is hydrogen or (C1-C3)-alkyl;
      • Ra in CONReSO2Ra is (C1-C6)-alkyl or (C1-C3)-haloalkyl;
      • Rb1 in CONRb1SO2NRb2Rb3 is hydrogen or (C1-C3)-alkyl;
      • Rb2 in CONRb1SO2NRb2Rb3 is hydrogen or (C1-C3)-alkyl;
      • Rb3 in CONRb1SO2NRb2Rb3 is (C1-C6)-alkyl; or
      • Rb2 and Rb3, together with the nitrogen atom they are bound to, form a saturated 5- or 6-membered N-bound heterocyclic ring; and
    • p is 1 or 2, preferably 1.


In an alternative even more particular embodiment, in the compounds of formula (I), the substituents have the following meanings:

    • R1 is hydrogen;
    • R2 is hydrogen or halogen;
    • R3 is hydrogen, halogen, (C1-C3)-alkyl, (C1-C3)-haloalkyl, (C1-C3)-alkoxy or (C1-C3)-haloalkoxy;
    • R4 is hydrogen or halogen;
    • R5 is hydrogen or halogen;
    • R6 is hydrogen;
    • R7 is (C1-C6)-alkyl or (C3-C6)-cycloalkyl;
    • R8 is hydrogen;
    • X is a bond;
    • Y is Z; where Z is a five- or six-membered saturated or partly unsaturated carbocyclic ring (preferably a five-membered partly unsaturated carbocyclic ring) which is substituted by p radicals CO2Re, where Re is hydrogen, (C1-C6)-alkyl, (C1-C6)-alkyl which carries a cyano group, phenyl-(C1-C2)-alkyl or (C3-C6)-cycloalkyl; or
      • Y is (C1-C6)-alkyl which is substituted by p radicals selected from the group consisting of CO2Re, CONRbRh, CONReS(O)Ra, CONReSO2Ra and CONRb1SO2NRb2Rb3, where
      • Re in CO2Re is hydrogen, (C1-C6)-alkyl which may carry a cyano substituent; (C3-C6)-cycloalkyl; (C2-C4)-alkynyl or phenyl-(C1-C3)-alkyl; preferably hydrogen, (C1-C6)-alkyl, (C1-C2)-alkyl which carries a cyano group, (C2-C4)-alkynyl, phenyl-(C1-C2)-alkyl or (C3-C6)-cycloalkyl; more preferably hydrogen, (C1-C6)-alkyl, (C1-C2)-alkyl which carries a cyano group, (C2-C4)-alkynyl or phenyl-(C1-C2)-alkyl; specifically (C1-C6)-alkyl;
      • Rb in CONRbRh is hydrogen or (C1-C3)-alkyl;
      • Rh in CONRbRh is (C1-C3)-alkoxy;
      • Re in CONReS(O)Ra is hydrogen or (C1-C3)-alkyl;
      • Ra in CONReS(O)Ra is (C1-C6)-alkyl or (C1-C3)-haloalkyl;
      • Re in CONReSO2Ra is hydrogen or (C1-C3)-alkyl;
      • Ra in CONReSO2Ra is (C1-C6)-alkyl or (C1-C3)-haloalkyl;
      • Rb1 in CONRb1SO2NRb2Rb3 is hydrogen or (C1-C3)-alkyl;
      • Rb2 in CONRb1SO2NRb2Rb3 is hydrogen or (C1-C3)-alkyl;
      • Rb3 in CONRb1SO2NRb2Rb3 is (C1-C6)-alkyl; or
      • Rb2 and Rb3, together with the nitrogen atom they are bound to, form a saturated 5- or 6-membered N-bound heterocyclic ring; and
    • p is 1 or 2, preferably 1.


In an alternative specific embodiment, in the compounds of formula (I), the substituents have the following meanings:

    • R1 is hydrogen;
    • R2 is hydrogen or halogen;
    • R3 is hydrogen, halogen, (C1-C3)-alkyl, (C1-C3)-haloalkyl, (C1-C3)-alkoxy or (C1-C3)-haloalkoxy;
    • R4 is hydrogen or halogen;
    • R5 is hydrogen or halogen;
    • R6 is hydrogen;
    • R7 is (C1-C6)-alkyl or (C3-C6)-cycloalkyl;
    • R8 is hydrogen;
    • X is a bond;
    • Y is Z; where Z is a five- or six-membered saturated or partly unsaturated carbocyclic ring (preferably a five-membered partly unsaturated carbocyclic ring) which is substituted by p radicals CO2Re, where Re is hydrogen, (C1-C6)-alkyl, (C1-C6)-alkyl which carries a cyano group, phenyl-(C1-C2)-alkyl or (C3-C6)-cycloalkyl; specifically hydrogen or (C1-C6)-alkyl; or
      • Y is (C1-C6)-alkyl which is substituted by p radicals selected from the group consisting of CO2Re, CONRbRh, CONReS(O)Ra, CONReSO2Ra and CONRb1SO2NRb2Rb3, where
      • Re in CO2Re is hydrogen, (C1-C6)-alkyl which may carry a cyano substituent; (C3-C6)-cycloalkyl; (C2-C4)-alkynyl or phenyl-(C1-C3)-alkyl; preferably hydrogen, (C1-C6)-alkyl, (C1-C2)-alkyl which carries a cyano group, (C2-C4)-alkynyl, phenyl-(C1-C2)-alkyl or (C3-C6)-cycloalkyl; more preferably hydrogen, (C1-C6)-alkyl, (C1-C2)-alkyl which carries a cyano group, (C2-C4)-alkynyl or phenyl-(C1-C2)-alkyl; specifically (C1-C6)-alkyl;
      • Rb in CONRbRh is hydrogen or (C1-C3)-alkyl;
      • Rh in CONRbRh is (C1-C3)-alkoxy;
      • Re in CONReS(O)Ra is hydrogen or (C1-C3)-alkyl;
      • Ra in CONReS(O)Ra is (C1-C6)-alkyl or (C1-C3)-haloalkyl;
      • Re in CONReSO2Ra is hydrogen or (C1-C3)-alkyl;
      • Ra in CONReSO2Ra is (C1-C6)-alkyl or (C1-C3)-haloalkyl;
      • Rb1 in CONRb1SO2NRb2Rb3 is hydrogen or (C1-C3)-alkyl;
      • Rb2 in CONRb1SO2NRb2Rb3 is hydrogen or (C1-C3)-alkyl;
      • Rb3 in CONRb1SO2NRb2Rb3 is (C1-C6)-alkyl; or
      • Rb2 and Rb3, together with the nitrogen atom they are bound to, form a saturated 5- or 6-membered N-bound heterocyclic ring; and
    • p is 1 or 2, preferably 1.


In a more specific embodiment, in the compounds of formula (I), the substituents have the following meanings:

    • R1 is hydrogen;
    • R2 is hydrogen or halogen;
    • R3 is hydrogen, halogen, (C1-C3)-alkyl, (C1-C3)-haloalkyl, (C1-C3)-alkoxy or (C1-C3)-haloalkoxy;
    • R4 is hydrogen or halogen;
    • R5 is hydrogen or halogen;
    • R6 is hydrogen;
    • R7 is (C1-C6)-alkyl or (C3-C6)-cycloalkyl;
    • R8 is hydrogen;
    • X is a bond; and Y is Z; where Z is a five-membered partly unsaturated carbocyclic ring which is substituted by p radicals CO2Re, where Re is hydrogen, (C1-C6)-alkyl, (C1-C6)-alkyl which carries a cyano group, phenyl-(C1-C2)-alkyl or (C3-C6)-cycloalkyl; or
      • Y is (C1-C6)-alkyl which is substituted by p radicals selected from the group consisting of CO2Re, CONRbRh, CONReS(O)Ra, CONReSO2Ra and CONRb1SO2NRb2Rb3, where
      • Re in CO2Re is hydrogen, (C1-C6)-alkyl which may carry a cyano substituent;
      • (C2-C4)-alkynyl or phenyl-(C1-C3)-alkyl; preferably hydrogen, (C1-C6)-alkyl, (C1-C2)-alkyl which carries a cyano group, (C2-C4)-alkynyl or phenyl-(C1-C2)-alkyl; specifically (C1-C6)-alkyl;
      • Rb in CONRbRh is hydrogen or (C1-C3)-alkyl;
      • Rh in CONRbRh is (C1-C3)-alkoxy;
      • Re in CONReS(O)Ra is hydrogen or (C1-C3)-alkyl;
      • Ra in CONReS(O)Ra is (C1-C6)-alkyl or (C1-C3)-haloalkyl;
      • Re in CONReSO2Ra is hydrogen or (C1-C3)-alkyl;
      • Ra in CONReSO2Ra is (C1-C6)-alkyl or (C1-C3)-haloalkyl;
      • Rb1 in CONRb1SO2NRb2Rb3 is hydrogen or (C1-C3)-alkyl;
      • Rb2 in CONRb1SO2NRb2Rb3 is hydrogen or (C1-C3)-alkyl;
      • Rb3 in CONRb1SO2NRb2Rb3 is (C1-C6)-alkyl; or
      • Rb2 and Rb3, together with the nitrogen atom they are bound to, form a saturated 5- or 6-membered N-bound heterocyclic ring; and
    • p is 1.


In a very specific embodiment,

    • R1 is hydrogen;
    • R2 is hydrogen;
    • R3 is hydrogen, halogen, (C1-C3)-alkyl, (C1-C3)-haloalkyl, (C1-C3)-alkoxy or (C1-C3)-haloalkoxy;
    • R4 is hydrogen or halogen;
    • R5 is hydrogen or halogen;
    • R6 is hydrogen;
    • R7 is (C1-C4)-alkyl or (C3-C4)-cycloalkyl;
    • R8 hydrogen; and
    • X is a bond; and Y is Z; where Z is a five-membered partly unsaturated carbocyclic ring which is substituted by p radicals CO2Re, where Re is hydrogen, (C1-C6)-alkyl, (C1-C2)-alkyl which carries a cyano group, benzyl or (C3-C6)-cycloalkyl; or
      • Y is (C1-C6)-alkyl which is substituted by p radicals selected from the group consisting of CO2Re, CONRbRh, CONReSO2Ra and CONRb1SO2NRb2Rb3, where
      • Re in CO2Re is hydrogen, (C1-C6)-alkyl, (C1-C2)-alkyl which carries a cyano group, benzyl or (C2-C4)-alkynyl; and is specifically (C1-C6)-alkyl;
      • Rb in CONRbRh is hydrogen;
      • Rh in CONRbRh is (C1-C3)-alkoxy;
      • Re in CONReSO2Ra is hydrogen;
      • Ra in CONReSO2Ra is (C1-C6)-alkyl;
      • Rb1 in CONRb1SO2NRb2Rb3 is hydrogen;
      • Rb2 in CONRb1SO2NRb2Rb3 is hydrogen or (C1-C3)-alkyl;
      • Rb3 in CONRb1SO2NRb2Rb3 is (C1-C6)-alkyl; or
      • Rb2 and Rb3, together with the nitrogen atom they are bound to, form a saturated 6-membered N-bound heterocyclic ring; and
    • p is 1.


In the above particular and specific embodiments, the five-membered partly unsaturated carbocyclic ring Z is preferably a ring Z9 (depicted below), wherein # denotes the attachment point to the remainder of the molecule and Rx is CO2Re.


In another particular embodiment, in the compounds of formula (I), the substituents have the following meanings:

    • R1 is hydrogen;
    • R2 is hydrogen or halogen;
    • R3 is hydrogen, halogen, (C1-C3)-alkyl, (C1-C3)-haloalkyl, (C1-C3)-alkoxy or (C1-C3)-haloalkoxy;
    • R4 is hydrogen or halogen;
    • R5 is hydrogen, halogen, (C1-C3)-alkyl, (C1-C3)-haloalkyl, (C1-C3)-alkoxy or (C1-C3)-haloalkoxy; preferably hydrogen or halogen;
    • R6 is hydrogen;
    • R7 is (C1-C6)-alkyl or (C3-C6)-cycloalkyl;
    • R8 is hydrogen; and
    • —X—Y form together a group of the formula (XY1) or (XY2)




embedded image




    • where

    • # designates the attachment point to NR8;

    • RA, RB, RC, RD, RE and RF, independently of each other, have one of the meanings given for R10 and R11; or

    • RA and RC, together with the carbon atoms they are bound to, form a 3-, 4-, 5- or 6-membered saturated or partially unsaturated carbocyclic ring; or

    • RC and RE, together with the carbon atoms they are bound to, form a 3-, 4-, 5- or 6-membered saturated or partially unsaturated carbocyclic ring; or

    • RA and RE, together with the carbon atoms they are bound to, form a 3-, 4-, 5- or 6-membered saturated or partially unsaturated carbocyclic ring.





Re in this context is preferably hydrogen, (C1-C6)-alkyl which may carry a cyano substituent; (C3-C6)-cycloalkyl; (C2-C4)-alkynyl or phenyl-(C1-C3)-alkyl; in particular hydrogen, (C1-C6)-alkyl, (C1-C2)-alkyl which carries a cyano substituent; (C3-C6)-cycloalkyl; (C2-C4)-alkynyl or phenyl-(C1-C2)-alkyl; in particular hydrogen, (C1-C6)-alkyl, (C1-C2)-alkyl which carries a cyano substituent; (C3-C6)-cycloalkyl; (C2-C4)-alkynyl or benzyl; more particularly hydrogen or (C1-C6)-alkyl and specifically (C1-C6)-alkyl.


Preferably,

    • in XY1
    • RA is hydrogen or methyl; and
    • RB, RC and RD are hydrogen; or
    • in XY2
    • RA is hydrogen or methyl; and
    • RB, RC, RD, RE and RF are hydrogen; or
    • in XY2
    • RA and RE, together with the carbon atoms they are bound to, form a 5- or 6-membered saturated or partly unsaturated carbocyclic ring; and form preferably a 5-membered partly unsaturated carbocyclic ring; and
    • RB, RC, RD and RF are hydrogen;
    • and
    • Re is hydrogen, (C1-C6)-alkyl, (C1-C2)-alkyl which carries a CN substituent, phenyl-(C1-C2)-alkyl (e.g.)benzyl′), (C2-C4)-alkynyl or (C3-C6)-cycloalkyl; and is in particular hydrogen or (C1-C6)-alkyl and is specifically (C1-C4)-alkyl.


In another particular embodiment, in the compounds of formula (I), the substituents have the following meanings:

    • R1 is hydrogen;
    • R2 is hydrogen or halogen;
    • R3 is hydrogen, halogen, (C1-C3)-alkyl, (C1-C3)-haloalkyl, (C1-C3)-alkoxy or (C1-C3)-haloalkoxy;
    • R4 is hydrogen or halogen;
    • R5 is hydrogen, halogen, (C1-C3)-alkyl, (C1-C3)-haloalkyl, (C1-C3)-alkoxy or (C1-C3)-haloalkoxy;
    • R6 is hydrogen;
    • R7 is (C1-C6)-alkyl or (C3-C6)-cycloalkyl;
    • R8 is hydrogen; and
    • —X—Y form together a group of the formula (XY1) or (XY2)




embedded image




    • where

    • # designates the attachment point to NR8;

    • RA and RC, together with the carbon atoms they are bound to, form a 3-, 4-, 5- or 6-membered saturated or partially unsaturated heterocyclic ring containing 1 or 2 oxygen atoms as ring members; or

    • RC and RE, together with the carbon atoms they are bound to, form a 3-, 4-, 5- or 6-membered saturated or partially unsaturated heterocyclic ring containing 1 or 2 oxygen atoms as ring members; or

    • RA and RE, together with the carbon atoms they are bound to, form a 3-, 4-, 5- or 6-membered saturated or partially unsaturated heterocyclic ring containing 1 or 2 oxygen atoms as ring members.





Re in this context is preferably hydrogen, (C1-C6)-alkyl or (C3-C6)-cycloalkyl; in particular hydrogen or (C1-C6)-alkyl; and specifically (C1-C6)-alkyl.


Preferably,

    • —XY form a group XY2, where
    • RA and RE, together with the carbon atoms they are bound to, form a 5- or 6-membered saturated or partly unsaturated heterocyclic ring containing one oxygen atom as ring member; and form preferably a 5-membered saturated or partly unsaturated heterocyclic ring containing one oxygen atom as ring member; and
    • RB, RC, RD and RF are hydrogen;
    • and
    • Re is (C1-C4)-alkyl.


More particularly, in the compounds of formula (I), the substituents have the following meanings:

    • R1 is hydrogen;
    • R2 is hydrogen or halogen;
    • R3 is hydrogen, halogen, (C1-C3)-alkyl, (C1-C3)-haloalkyl, (C1-C3)-alkoxy or (C1-C3)-haloalkoxy;
    • R4 is hydrogen or halogen;
    • R5 is hydrogen, halogen, (C1-C3)-alkyl, (C1-C3)-haloalkyl, (C1-C3)-alkoxy or (C1-C3)-haloalkoxy;
    • R6 is hydrogen;
    • R7 is (C1-C6)-alkyl or (C3-C6)-cycloalkyl;
    • R8 is hydrogen;
    • X is a bond; and Y is Z; where Z is a five- or six-membered partly unsaturated carbocyclic ring which is substituted by p radicals CO2Re, where Re is hydrogen or (C1-C6)-alkyl; or
    • X is CH(CH3); and Y is (C1-C4)-alkyl which is substituted by p radicals selected from the group consisting of CO2Re, CONRbRh, CONReS(O)Ra, CONReSO2Ra and CONRb1SO2NRb2Rb3, where
      • Re in CO2Re is (C1-C6)-alkyl;
      • Rb in CONRbRh is hydrogen or (C1-C3)-alkyl;
      • Rh in CONRbRh is (C1-C3)-alkoxy;
      • Re in CONReS(O)Ra is hydrogen or (C1-C3)-alkyl;
      • Ra in CONReS(O)Ra is (C1-C6)-alkyl or (C1-C3)-haloalkyl;
      • Re in CONReSO2Ra is hydrogen or (C1-C3)-alkyl;
      • Ra in CONReSO2Ra is (C1-C6)-alkyl or (C1-C3)-haloalkyl;
      • Rb1 in CONRb1SO2NRb2Rb3 is hydrogen or (C1-C3)-alkyl;
      • Rb2 in CONRb1SO2NRb2Rb3 is hydrogen or (C1-C3)-alkyl;
      • Rb3 in CONRb1SO2NRb2Rb3 is (C1-C6)-alkyl; or
      • Rb2 and Rb3, together with the nitrogen atom they are bound to, form a saturated 5- or 6-membered N-bound heterocyclic ring; and
    • p is 1 or 2, preferably 1.


Specifically, in the compounds of formula (I), the substituents have the following meanings:

    • R1 is hydrogen;
    • R2 is hydrogen or halogen;
    • R3 is hydrogen, halogen, (C1-C3)-alkyl, (C1-C3)-haloalkyl, (C1-C3)-alkoxy or (C1-C3)-haloalkoxy;
    • R4 is hydrogen or halogen;
    • R5 is hydrogen or halogen;
    • R6 is hydrogen;
    • R7 is (C1-C6)-alkyl or (C3-C6)-cycloalkyl;
    • R8 hydrogen;
    • X is a bond; and Y is Z; where Z is a five- or six-membered partly unsaturated carbocyclic ring which is substituted by p radicals CO2Re, where Re is hydrogen or (C1-C6)-alkyl; or
    • X is CH(CH3); and Y is (C1-C4)-alkyl which is substituted by p radicals selected from the group consisting of CO2Re, CONRbRh, CONReS(O)Ra, CONReSO2Ra and CONRb1SO2NRb2Rb3, where
      • Re in CO2Re is (C1-C6)-alkyl;
      • Rb in CONRbRh is hydrogen or (C1-C3)-alkyl;
      • Rh in CONRbRh is (C1-C3)-alkoxy;
      • Re in CONReS(O)Ra is hydrogen or (C1-C3)-alkyl;
      • Ra in CONReS(O)Ra is (C1-C6)-alkyl or (C1-C3)-haloalkyl;
      • Re in CONReSO2Ra is hydrogen or (C1-C3)-alkyl;
      • Ra in CONReSO2Ra is (C1-C6)-alkyl or (C1-C3)-haloalkyl;
      • Rb1 in CONRb1SO2NRb2Rb3 is hydrogen or (C1-C3)-alkyl;
      • Rb2 in CONRb1SO2NRb2Rb3 is hydrogen or (C1-C3)-alkyl;
      • Rb3 in CONRb1SO2NRb2Rb3 is (C1-C6)-alkyl; or
      • Rb2 and Rb3, together with the nitrogen atom they are bound to, form a saturated 5- or 6-membered N-bound heterocyclic ring; and
    • p is 1 or 2, preferably 1.


In an alternative more particular embodiment, in the compounds of formula (I), the substituents have the following meanings:

    • R1 is hydrogen;
    • R2 is hydrogen or halogen;
    • R3 is hydrogen, halogen, (C1-C3)-alkyl, (C1-C3)-haloalkyl, (C1-C3)-alkoxy or (C1-C3)-haloalkoxy;
    • R4 is hydrogen or halogen;
    • R5 is hydrogen, halogen, (C1-C3)-alkyl, (C1-C3)-haloalkyl, (C1-C3)-alkoxy or (C1-C3)-haloalkoxy;
    • R6 is hydrogen;
    • R7 is (C1-C6)-alkyl or (C3-C6)-cycloalkyl;
    • R8 is hydrogen;
    • X is a bond;
    • Y is Z; where Z is a five- or six-membered partly unsaturated carbocyclic ring which is substituted by p radicals CO2Re, where Re is hydrogen or (C1-C6)-alkyl; or
      • Y is CH(CH3)—(C1-C4)-alkyl which is substituted by p radicals selected from the group consisting of CO2Re, CONRbRh, CONReS(O)Ra, CONReSO2Ra and CONRb1SO2NRb2Rb3, where
      • Re in CO2Re is (C1-C6)-alkyl;
      • Rb in CONRbRh is hydrogen or (C1-C3)-alkyl;
      • Rh in CONRbRh is (C1-C3)-alkoxy;
      • Re in CONReS(O)Ra is hydrogen or (C1-C3)-alkyl;
      • Ra in CONReS(O)Ra is (C1-C6)-alkyl or (C1-C3)-haloalkyl;
      • Re in CONReSO2Ra is hydrogen or (C1-C3)-alkyl;
      • Ra in CONReSO2Ra is (C1-C6)-alkyl or (C1-C3)-haloalkyl;
      • Rb1 in CONRb1SO2NRb2Rb3 is hydrogen or (C1-C3)-alkyl;
      • Rb2 in CONRb1SO2NRb2Rb3 is hydrogen or (C1-C3)-alkyl;
      • Rb3 in CONRb1SO2NRb2Rb3 is (C1-C6)-alkyl; or
      • Rb2 and Rb3, together with the nitrogen atom they are bound to, form a saturated 5- or 6-membered N-bound heterocyclic ring; and
    • p is 1 or 2, preferably 1.


In an alternative specific embodiment, in the compounds of formula (I), the substituents have the following meanings:

    • R1 hydrogen;
    • R2 is hydrogen or halogen;
    • R3 is hydrogen, halogen, (C1-C3)-alkyl, (C1-C3)-haloalkyl, (C1-C3)-alkoxy or (C1-C3)-haloalkoxy;
    • R4 is hydrogen or halogen;
    • R5 is hydrogen or halogen;
    • R6 is hydrogen;
    • R7 is (C1-C6)-alkyl or (C3-C6)-cycloalkyl;
    • R8 hydrogen;
    • X is a bond;
    • Y is Z; where Z is a five- or six-membered partly unsaturated carbocyclic ring which is substituted by p radicals CO2Re, where Re is hydrogen or (C1-C6)-alkyl; or
      • Y is CH(CH3)—(C1-C4)-alkyl which is substituted by p radicals selected from the group consisting of CO2Re, CONRbRh, CONReS(O)Ra, CONReSO2Ra and CONRb1SO2NRb2Rb3, where
      • Re in CO2Re is (C1-C6)-alkyl;
      • Rb in CONRbRh is hydrogen or (C1-C3)-alkyl;
      • Rh in CONRbRh is (C1-C3)-alkoxy;
      • Re in CONReS(O)Ra is hydrogen or (C1-C3)-alkyl;
      • Ra in CONReS(O)Ra is (C1-C6)-alkyl or (C1-C3)-haloalkyl;
      • Re in CONReSO2Ra is hydrogen or (C1-C3)-alkyl;
      • Ra in CONReSO2Ra is (C1-C6)-alkyl or (C1-C3)-haloalkyl;
      • Rb1 in CONRb1SO2NRb2Rb3 is hydrogen or (C1-C3)-alkyl;
      • Rb2 in CONRb1SO2NRb2Rb3 is hydrogen or (C1-C3)-alkyl;
      • Rb3 in CONRb1SO2NRb2Rb3 is (C1-C6)-alkyl; or
      • Rb2 and Rb3, together with the nitrogen atom they are bound to, form a saturated 5- or 6-membered N-bound heterocyclic ring; and
    • p is 1 or 2, preferably 1.


Compounds (I), wherein R1, R6 and R8 are hydrogen and R2, R3, R4, R5 and R7 have the meanings as defined in each line of table A below are particularly preferred.














TABLE A





No.
R2
R3
R4
R5
R7




















1.
H
H
H
H
CH3


2.
H
F
H
H
CH3


3.
H
Cl
H
H
CH3


4.
H
Br
H
H
CH3


5.
H
I
H
H
CH3


6.
H
CH3
H
H
CH3


7.
H
Et
H
H
CH3


8.
H
CF3
H
H
CH3


9.
H
OCH3
H
H
CH3


10.
H
OCF3
H
H
CH3


11.
H
CN
H
H
CH3


12.
H
H
H
H
Et


13.
H
F
H
H
Et


14.
H
Cl
H
H
Et


15.
H
Br
H
H
Et


16.
H
I
H
H
Et


17.
H
CH3
H
H
Et


18.
H
Et
H
H
Et


19.
H
CF3
H
H
Et


20.
H
OCH3
H
H
Et


21.
H
OCF3
H
H
Et


22.
H
CN
H
H
Et


23.
H
H
H
H
n-Pr


24.
H
F
H
H
n-Pr


25.
H
Cl
H
H
n-Pr


26.
H
Br
H
H
n-Pr


27.
H
I
H
H
n-Pr


28.
H
CH3
H
H
n-Pr


29.
H
Et
H
H
n-Pr


30.
H
CF3
H
H
n-Pr


31.
H
OCH3
H
H
n-Pr


32.
H
OCF3
H
H
n-Pr


33.
H
CN
H
H
n-Pr


34.
H
H
H
H
iPr


35.
H
F
H
H
iPr


36.
H
Cl
H
H
iPr


37.
H
Br
H
H
iPr


38.
H
I
H
H
iPr


39.
H
CH3
H
H
iPr


40.
H
Et
H
H
iPr


41.
H
CF3
H
H
iPr


42.
H
OCH3
H
H
iPr


43.
H
OCF3
H
H
iPr


44.
H
CN
H
H
iPr


45.
H
H
H
H
cPr


46.
H
F
H
H
cPr


47.
H
Cl
H
H
cPr


48.
H
Br
H
H
cPr


49.
H
I
H
H
cPr


50.
H
CH3
H
H
cPr


51.
H
Et
H
H
cPr


52.
H
CF3
H
H
cPr


53.
H
OCH3
H
H
cPr


54.
H
OCF3
H
H
cPr


55.
H
CN
H
H
cPr


56.
H
F
H
F
CH3


57.
H
Cl
H
F
CH3


58.
H
Br
H
F
CH3


59.
H
I
H
F
CH3


60.
H
CH3
H
F
CH3


61.
H
Et
H
F
CH3


62.
H
CF3
H
F
CH3


63.
H
OCH3
H
F
CH3


64.
H
OCF3
H
F
CH3


65.
H
CN
H
F
CH3


66.
H
F
H
F
Et


67.
H
Cl
H
F
Et


68.
H
Br
H
F
Et


69.
H
I
H
F
Et


70.
H
CH3
H
F
Et


71.
H
Et
H
F
Et


72.
H
CF3
H
F
Et


73.
H
OCH3
H
F
Et


74.
H
OCF3
H
F
Et


75.
H
CN
H
F
Et


76.
H
F
H
F
n-Pr


77.
H
Cl
H
F
n-Pr


78.
H
Br
H
F
n-Pr


79.
H
I
H
F
n-Pr


80.
H
CH3
H
F
n-Pr


81.
H
Et
H
F
n-Pr


82.
H
CF3
H
F
n-Pr


83.
H
OCH3
H
F
n-Pr


84.
H
OCF3
H
F
n-Pr


85.
H
CN
H
F
n-Pr


86.
H
F
H
F
iPr


87.
H
Cl
H
F
iPr


88.
H
Br
H
F
iPr


89.
H
I
H
F
iPr


90.
H
CH3
H
F
iPr


91.
H
Et
H
F
iPr


92.
H
CF3
H
F
iPr


93.
H
OCH3
H
F
iPr


94.
H
OCF3
H
F
iPr


95.
H
CN
H
F
iPr


96.
H
F
H
F
cPr


97.
H
Cl
H
F
cPr


98.
H
Br
H
F
cPr


99.
H
I
H
F
cPr


100.
H
CH3
H
F
cPr


101.
H
Et
H
F
cPr


102.
H
CF3
H
F
cPr


103.
H
OCH3
H
F
cPr


104.
H
OCF3
H
F
cPr


105.
H
CN
H
F
cPr


106.
H
Cl
H
Cl
CH3


107.
H
Br
H
Cl
CH3


108.
H
I
H
Cl
CH3


109.
H
CH3
H
Cl
CH3


110.
H
Et
H
Cl
CH3


111.
H
CF3
H
Cl
CH3


112.
H
OCH3
H
Cl
CH3


113.
H
OCF3
H
Cl
CH3


114.
H
CN
H
Cl
CH3


115.
H
Cl
H
Cl
Et


116.
H
Br
H
Cl
Et


117.
H
I
H
Cl
Et


118.
H
CH3
H
Cl
Et


119.
H
Et
H
Cl
Et


120.
H
CF3
H
Cl
Et


121.
H
OCH3
H
Cl
Et


122.
H
OCF3
H
Cl
Et


123.
H
CN
H
Cl
Et


124.
H
Cl
H
Cl
n-Pr


125.
H
Br
H
Cl
n-Pr


126.
H
I
H
Cl
n-Pr


127.
H
CH3
H
Cl
n-Pr


128.
H
Et
H
Cl
n-Pr


129.
H
CF3
H
Cl
n-Pr


130.
H
OCH3
H
Cl
n-Pr


131.
H
OCF3
H
Cl
n-Pr


132.
H
CN
H
Cl
n-Pr


133.
H
Cl
H
Cl
iPr


134.
H
Br
H
Cl
iPr


135.
H
I
H
Cl
iPr


136.
H
CH3
H
Cl
iPr


137.
H
Et
H
Cl
iPr


138.
H
CF3
H
Cl
iPr


139.
H
OCH3
H
Cl
iPr


140.
H
OCF3
H
Cl
iPr


141.
H
CN
H
Cl
iPr


142.
H
Cl
H
Cl
cPr


143.
H
Br
H
Cl
cPr


144.
H
I
H
Cl
cPr


145.
H
CH3
H
Cl
cPr


146.
H
Et
H
Cl
cPr


147.
H
CF3
H
Cl
cPr


148.
H
OCH3
H
Cl
cPr


149.
H
OCF3
H
Cl
cPr


150.
H
CN
H
Cl
cPr


151.
H
Br
H
Br
CH3


152.
H
Br
H
Br
Et


153.
H
Br
H
Br
n-Pr


154.
H
Br
H
Br
iPr


155.
H
Br
H
Br
cPr


156.
H
I
H
I
CH3


157.
H
I
H
I
Et


158.
H
I
H
I
n-Pr


159.
H
I
H
I
iPr


160.
H
I
H
I
cPr


161.
H
Br
H
CN
CH3


162.
H
I
H
CN
CH3


163.
H
CH3
H
CN
CH3


164.
H
Et
H
CN
CH3


165.
H
CF
H
CN
CH3


166.
H
OCH3
H
CN
CH3


167.
H
OCF3
H
CN
CH3


168.
H
CN
H
CN
CH3


169.
H
Br
H
CN
Et


170.
H
I
H
CN
Et


171.
H
CH3
H
CN
Et


172.
H
Et
H
CN
Et


173.
H
CF3
H
CN
Et


174.
H
OCH3
H
CN
Et


175.
H
OCF3
H
CN
Et


176.
H
CN
H
CN
Et


177.
H
Br
H
CN
n-Pr


178.
H
I
H
CN
n-Pr


179.
H
CH3
H
CN
n-Pr


180.
H
Et
H
CN
n-Pr


181.
H
CF3
H
CN
n-Pr


182.
H
OCH3
H
CN
n-Pr


183.
H
OCF3
H
CN
n-Pr


184.
H
CN
H
CN
n-Pr


185.
H
Br
H
CN
iPr


186.
H
I
H
CN
iPr


187.
H
CH3
H
CN
iPr


188.
H
Et
H
CN
iPr


189.
H
CF3
H
CN
iPr


190.
H
OCH3
H
CN
iPr


191.
H
OCF3
H
CN
iPr


192.
H
CN
H
CN
iPr


193.
H
Br
H
CN
cPr


194.
H
I
H
CN
cPr


195.
H
CH3
H
CN
cPr


196.
H
Et
H
CN
cPr


197.
H
CF3
H
CN
cPr


198.
H
OCH3
H
CN
cPr


199.
H
OCF3
H
CN
cPr


200.
H
CN
H
CN
cPr


201.
H
H
F
H
CH3


202.
H
F
F
H
CH3


203.
H
Cl
F
H
CH3


204.
H
Br
F
H
CH3


205.
H
I
F
H
CH3


206.
H
CH3
F
H
CH3


207.
H
Et
F
H
CH3


208.
H
CF3
F
H
CH3


209.
H
OCH3
F
H
CH3


210.
H
OCF3
F
H
CH3


211.
H
CN
F
H
CH3


212.
H
H
F
H
Et


213.
H
F
F
H
Et


214.
H
Cl
F
H
Et


215.
H
Br
F
H
Et


216.
H
I
F
H
Et


217.
H
CH3
F
H
Et


218.
H
Et
F
H
Et


219.
H
CF3
F
H
Et


220.
H
OCH3
F
H
Et


221.
H
OCF3
F
H
Et


222.
H
CN
F
H
Et


223.
H
H
F
H
n-Pr


224.
H
F
F
H
n-Pr


225.
H
Cl
F
H
n-Pr


226.
H
Br
F
H
n-Pr


227.
H
I
F
H
n-Pr


228.
H
CH3
F
H
n-Pr


229.
H
Et
F
H
n-Pr


230.
H
CF3
F
H
n-Pr


231.
H
OCH3
F
H
n-Pr


232.
H
OCF3
F
H
n-Pr


233.
H
CN
F
H
n-Pr


234.
H
H
F
H
iPr


235.
H
F
F
H
iPr


236.
H
Cl
F
H
iPr


237.
H
Br
F
H
iPr


238.
H
I
F
H
iPr


239.
H
CH3
F
H
iPr


240.
H
Et
F
H
iPr


241.
H
CF3
F
H
iPr


242.
H
OCH3
F
H
iPr


243.
H
OCF3
F
H
iPr


244.
H
CN
F
H
iPr


245.
H
H
F
H
cPr


246.
H
F
F
H
cPr


247.
H
Cl
F
H
cPr


248.
H
Br
F
H
cPr


249.
H
I
F
H
cPr


250.
H
CH3
F
H
cPr


251.
H
Et
F
H
cPr


252.
H
CF3
F
H
cPr


253.
H
OCH3
F
H
cPr


254.
H
OCF3
F
H
cPr


255.
H
CN
F
H
cPr


256.
H
F
F
F
CH3


257.
H
Cl
F
F
CH3


258.
H
Br
F
F
CH3


259.
H
I
F
F
CH3


260.
H
CH3
F
F
CH3


261.
H
Et
F
F
CH3


262.
H
CF3
F
F
CH3


263.
H
OCH3
F
F
CH3


264.
H
OCF3
F
F
CH3


265.
H
CN
F
F
CH3


266.
H
F
F
F
Et


267.
H
Cl
F
F
Et


268.
H
Br
F
F
Et


269.
H
I
F
F
Et


270.
H
CH3
F
F
Et


271.
H
Et
F
F
Et


272.
H
CF3
F
F
Et


273.
H
OCH3
F
F
Et


274.
H
OCF3
F
F
Et


275.
H
CN
F
F
Et


276.
H
F
F
F
n-Pr


277.
H
Cl
F
F
n-Pr


278.
H
Br
F
F
n-Pr


279.
H
I
F
F
n-Pr


280.
H
CH3
F
F
n-Pr


281.
H
Et
F
F
n-Pr


282.
H
CF3
F
F
n-Pr


283.
H
OCH3
F
F
n-Pr


284.
H
OCF3
F
F
n-Pr


285.
H
CN
F
F
n-Pr


286.
H
F
F
F
iPr


287.
H
Cl
F
F
iPr


288.
H
Br
F
F
iPr


289.
H
I
F
F
iPr


290.
H
CH3
F
F
iPr


291.
H
Et
F
F
iPr


292.
H
CF3
F
F
iPr


293.
H
OCH3
F
F
iPr


294.
H
OCF3
F
F
iPr


295.
H
CN
F
F
iPr


296.
H
F
F
F
cPr


297.
H
Cl
F
F
cPr


298.
H
Br
F
F
cPr


299.
H
I
F
F
cPr


300.
H
CH3
F
F
cPr


301.
H
Et
F
F
cPr


302.
H
CF3
F
F
cPr


303.
H
OCH3
F
F
cPr


304.
H
OCF3
F
F
cPr


305.
H
CN
F
F
cPr


306.
H
Cl
F
Cl
CH3


307.
H
Br
F
Cl
CH3


308.
H
I
F
Cl
CH3


309.
H
CH3
F
Cl
CH3


310.
H
Et
F
Cl
CH3


311.
H
CF3
F
Cl
CH3


312.
H
OCH3
F
Cl
CH3


313.
H
OCF3
F
Cl
CH3


314.
H
CN
F
Cl
CH3


315.
H
Cl
F
Cl
Et


316.
H
Br
F
Cl
Et


317.
H
I
F
Cl
Et


318.
H
CH3
F
Cl
Et


319.
H
Et
F
Cl
Et


320.
H
CF3
F
Cl
Et


321.
H
OCH3
F
Cl
Et


322.
H
OCF3
F
Cl
Et


323.
H
CN
F
Cl
Et


324.
H
Cl
F
Cl
n-Pr


325.
H
Br
F
Cl
n-Pr


326.
H
I
F
Cl
n-Pr


327.
H
CH3
F
Cl
n-Pr


328.
H
Et
F
Cl
n-Pr


329.
H
CF3
F
Cl
n-Pr


330.
H
OCH3
F
Cl
n-Pr


331.
H
OCF3
F
Cl
n-Pr


332.
H
CN
F
Cl
n-Pr


333.
H
Cl
F
Cl
iPr


334.
H
Br
F
Cl
iPr


335.
H
I
F
Cl
iPr


336.
H
CH3
F
Cl
iPr


337.
H
Et
F
Cl
iPr


338.
H
CF3
F
Cl
iPr


339.
H
OCH3
F
Cl
iPr


340.
H
OCF3
F
Cl
iPr


341.
H
CN
F
Cl
iPr


342.
H
Cl
F
Cl
cPr


343.
H
Br
F
Cl
cPr


344.
H
I
F
Cl
cPr


345.
H
CH3
F
Cl
cPr


346.
H
Et
F
Cl
cPr


347.
H
CF3
F
Cl
cPr


348.
H
OCH3
F
Cl
cPr


349.
H
OCF3
F
Cl
cPr


350.
H
CN
F
Cl
cPr


351.
H
Br
F
Br
CH3


352.
H
Br
F
Br
Et


353.
H
Br
F
Br
n-Pr


354.
H
Br
F
Br
iPr


355.
H
Br
F
Br
cPr


356.
H
I
F
I
CH3


357.
H
I
F
I
Et


358.
H
I
F
I
n-Pr


359.
H
I
F
I
iPr


360.
H
I
F
I
cPr


361.
H
Br
F
CN
CH3


362.
H
I
F
CN
CH3


363.
H
CH3
F
CN
CH3


364.
H
Et
F
CN
CH3


365.
H
CF3
F
CN
CH3


366.
H
OCH3
F
CN
CH3


367.
H
OCF3
F
CN
CH3


368.
H
CN
F
CN
CH3


369.
H
Br
F
CA
Et


370.
H
I
F
CN
Et


371.
H
CH3
F
CN
Et


372.
H
Et
F
CN
Et


373.
H
CF3
F
CN
Et


374.
H
OCH3
F
CN
Et


375.
H
OCF3
F
CN
Et


376.
H
CN
F
CN
Et


377.
H
Br
F
CN
n-Pr


378.
H
I
F
CN
n-Pr


379.
H
CH3
F
CN
n-Pr


380.
H
Et
F
CN
n-Pr


381.
H
CF3
F
CN
n-Pr


382.
H
OCH3
F
CN
n-Pr


383.
H
OCF3
F
CN
n-Pr


384.
H
CN
F
CN
n-Pr


385.
H
Br
F
CN
iPr


386.
H
I
F
CN
iPr


387.
H
CH3
F
CN
iPr


388.
H
Et
F
CN
iPr


389.
H
CF3
F
CN
iPr


390.
H
OCH3
F
CN
iPr


391.
H
OCF3
F
CN
iPr


392.
H
CN
F
CN
iPr


393.
H
Br
F
CN
cPr


394.
H
I
F
CN
cPr


395.
H
CH3
F
CN
cPr


396.
H
Et
F
CN
cPr


397.
H
CF3
F
CN
cPr


398.
H
OCH3
F
CN
cPr


399.
H
OCF3
F
CN
cPr


400.
H
CN
F
CN
cPr


401.
H
H
Cl
H
CH3


402.
H
F
Cl
H
CH3


403.
H
Cl
Cl
H
CH3


404.
H
Br
Cl
H
CH3


405.
H
I
Cl
H
CH3


406.
H
CH3
Cl
H
CH3


407.
H
Et
Cl
H
CH3


408.
H
CF3
Cl
H
CH3


409.
H
OCH3
Cl
H
CH3


410.
H
OCF3
Cl
H
CH3


411.
H
CN
Cl
H
CH3


412.
H
H
Cl
H
Et


413.
H
F
Cl
H
Et


414.
H
Cl
Cl
H
Et


415.
H
Br
Cl
H
Et


416.
H
I
Cl
H
Et


417.
H
CH3
Cl
H
Et


418.
H
Et
Cl
H
Et


419.
H
CF3
Cl
H
Et


420.
H
OCH3
Cl
H
Et


421.
H
OCF3
Cl
H
Et


422.
H
CN
Cl
H
Et


423.
H
H
Cl
H
n-Pr


424.
H
F
Cl
H
n-Pr


425.
H
Cl
Cl
H
n-Pr


426.
H
Br
Cl
H
n-Pr


427.
H
I
Cl
H
n-Pr


428.
H
CH3
Cl
H
n-Pr


429.
H
Et
Cl
H
n-Pr


430.
H
CF3
Cl
H
n-Pr


431.
H
OCH3
Cl
H
n-Pr


432.
H
OCF3
Cl
H
n-Pr


433.
H
CN
Cl
H
n-Pr


434.
H
H
Cl
H
iPr


435.
H
F
Cl
H
iPr


436.
H
Cl
Cl
H
iPr


437.
H
Br
Cl
H
iPr


438.
H
I
Cl
H
iPr


439.
H
CH3
Cl
H
iPr


440.
H
Et
Cl
H
iPr


441.
H
CF3
Cl
H
iPr


442.
H
OCH3
Cl
H
iPr


443.
H
OCF3
Cl
H
iPr


444.
H
CN
Cl
H
iPr


445.
H
H
Cl
H
cPr


446.
H
F
Cl
H
cPr


447.
H
Cl
Cl
H
cPr


448.
H
Br
Cl
H
cPr


449.
H
I
Cl
H
cPr


450.
H
CH3
Cl
H
cPr


451.
H
Et
Cl
H
cPr


452.
H
CF3
Cl
H
cPr


453.
H
OCH3
Cl
H
cPr


454.
H
OCF3
Cl
H
cPr


455.
H
CN
Cl
H
cPr


456.
H
F
Cl
F
CH3


457.
H
Cl
Cl
F
CH3


458.
H
Br
Cl
F
CH3


459.
H
I
Cl
F
CH3


460.
H
CH3
Cl
F
CH3


461.
H
Et
Cl
F
CH3


462.
H
CF3
Cl
F
CH3


463.
H
OCH3
Cl
F
CH3


464.
H
OCF3
Cl
F
CH3


465.
H
CN
Cl
F
CH3


466.
H
F
Cl
F
Et


467.
H
Cl
Cl
F
Et


468.
H
Br
Cl
F
Et


469.
H
I
Cl
F
Et


470.
H
CH3
Cl
F
Et


471.
H
Et
Cl
F
Et


472.
H
CF3
Cl
F
Et


473.
H
OCH3
Cl
F
Et


474.
H
OCF3
Cl
F
Et


475.
H
CN
Cl
F
Et


476.
H
F
Cl
F
n-Pr


477.
H
Cl
Cl
F
n-Pr


478.
H
Br
Cl
F
n-Pr


479.
H
I
Cl
F
n-Pr


480.
H
CH3
Cl
F
n-Pr


481.
H
Et
Cl
F
n-Pr


482.
H
CF3
Cl
F
n-Pr


483.
H
OCH3
Cl
F
n-Pr


484.
H
OCF3
Cl
F
n-Pr


485.
H
CN
Cl
F
n-Pr


486.
H
F
Cl
F
iPr


487.
H
Cl
Cl
F
iPr


488.
H
Br
Cl
F
iPr


489.
H
I
Cl
F
iPr


490.
H
CH3
Cl
F
iPr


491.
H
Et
Cl
F
iPr


492.
H
CF3
Cl
F
iPr


493.
H
OCH3
Cl
F
iPr


494.
H
OCF3
Cl
F
iPr


495.
H
CN
Cl
F
iPr


496.
H
F
Cl
F
cPr


497.
H
Cl
Cl
F
cPr


498.
H
Br
Cl
F
cPr


499.
H
I
Cl
F
cPr


500.
H
CH3
Cl
F
cPr


501.
H
Et
Cl
F
cPr


502.
H
CF3
Cl
F
cPr


503.
H
OCH3
Cl
F
cPr


504.
H
OCF3
Cl
F
cPr


505.
H
CN
Cl
F
cPr


506.
H
Cl
Cl
Cl
CH3


507.
H
Br
Cl
Cl
CH3


508.
H
I
Cl
Cl
CH3


509.
H
CH3
Cl
Cl
CH3


510.
H
Et
Cl
Cl
CH3


511.
H
CF3
Cl
Cl
CH3


512.
H
OCH3
Cl
Cl
CH3


513.
H
OCF3
Cl
Cl
CH3


514.
H
CN
Cl
Cl
CH3


515.
H
Cl
Cl
Cl
Et


516.
H
Br
Cl
Cl
Et


517.
H
I
Cl
Cl
Et


518.
H
CH3
Cl
Cl
Et


519.
H
Et
Cl
Cl
Et


520.
H
CF3
Cl
Cl
Et


521.
H
OCH3
Cl
Cl
Et


522.
H
OCF3
Cl
Cl
Et


523.
H
CN
Cl
Cl
Et


524.
H
Cl
Cl
Cl
n-Pr


525.
H
Br
Cl
Cl
n-Pr


526.
H
I
Cl
Cl
n-Pr


527.
H
CH3
Cl
Cl
n-Pr


528.
H
Et
Cl
Cl
n-Pr


529.
H
CF3
Cl
Cl
n-Pr


530.
H
OCH3
Cl
Cl
n-Pr


531.
H
OCF3
Cl
Cl
n-Pr


532.
H
CN
Cl
Cl
n-Pr


533.
H
Cl
Cl
Cl
iPr


534.
H
Br
Cl
Cl
iPr


535.
H
I
Cl
Cl
iPr


536.
H
CH3
Cl
Cl
iPr


537.
H
Et
Cl
Cl
iPr


538.
H
CF3
Cl
Cl
iPr


539.
H
OCH3
Cl
Cl
iPr


540.
H
OCF3
Cl
Cl
iPr


541.
H
CN
Cl
Cl
iPr


542.
H
Cl
Cl
Cl
cPr


543.
H
Br
Cl
Cl
cPr


544.
H
I
Cl
Cl
cPr


545.
H
CH3
Cl
Cl
cPr


546.
H
Et
Cl
Cl
cPr


547.
H
CF3
Cl
Cl
cPr


548.
H
OCH3
Cl
Cl
cPr


549.
H
OCF3
Cl
Cl
cPr


550.
H
CN
Cl
Cl
cPr


551.
H
Br
Cl
Br
CH3


552.
H
Br
Cl
Br
Et


553.
H
Br
Cl
Br
n-Pr


554.
H
Br
Cl
Br
iPr


555.
H
Br
Cl
Br
cPr


556.
H
I
Cl
I
CH3


557.
H
I
Cl
I
Et


558.
H
I
Cl
I
n-Pr


559.
H
I
Cl
I
iPr


560.
H
I
Cl
I
cPr


561.
H
Br
Cl
CN
CH3


562.
H
I
Cl
CN
CH3


563.
H
CH3
Cl
CN
CH3


564.
H
Et
Cl
CN
CH3


565.
H
CF3
Cl
CN
CH3


566.
H
OCH3
Cl
CN
CH3


567.
H
OCF3
Cl
CN
CH3


568.
H
CN
Cl
CN
CH3


569.
H
Br
Cl
CN
Et


570.
H
I
Cl
CN
Et


571.
H
CH3
Cl
CN
Et


572.
H
Et
Cl
CN
Et


573.
H
CF3
Cl
CN
Et


574.
H
OCH3
Cl
CN
Et


575.
H
OCF3
Cl
CN
Et


576.
H
CN
Cl
CN
Et


577.
H
Br
Cl
CN
n-Pr


578.
H
I
Cl
CN
n-Pr


579.
H
CH3
Cl
CN
n-Pr


580.
H
Et
Cl
CN
n-Pr


581.
H
CF3
Cl
CN
n-Pr


582.
H
OCH3
Cl
CN
n-Pr


583.
H
OCF3
Cl
CN
n-Pr


584.
H
CN
Cl
CN
n-Pr


585.
H
Br
Cl
CN
iPr


586.
H
I
Cl
CN
iPr


587.
H
CH3
Cl
CN
iPr


588.
H
Et
Cl
CN
iPr


589.
H
CF3
Cl
CN
iPr


590.
H
OCH3
Cl
CN
iPr


591.
H
OCF3
Cl
CN
iPr


592.
H
CN
Cl
CN
iPr


593.
H
Br
Cl
CN
cPr


594.
H
I
Cl
CN
cPr


595.
H
CH3
Cl
CN
cPr


596.
H
Et
Cl
CN
cPr


597.
H
CF3
Cl
CN
cPr


598.
H
OCH3
Cl
CN
cPr


599.
H
OCF3
Cl
CN
cPr


600.
H
CN
Cl
CN
cPr


601.
F
H
H
H
CH3


602.
F
F
H
H
CH3


603.
F
Cl
H
H
CH3


604.
F
Br
H
H
CH3


605.
F
I
H
H
CH3


606.
F
CH3
H
H
CH3


607.
F
Et
H
H
CH3


608.
F
CF3
H
H
CH3


609.
F
OCH3
H
H
CH3


610.
F
OCF3
H
H
CH3


611.
F
CN
H
H
CH3


612.
F
H
H
H
Et


613.
F
F
H
H
Et


614.
F
Cl
H
H
Et


615.
F
Br
H
H
Et


616.
F
I
H
H
Et


617.
F
CH3
H
H
Et


618.
F
Et
H
H
Et


619.
F
CF3
H
H
Et


620.
F
OCH3
H
H
Et


621.
F
OCF3
H
H
Et


622.
F
CN
H
H
Et


623.
F
H
H
H
n-Pr


624.
F
F
H
H
n-Pr


625.
F
Cl
H
H
n-Pr


626.
F
Br
H
H
n-Pr


627.
F
I
H
H
n-Pr


628.
F
CH3
H
H
n-Pr


629.
F
Et
H
H
n-Pr


630.
F
CF3
H
H
n-Pr


631.
F
OCH3
H
H
n-Pr


632.
F
OCF3
H
H
n-Pr


633.
F
CN
H
H
n-Pr


634.
F
H
H
H
iPr


635.
F
F
H
H
iPr


636.
F
Cl
H
H
iPr


637.
F
Br
H
H
iPr


638.
F
I
H
H
iPr


639.
F
CH3
H
H
iPr


640.
F
Et
H
H
iPr


641.
F
CF3
H
H
iPr


642.
F
OCH3
H
H
iPr


643.
F
OCF3
H
H
iPr


644.
F
CN
H
H
iPr


645.
F
H
H
H
cPr


646.
F
F
H
H
cPr


647.
F
Cl
H
H
cPr


648.
F
Br
H
H
cPr


649.
F
I
H
H
cPr


650.
F
CH3
H
H
cPr


651.
F
Et
H
H
cPr


652.
F
CF3
H
H
cPr


653.
F
OCH3
H
H
cPr


654.
F
OCF3
H
H
cPr


655.
F
CN
H
H
cPr


656.
F
H
H
F
CH3


657.
F
F
H
F
CH3


658.
F
Cl
H
F
CH3


659.
F
Br
H
F
CH3


660.
F
I
H
F
CH3


661.
F
CH3
H
F
CH3


662.
F
Et
H
F
CH3


663.
F
CF3
H
F
CH3


664.
F
OCH3
H
F
CH3


665.
F
OCF3
H
F
CH3


666.
F
CN
H
F
CH3


667.
F
H
H
F
Et


668.
F
F
H
F
Et


669.
F
Cl
H
F
Et


670.
F
Br
H
F
Et


671.
F
I
H
F
Et


672.
F
CH3
H
F
Et


673.
F
Et
H
F
Et


674.
F
CF3
H
F
Et


675.
F
OCH3
H
F
Et


676.
F
OCF3
H
F
Et


677.
F
CN
H
F
Et


678.
F
H
H
F
n-Pr


679.
F
F
H
F
n-Pr


680.
F
Cl
H
F
n-Pr


681.
F
Br
H
F
n-Pr


682.
F
I
H
F
n-Pr


683.
F
CH3
H
F
n-Pr


684.
F
Et
H
F
n-Pr


685.
F
CF3
H
F
n-Pr


686.
F
OCH3
H
F
n-Pr


687.
F
OCF3
H
F
n-Pr


688.
F
CN
H
F
n-Pr


689.
F
H
H
F
iPr


690.
F
F
H
F
iPr


691.
F
Cl
H
F
iPr


692.
F
Br
H
F
iPr


693.
F
I
H
F
iPr


694.
F
CH3
H
F
iPr


695.
F
Et
H
F
iPr


696.
F
CF3
H
F
iPr


697.
F
OCH3
H
F
iPr


698.
F
OCF3
H
F
iPr


699.
F
CN
H
F
iPr


700.
F
H
H
F
cPr


701.
F
F
H
F
cPr


702.
F
Cl
H
F
cPr


703.
F
Br
H
F
cPr


704.
F
I
H
F
cPr


705.
F
CH3
H
F
cPr


706.
F
Et
H
F
cPr


707.
F
CF3
H
F
cPr


708.
F
OCH3
H
F
cPr


709.
F
OCF3
H
F
cPr


710.
F
CN
H
F
cPr


711.
F
H
H
Cl
CH3


712.
F
F
H
Cl
CH3


713.
F
Cl
H
Cl
CH3


714.
F
Br
H
Cl
CH3


715.
F
I
H
Cl
CH3


716.
F
CH3
H
Cl
CH3


717.
F
Et
H
Cl
CH3


718.
F
CF3
H
Cl
CH3


719.
F
OCH3
H
Cl
CH3


720.
F
OCF3
H
Cl
CH3


721.
F
CN
H
Cl
CH3


722.
F
H
H
Cl
Et


723.
F
F
H
Cl
Et


724.
F
Cl
H
Cl
Et


725.
F
Br
H
Cl
Et


726.
F
I
H
Cl
Et


727.
F
CH3
H
Cl
Et


728.
F
Et
H
Cl
Et


729.
F
CF3
H
Cl
Et


730.
F
OCH3
H
Cl
Et


731.
F
OCF3
H
Cl
Et


732.
F
CN
H
Cl
Et


733.
F
H
H
Cl
n-Pr


734.
F
F
H
Cl
n-Pr


735.
F
Cl
H
Cl
n-Pr


736.
F
Br
H
Cl
n-Pr


737.
F
I
H
Cl
n-Pr


738.
F
CH3
H
Cl
n-Pr


739.
F
Et
H
Cl
n-Pr


740.
F
CF3
H
Cl
n-Pr


741.
F
OCH3
H
Cl
n-Pr


742.
F
OCF3
H
Cl
n-Pr


743.
F
CN
H
Cl
n-Pr


744.
F
H
H
Cl
iPr


745.
F
F
H
Cl
iPr


746.
F
Cl
H
Cl
iPr


747.
F
Br
H
Cl
iPr


748.
F
I
H
Cl
iPr


749.
F
CH3
H
Cl
iPr


750.
F
Et
H
Cl
iPr


751.
F
CF3
H
Cl
iPr


752.
F
OCH3
H
Cl
iPr


753.
F
OCF3
H
Cl
iPr


754.
F
CN
H
Cl
iPr


755.
F
H
H
Cl
cPr


756.
F
F
H
Cl
cPr


757.
F
Cl
H
Cl
cPr


758.
F
Br
H
Cl
cPr


759.
F
I
H
Cl
cPr


760.
F
CH3
H
Cl
cPr


761.
F
Et
H
Cl
cPr


762.
F
CF3
H
Cl
cPr


763.
F
OCH3
H
Cl
cPr


764.
F
OCF3
H
Cl
cPr


765.
F
CN
H
Cl
cPr


766.
F
Br
H
Br
CH3


767.
F
Br
H
Br
Et


768.
F
Br
H
Br
n-Pr


769.
F
Br
H
Br
iPr


770.
F
Br
H
Br
cPr


771.
F
I
H
I
CH3


772.
F
I
H
I
Et


773.
F
I
H
I
n-Pr


774.
F
I
H
I
iPr


775.
F
I
H
I
cPr


776.
F
H
H
CN
CH3


777.
F
F
H
CN
CH3


778.
F
Cl
H
CN
CH3


779.
F
Br
H
CN
CH3


780.
F
I
H
CN
CH3


781.
F
CH3
H
CN
CH3


782.
F
Et
H
CN
CH3


783.
F
CF3
H
CN
CH3


784.
F
OCH3
H
CN
CH3


785.
F
OCF3
H
CN
CH3


786.
F
CN
H
CN
CH3


787.
F
H
H
CN
Et


788.
F
F
H
CN
Et


789.
F
Cl
H
CN
Et


790.
F
Br
H
CN
Et


791.
F
I
H
CN
Et


792.
F
CH3
H
CN
Et


793.
F
Et
H
CN
Et


794.
F
CF3
H
CN
Et


795.
F
OCH3
H
CN
Et


796.
F
OCF3
H
CN
Et


797.
F
CN
H
CN
Et


798.
F
H
H
CN
n-Pr


799.
F
F
H
CN
n-Pr


800.
F
Cl
H
CN
n-Pr


801.
F
Br
H
CN
n-Pr


802.
F
I
H
CN
n-Pr


803.
F
CH3
H
CN
n-Pr


804.
F
Et
H
CN
n-Pr


805.
F
CF3
H
CN
n-Pr


806.
F
OCH3
H
CN
n-Pr


807.
F
OCF3
H
CN
n-Pr


808.
F
CN
H
CN
n-Pr


809.
F
H
H
CN
iPr


810.
F
F
H
CN
iPr


811.
F
Cl
H
CN
iPr


812.
F
Br
H
CN
iPr


813.
F
I
H
CN
iPr


814.
F
CH3
H
CN
iPr


815.
F
Et
H
CN
iPr


816.
F
CF3
H
CN
iPr


817.
F
OCH3
H
CN
iPr


818.
F
OCF3
H
CN
iPr


819.
F
CN
H
CN
iPr


820.
F
H
H
CN
cPr


821.
F
F
H
CN
cPr


822.
F
Cl
H
CN
cPr


823.
F
Br
H
CN
cPr


824.
F
I
H
CN
cPr


825.
F
CH3
H
CN
cPr


826.
F
Et
H
CN
cPr


827.
F
CF3
H
CN
cPr


828.
F
OCH3
H
CN
cPr


829.
F
OCF3
H
CN
cPr


830.
F
CN
H
CN
cPr


831.
F
H
F
H
CH3


832.
F
F
F
H
CH3


833.
F
Cl
F
H
CH3


834.
F
Br
F
H
CH3


835.
F
I
F
H
CH3


836.
F
CH3
F
H
CH3


837.
F
Et
F
H
CH3


838.
F
CF3
F
H
CH3


839.
F
OCH3
F
H
CH3


840.
F
OCF3
F
H
CH3


841.
F
CN
F
H
CH3


842.
F
H
F
H
Et


843.
F
F
F
H
Et


844.
F
Cl
F
H
Et


845.
F
Br
F
H
Et


846.
F
I
F
H
Et


847.
F
CH3
F
H
Et


848.
F
Et
F
H
Et


849.
F
CF3
F
H
Et


850.
F
OCH3
F
H
Et


851.
F
OCF3
F
H
Et


852.
F
CN
F
H
Et


853.
F
H
F
H
n-Pr


854.
F
F
F
H
n-Pr


855.
F
Cl
F
H
n-Pr


856.
F
Br
F
H
n-Pr


857.
F
I
F
H
n-Pr


858.
F
CH3
F
H
n-Pr


859.
F
Et
F
H
n-Pr


860.
F
CF3
F
H
n-Pr


861.
F
OCH3
F
H
n-Pr


862.
F
OCF3
F
H
n-Pr


863.
F
CN
F
H
n-Pr


864.
F
H
F
H
iPr


865.
F
F
F
H
iPr


866.
F
Cl
F
H
iPr


867.
F
Br
F
H
iPr


868.
F
I
F
H
iPr


869.
F
CH3
F
H
iPr


870.
F
Et
F
H
iPr


871.
F
CF3
F
H
iPr


872.
F
OCH3
F
H
iPr


873.
F
OCF3
F
H
iPr


874.
F
CN
F
H
iPr


875.
F
H
F
H
cPr


876.
F
F
F
H
cPr


877.
F
Cl
F
H
cPr


878.
F
Br
F
H
cPr


879.
F
I
F
H
cPr


880.
F
CH3
F
H
cPr


881.
F
Et
F
H
cPr


882.
F
CF3
F
H
cPr


883.
F
OCH3
F
H
cPr


884.
F
OCF3
F
H
cPr


885.
F
CN
F
H
cPr


886.
F
H
F
F
CH3


887.
F
F
F
F
CH3


888.
F
Cl
F
F
CH3


889.
F
Br
F
F
CH3


890.
F
I
F
F
CH3


891.
F
CH3
F
F
CH3


892.
F
Et
F
F
CH3


893.
F
CF3
F
F
CH3


894.
F
OCH3
F
F
CH3


895.
F
OCF3
F
F
CH3


896.
F
CN
F
F
CH3


897.
F
H
F
F
Et


898.
F
F
F
F
Et


899.
F
Cl
F
F
Et


900.
F
Br
F
F
Et


901.
F
I
F
F
Et


902.
F
CH3
F
F
Et


903.
F
Et
F
F
Et


904.
F
CF3
F
F
Et


905.
F
OCH3
F
F
Et


906.
F
OCF3
F
F
Et


907.
F
CN
F
F
Et


908.
F
H
F
F
n-Pr


909.
F
F
F
F
n-Pr


910.
F
Cl
F
F
n-Pr


911.
F
Br
F
F
n-Pr


912.
F
I
F
F
n-Pr


913.
F
CH3
F
F
n-Pr


914.
F
Et
F
F
n-Pr


915.
F
CF3
F
F
n-Pr


916.
F
OCH3
F
F
n-Pr


917.
F
OCF3
F
F
n-Pr


918.
F
CN
F
F
n-Pr


919.
F
H
F
F
iPr


920.
F
F
F
F
iPr


921.
F
Cl
F
F
iPr


922.
F
Br
F
F
iPr


923.
F
I
F
F
iPr


924.
F
CH3
F
F
iPr


925.
F
Et
F
F
iPr


926.
F
CF3
F
F
iPr


927.
F
OCH3
F
F
iPr


928.
F
OCF3
F
F
iPr


929.
F
CN
F
F
iPr


930.
F
H
F
F
cPr


931.
F
F
F
F
cPr


932.
F
Cl
F
F
cPr


933.
F
Br
F
F
cPr


934.
F
I
F
F
cPr


935.
F
CH3
F
F
cPr


936.
F
Et
F
F
cPr


937.
F
CF3
F
F
cPr


938.
F
OCH3
F
F
cPr


939.
F
OCF3
F
F
cPr


940.
F
CN
F
F
cPr


941.
F
H
F
Cl
CH3


942.
F
F
F
Cl
CH3


943.
F
Cl
F
Cl
CH3


944.
F
Br
F
Cl
CH3


945.
F
I
F
Cl
CH3


946.
F
CH3
F
Cl
CH3


947.
F
Et
F
Cl
CH3


948.
F
CF3
F
Cl
CH3


949.
F
OCH3
F
Cl
CH3


950.
F
OCF3
F
Cl
CH3


951.
F
CN
F
Cl
CH3


952.
F
H
F
Cl
Et


953.
F
F
F
Cl
Et


954.
F
Cl
F
Cl
Et


955.
F
Br
F
Cl
Et


956.
F
I
F
Cl
Et


957.
F
CH3
F
Cl
Et


958.
F
Et
F
Cl
Et


959.
F
CF3
F
Cl
Et


960.
F
OCH3
F
Cl
Et


961.
F
OCF3
F
Cl
Et


962.
F
CN
F
Cl
Et


963.
F
H
F
Cl
n-Pr


964.
F
F
F
Cl
n-Pr


965.
F
Cl
F
Cl
n-Pr


966.
F
Br
F
Cl
n-Pr


967.
F
I
F
Cl
n-Pr


968.
F
CH3
F
Cl
n-Pr


969.
F
Et
F
Cl
n-Pr


970.
F
CF3
F
Cl
n-Pr


971.
F
OCH3
F
Cl
n-Pr


972.
F
OCF3
F
Cl
n-Pr


973.
F
CN
F
Cl
n-Pr


974.
F
H
F
Cl
iPr


975.
F
F
F
Cl
iPr


976.
F
Cl
F
Cl
iPr


977.
F
Br
F
Cl
iPr


978.
F
I
F
Cl
iPr


979.
F
CH3
F
Cl
iPr


980.
F
Et
F
Cl
iPr


981.
F
CF3
F
Cl
iPr


982.
F
OCH3
F
Cl
iPr


983.
F
OCF3
F
Cl
iPr


984.
F
CN
F
Cl
iPr


985.
F
H
F
Cl
cPr


986.
F
F
F
Cl
cPr


987.
F
Cl
F
Cl
cPr


988.
F
Br
F
Cl
cPr


989.
F
I
F
Cl
cPr


990.
F
CH3
F
Cl
cPr


991.
F
Et
F
Cl
cPr


992.
F
CF3
F
Cl
cPr


993.
F
OCH3
F
Cl
cPr


994.
F
OCF3
F
Cl
cPr


995.
F
CN
F
Cl
cPr


996.
F
Br
F
Br
CH3


997.
F
Br
F
Br
Et


998.
F
Br
F
Br
n-Pr


999.
F
Br
F
Br
iPr


1000.
F
Br
F
Br
cPr


1001.
F
I
F
I
CH3


1002.
F
I
F
I
Et


1003.
F
I
F
I
n-Pr


1004.
F
I
F
I
iPr


1005.
F
I
F
I
cPr


1006.
F
H
F
CN
CH3


1007.
F
F
F
CN
CH3


1008.
F
Cl
F
CN
CH3


1009.
F
Br
F
CN
CH3


1010.
F
I
F
CN
CH3


1011.
F
CH3
F
CN
CH3


1012.
F
Et
F
CN
CH3


1013.
F
CF3
F
CN
CH3


1014.
F
OCH3
F
CN
CH3


1015.
F
OCF3
F
CN
CH3


1016.
F
CN
F
CN
CH3


1017.
F
H
F
CN
Et


1018.
F
F
F
CN
Et


1019.
F
Cl
F
CN
Et


1020.
F
Br
F
CN
Et


1021.
F
I
F
CN
Et


1022.
F
CH3
F
CN
Et


1023.
F
Et
F
CN
Et


1024.
F
CF3
F
CN
Et


1025.
F
OCH3
F
CN
Et


1026.
F
OCF3
F
CN
Et


1027.
F
CN
F
CN
Et


1028.
F
H
F
CN
n-Pr


1029.
F
F
F
CN
n-Pr


1030.
F
Cl
F
CN
n-Pr


1031.
F
Br
F
CN
n-Pr


1032.
F
I
F
CN
n-Pr


1033.
F
CH3
F
CN
n-Pr


1034.
F
Et
F
CN
n-Pr


1035.
F
CF3
F
CN
n-Pr


1036.
F
OCH3
F
CN
n-Pr


1037.
F
OCF3
F
CN
n-Pr


1038.
F
CN
F
CN
n-Pr


1039.
F
H
F
CN
iPr


1040.
F
F
F
CN
iPr


1041.
F
Cl
F
CN
iPr


1042.
F
Br
F
CN
iPr


1043.
F
I
F
CN
iPr


1044.
F
CH3
F
CN
iPr


1045.
F
Et
F
CN
iPr


1046.
F
CF3
F
CN
iPr


1047.
F
OCH3
F
CN
iPr


1048.
F
OCF3
F
CN
iPr


1049.
F
CN
F
CN
iPr


1050.
F
H
F
CN
cPr


1051.
F
F
F
CN
cPr


1052.
F
Cl
F
CN
cPr


1053.
F
Br
F
CN
cPr


1054.
F
I
F
CN
cPr


1055.
F
CH3
F
CN
cPr


1056.
F
Et
F
CN
cPr


1057.
F
CF3
F
CN
cPr


1058.
F
OCH3
F
CN
cPr


1059.
F
OCF3
F
CN
cPr


1060.
F
CN
F
CN
cPr


1061.
F
H
Cl
H
CH3


1062.
F
F
Cl
H
CH3


1063.
F
Cl
Cl
H
CH3


1064.
F
Br
Cl
H
CH3


1065.
F
I
Cl
H
CH3


1066.
F
CH3
Cl
H
CH3


1067.
F
Et
Cl
H
CH3


1068.
F
CF3
Cl
H
CH3


1069.
F
OCH3
Cl
H
CH3


1070.
F
OCF3
Cl
H
CH3


1071.
F
CN
Cl
H
CH3


1072.
F
H
Cl
H
Et


1073.
F
F
Cl
H
Et


1074.
F
Cl
Cl
H
Et


1075.
F
Br
Cl
H
Et


1076.
F
I
Cl
H
Et


1077.
F
CH3
Cl
H
Et


1078.
F
Et
Cl
H
Et


1079.
F
CF3
Cl
H
Et


1080.
F
OCH3
Cl
H
Et


1081.
F
OCF3
Cl
H
Et


1082.
F
CN
Cl
H
Et


1083.
F
H
Cl
H
n-Pr


1084.
F
F
Cl
H
n-Pr


1085.
F
Cl
Cl
H
n-Pr


1086.
F
Br
Cl
H
n-Pr


1087.
F
I
Cl
H
n-Pr


1088.
F
CH3
Cl
H
n-Pr


1089.
F
Et
Cl
H
n-Pr


1090.
F
CF3
Cl
H
n-Pr


1091.
F
OCH3
Cl
H
n-Pr


1092.
F
OCF3
Cl
H
n-Pr


1093.
F
CN
Cl
H
n-Pr


1094.
F
H
Cl
H
iPr


1095.
F
F
Cl
H
iPr


1096.
F
Cl
Cl
H
iPr


1097.
F
Br
Cl
H
iPr


1098.
F
I
Cl
H
iPr


1099.
F
CH3
Cl
H
iPr


1100.
F
Et
Cl
H
iPr


1101.
F
CF3
Cl
H
iPr


1102.
F
OCH3
Cl
H
iPr


1103.
F
OCF3
Cl
H
iPr


1104.
F
CN
Cl
H
iPr


1105.
F
H
Cl
H
cPr


1106.
F
F
Cl
H
cPr


1107.
F
Cl
Cl
H
cPr


1108.
F
Br
Cl
H
cPr


1109.
F
I
Cl
H
cPr


1110.
F
CH3
Cl
H
cPr


1111.
F
Et
Cl
H
cPr


1112.
F
CF3
Cl
H
cPr


1113.
F
OCH3
Cl
H
cPr


1114.
F
OCF3
Cl
H
cPr


1115.
F
CN
Cl
H
cPr


1116.
F
H
Cl
F
CH3


1117.
F
F
Cl
F
CH3


1118.
F
Cl
Cl
F
CH3


1119.
F
Br
Cl
F
CH3


1120.
F
I
Cl
F
CH3


1121.
F
CH3
Cl
F
CH3


1122.
F
Et
Cl
F
CH3


1123.
F
CF3
Cl
F
CH3


1124.
F
OCH3
Cl
F
CH3


1125.
F
OCF3
Cl
F
CH3


1126.
F
CN
Cl
F
CH3


1127.
F
H
Cl
F
Et


1128.
F
F
Cl
F
Et


1129.
F
Cl
Cl
F
Et


1130.
F
Br
Cl
F
Et


1131.
F
I
Cl
F
Et


1132.
F
CH3
Cl
F
Et


1133.
F
Et
Cl
F
Et


1134.
F
CF3
Cl
F
Et


1135.
F
OCH3
Cl
F
Et


1136.
F
OCF3
Cl
F
Et


1137.
F
CN
Cl
F
Et


1138.
F
H
Cl
F
n-Pr


1139.
F
F
Cl
F
n-Pr


1140.
F
Cl
Cl
F
n-Pr


1141.
F
Br
Cl
F
n-Pr


1142.
F
I
Cl
F
n-Pr


1143.
F
CH3
Cl
F
n-Pr


1144.
F
Et
Cl
F
n-Pr


1145.
F
CF3
Cl
F
n-Pr


1146.
F
OCH3
Cl
F
n-Pr


1147.
F
OCF3
Cl
F
n-Pr


1148.
F
CN
Cl
F
n-Pr


1149.
F
H
Cl
F
iPr


1150.
F
F
Cl
F
iPr


1151.
F
Cl
Cl
F
iPr


1152.
F
Br
Cl
F
iPr


1153.
F
I
Cl
F
iPr


1154.
F
CH3
Cl
F
iPr


1155.
F
Et
Cl
F
iPr


1156.
F
CF3
Cl
F
iPr


1157.
F
OCH3
Cl
F
iPr


1158.
F
OCF3
Cl
F
iPr


1159.
F
CN
Cl
F
iPr


1160.
F
H
Cl
F
cPr


1161.
F
F
Cl
F
cPr


1162.
F
Cl
Cl
F
cPr


1163.
F
Br
Cl
F
cPr


1164.
F
I
Cl
F
cPr


1165.
F
CH3
Cl
F
cPr


1166.
F
Et
Cl
F
cPr


1167.
F
CF3
Cl
F
cPr


1168.
F
OCH3
Cl
F
cPr


1169.
F
OCF3
Cl
F
cPr


1170.
F
CN
Cl
F
cPr


1171.
F
H
Cl
Cl
CH3


1172.
F
F
Cl
Cl
CH3


1173.
F
Cl
Cl
Cl
CH3


1174.
F
Br
Cl
Cl
CH3


1175.
F
I
Cl
Cl
CH3


1176.
F
CH3
Cl
Cl
CH3


1177.
F
Et
Cl
Cl
CH3


1178.
F
CF3
Cl
Cl
CH3


1179.
F
OCH3
Cl
Cl
CH3


1180.
F
OCF3
Cl
Cl
CH3


1181.
F
CN
Cl
Cl
CH3


1182.
F
H
Cl
Cl
Et


1183.
F
F
Cl
Cl
Et


1184.
F
Cl
Cl
Cl
Et


1185.
F
Br
Cl
Cl
Et


1186.
F
I
Cl
Cl
Et


1187.
F
CH3
Cl
Cl
Et


1188.
F
Et
Cl
Cl
Et


1189.
F
CF3
Cl
Cl
Et


1190.
F
OCH3
Cl
Cl
Et


1191.
F
OCF3
Cl
Cl
Et


1192.
F
CN
Cl
Cl
Et


1193.
F
H
Cl
Cl
n-Pr


1194.
F
F
Cl
Cl
n-Pr


1195.
F
Cl
Cl
Cl
n-Pr


1196.
F
Br
Cl
Cl
n-Pr


1197.
F
I
Cl
Cl
n-Pr


1198.
F
CH3
Cl
Cl
n-Pr


1199.
F
Et
Cl
Cl
n-Pr


1200.
F
CF3
Cl
Cl
n-Pr


1201.
F
OCH3
Cl
Cl
n-Pr


1202.
F
OCF3
Cl
Cl
n-Pr


1203.
F
CN
Cl
Cl
n-Pr


1204.
F
H
Cl
Cl
iPr


1205.
F
F
Cl
Cl
iPr


1206.
F
Cl
Cl
Cl
iPr


1207.
F
Br
Cl
Cl
iPr


1208.
F
I
Cl
Cl
iPr


1209.
F
CH3
Cl
Cl
iPr


1210.
F
Et
Cl
Cl
iPr


1211.
F
CF3
Cl
Cl
iPr


1212.
F
OCH3
Cl
Cl
iPr


1213.
F
OCF3
Cl
Cl
iPr


1214.
F
CN
Cl
Cl
iPr


1215.
F
H
Cl
Cl
cPr


1216.
F
F
Cl
Cl
cPr


1217.
F
Cl
Cl
Cl
cPr


1218.
F
Br
Cl
Cl
cPr


1219.
F
I
Cl
Cl
cPr


1220.
F
CH3
Cl
Cl
cPr


1221.
F
Et
Cl
Cl
cPr


1222.
F
CF3
Cl
Cl
cPr


1223.
F
OCH3
Cl
Cl
cPr


1224.
F
OCF3
Cl
Cl
cPr


1225.
F
CN
Cl
Cl
cPr


1226.
F
Br
Cl
Br
CH3


1227.
F
Br
Cl
Br
Et


1228.
F
Br
Cl
Br
n-Pr


1229.
F
Br
Cl
Br
iPr


1230.
F
Br
Cl
Br
cPr


1231.
F
I
Cl
I
CH3


1232.
F
I
Cl
I
Et


1233.
F
I
Cl
I
n-Pr


1234.
F
I
Cl
I
iPr


1235.
F
I
Cl
I
cPr


1236.
F
H
Cl
CN
CH3


1237.
F
F
Cl
CN
CH3


1238.
F
Cl
Cl
CN
CH3


1239.
F
Br
Cl
CN
CH3


1240.
F
I
Cl
CN
CH3


1241.
F
CH3
Cl
CN
CH3


1242.
F
Et
Cl
CN
CH3


1243.
F
CF3
Cl
CA
CH3


1244.
F
OCH3
Cl
CN
CH3


1245.
F
OCF3
Cl
CN
CH3


1246.
F
CN
Cl
CN
CH3


1247.
F
H
Cl
CN
Et


1248.
F
F
Cl
CN
Et


1249.
F
Cl
Cl
CN
Et


1250.
F
Br
Cl
CN
Et


1251.
F
I
Cl
CN
Et


1252.
F
CH3
Cl
CN
Et


1253.
F
Et
Cl
CN
Et


1254.
F
CF3
Cl
CN
Et


1255.
F
OCH3
Cl
CN
Et


1256.
F
OCF3
Cl
CN
Et


1257.
F
CN
Cl
CA
Et


1258.
F
H
Cl
CN
n-Pr


1259.
F
F
Cl
CN
n-Pr


1260.
F
Cl
Cl
CN
n-Pr


1261.
F
Br
Cl
CN
n-Pr


1262.
F
I
Cl
CN
n-Pr


1263.
F
CH3
Cl
CN
n-Pr


1264.
F
Et
Cl
CN
n-Pr


1265.
F
CF3
Cl
CN
n-Pr


1266.
F
OCH3
Cl
CN
n-Pr


1267.
F
OCF3
Cl
CN
n-Pr


1268.
F
CN
Cl
CN
n-Pr


1269.
F
H
Cl
CN
iPr


1270.
F
F
Cl
CN
iPr


1271.
F
Cl
Cl
CN
iPr


1272.
F
Br
Cl
CN
iPr


1273.
F
I
Cl
CN
iPr


1274.
F
CH3
Cl
CN
iPr


1275.
F
Et
Cl
CN
iPr


1276.
F
CF3
Cl
CN
iPr


1277.
F
OCH3
Cl
CN
iPr


1278.
F
OCF3
Cl
CN
iPr


1279.
F
CN
Cl
CN
iPr


1280.
F
H
Cl
CN
cPr


1281.
F
F
Cl
CN
cPr


1282.
F
Cl
Cl
CN
cPr


1283.
F
Br
Cl
CN
cPr


1284.
F
I
Cl
CN
cPr


1285.
F
CH3
Cl
CN
cPr


1286.
F
Et
Cl
CN
cPr


1287.
F
CF3
Cl
CN
cPr


1288.
F
OCH3
Cl
CN
cPr


1289.
F
OCF3
Cl
CN
cPr


1290.
F
CN
Cl
CN
cPr


1291.
Cl
H
H
H
CH3


1292.
Cl
F
H
H
CH3


1293.
Cl
Cl
H
H
CH3


1294.
Cl
Br
H
H
CH3


1295.
Cl
I
H
H
CH3


1296.
Cl
CH3
H
H
CH3


1297.
Cl
Et
H
H
CH3


1298.
Cl
CF
H
H
CH3


1299.
Cl
OCH3
H
H
CH3


1300.
Cl
OCF3
H
H
CH3


1301.
Cl
CN
H
H
CH3


1302.
Cl
H
H
H
Et


1303.
Cl
F
H
H
Et


1304.
Cl
Cl
H
H
Et


1305.
Cl
Br
H
H
Et


1306.
Cl
I
H
H
Et


1307.
Cl
CH3
H
H
Et


1308.
Cl
Et
H
H
Et


1309.
Cl
CF3
H
H
Et


1310.
Cl
OCH3
H
H
Et


1311.
Cl
OCF3
H
H
Et


1312.
Cl
CN
H
H
Et


1313.
Cl
H
H
H
n-Pr


1314.
Cl
F
H
H
n-Pr


1315.
Cl
Cl
H
H
n-Pr


1316.
Cl
Br
H
H
n-Pr


1317.
Cl
I
H
H
n-Pr


1318.
Cl
CH3
H
H
n-Pr


1319.
Cl
Et
H
H
n-Pr


1320.
Cl
CF3
H
H
n-Pr


1321.
Cl
OCH3
H
H
n-Pr


1322.
Cl
OCF3
H
H
n-Pr


1323.
Cl
CN
H
H
n-Pr


1324.
Cl
H
H
H
iPr


1325.
Cl
F
H
H
iPr


1326.
Cl
Cl
H
H
iPr


1327.
Cl
Br
H
H
iPr


1328.
Cl
I
H
H
iPr


1329.
Cl
CH3
H
H
iPr


1330.
Cl
Et
H
H
iPr


1331.
Cl
CF3
H
H
iPr


1332.
Cl
OCH3
H
H
iPr


1333.
Cl
OCF3
H
H
iPr


1334.
Cl
CN
H
H
iPr


1335.
Cl
H
H
H
cPr


1336.
Cl
F
H
H
cPr


1337.
Cl
Cl
H
H
cPr


1338.
Cl
Br
H
H
cPr


1339.
Cl
I
H
H
cPr


1340.
Cl
CH3
H
H
cPr


1341.
Cl
Et
H
H
cPr


1342.
Cl
CF3
H
H
cPr


1343.
Cl
OCH3
H
H
cPr


1344.
Cl
OCF3
H
H
cPr


1345.
Cl
CN
H
H
cPr


1346.
Cl
H
H
F
CH3


1347.
Cl
F
H
F
CH3


1348.
Cl
Cl
H
F
CH3


1349.
Cl
Br
H
F
CH3


1350.
Cl
I
H
F
CH3


1351.
Cl
CH3
H
F
CH3


1352.
Cl
Et
H
F
CH3


1353.
Cl
CF3
H
F
CH3


1354.
Cl
OCH3
H
F
CH3


1355.
Cl
OCF3
H
F
CH3


1356.
Cl
CN
H
F
CH3


1357.
Cl
H
H
F
Et


1358.
Cl
F
H
F
Et


1359.
Cl
Cl
H
F
Et


1360.
Cl
Br
H
F
Et


1361.
Cl
I
H
F
Et


1362.
Cl
CH3
H
F
Et


1363.
Cl
Et
H
F
Et


1364.
Cl
CF3
H
F
Et


1365.
Cl
OCH3
H
F
Et


1366.
Cl
OCF3
H
F
Et


1367.
Cl
CN
H
F
Et


1368.
Cl
H
H
F
n-Pr


1369.
Cl
F
H
F
n-Pr


1370.
Cl
Cl
H
F
n-Pr


1371.
Cl
Br
H
F
n-Pr


1372.
Cl
I
H
F
n-Pr


1373.
Cl
CH3
H
F
n-Pr


1374.
Cl
Et
H
F
n-Pr


1375.
Cl
CF3
H
F
n-Pr


1376.
Cl
OCH3
H
F
n-Pr


1377.
Cl
OCF3
H
F
n-Pr


1378.
Cl
CN
H
F
n-Pr


1379.
Cl
H
H
F
iPr


1380.
Cl
F
H
F
iPr


1381.
Cl
Cl
H
F
iPr


1382.
Cl
Br
H
F
iPr


1383.
Cl
I
H
F
iPr


1384.
Cl
CH3
H
F
iPr


1385.
Cl
Et
H
F
iPr


1386.
Cl
CF3
H
F
iPr


1387.
Cl
OCH3
H
F
iPr


1388.
Cl
OCF3
H
F
iPr


1389.
Cl
CN
H
F
iPr


1390.
Cl
H
H
F
cPr


1391.
Cl
F
H
F
cPr


1392.
Cl
Cl
H
F
cPr


1393.
Cl
Br
H
F
cPr


1394.
Cl
I
H
F
cPr


1395.
Cl
CH3
H
F
cPr


1396.
Cl
Et
H
F
cPr


1397.
Cl
CF3
H
F
cPr


1398.
Cl
OCH3
H
F
cPr


1399.
Cl
OCF3
H
F
cPr


1400.
Cl
CN
H
F
cPr


1401.
Cl
H
H
Cl
CH3


1402.
Cl
F
H
Cl
CH3


1403.
Cl
Cl
H
Cl
CH3


1404.
Cl
Br
H
Cl
CH3


1405.
Cl
I
H
Cl
CH3


1406.
Cl
CH3
H
Cl
CH3


1407.
Cl
Et
H
Cl
CH3


1408.
Cl
CF3
H
Cl
CH3


1409.
Cl
OCH3
H
Cl
CH3


1410.
Cl
OCF3
H
Cl
CH3


1411.
Cl
CN
H
Cl
CH3


1412.
Cl
H
H
Cl
Et


1413.
Cl
F
H
Cl
Et


1414.
Cl
Cl
H
Cl
Et


1415.
Cl
Br
H
Cl
Et


1416.
Cl
I
H
Cl
Et


1417.
Cl
CH3
H
Cl
Et


1418.
Cl
Et
H
Cl
Et


1419.
Cl
CF3
H
Cl
Et


1420.
Cl
OCH3
H
Cl
Et


1421.
Cl
OCF3
H
Cl
Et


1422.
Cl
CN
H
Cl
Et


1423.
Cl
H
H
Cl
n-Pr


1424.
Cl
F
H
Cl
n-Pr


1425.
Cl
Cl
H
Cl
n-Pr


1426.
Cl
Br
H
Cl
n-Pr


1427.
Cl
I
H
Cl
n-Pr


1428.
Cl
CH3
H
Cl
n-Pr


1429.
Cl
Et
H
Cl
n-Pr


1430.
Cl
CF3
H
Cl
n-Pr


1431.
Cl
OCH3
H
Cl
n-Pr


1432.
Cl
OCF3
H
Cl
n-Pr


1433.
Cl
CN
H
Cl
n-Pr


1434.
Cl
H
H
Cl
iPr


1435.
Cl
F
H
Cl
iPr


1436.
Cl
Cl
H
Cl
iPr


1437.
Cl
Br
H
Cl
iPr


1438.
Cl
I
H
Cl
iPr


1439.
Cl
CH3
H
Cl
iPr


1440.
Cl
Et
H
Cl
iPr


1441.
Cl
CF3
H
Cl
iPr


1442.
Cl
OCH3
H
Cl
iPr


1443.
Cl
OCF3
H
Cl
iPr


1444.
Cl
CN
H
Cl
iPr


1445.
Cl
H
H
Cl
cPr


1446.
Cl
F
H
Cl
cPr


1447.
Cl
Cl
H
Cl
cPr


1448.
Cl
Br
H
Cl
cPr


1449.
Cl
I
H
Cl
cPr


1450.
Cl
CH3
H
Cl
cPr


1451.
Cl
Et
H
Cl
cPr


1452.
Cl
CF3
H
Cl
cPr


1453.
Cl
OCH3
H
Cl
cPr


1454.
Cl
OCF3
H
Cl
cPr


1455.
Cl
CN
H
Cl
cPr


1456.
Cl
Br
H
Br
CH3


1457.
Cl
Br
H
Br
Et


1458.
Cl
Br
H
Br
n-Pr


1459.
Cl
Br
H
Br
iPr


1460.
Cl
Br
H
Br
cPr


1461.
Cl
I
H
I
CH3


1462.
Cl
I
H
I
Et


1463.
Cl
I
H
I
n-Pr


1464.
Cl
I
H
I
iPr


1465.
Cl
I
H
I
cPr


1466.
Cl
H
H
CN
CH3


1467.
Cl
F
H
CN
CH3


1468.
Cl
Cl
H
CN
CH3


1469.
Cl
Br
H
CN
CH3


1470.
Cl
I
H
CN
CH3


1471.
Cl
CH3
H
CN
CH3


1472.
Cl
Et
H
CN
CH3


1473.
Cl
CF3
H
CN
CH3


1474.
Cl
OCH3
H
CN
CH3


1475.
Cl
OCF3
H
CN
CH3


1476.
Cl
CN
H
CN
CH3


1477.
Cl
H
H
CN
Et


1478.
Cl
F
H
CN
Et


1479.
Cl
Cl
H
CN
Et


1480.
Cl
Br
H
CN
Et


1481.
Cl
I
H
CN
Et


1482.
Cl
CH3
H
CN
Et


1483.
Cl
Et
H
CN
Et


1484.
Cl
CF3
H
CN
Et


1485.
Cl
OCH3
H
CN
Et


1486.
Cl
OCF3
H
CN
Et


1487.
Cl
CN
H
CN
Et


1488.
Cl
H
H
CN
n-Pr


1489.
Cl
F
H
CN
n-Pr


1490.
Cl
Cl
H
CN
n-Pr


1491.
Cl
Br
H
CN
n-Pr


1492.
Cl
I
H
CN
n-Pr


1493.
Cl
CH3
H
CN
n-Pr


1494.
Cl
Et
H
CN
n-Pr


1495.
Cl
CF3
H
CN
n-Pr


1496.
Cl
OCH3
H
CN
n-Pr


1497.
Cl
OCF3
H
CN
n-Pr


1498.
Cl
CN
H
CN
n-Pr


1499.
Cl
H
H
CN
iPr


1500.
Cl
F
H
CN
iPr


1501.
Cl
Cl
H
CN
iPr


1502.
Cl
Br
H
CN
iPr


1503.
Cl
I
H
CN
iPr


1504.
Cl
CH3
H
CN
iPr


1505.
Cl
Et
H
CN
iPr


1506.
Cl
CF3
H
CN
iPr


1507.
Cl
OCH3
H
CN
iPr


1508.
Cl
OCF3
H
CN
iPr


1509.
Cl
CN
H
CN
iPr


1510.
Cl
H
H
CN
cPr


1511.
Cl
F
H
CN
cPr


1512.
Cl
Cl
H
CN
cPr


1513.
Cl
Br
H
CN
cPr


1514.
Cl
I
H
CN
cPr


1515.
Cl
CH3
H
CN
cPr


1516.
Cl
Et
H
CN
cPr


1517.
Cl
CF3
H
CN
cPr


1518.
Cl
OCH3
H
CN
cPr


1519.
Cl
OCF3
H
CN
cPr


1520.
Cl
CN
H
CN
cPr


1521.
Cl
H
F
H
CH3


1522.
Cl
F
F
H
CH3


1523.
Cl
Cl
F
H
CH3


1524.
Cl
Br
F
H
CH3


1525.
Cl
I
F
H
CH3


1526.
Cl
CH3
F
H
CH3


1527.
Cl
Et
F
H
CH3


1528.
Cl
CF3
F
H
CH3


1529.
Cl
OCH3
F
H
CH3


1530.
Cl
OCF3
F
H
CH3


1531.
Cl
CN
F
H
CH3


1532.
Cl
H
F
H
Et


1533.
Cl
F
F
H
Et


1534.
Cl
Cl
F
H
Et


1535.
Cl
Br
F
H
Et


1536.
Cl
I
F
H
Et


1537.
Cl
CH3
F
H
Et


1538.
Cl
Et
F
H
Et


1539.
Cl
CF
F
H
Et


1540.
Cl
OCH3
F
H
Et


1541.
Cl
OCF3
F
H
Et


1542.
Cl
CN
F
H
Et


1543.
Cl
H
F
H
n-Pr


1544.
Cl
F
F
H
n-Pr


1545.
Cl
Cl
F
H
n-Pr


1546.
Cl
Br
F
H
n-Pr


1547.
Cl
I
F
H
n-Pr


1548.
Cl
CH3
F
H
n-Pr


1549.
Cl
Et
F
H
n-Pr


1550.
Cl
CF3
F
H
n-Pr


1551.
Cl
OCH3
F
H
n-Pr


1552.
Cl
OCF3
F
H
n-Pr


1553.
Cl
CN
F
H
n-Pr


1554.
Cl
H
F
H
iPr


1555.
Cl
F
F
H
iPr


1556.
Cl
Cl
F
H
iPr


1557.
Cl
Br
F
H
iPr


1558.
Cl
I
F
H
iPr


1559.
Cl
CH3
F
H
iPr


1560.
Cl
Et
F
H
iPr


1561.
Cl
CF3
F
H
iPr


1562.
Cl
OCH3
F
H
iPr


1563.
Cl
OCF3
F
H
iPr


1564.
Cl
CN
F
H
iPr


1565.
Cl
H
F
H
cPr


1566.
Cl
F
F
H
cPr


1567.
Cl
Cl
F
H
cPr


1568.
Cl
Br
F
H
cPr


1569.
Cl
I
F
H
cPr


1570.
Cl
CH3
F
H
cPr


1571.
Cl
Et
F
H
cPr


1572.
Cl
CF3
F
H
cPr


1573.
Cl
OCH3
F
H
cPr


1574.
Cl
OCF3
F
H
cPr


1575.
Cl
CN
F
H
cPr


1576.
Cl
H
F
F
CH3


1577.
Cl
F
F
F
CH3


1578.
Cl
Cl
F
F
CH3


1579.
Cl
Br
F
F
CH3


1580.
Cl
I
F
F
CH3


1581.
Cl
CH3
F
F
CH3


1582.
Cl
Et
F
F
CH3


1583.
Cl
CF3
F
F
CH3


1584.
Cl
OCH3
F
F
CH3


1585.
Cl
OCF3
F
F
CH3


1586.
Cl
CN
F
F
CH3


1587.
Cl
H
F
F
Et


1588.
Cl
F
F
F
Et


1589.
Cl
Cl
F
F
Et


1590.
Cl
Br
F
F
Et


1591.
Cl
I
F
F
Et


1592.
Cl
CH3
F
F
Et


1593.
Cl
Et
F
F
Et


1594.
Cl
CF3
F
F
Et


1595.
Cl
OCH3
F
F
Et


1596.
Cl
OCF3
F
F
Et


1597.
Cl
CN
F
F
Et


1598.
Cl
H
F
F
n-Pr


1599.
Cl
F
F
F
n-Pr


1600.
Cl
Cl
F
F
n-Pr


1601.
Cl
Br
F
F
n-Pr


1602.
Cl
I
F
F
n-Pr


1603.
Cl
CH3
F
F
n-Pr


1604.
Cl
Et
F
F
n-Pr


1605.
Cl
CF3
F
F
n-Pr


1606.
Cl
OCH3
F
F
n-Pr


1607.
Cl
OCF3
F
F
n-Pr


1608.
Cl
CN
F
F
n-Pr


1609.
Cl
H
F
F
iPr


1610.
Cl
F
F
F
iPr


1611.
Cl
Cl
F
F
iPr


1612.
Cl
Br
F
F
iPr


1613.
Cl
I
F
F
iPr


1614.
Cl
CH3
F
F
iPr


1615.
Cl
Et
F
F
iPr


1616.
Cl
CF3
F
F
iPr


1617.
Cl
OCH3
F
F
iPr


1618.
Cl
OCF3
F
F
iPr


1619.
Cl
CN
F
F
iPr


1620.
Cl
H
F
F
cPr


1621.
Cl
F
F
F
cPr


1622.
Cl
Cl
F
F
cPr


1623.
Cl
Br
F
F
cPr


1624.
Cl
I
F
F
cPr


1625.
Cl
CH3
F
F
cPr


1626.
Cl
Et
F
F
cPr


1627.
Cl
CF3
F
F
cPr


1628.
Cl
OCH3
F
F
cPr


1629.
Cl
OCF3
F
F
cPr


1630.
Cl
CN
F
F
cPr


1631.
Cl
H
F
Cl
CH3


1632.
Cl
F
F
Cl
CH3


1633.
Cl
Cl
F
Cl
CH3


1634.
Cl
Br
F
Cl
CH3


1635.
Cl
I
F
Cl
CH3


1636.
Cl
CH3
F
Cl
CH3


1637.
Cl
Et
F
Cl
CH3


1638.
Cl
CF3
F
Cl
CH3


1639.
Cl
OCH3
F
Cl
CH3


1640.
Cl
OCF3
F
Cl
CH3


1641.
Cl
CN
F
Cl
CH3


1642.
Cl
H
F
Cl
Et


1643.
Cl
F
F
Cl
Et


1644.
Cl
Cl
F
Cl
Et


1645.
Cl
Br
F
Cl
Et


1646.
Cl
I
F
Cl
Et


1647.
Cl
CH3
F
Cl
Et


1648.
Cl
Et
F
Cl
Et


1649.
Cl
CF3
F
Cl
Et


1650.
Cl
OCH3
F
Cl
Et


1651.
Cl
OCF3
F
Cl
Et


1652.
Cl
CN
F
Cl
Et


1653.
Cl
H
F
Cl
n-Pr


1654.
Cl
F
F
Cl
n-Pr


1655.
Cl
Cl
F
Cl
n-Pr


1656.
Cl
Br
F
Cl
n-Pr


1657.
Cl
I
F
Cl
n-Pr


1658.
Cl
CH3
F
Cl
n-Pr


1659.
Cl
Et
F
Cl
n-Pr


1660.
Cl
CF3
F
Cl
n-Pr


1661.
Cl
OCH3
F
Cl
n-Pr


1662.
Cl
OCF3
F
Cl
n-Pr


1663.
Cl
CN
F
Cl
n-Pr


1664.
Cl
H
F
Cl
iPr


1665.
Cl
F
F
Cl
iPr


1666.
Cl
Cl
F
Cl
iPr


1667.
Cl
Br
F
Cl
iPr


1668.
Cl
I
F
Cl
iPr


1669.
Cl
CH3
F
Cl
iPr


1670.
Cl
Et
F
Cl
iPr


1671.
Cl
CF3
F
Cl
iPr


1672.
Cl
OCH3
F
Cl
iPr


1673.
Cl
OCF3
F
Cl
iPr


1674.
Cl
CN
F
Cl
iPr


1675.
Cl
H
F
Cl
cPr


1676.
Cl
F
F
Cl
cPr


1677.
Cl
Cl
F
Cl
cPr


1678.
Cl
Br
F
Cl
cPr


1679.
Cl
I
F
Cl
cPr


1680.
Cl
CH3
F
Cl
cPr


1681.
Cl
Et
F
Cl
cPr


1682.
Cl
CF3
F
Cl
cPr


1683.
Cl
OCH3
F
Cl
cPr


1684.
Cl
OCF3
F
Cl
cPr


1685.
Cl
CN
F
Cl
cPr


1686.
Cl
Br
F
Br
CH3


1687.
Cl
Br
F
Br
Et


1688.
Cl
Br
F
Br
n-Pr


1689.
Cl
Br
F
Br
iPr


1690.
Cl
Br
F
Br
cPr


1691.
Cl
I
F
I
CH3


1692.
Cl
I
F
I
Et


1693.
Cl
I
F
I
n-Pr


1694.
Cl
I
F
I
iPr


1695.
Cl
I
F
I
cPr


1696.
Cl
H
F
CN
CH3


1697.
Cl
F
F
CN
CH3


1698.
Cl
Cl
F
CN
CH3


1699.
Cl
Br
F
CN
CH3


1700.
Cl
I
F
CN
CH3


1701.
Cl
CH3
F
CN
CH3


1702.
Cl
Et
F
CN
CH3


1703.
Cl
CF3
F
CN
CH3


1704.
Cl
OCH3
F
CN
CH3


1705.
Cl
OCF3
F
CN
CH3


1706.
Cl
CN
F
CN
CH3


1707.
Cl
H
F
CN
Et


1708.
Cl
F
F
CN
Et


1709.
Cl
Cl
F
CN
Et


1710.
Cl
Br
F
CN
Et


1711.
Cl
I
F
CN
Et


1712.
Cl
CH3
F
CN
Et


1713.
Cl
Et
F
CN
Et


1714.
Cl
CF3
F
CN
Et


1715.
Cl
OCH3
F
CN
Et


1716.
Cl
OCF3
F
CN
Et


1717.
Cl
CN
F
CN
Et


1718.
Cl
H
F
CN
n-Pr


1719.
Cl
F
F
CN
n-Pr


1720.
Cl
Cl
F
CN
n-Pr


1721.
Cl
Br
F
CN
n-Pr


1722.
Cl
I
F
CN
n-Pr


1723.
Cl
CH3
F
CN
n-Pr


1724.
Cl
Et
F
CN
n-Pr


1725.
Cl
CF3
F
CN
n-Pr


1726.
Cl
OCH3
F
CN
n-Pr


1727.
Cl
OCF3
F
CN
n-Pr


1728.
Cl
CN
F
CN
n-Pr


1729.
Cl
H
F
CN
iPr


1730.
Cl
F
F
CN
iPr


1731.
Cl
Cl
F
CN
iPr


1732.
Cl
Br
F
CN
iPr


1733.
Cl
I
F
CN
iPr


1734.
Cl
CH3
F
CN
iPr


1735.
Cl
Et
F
CN
iPr


1736.
Cl
CF3
F
CN
iPr


1737.
Cl
OCH3
F
CN
iPr


1738.
Cl
OCF3
F
CN
iPr


1739.
Cl
CN
F
CN
iPr


1740.
Cl
H
F
CN
cPr


1741.
Cl
F
F
CN
cPr


1742.
Cl
Cl
F
CN
cPr


1743.
Cl
Br
F
CN
cPr


1744.
Cl
I
F
CN
cPr


1745.
Cl
CH3
F
CN
cPr


1746.
Cl
Et
F
CN
cPr


1747.
Cl
CF3
F
CN
cPr


1748.
Cl
OCH3
F
CN
cPr


1749.
Cl
OCF3
F
CN
cPr


1750.
Cl
CN
F
CN
cPr


1751.
Cl
H
Cl
H
CH3


1752.
Cl
F
Cl
H
CH3


1753.
Cl
Cl
Cl
H
CH3


1754.
Cl
Br
Cl
H
CH3


1755.
Cl
I
Cl
H
CH3


1756.
Cl
CH3
Cl
H
CH3


1757.
Cl
Et
Cl
H
CH3


1758.
Cl
CF3
Cl
H
CH3


1759.
Cl
OCH3
Cl
H
CH3


1760.
Cl
OCF3
Cl
H
CH3


1761.
Cl
CN
Cl
H
CH3


1762.
Cl
H
Cl
H
Et


1763.
Cl
F
Cl
H
Et


1764.
Cl
Cl
Cl
H
Et


1765.
Cl
Br
Cl
H
Et


1766.
Cl
I
Cl
H
Et


1767.
Cl
CH3
Cl
H
Et


1768.
Cl
Et
Cl
H
Et


1769.
Cl
CF3
Cl
H
Et


1770.
Cl
OCH3
Cl
H
Et


1771.
Cl
OCF3
Cl
H
Et


1772.
Cl
CN
Cl
H
Et


1773.
Cl
H
Cl
H
n-Pr


1774.
Cl
F
Cl
H
n-Pr


1775.
Cl
Cl
Cl
H
n-Pr


1776.
Cl
Br
Cl
H
n-Pr


1777.
Cl
I
Cl
H
n-Pr


1778.
Cl
CH3
Cl
H
n-Pr


1779.
Cl
Et
Cl
H
n-Pr


1780.
Cl
CF3
Cl
H
n-Pr


1781.
Cl
OCH3
Cl
H
n-Pr


1782.
Cl
OCF3
Cl
H
n-Pr


1783.
Cl
CN
Cl
H
n-Pr


1784.
Cl
H
Cl
H
iPr


1785.
Cl
F
Cl
H
iPr


1786.
Cl
Cl
Cl
H
iPr


1787.
Cl
Br
Cl
H
iPr


1788.
Cl
I
Cl
H
iPr


1789.
Cl
CH3
Cl
H
iPr


1790.
Cl
Et
Cl
H
iPr


1791.
Cl
CF3
Cl
H
iPr


1792.
Cl
OCH3
Cl
H
iPr


1793.
Cl
OCF3
Cl
H
iPr


1794.
Cl
CN
Cl
H
iPr


1795.
Cl
H
Cl
H
cPr


1796.
Cl
F
Cl
H
cPr


1797.
Cl
Cl
Cl
H
cPr


1798.
Cl
Br
Cl
H
cPr


1799.
Cl
I
Cl
H
cPr


1800.
Cl
CH3
Cl
H
cPr


1801.
Cl
Et
Cl
H
cPr


1802.
Cl
CF3
Cl
H
cPr


1803.
Cl
OCH3
Cl
H
cPr


1804.
Cl
OCF3
Cl
H
cPr


1805.
Cl
CN
Cl
H
cPr


1806.
Cl
H
Cl
F
CH3


1807.
Cl
F
Cl
F
CH3


1808.
Cl
Cl
Cl
F
CH3


1809.
Cl
Br
Cl
F
CH3


1810.
Cl
I
Cl
F
CH3


1811.
Cl
CH3
Cl
F
CH3


1812.
Cl
Et
Cl
F
CH3


1813.
Cl
CF
Cl
F
CH3


1814.
Cl
OCH3
Cl
F
CH3


1815.
Cl
OCF3
Cl
F
CH3


1816.
Cl
CN
Cl
F
CH3


1817.
Cl
H
Cl
F
Et


1818.
Cl
F
Cl
F
Et


1819.
Cl
Cl
Cl
F
Et


1820.
Cl
Br
Cl
F
Et


1821.
Cl
I
Cl
F
Et


1822.
Cl
CH3
Cl
F
Et


1823.
Cl
Et
Cl
F
Et


1824.
Cl
CF3
Cl
F
Et


1825.
Cl
OCH3
Cl
F
Et


1826.
Cl
OCF3
Cl
F
Et


1827.
Cl
CN
Cl
F
Et


1828.
Cl
H
Cl
F
n-Pr


1829.
Cl
F
Cl
F
n-Pr


1830.
Cl
Cl
Cl
F
n-Pr


1831.
Cl
Br
Cl
F
n-Pr


1832.
Cl
I
Cl
F
n-Pr


1833.
Cl
CH3
Cl
F
n-Pr


1834.
Cl
Et
Cl
F
n-Pr


1835.
Cl
CF3
Cl
F
n-Pr


1836.
Cl
OCH3
Cl
F
n-Pr


1837.
Cl
OCF3
Cl
F
n-Pr


1838.
Cl
CN
Cl
F
n-Pr


1839.
Cl
H
Cl
F
iPr


1840.
Cl
F
Cl
F
iPr


1841.
Cl
Cl
Cl
F
iPr


1842.
Cl
Br
Cl
F
iPr


1843.
Cl
I
Cl
F
iPr


1844.
Cl
CH3
Cl
F
iPr


1845.
Cl
Et
Cl
F
iPr


1846.
Cl
CF3
Cl
F
iPr


1847.
Cl
OCH3
Cl
F
iPr


1848.
Cl
OCF3
Cl
F
iPr


1849.
Cl
CN
Cl
F
iPr


1850.
Cl
H
Cl
F
cPr


1851.
Cl
F
Cl
F
cPr


1852.
Cl
Cl
Cl
F
cPr


1853.
Cl
Br
Cl
F
cPr


1854.
Cl
I
Cl
F
cPr


1855.
Cl
CH3
Cl
F
cPr


1856.
Cl
Et
Cl
F
cPr


1857.
Cl
CF3
Cl
F
cPr


1858.
Cl
OCH3
Cl
F
cPr


1859.
Cl
OCF3
Cl
F
cPr


1860.
Cl
CN
Cl
F
cPr


1861.
Cl
H
Cl
Cl
CH3


1862.
Cl
F
Cl
Cl
CH3


1863.
Cl
Cl
Cl
Cl
CH3


1864.
Cl
Br
Cl
Cl
CH3


1865.
Cl
I
Cl
Cl
CH3


1866.
Cl
CH3
Cl
Cl
CH3


1867.
Cl
Et
Cl
Cl
CH3


1868.
Cl
CF3
Cl
Cl
CH3


1869.
Cl
OCH3
Cl
Cl
CH3


1870.
Cl
OCF3
Cl
Cl
CH3


1871.
Cl
CN
Cl
Cl
CH3


1872.
Cl
H
Cl
Cl
Et


1873.
Cl
F
Cl
Cl
Et


1874.
Cl
Cl
Cl
Cl
Et


1875.
Cl
Br
Cl
Cl
Et


1876.
Cl
I
Cl
Cl
Et


1877.
Cl
CH3
Cl
Cl
Et


1878.
Cl
Et
Cl
Cl
Et


1879.
Cl
CF
Cl
Cl
Et


1880.
Cl
OCH3
Cl
Cl
Et


1881.
Cl
OCF3
Cl
Cl
Et


1882.
Cl
CN
Cl
Cl
Et


1883.
Cl
H
Cl
Cl
n-Pr


1884.
Cl
F
Cl
Cl
n-Pr


1885.
Cl
Cl
Cl
Cl
n-Pr


1886.
Cl
Br
Cl
Cl
n-Pr


1887.
Cl
I
Cl
Cl
n-Pr


1888.
Cl
CH3
Cl
Cl
n-Pr


1889.
Cl
Et
Cl
Cl
n-Pr


1890.
Cl
CF3
Cl
Cl
n-Pr


1891.
Cl
OCH3
Cl
Cl
n-Pr


1892.
Cl
OCF3
Cl
Cl
n-Pr


1893.
Cl
CN
Cl
Cl
n-Pr


1894.
Cl
H
Cl
Cl
iPr


1895.
Cl
F
Cl
Cl
iPr


1896.
Cl
Cl
Cl
Cl
iPr


1897.
Cl
Br
Cl
Cl
iPr


1898.
Cl
I
Cl
Cl
iPr


1899.
Cl
CH3
Cl
Cl
iPr


1900.
Cl
Et
Cl
Cl
iPr


1901.
Cl
CF3
Cl
Cl
iPr


1902.
Cl
OCH3
Cl
Cl
iPr


1903.
Cl
OCF3
Cl
Cl
iPr


1904.
Cl
CN
Cl
Cl
iPr


1905.
Cl
H
Cl
Cl
cPr


1906.
Cl
F
Cl
Cl
cPr


1907.
Cl
Cl
Cl
Cl
cPr


1908.
Cl
Br
Cl
Cl
cPr


1909.
Cl
I
Cl
Cl
cPr


1910.
Cl
CH3
Cl
Cl
cPr


1911.
Cl
Et
Cl
Cl
cPr


1912.
Cl
CF3
Cl
Cl
cPr


1913.
Cl
OCH3
Cl
Cl
cPr


1914.
Cl
OCF3
Cl
Cl
cPr


1915.
Cl
CN
Cl
Cl
cPr


1916.
Cl
Br
Cl
Br
CH3


1917.
Cl
Br
Cl
Br
Et


1918.
Cl
Br
Cl
Br
n-Pr


1919.
Cl
Br
Cl
Br
iPr


1920.
Cl
Br
Cl
Br
cPr


1921.
Cl
I
Cl
I
CH3


1922.
Cl
I
Cl
I
Et


1923.
Cl
I
Cl
I
n-Pr


1924.
Cl
I
Cl
I
iPr


1925.
Cl
I
Cl
I
cPr


1926.
Cl
H
Cl
CN
CH3


1927.
Cl
F
Cl
CN
CH3


1928.
Cl
Cl
Cl
CN
CH3


1929.
Cl
Br
Cl
CN
CH3


1930.
Cl
I
Cl
CN
CH3


1931.
Cl
CH3
Cl
CN
CH3


1932.
Cl
Et
Cl
CN
CH3


1933.
Cl
CF3
Cl
CN
CH3


1934.
Cl
OCH3
Cl
CN
CH3


1935.
Cl
OCF3
Cl
CN
CH3


1936.
Cl
CN
Cl
CN
CH3


1937.
Cl
H
Cl
CN
Et


1938.
Cl
F
Cl
CN
Et


1939.
Cl
Cl
Cl
CN
Et


1940.
Cl
Br
Cl
CN
Et


1941.
Cl
I
Cl
CN
Et


1942.
Cl
CH3
Cl
CN
Et


1943.
Cl
Et
Cl
CN
Et


1944.
Cl
CF3
Cl
CN
Et


1945.
Cl
OCH3
Cl
CN
Et


1946.
Cl
OCF3
Cl
CN
Et


1947.
Cl
CN
Cl
CN
Et


1948.
Cl
H
Cl
CN
n-Pr


1949.
Cl
F
Cl
CN
n-Pr


1950.
Cl
Cl
Cl
CN
n-Pr


1951.
Cl
Br
Cl
CN
n-Pr


1952.
Cl
I
Cl
CN
n-Pr


1953.
Cl
CH3
Cl
CN
n-Pr


1954.
Cl
Et
Cl
CN
n-Pr


1955.
Cl
CF3
Cl
CN
n-Pr


1956.
Cl
OCH3
Cl
CN
n-Pr


1957.
Cl
OCF3
Cl
CN
n-Pr


1958.
Cl
CN
Cl
CN
n-Pr


1959.
Cl
H
Cl
CN
iPr


1960.
Cl
F
Cl
CN
iPr


1961.
Cl
Cl
Cl
CN
iPr


1962.
Cl
Br
Cl
CN
iPr


1963.
Cl
I
Cl
CN
iPr


1964.
Cl
CH3
Cl
CN
iPr


1965.
Cl
Et
Cl
CN
iPr


1966.
Cl
CF3
Cl
CN
iPr


1967.
Cl
OCH3
Cl
CN
iPr


1968.
Cl
OCF3
Cl
CN
iPr


1969.
Cl
CN
Cl
CN
iPr


1970.
Cl
H
Cl
CN
cPr


1971.
Cl
F
Cl
CN
cPr


1972.
Cl
Cl
Cl
CN
cPr


1973.
Cl
Br
Cl
CN
cPr


1974.
Cl
I
Cl
CN
cPr


1975.
Cl
CH3
Cl
CN
cPr


1976.
Cl
Et
Cl
CN
cPr


1977.
Cl
CF3
Cl
CN
cPr


1978.
Cl
OCH3
Cl
CN
cPr


1979.
Cl
OCF3
Cl
CN
cPr


1980.
Cl
CN
Cl
CN
cPr





Et ethyl


n-Pr n-propyl


iPr isopropy


cPr cyclopropyl






Particularly preferred are moreover compounds (I) in which for a single compound R1, R6 and R8 are hydrogen, R2, R3, R4, R5 and R7 have one of the meanings as defined in a single line of table A and X—Y in combination stand for —CH(CH3)—CH2—C(═O)O—H.


Particularly preferred are moreover compounds (I) in which for a single compound R1, R6 and R8 are hydrogen, R2, R3, R4, R5 and R7 have one of the meanings as defined in a single line of table A and X—Y in combination stand for —CH(CH3)—CH2—C(═O)O—CH3.


Particularly preferred are moreover compounds (I) in which for a single compound R1, R6 and R8 are hydrogen, R2, R3, R4, R5 and R7 have one of the meanings as defined in a single line of table A and X—Y in combination stand for —CH(CH3)—CH2—C(═O)O—CH2CH3.


Particularly preferred are moreover compounds (I) in which for a single compound R1, R6 and R8 are hydrogen, R2, R3, R4, R5 and R7 have one of the meanings as defined in a single line of table A and X—Y in combination stand for —CH(CH3)—CH2—C(═O)O—CH2CH2CH3.


Particularly preferred are moreover compounds (I) in which for a single compound R1, R6 and R8 are hydrogen, R2, R3, R4, R5 and R7 have one of the meanings as defined in a single line of table A and X—Y in combination stand for —CH(CH3)—CH2—C(═O)O—CH(CH3)2.


Particularly preferred are moreover compounds (I) in which for a single compound R1, R6 and R8 are hydrogen, R2, R3, R4, R5 and R7 have one of the meanings as defined in a single line of table A and X—Y in combination stand for —CH(CH3)—CH2—C(═O)O—CH2CH2CH2CH3.


Particularly preferred are moreover compounds (I) in which for a single compound R1, R6 and R8 are hydrogen, R2, R3, R4, R5 and R7 have one of the meanings as defined in a single line of table A and X—Y in combination stand for —CH(CH3)—CH2—C(═O)O—CH(CH3)CH2CH3.


Particularly preferred are moreover compounds (I) in which for a single compound R1, R6 and R8 are hydrogen, R2, R3, R4, R5 and R7 have one of the meanings as defined in a single line of table A and X—Y in combination stand for —CH(CH3)—CH2—C(═O)O—CH2CH(CH3)2.


Particularly preferred are moreover compounds (I) in which for a single compound R1, R6 and R8 are hydrogen, R2, R3, R4, R5 and R7 have one of the meanings as defined in a single line of table A and X—Y in combination stand for —CH(CH3)—CH2—C(═O)O—C(CH3)3.


Particularly preferred are moreover compounds (I) in which for a single compound R1, R6 and R8 are hydrogen, R2, R3, R4, R5 and R7 have one of the meanings as defined in a single line of table A and X—Y in combination stand for —CH(CH3)—CH2—C(═O)O—CH2CN.


Particularly preferred are moreover compounds (I) in which for a single compound R1, R6 and R8 are hydrogen, R2, R3, R4, R5 and R7 have one of the meanings as defined in a single line of table A and X—Y in combination stand for —CH(CH3)—CH2—C(═O)O—CH2CHF2.


Particularly preferred are moreover compounds (I) in which for a single compound R1, R6 and R8 are hydrogen, R2, R3, R4, R5 and R7 have one of the meanings as defined in a single line of table A and X—Y in combination stand for —CH(CH3)—CH2—C(═O)O—CH2CH2F.


Particularly preferred are moreover compounds (I) in which for a single compound R1, R6 and R8 are hydrogen, R2, R3, R4, R5 and R7 have one of the meanings as defined in a single line of table A and X—Y in combination stand for —CH(CH3)—CH2—C(═O)O—CH2CF3.


Particularly preferred are moreover compounds (I) in which for a single compound R1, R6 and R8 are hydrogen, R2, R3, R4, R5 and R7 have one of the meanings as defined in a single line of table A and X—Y in combination stand for —CH(CH3)—CH2—C(═O)O—CH2CH═CH2.


Particularly preferred are moreover compounds (I) in which for a single compound R1, R6 and R8 are hydrogen, R2, R3, R4, R5 and R7 have one of the meanings as defined in a single line of table A and X—Y in combination stand for —CH(CH3)—CH2—C(═O)O—CH2C≡CH.


Particularly preferred are moreover compounds (I) in which for a single compound R1, R6 and R8 are hydrogen, R2, R3, R4, R5 and R7 have one of the meanings as defined in a single line of table A and X—Y in combination stand for —CH(CH3)—CH2—C(═O)O—CH2C6H5 (CH2C6H5=benzyl).


Particularly preferred are moreover compounds (I) in which for a single compound R1, R6 and R8 are hydrogen, R2, R3, R4, R5 and R7 have one of the meanings as defined in a single line of table A and X—Y in combination stand for —CH(CH3)—CH2—C(═O)O-cyclopropyl.


Particularly preferred are moreover compounds (I) in which for a single compound R1, R6 and R8 are hydrogen, R2, R3, R4, R5 and R7 have one of the meanings as defined in a single line of table A and X—Y in combination stand for —CH(CH3)—CH2—C(═O)O-cyclobutyl.


Particularly preferred are moreover compounds (I) in which for a single compound R1, R6 and R8 are hydrogen, R2, R3, R4, R5 and R7 have one of the meanings as defined in a single line of table A and X—Y in combination stand for —CH(CH3)—CH2—C(═O)O-cyclopentyl.


Particularly preferred are moreover compounds (I) in which for a single compound R1, R6 and R8 are hydrogen, R2, R3, R4, R5 and R7 have one of the meanings as defined in a single line of table A and X—Y in combination stand for —CH(CH3)—CH2—C(═O)O-cyclohexyl.


Particularly preferred are moreover compounds (I) in which for a single compound R1, R6 and R8 are hydrogen, R2, R3, R4, R5 and R7 have one of the meanings as defined in a single line of table A and X—Y in combination stand for —CH(CH3)—CH2CH2—C(═O)O—H.


Particularly preferred are moreover compounds (I) in which for a single compound R1, R6 and R8 are hydrogen, R2, R3, R4, R5 and R7 have one of the meanings as defined in a single line of table A and X—Y in combination stand for —CH(CH3)—CH2CH2—C(═O)O—CH3.


Particularly preferred are moreover compounds (I) in which for a single compound R1, R6 and R8 are hydrogen, R2, R3, R4, R5 and R7 have one of the meanings as defined in a single line of table A and X—Y in combination stand for —CH(CH3)—CH2CH2—C(═O)O—CH2CH3.


Particularly preferred are moreover compounds (I) in which for a single compound R1, R6 and R8 are hydrogen, R2, R3, R4, R5 and R7 have one of the meanings as defined in a single line of table A and X—Y in combination stand for —CH(CH3)—CH2CH2—C(═O)O—CH2CH2CH3.


Particularly preferred are moreover compounds (I) in which for a single compound R1, R6 and R8 are hydrogen, R2, R3, R4, R5 and R7 have one of the meanings as defined in a single line of table A and X—Y in combination stand for —CH(CH3)—CH2CH2—C(═O)O—CH(CH3)2.


Particularly preferred are moreover compounds (I) in which for a single compound R1, R6 and R8 are hydrogen, R2, R3, R4, R5 and R7 have one of the meanings as defined in a single line of table A and X—Y in combination stand for —CH(CH3)—CH2CH2—C(═O)O—CH2CH2CH2CH3.


Particularly preferred are moreover compounds (I) in which for a single compound R1, R6 and R8 are hydrogen, R2, R3, R4, R5 and R7 have one of the meanings as defined in a single line of table A and X—Y in combination stand for —CH(CH3)—CH2CH2—C(═O)O—CH(CH3)CH2CH3.


Particularly preferred are moreover compounds (I) in which for a single compound R1, R6 and R8 are hydrogen, R2, R3, R4, R5 and R7 have one of the meanings as defined in a single line of table A and X—Y in combination stand for —CH(CH3)—CH2CH2—C(═O)O—CH2CH(CH3)2.


Particularly preferred are moreover compounds (I) in which for a single compound R1, R6 and R8 are hydrogen, R2, R3, R4, R5 and R7 have one of the meanings as defined in a single line of table A and X—Y in combination stand for —CH(CH3)—CH2CH2—C(═O)O—C(CH3)3.


Particularly preferred are moreover compounds (I) in which for a single compound R1, R6 and R8 are hydrogen, R2, R3, R4, R5 and R7 have one of the meanings as defined in a single line of table A and X—Y in combination stand for —CH(CH3)—CH2CH2—C(═O)O—CH2CN.


Particularly preferred are moreover compounds (I) in which for a single compound R1, R6 and R8 are hydrogen, R2, R3, R4, R5 and R7 have one of the meanings as defined in a single line of table A and X—Y in combination stand for —CH(CH3)—CH2CH2—C(═O)O—CH2CHF2.


Particularly preferred are moreover compounds (I) in which for a single compound R1, R6 and R8 are hydrogen, R2, R3, R4, R5 and R7 have one of the meanings as defined in a single line of table A and X—Y in combination stand for —CH(CH3)—CH2CH2—C(═O)O—CH2CH2F.


Particularly preferred are moreover compounds (I) in which for a single compound R1, R6 and R8 are hydrogen, R2, R3, R4, R5 and R7 have one of the meanings as defined in a single line of table A and X—Y in combination stand for —CH(CH3)—CH2CH2—C(═O)O—CH2CF3.


Particularly preferred are moreover compounds (I) in which for a single compound R1, R6 and R8 are hydrogen, R2, R3, R4, R5 and R7 have one of the meanings as defined in a single line of table A and X—Y in combination stand for —CH(CH3)—CH2CH2—C(═O)O—CH2CH═CH2.


Particularly preferred are moreover compounds (I) in which for a single compound R1, R6 and R8 are hydrogen, R2, R3, R4, R5 and R7 have one of the meanings as defined in a single line of table A and X—Y in combination stand for —CH(CH3)—CH2CH2—C(═O)O—CH2C≡CH.


Particularly preferred are moreover compounds (I) in which for a single compound R1, R6 and R8 are hydrogen, R2, R3, R4, R5 and R7 have one of the meanings as defined in a single line of table A and X—Y in combination stand for —CH(CH3)—CH2CH2—C(═O)O—CH2C6H5 (CH2C6H5=benzyl).


Particularly preferred are moreover compounds (I) in which for a single compound R1, R6 and R8 are hydrogen, R2, R3, R4, R5 and R7 have one of the meanings as defined in a single line of table A and X—Y in combination stand for —CH(CH3)—CH2CH2—C(═O)O-cyclopropyl.


Particularly preferred are moreover compounds (I) in which for a single compound R1, R6 and R8 are hydrogen, R2, R3, R4, R5 and R7 have one of the meanings as defined in a single line of table A and X—Y in combination stand for —CH(CH3)—CH2CH2—C(═O)O-cyclobutyl.


Particularly preferred are moreover compounds (I) in which for a single compound R1, R6 and R8 are hydrogen, R2, R3, R4, R5 and R7 have one of the meanings as defined in a single line of table A and X—Y in combination stand for —CH(CH3)—CH2CH2—C(═O)O-cyclopentyl.


Particularly preferred are moreover compounds (I) in which for a single compound R1, R6 and R8 are hydrogen, R2, R3, R4, R5 and R7 have one of the meanings as defined in a single line of table A and X—Y in combination stand for —CH(CH3)—CH2CH2—C(═O)O-cyclohexyl.


Particularly preferred are moreover compounds (I) in which for a single compound R1, R6 and R8 are hydrogen, R2, R3, R4, R5 and R7 have one of the meanings as defined in a single line of table A and X—Y in combination stand for —CH(CH3)—CH2—C(═O)NH—CH3.


Particularly preferred are moreover compounds (I) in which for a single compound R1, R6 and R8 are hydrogen, R2, R3, R4, R5 and R7 have one of the meanings as defined in a single line of table A and X—Y in combination stand for —CH(CH3)—CH2—C(═O)NH—CH2CH3.


Particularly preferred are moreover compounds (I) in which for a single compound R1, R6 and R8 are hydrogen, R2, R3, R4, R5 and R7 have one of the meanings as defined in a single line of table A and X—Y in combination stand for —CH(CH3)—CH2—C(═O)NH—OCH3.


Particularly preferred are moreover compounds (I) in which for a single compound R1, R6 and R8 are hydrogen, R2, R3, R4, R5 and R7 have one of the meanings as defined in a single line of table A and X—Y in combination stand for —CH(CH3)—CH2—C(═O)NH—OCH2CH3.


Particularly preferred are moreover compounds (I) in which for a single compound R1, R6 and R8 are hydrogen, R2, R3, R4, R5 and R7 have one of the meanings as defined in a single line of table A and X—Y in combination stand for —CH(CH3)—CH2—C(═O)NH—S(O)—CH3.


Particularly preferred are moreover compounds (I) in which for a single compound R1, R6 and R8 are hydrogen, R2, R3, R4, R5 and R7 have one of the meanings as defined in a single line of table A and X—Y in combination stand for —CH(CH3)—CH2—C(═O)NH—S(O)—CH2CH3.


Particularly preferred are moreover compounds (I) in which for a single compound R1, R6 and R8 are hydrogen, R2, R3, R4, R5 and R7 have one of the meanings as defined in a single line of table A and X—Y in combination stand for —CH(CH3)—CH2—C(═O)NH—S(O)—CF3.


Particularly preferred are moreover compounds (I) in which for a single compound R1, R6 and R8 are hydrogen, R2, R3, R4, R5 and R7 have one of the meanings as defined in a single line of table A and X—Y in combination stand for —CH(CH3)—CH2—C(═O)NH—S(O)—CH2CH2F.


Particularly preferred are moreover compounds (I) in which for a single compound R1, R6 and R8 are hydrogen, R2, R3, R4, R5 and R7 have one of the meanings as defined in a single line of table A and X—Y in combination stand for —CH(CH3)—CH2—C(═O)NH—S(O)—CH2CHF2.


Particularly preferred are moreover compounds (I) in which for a single compound R1, R6 and R8 are hydrogen, R2, R3, R4, R5 and R7 have one of the meanings as defined in a single line of table A and X—Y in combination stand for —CH(CH3)—CH2—C(═O)NH—S(O)—CH2CF3.


Particularly preferred are moreover compounds (I) in which for a single compound R1, R6 and R8 are hydrogen, R2, R3, R4, R5 and R7 have one of the meanings as defined in a single line of table A and X—Y in combination stand for —CH(CH3)—CH2—C(═O)NH—S(O)2—CH3.


Particularly preferred are moreover compounds (I) in which for a single compound R1, R6 and R8 are hydrogen, R2, R3, R4, R5 and R7 have one of the meanings as defined in a single line of table A and X—Y in combination stand for —CH(CH3)—CH2—C(═O)NH—S(O)2—CH2CH3.


Particularly preferred are moreover compounds (I) in which for a single compound R1, R6 and R8 are hydrogen, R2, R3, R4, R5 and R7 have one of the meanings as defined in a single line of table A and X—Y in combination stand for —CH(CH3)—CH2—C(═O)NH—S(O)2—CH2CH2CH3.


Particularly preferred are moreover compounds (I) in which for a single compound R1, R6 and R8 are hydrogen, R2, R3, R4, R5 and R7 have one of the meanings as defined in a single line of table A and X—Y in combination stand for —CH(CH3)—CH2—C(═O)NH—S(O)2—CH(CH3)2.


Particularly preferred are moreover compounds (I) in which for a single compound R1, R6 and R8 are hydrogen, R2, R3, R4, R5 and R7 have one of the meanings as defined in a single line of table A and X—Y in combination stand for —CH(CH3)—CH2—C(═O)NH—S(O)2—CH2CH2CH2CH3.


Particularly preferred are moreover compounds (I) in which for a single compound R1, R6 and R8 are hydrogen, R2, R3, R4, R5 and R7 have one of the meanings as defined in a single line of table A and X—Y in combination stand for —CH(CH3)—CH2—C(═O)NH—S(O)2—CH(CH3)CH2CH3.


Particularly preferred are moreover compounds (I) in which for a single compound R1, R6 and R8 are hydrogen, R2, R3, R4, R5 and R7 have one of the meanings as defined in a single line of table A and X—Y in combination stand for —CH(CH3)—CH2—C(═O)NH—S(O)2—CH2CH(CH3)2.


Particularly preferred are moreover compounds (I) in which for a single compound R1, R6 and R8 are hydrogen, R2, R3, R4, R5 and R7 have one of the meanings as defined in a single line of table A and X—Y in combination stand for —CH(CH3)—CH2—C(═O)NH—S(O)2—C(CH3)3.


Particularly preferred are moreover compounds (I) in which for a single compound R1, R6 and R8 are hydrogen, R2, R3, R4, R5 and R7 have one of the meanings as defined in a single line of table A and X—Y in combination stand for —CH(CH3)—CH2—C(═O)NH—S(O)2—CF3.


Particularly preferred are moreover compounds (I) in which for a single compound R1, R6 and R8 are hydrogen, R2, R3, R4, R5 and R7 have one of the meanings as defined in a single line of table A and X—Y in combination stand for —CH(CH3)—CH2—C(═O)NH—S(O)2—CH2CHF2.


Particularly preferred are moreover compounds (I) in which for a single compound R1, R6 and R8 are hydrogen, R2, R3, R4, R5 and R7 have one of the meanings as defined in a single line of table A and X—Y in combination stand for —CH(CH3)—CH2—C(═O)NH—S(O)2—CH2CH2F.


Particularly preferred are moreover compounds (I) in which for a single compound R1, R6 and R8 are hydrogen, R2, R3, R4, R5 and R7 have one of the meanings as defined in a single line of table A and X—Y in combination stand for —CH(CH3)—CH2—C(═O)NH—S(O)2—CH2CF3.


Particularly preferred are moreover compounds (I) in which for a single compound R1, R6 and R8 are hydrogen, R2, R3, R4, R5 and R7 have one of the meanings as defined in a single line of table A and X—Y in combination stand for —CH(CH3)—CH2—C(═O)NH—S(O)2—N(H)CH3.


Particularly preferred are moreover compounds (I) in which for a single compound R1, R6 and R8 are hydrogen, R2, R3, R4, R5 and R7 have one of the meanings as defined in a single line of table A and X—Y in combination stand for —CH(CH3)—CH2—C(═O)NH—S(O)2—N(H)CH2CH3.


Particularly preferred are moreover compounds (I) in which for a single compound R1, R6 and R8 are hydrogen, R2, R3, R4, R5 and R7 have one of the meanings as defined in a single line of table A and X—Y in combination stand for —CH(CH3)—CH2—C(═O)NH—S(O)2—N(H)CH2CH2CH3.


Particularly preferred are moreover compounds (I) in which for a single compound R1, R6 and R8 are hydrogen, R2, R3, R4, R5 and R7 have one of the meanings as defined in a single line of table A and X—Y in combination stand for —CH(CH3)—CH2—C(═O)NH—S(O)2—N(H)CH(CH3)2.


Particularly preferred are moreover compounds (I) in which for a single compound R1, R6 and R8 are hydrogen, R2, R3, R4, R5 and R7 have one of the meanings as defined in a single line of table A and X—Y in combination stand for —CH(CH3)—CH2—C(═O)NH—S(O)2—N(H)CH2CH2CH2CH3.


Particularly preferred are moreover compounds (I) in which for a single compound R1, R6 and R8 are hydrogen, R2, R3, R4, R5 and R7 have one of the meanings as defined in a single line of table A and X—Y in combination stand for —CH(CH3)—CH2—C(═O)NH—S(O)2—N(H)CH(CH3)CH2CH3.


Particularly preferred are moreover compounds (I) in which for a single compound R1, R6 and R8 are hydrogen, R2, R3, R4, R5 and R7 have one of the meanings as defined in a single line of table A and X—Y in combination stand for —CH(CH3)—CH2—C(═O)NH—S(O)2—N(H)CH2CH(CH3)2.


Particularly preferred are moreover compounds (I) in which for a single compound R1, R6 and R8 are hydrogen, R2, R3, R4, R5 and R7 have one of the meanings as defined in a single line of table A and X—Y in combination stand for —CH(CH3)—CH2—C(═O)NH—S(O)2—N(H)C(CH3)2.


Particularly preferred are moreover compounds (I) in which for a single compound R1, R6 and R8 are hydrogen, R2, R3, R4, R5 and R7 have one of the meanings as defined in a single line of table A and X—Y in combination stand for —CH(CH3)—CH2—C(═O)NH—S(O)2—N(CH3)2.


Particularly preferred are moreover compounds (I) in which for a single compound R1, R6 and R8 are hydrogen, R2, R3, R4, R5 and R7 have one of the meanings as defined in a single line of table A and X—Y in combination stand for —CH(CH3)—CH2—C(═O)NH—S(O)2—N(CH3)CH2CH3.


Particularly preferred are moreover compounds (I) in which for a single compound R1, R6 and R8 are hydrogen, R2, R3, R4, R5 and R7 have one of the meanings as defined in a single line of table A and X—Y in combination stand for —CH(CH3)—CH2—C(═O)NH—S(O)2—N(CH3)CH2CH2CH3.


Particularly preferred are moreover compounds (I) in which for a single compound R1, R6 and R8 are hydrogen, R2, R3, R4, R5 and R7 have one of the meanings as defined in a single line of table A and X—Y in combination stand for —CH(CH3)—CH2—C(═O)NH—S(O)2—N(CH3)CH(CH3)2.


Particularly preferred are moreover compounds (I) in which for a single compound R1, R6 and R8 are hydrogen, R2, R3, R4, R5 and R7 have one of the meanings as defined in a single line of table A and X—Y in combination stand for —CH(CH3)—CH2—C(═O)NH—S(O)2—N(CH3)CH2CH2CH2CH3.


Particularly preferred are moreover compounds (I) in which for a single compound R1, R6 and R8 are hydrogen, R2, R3, R4, R5 and R7 have one of the meanings as defined in a single line of table A and X—Y in combination stand for —CH(CH3)—CH2—C(═O)NH—S(O)2—N(CH3)CH(CH3)CH2CH3.


Particularly preferred are moreover compounds (I) in which for a single compound R1, R6 and R8 are hydrogen, R2, R3, R4, R5 and R7 have one of the meanings as defined in a single line of table A and X—Y in combination stand for —CH(CH3)—CH2—C(═O)NH—S(O)2—N(CH3)CH2CH(CH3)2.


Particularly preferred are moreover compounds (I) in which for a single compound R1, R6 and R8 are hydrogen, R2, R3, R4, R5 and R7 have one of the meanings as defined in a single line of table A and X—Y in combination stand for —CH(CH3)—CH2—C(═O)NH—S(O)2—N(CH3)C(CH3)2.


Particularly preferred are moreover compounds (I) in which for a single compound R1, R6 and R8 are hydrogen, R2, R3, R4, R5 and R7 have one of the meanings as defined in a single line of table A and X—Y in combination stand for —CH(CH3)—CH2—C(═O)NH—S(O)2-piperidin-1-yl.


Particularly preferred are moreover compounds (I) in which for a single compound R1, R6 and R8 are hydrogen, R2, R3, R4, R5 and R7 have one of the meanings as defined in a single line of table A and X—Y in combination stand for —CH(CH3)—CH2—C(═O)NH—S(O)2-piperazin-1-yl.


Particularly preferred are moreover compounds (I) in which for a single compound R1, R6 and R8 are hydrogen, R2, R3, R4, R5 and R7 have one of the meanings as defined in a single line of table A and X—Y in combination stand for —CH(CH3)—CH2—C(═O)NH—S(O)2-morpholin-4-yl.


Particularly preferred are moreover compounds (I) in which for a single compound R1, R6 and R8 are hydrogen, R2, R3, R4, R5 and R7 have one of the meanings as defined in a single line of table A and X—Y in combination stand for —CH(CH3)—CH2—C(═O)NH—S(O)2-thiomorpholin-4-yl.


Particularly preferred are moreover compounds (I) in which for a single compound R1, R6 and R8 are hydrogen, R2, R3, R4, R5 and R7 have one of the meanings as defined in a single line of table A and X—Y in combination stand for a ring of the formula (Z1), wherein # denotes the attachment point to the remainder of the molecule and Rx is —C(═O)OH.


Particularly preferred are moreover compounds (I) in which for a single compound R1, R6 and R8 are hydrogen, R2, R3, R4, R5 and R7 have one of the meanings as defined in a single line of table A and X—Y in combination stand for a ring of the formula (Z1), wherein # denotes the attachment point to the remainder of the molecule and Rx is —C(═O)O—CH3.


Particularly preferred are moreover compounds (I) in which for a single compound R1, R6 and R8 are hydrogen, R2, R3, R4, R5 and R7 have one of the meanings as defined in a single line of table A and X—Y in combination stand for a ring of the formula (Z1), wherein # denotes the attachment point to the remainder of the molecule and Rx is —C(═O)O—CH2CH3.


Particularly preferred are moreover compounds (I) in which for a single compound R1, R6 and R8 are hydrogen, R2, R3, R4, R5 and R7 have one of the meanings as defined in a single line of table A and X—Y in combination stand for a ring of the formula (Z1), wherein # denotes the attachment point to the remainder of the molecule and Rx is —C(═O)O—CH(CH3)2.


Particularly preferred are moreover compounds (I) in which for a single compound R1, R6 and R8 are hydrogen, R2, R3, R4, R5 and R7 have one of the meanings as defined in a single line of table A and X—Y in combination stand for a ring of the formula (Z1), wherein # denotes the attachment point to the remainder of the molecule and Rx is —C(═O)O—CH2CN.


Particularly preferred are moreover compounds (I) in which for a single compound R1, R6 and R8 are hydrogen, R2, R3, R4, R5 and R7 have one of the meanings as defined in a single line of table A and X—Y in combination stand for a ring of the formula (Z1), wherein # denotes the attachment point to the remainder of the molecule and Rx is —C(═O)O-cyclobutyl.


Particularly preferred are moreover compounds (I) in which for a single compound R1, R6 and R8 are hydrogen, R2, R3, R4, R5 and R7 have one of the meanings as defined in a single line of table A and X—Y in combination stand for a ring of the formula (Z1), wherein # denotes the attachment point to the remainder of the molecule and Rx is —C(═O)O—CH2C6H5 (CH2C6H5=benzyl).


Particularly preferred are moreover compounds (I) in which for a single compound R1, R6 and R8 are hydrogen, R2, R3, R4, R5 and R7 have one of the meanings as defined in a single line of table A and X—Y in combination stand for a ring of the formula (Z1), wherein # denotes the attachment point to the remainder of the molecule and Rx is —C(═O)O—CH2C≡CH (CH2C≡CH=propargyl).


Particularly preferred are moreover compounds (I) in which for a single compound R1, R6 and R8 are hydrogen, R2, R3, R4, R5 and R7 have one of the meanings as defined in a single line of table A and X—Y in combination stand for a ring of the formula (Z2), wherein # denotes the attachment point to the remainder of the molecule and Rx is —C(═O)OH.


Particularly preferred are moreover compounds (I) in which for a single compound R1, R6 and R8 are hydrogen, R2, R3, R4, R5 and R7 have one of the meanings as defined in a single line of table A and X—Y in combination stand for a ring of the formula (Z2), wherein # denotes the attachment point to the remainder of the molecule and Rx is —C(═O)O—CH3.


Particularly preferred are moreover compounds (I) in which for a single compound R1, R6 and R8 are hydrogen, R2, R3, R4, R5 and R7 have one of the meanings as defined in a single line of table A and X—Y in combination stand for a ring of the formula (Z2), wherein # denotes the attachment point to the remainder of the molecule and Rx is —C(═O)O—CH2CH3.


Particularly preferred are moreover compounds (I) in which for a single compound R1, R6 and R8 are hydrogen, R2, R3, R4, R5 and R7 have one of the meanings as defined in a single line of table A and X—Y in combination stand for a ring of the formula (Z2), wherein # denotes the attachment point to the remainder of the molecule and Rx is —C(═O)O—CH(CH3)2.


Particularly preferred are moreover compounds (I) in which for a single compound R1, R6 and R8 are hydrogen, R2, R3, R4, R5 and R7 have one of the meanings as defined in a single line of table A and X—Y in combination stand for a ring of the formula (Z2), wherein # denotes the attachment point to the remainder of the molecule and Rx is —C(═O)O—CH2CN.


Particularly preferred are moreover compounds (I) in which for a single compound R1, R6 and R8 are hydrogen, R2, R3, R4, R5 and R7 have one of the meanings as defined in a single line of table A and X—Y in combination stand for a ring of the formula (Z2), wherein # denotes the attachment point to the remainder of the molecule and Rx is —C(═O)O-cyclobutyl.


Particularly preferred are moreover compounds (I) in which for a single compound R1, R6 and R8 are hydrogen, R2, R3, R4, R5 and R7 have one of the meanings as defined in a single line of table A and X—Y in combination stand for a ring of the formula (Z2), wherein # denotes the attachment point to the remainder of the molecule and Rx is —C(═O)O—CH2C6H5 (CH2C6H5=benzyl).


Particularly preferred are moreover compounds (I) in which for a single compound R1, R6 and R8 are hydrogen, R2, R3, R4, R5 and R7 have one of the meanings as defined in a single line of table A and X—Y in combination stand for a ring of the formula (Z2), wherein # denotes the attachment point to the remainder of the molecule and Rx is —C(═O)O—CH2C≡CH (CH2C≡CH=propargyl).


Particularly preferred are moreover compounds (I) in which for a single compound R1, R6 and R8 are hydrogen, R2, R3, R4, R5 and R7 have one of the meanings as defined in a single line of table A and X—Y in combination stand for a ring of the formula (Z3), wherein # denotes the attachment point to the remainder of the molecule and Rx is —C(═O)OH.


Particularly preferred are moreover compounds (I) in which for a single compound R1, R6 and R8 are hydrogen, R2, R3, R4, R5 and R7 have one of the meanings as defined in a single line of table A and X—Y in combination stand for a ring of the formula (Z3), wherein # denotes the attachment point to the remainder of the molecule and Rx is —C(═O)O—CH3.


Particularly preferred are moreover compounds (I) in which for a single compound R1, R6 and R8 are hydrogen, R2, R3, R4, R5 and R7 have one of the meanings as defined in a single line of table A and X—Y in combination stand for a ring of the formula (Z3), wherein # denotes the attachment point to the remainder of the molecule and Rx is —C(═O)O—CH2CH3.


Particularly preferred are moreover compounds (I) in which for a single compound R1, R6 and R8 are hydrogen, R2, R3, R4, R5 and R7 have one of the meanings as defined in a single line of table A and X—Y in combination stand for a ring of the formula (Z3), wherein # denotes the attachment point to the remainder of the molecule and Rx is —C(═O)O—CH(CH3)2.


Particularly preferred are moreover compounds (I) in which for a single compound R1, R6 and R8 are hydrogen, R2, R3, R4, R5 and R7 have one of the meanings as (Z3), wherein # denotes the attachment point to the remainder of the molecule and Rx is —C(═O)O—CH2CN.


Particularly preferred are moreover compounds (I) in which for a single compound R1, R6 and R8 are hydrogen, R2, R3, R4, R5 and R7 have one of the meanings as defined in a single line of table A and X—Y in combination stand for a ring of the formula (Z3), wherein # denotes the attachment point to the remainder of the molecule and Rx is —C(═O)O-cyclobutyl.


Particularly preferred are moreover compounds (I) in which for a single compound R1, R6 and R8 are hydrogen, R2, R3, R4, R5 and R7 have one of the meanings as defined in a single line of table A and X—Y in combination stand for a ring of the formula (Z3), wherein # denotes the attachment point to the remainder of the molecule and Rx is —C(═O)O—CH2C6H5 (CH2C6H5=benzyl).


Particularly preferred are moreover compounds (I) in which for a single compound R1, R6 and R8 are hydrogen, R2, R3, R4, R5 and R7 have one of the meanings as defined in a single line of table A and X—Y in combination stand for a ring of the formula (Z3), wherein # denotes the attachment point to the remainder of the molecule and Rx is —C(═O)O—CH2C≡CH (CH2C≡CH=propargyl).


Particularly preferred are moreover compounds (I) in which for a single compound R1, R6 and R8 are hydrogen, R2, R3, R4, R5 and R7 have one of the meanings as defined in a single line of table A and X—Y in combination stand for a ring of the formula (Z4), wherein # denotes the attachment point to the remainder of the molecule and Rx is —C(═O)OH.


Particularly preferred are moreover compounds (I) in which for a single compound R1, R6 and R8 are hydrogen, R2, R3, R4, R5 and R7 have one of the meanings as defined in a single line of table A and X—Y in combination stand for a ring of the formula (Z4), wherein # denotes the attachment point to the remainder of the molecule and Rx is —C(═O)O—CH3.


Particularly preferred are moreover compounds (I) in which for a single compound R1, R6 and R8 are hydrogen, R2, R3, R4, R5 and R7 have one of the meanings as defined in a single line of table A and X—Y in combination stand for a ring of the formula (Z4), wherein # denotes the attachment point to the remainder of the molecule and Rx is —C(═O)O—CH2CH3.


Particularly preferred are moreover compounds (I) in which for a single compound R1, R6 and R8 are hydrogen, R2, R3, R4, R5 and R7 have one of the meanings as defined in a single line of table A and X—Y in combination stand for a ring of the formula (Z4), wherein # denotes the attachment point to the remainder of the molecule and Rx is —C(═O)O—CH(CH3)2.


Particularly preferred are moreover compounds (I) in which for a single compound R1, R6 and R8 are hydrogen, R2, R3, R4, R5 and R7 have one of the meanings as defined in a single line of table A and X—Y in combination stand for a ring of the formula (Z4), wherein # denotes the attachment point to the remainder of the molecule and Rx is —C(═O)O—CH2CN.


Particularly preferred are moreover compounds (I) in which for a single compound R1, R6 and R8 are hydrogen, R2, R3, R4, R5 and R7 have one of the meanings as defined in a single line of table A and X—Y in combination stand for a ring of the formula (Z4), wherein # denotes the attachment point to the remainder of the molecule and Rx is —C(═O)O-cyclobutyl.


Particularly preferred are moreover compounds (I) in which for a single compound R1, R6 and R8 are hydrogen, R2, R3, R4, R5 and R7 have one of the meanings as defined in a single line of table A and X—Y in combination stand for a ring of the formula (Z4), wherein # denotes the attachment point to the remainder of the molecule and Rx is —C(═O)O—CH2C6H5 (CH2C6H5=benzyl).


Particularly preferred are moreover compounds (I) in which for a single compound R1, R6 and R8 are hydrogen, R2, R3, R4, R5 and R7 have one of the meanings as defined in a single line of table A and X—Y in combination stand for a ring of the formula (Z4), wherein # denotes the attachment point to the remainder of the molecule and Rx is —C(═O)O—CH2C≡CH (CH2C≡CH=propargyl).


Particularly preferred are moreover compounds (I) in which for a single compound R1, R6 and R8 are hydrogen, R2, R3, R4, R5 and R7 have one of the meanings as defined in a single line of table A and X—Y in combination stand for a ring of the formula (Z5), wherein # denotes the attachment point to the remainder of the molecule and Rx is —C(═O)OH.


Particularly preferred are moreover compounds (I) in which for a single compound R1, R6 and R8 are hydrogen, R2, R3, R4, R5 and R7 have one of the meanings as defined in a single line of table A and X—Y in combination stand for a ring of the formula (Z5), wherein # denotes the attachment point to the remainder of the molecule and Rx is —C(═O)O—CH3.


Particularly preferred are moreover compounds (I) in which for a single compound R1, R6 and R8 are hydrogen, R2, R3, R4, R5 and R7 have one of the meanings as defined in a single line of table A and X—Y in combination stand for a ring of the formula (Z5), wherein # denotes the attachment point to the remainder of the molecule and Rx is —C(═O)O—CH2CH3.


Particularly preferred are moreover compounds (I) in which for a single compound R1, R6 and R8 are hydrogen, R2, R3, R4, R5 and R7 have one of the meanings as defined in a single line of table A and X—Y in combination stand for a ring of the formula (Z5), wherein # denotes the attachment point to the remainder of the molecule and Rx is —C(═O)O—CH(CH3)2.


Particularly preferred are moreover compounds (I) in which for a single compound R1, R6 and R8 are hydrogen, R2, R3, R4, R5 and R7 have one of the meanings as defined in a single line of table A and X—Y in combination stand for a ring of the formula (Z5), wherein # denotes the attachment point to the remainder of the molecule and Rx is —C(═O)O—CH2CN.


Particularly preferred are moreover compounds (I) in which for a single compound R1, R6 and R8 are hydrogen, R2, R3, R4, R5 and R7 have one of the meanings as defined in a single line of table A and X—Y in combination stand for a ring of the formula (Z5), wherein # denotes the attachment point to the remainder of the molecule and Rx is —C(═O)O-cyclobutyl.


Particularly preferred are moreover compounds (I) in which for a single compound R1, R6 and R8 are hydrogen, R2, R3, R4, R5 and R7 have one of the meanings as defined in a single line of table A and X—Y in combination stand for a ring of the formula (Z5), wherein # denotes the attachment point to the remainder of the molecule and Rx is —C(═O)O—CH2C6H5 (CH2C6H5=benzyl).


Particularly preferred are moreover compounds (I) in which for a single compound R1, R6 and R8 are hydrogen, R2, R3, R4, R5 and R7 have one of the meanings as defined in a single line of table A and X—Y in combination stand for a ring of the formula (Z5), wherein # denotes the attachment point to the remainder of the molecule and Rx is —C(═O)O—CH2C≡CH (CH2C≡CH=propargyl).


Particularly preferred are moreover compounds (I) in which for a single compound R1, R6 and R8 are hydrogen, R2, R3, R4, R5 and R7 have one of the meanings as defined in a single line of table A and X—Y in combination stand for a ring of the formula (Z6), wherein # denotes the attachment point to the remainder of the molecule and Rx is —C(═O)OH.


Particularly preferred are moreover compounds (I) in which for a single compound R1, R6 and R8 are hydrogen, R2, R3, R4, R5 and R7 have one of the meanings as defined in a single line of table A and X—Y in combination stand for a ring of the formula (Z6), wherein # denotes the attachment point to the remainder of the molecule and Rx is —C(═O)O—CH3.


Particularly preferred are moreover compounds (I) in which for a single compound R1, R6 and R8 are hydrogen, R2, R3, R4, R5 and R7 have one of the meanings as defined in a single line of table A and X—Y in combination stand for a ring of the formula (Z6), wherein # denotes the attachment point to the remainder of the molecule and Rx is —C(═O)O—CH2CH3.


Particularly preferred are moreover compounds (I) in which for a single compound R1, R6 and R8 are hydrogen, R2, R3, R4, R5 and R7 have one of the meanings as (Z6), wherein # denotes the attachment point to the remainder of the molecule and Rx is —C(═O)O—CH(CH3)2.


Particularly preferred are moreover compounds (I) in which for a single compound R1, R6 and R8 are hydrogen, R2, R3, R4, R5 and R7 have one of the meanings as defined in a single line of table A and X—Y in combination stand for a ring of the formula (Z6), wherein # denotes the attachment point to the remainder of the molecule and Rx is —C(═O)O—CH2CN.


Particularly preferred are moreover compounds (I) in which for a single compound R1, R6 and R8 are hydrogen, R2, R3, R4, R5 and R7 have one of the meanings as defined in a single line of table A and X—Y in combination stand for a ring of the formula (Z6), wherein # denotes the attachment point to the remainder of the molecule and Rx is —C(═O)O-cyclobutyl.


Particularly preferred are moreover compounds (I) in which for a single compound R1, R6 and R8 are hydrogen, R2, R3, R4, R5 and R7 have one of the meanings as defined in a single line of table A and X—Y in combination stand for a ring of the formula (Z6), wherein # denotes the attachment point to the remainder of the molecule and Rx is —C(═O)O—CH2C6H5 (CH2C6H5=benzyl).


Particularly preferred are moreover compounds (I) in which for a single compound R1, R6 and R8 are hydrogen, R2, R3, R4, R5 and R7 have one of the meanings as defined in a single line of table A and X—Y in combination stand for a ring of the formula (Z6), wherein # denotes the attachment point to the remainder of the molecule and Rx is —C(═O)O—CH2C≡CH (CH2C≡CH=propargyl).


Particularly preferred are moreover compounds (I) in which for a single compound R1, R6 and R8 are hydrogen, R2, R3, R4, R5 and R7 have one of the meanings as defined in a single line of table A and X—Y in combination stand for a ring of the formula (Z7), wherein # denotes the attachment point to the remainder of the molecule and Rx is —C(═O)OH.


Particularly preferred are moreover compounds (I) in which for a single compound R1, R6 and R8 are hydrogen, R2, R3, R4, R5 and R7 have one of the meanings as defined in a single line of table A and X—Y in combination stand for a ring of the formula (Z7), wherein # denotes the attachment point to the remainder of the molecule and Rx is —C(═O)O—CH3.


Particularly preferred are moreover compounds (I) in which for a single compound R1, R6 and R8 are hydrogen, R2, R3, R4, R5 and R7 have one of the meanings as defined in a single line of table A and X—Y in combination stand for a ring of the formula (Z7), wherein # denotes the attachment point to the remainder of the molecule and Rx is —C(═O)O—CH2CH3.


Particularly preferred are moreover compounds (I) in which for a single compound R1, R6 and R8 are hydrogen, R2, R3, R4, R5 and R7 have one of the meanings as defined in a single line of table A and X—Y in combination stand for a ring of the formula (Z7), wherein # denotes the attachment point to the remainder of the molecule and Rx is —C(═O)O—CH(CH3)2.


Particularly preferred are moreover compounds (I) in which for a single compound R1, R6 and R8 are hydrogen, R2, R3, R4, R5 and R7 have one of the meanings as defined in a single line of table A and X—Y in combination stand for a ring of the formula (Z7), wherein # denotes the attachment point to the remainder of the molecule and Rx is —C(═O)O—CH2CN.


Particularly preferred are moreover compounds (I) in which for a single compound R1, R6 and R8 are hydrogen, R2, R3, R4, R5 and R7 have one of the meanings as defined in a single line of table A and X—Y in combination stand for a ring of the formula (Z7), wherein # denotes the attachment point to the remainder of the molecule and Rx is —C(═O)O-cyclobutyl.


Particularly preferred are moreover compounds (I) in which for a single compound R1, R6 and R8 are hydrogen, R2, R3, R4, R5 and R7 have one of the meanings as defined in a single line of table A and X—Y in combination stand for a ring of the formula (Z7), wherein # denotes the attachment point to the remainder of the molecule and Rx is —C(═O)O—CH2C6H5 (CH2C6H5=benzyl).


Particularly preferred are moreover compounds (I) in which for a single compound R1, R6 and R8 are hydrogen, R2, R3, R4, R5 and R7 have one of the meanings as defined in a single line of table A and X—Y in combination stand for a ring of the formula (Z7), wherein # denotes the attachment point to the remainder of the molecule and Rx is —C(═O)O—CH2C≡CH (CH2C≡CH=propargyl).


Particularly preferred are moreover compounds (I) in which for a single compound R1, R6 and R8 are hydrogen, R2, R3, R4, R5 and R7 have one of the meanings as defined in a single line of table A and X—Y in combination stand for a ring of the formula (Z8), wherein # denotes the attachment point to the remainder of the molecule and Rx is —C(═O)OH.


Particularly preferred are moreover compounds (I) in which for a single compound R1, R6 and R8 are hydrogen, R2, R3, R4, R5 and R7 have one of the meanings as defined in a single line of table A and X—Y in combination stand for a ring of the formula (Z8), wherein # denotes the attachment point to the remainder of the molecule and Rx is —C(═O)O—CH3.


Particularly preferred are moreover compounds (I) in which for a single compound R1, R6 and R8 are hydrogen, R2, R3, R4, R5 and R7 have one of the meanings as defined in a single line of table A and X—Y in combination stand for a ring of the formula (Z8), wherein # denotes the attachment point to the remainder of the molecule and Rx is —C(═O)O—CH2CH3.


Particularly preferred are moreover compounds (I) in which for a single compound R1, R6 and R8 are hydrogen, R2, R3, R4, R5 and R7 have one of the meanings as defined in a single line of table A and X—Y in combination stand for a ring of the formula (Z8), wherein # denotes the attachment point to the remainder of the molecule and Rx is —C(═O)O—CH(CH3)2.


Particularly preferred are moreover compounds (I) in which for a single compound R1, R6 and R8 are hydrogen, R2, R3, R4, R5 and R7 have one of the meanings as defined in a single line of table A and X—Y in combination stand for a ring of the formula (Z8), wherein # denotes the attachment point to the remainder of the molecule and Rx is —C(═O)O—CH2CN.


Particularly preferred are moreover compounds (I) in which for a single compound R1, R6 and R8 are hydrogen, R2, R3, R4, R5 and R7 have one of the meanings as defined in a single line of table A and X—Y in combination stand for a ring of the formula (Z8), wherein # denotes the attachment point to the remainder of the molecule and Rx is —C(═O)O-cyclobutyl.


Particularly preferred are moreover compounds (I) in which for a single compound R1, R6 and R8 are hydrogen, R2, R3, R4, R5 and R7 have one of the meanings as defined in a single line of table A and X—Y in combination stand for a ring of the formula (Z8), wherein # denotes the attachment point to the remainder of the molecule and Rx is —C(═O)O—CH2C6H5 (CH2C6H5=benzyl).


Particularly preferred are moreover compounds (I) in which for a single compound R1, R6 and R8 are hydrogen, R2, R3, R4, R5 and R7 have one of the meanings as defined in a single line of table A and X—Y in combination stand for a ring of the formula (Z8), wherein # denotes the attachment point to the remainder of the molecule and Rx is —C(═O)O—CH2C≡CH (CH2C≡CH=propargyl).


Particularly preferred are moreover compounds (I) in which for a single compound R1, R6 and R8 are hydrogen, R2, R3, R4, R5 and R7 have one of the meanings as defined in a single line of table A and X—Y in combination stand for a ring of the formula (Z9), wherein # denotes the attachment point to the remainder of the molecule and Rx is —C(═O)OH.


Particularly preferred are moreover compounds (I) in which for a single compound R1, R6 and R8 are hydrogen, R2, R3, R4, R5 and R7 have one of the meanings as defined in a single line of table A and X—Y in combination stand for a ring of the formula (Z9), wherein # denotes the attachment point to the remainder of the molecule and Rx is —C(═O)O—CH3.


Particularly preferred are moreover compounds (I) in which for a single compound R1, R6 and R8 are hydrogen, R2, R3, R4, R5 and R7 have one of the meanings as (Z9), wherein # denotes the attachment point to the remainder of the molecule and Rx is —C(═O)O—CH2CH3.


Particularly preferred are moreover compounds (I) in which for a single compound R1, R6 and R8 are hydrogen, R2, R3, R4, R5 and R7 have one of the meanings as defined in a single line of table A and X—Y in combination stand for a ring of the formula (Z9), wherein # denotes the attachment point to the remainder of the molecule and Rx is —C(═O)O—CH(CH3)2.


Particularly preferred are moreover compounds (I) in which for a single compound R1, R6 and R8 are hydrogen, R2, R3, R4, R5 and R7 have one of the meanings as defined in a single line of table A and X—Y in combination stand for a ring of the formula (Z9), wherein # denotes the attachment point to the remainder of the molecule and Rx is —C(═O)O—CH2CN.


Particularly preferred are moreover compounds (I) in which for a single compound R1, R6 and R8 are hydrogen, R2, R3, R4, R5 and R7 have one of the meanings as defined in a single line of table A and X—Y in combination stand for a ring of the formula (Z9), wherein # denotes the attachment point to the remainder of the molecule and Rx is —C(═O)O-cyclobutyl.


Particularly preferred are moreover compounds (I) in which for a single compound R1, R6 and R8 are hydrogen, R2, R3, R4, R5 and R7 have one of the meanings as defined in a single line of table A and X—Y in combination stand for a ring of the formula (Z9), wherein # denotes the attachment point to the remainder of the molecule and Rx is —C(═O)O—CH2C6H5 (CH2C6H5=benzyl).


Particularly preferred are moreover compounds (I) in which for a single compound R1, R6 and R8 are hydrogen, R2, R3, R4, R5 and R7 have one of the meanings as defined in a single line of table A and X—Y in combination stand for a ring of the formula (Z9), wherein # denotes the attachment point to the remainder of the molecule and Rx is —C(═O)O—CH2C≡CH (CH2C≡CH=propargyl).


Particularly preferred are moreover compounds (I) in which for a single compound R1, R6 and R8 are hydrogen, R2, R3, R4, R5 and R7 have one of the meanings as defined in a single line of table A and X—Y in combination stand for a ring of the formula (Z10), wherein # denotes the attachment point to the remainder of the molecule and Rx is —C(═O)OH.


Particularly preferred are moreover compounds (I) in which for a single compound R1, R6 and R8 are hydrogen, R2, R3, R4, R5 and R7 have one of the meanings as defined in a single line of table A and X—Y in combination stand for a ring of the formula (Z10), wherein # denotes the attachment point to the remainder of the molecule and Rx is —C(═O)O—CH3.


Particularly preferred are moreover compounds (I) in which for a single compound R1, R6 and R8 are hydrogen, R2, R3, R4, R5 and R7 have one of the meanings as defined in a single line of table A and X—Y in combination stand for a ring of the formula (Z10), wherein # denotes the attachment point to the remainder of the molecule and Rx is —C(═O)O—CH2CH3.


Particularly preferred are moreover compounds (I) in which for a single compound R1, R6 and R8 are hydrogen, R2, R3, R4, R5 and R7 have one of the meanings as defined in a single line of table A and X—Y in combination stand for a ring of the formula (Z10), wherein # denotes the attachment point to the remainder of the molecule and Rx is —C(═O)O—CH(CH3)2.


Particularly preferred are moreover compounds (I) in which for a single compound R1, R6 and R8 are hydrogen, R2, R3, R4, R5 and R7 have one of the meanings as defined in a single line of table A and X—Y in combination stand for a ring of the formula (Z10), wherein # denotes the attachment point to the remainder of the molecule and Rx is —C(═O)O—CH2CN.


Particularly preferred are moreover compounds (I) in which for a single compound R1, R6 and R8 are hydrogen, R2, R3, R4, R5 and R7 have one of the meanings as defined in a single line of table A and X—Y in combination stand for a ring of the formula (Z10), wherein # denotes the attachment point to the remainder of the molecule and Rx is —C(═O)O-cyclobutyl.


Particularly preferred are moreover compounds (I) in which for a single compound R1, R6 and R8 are hydrogen, R2, R3, R4, R5 and R7 have one of the meanings as defined in a single line of table A and X—Y in combination stand for a ring of the formula (Z10), wherein # denotes the attachment point to the remainder of the molecule and Rx is —C(═O)O—CH2C6H5 (CH2C6H5=benzyl).


Particularly preferred are moreover compounds (I) in which for a single compound R1, R6 and R8 are hydrogen, R2, R3, R4, R5 and R7 have one of the meanings as defined in a single line of table A and X—Y in combination stand for a ring of the formula (Z10), wherein # denotes the attachment point to the remainder of the molecule and Rx is —C(═O)O—CH2C≡CH (CH2C≡CH=propargyl).


Particularly preferred are moreover compounds (I) in which for a single compound R1, R6 and R8 are hydrogen, R2, R3, R4, R5 and R7 have one of the meanings as defined in a single line of table A and X—Y in combination stand for a ring of the formula (Z11), wherein # denotes the attachment point to the remainder of the molecule and Rx is —C(═O)OH.


Particularly preferred are moreover compounds (I) in which for a single compound R1, R6 and R8 are hydrogen, R2, R3, R4, R5 and R7 have one of the meanings as defined in a single line of table A and X—Y in combination stand for a ring of the formula (Z11), wherein # denotes the attachment point to the remainder of the molecule and Rx is —C(═O)O—CH3.


Particularly preferred are moreover compounds (I) in which for a single compound R1, R6 and R8 are hydrogen, R2, R3, R4, R5 and R7 have one of the meanings as defined in a single line of table A and X—Y in combination stand for a ring of the formula (Z11), wherein # denotes the attachment point to the remainder of the molecule and Rx is —C(═O)O—CH2CH3.


Particularly preferred are moreover compounds (I) in which for a single compound R1, R6 and R8 are hydrogen, R2, R3, R4, R5 and R7 have one of the meanings as defined in a single line of table A and X—Y in combination stand for a ring of the formula (Z11), wherein # denotes the attachment point to the remainder of the molecule and Rx is —C(═O)O—CH(CH3)2.


Particularly preferred are moreover compounds (I) in which for a single compound R1, R6 and R8 are hydrogen, R2, R3, R4, R5 and R7 have one of the meanings as defined in a single line of table A and X—Y in combination stand for a ring of the formula (Z11), wherein # denotes the attachment point to the remainder of the molecule and Rx is —C(═O)O—CH2CN.


Particularly preferred are moreover compounds (I) in which for a single compound R1, R6 and R8 are hydrogen, R2, R3, R4, R5 and R7 have one of the meanings as defined in a single line of table A and X—Y in combination stand for a ring of the formula (Z11), wherein # denotes the attachment point to the remainder of the molecule and Rx is —C(═O)O-cyclobutyl.


Particularly preferred are moreover compounds (I) in which for a single compound R1, R6 and R8 are hydrogen, R2, R3, R4, R5 and R7 have one of the meanings as defined in a single line of table A and X—Y in combination stand for a ring of the formula (Z11), wherein # denotes the attachment point to the remainder of the molecule and Rx is —C(═O)O—CH2C6H5 (CH2C6H5=benzyl).


Particularly preferred are moreover compounds (I) in which for a single compound R1, R6 and R8 are hydrogen, R2, R3, R4, R5 and R7 have one of the meanings as defined in a single line of table A and X—Y in combination stand for a ring of the formula (Z11), wherein # denotes the attachment point to the remainder of the molecule and Rx is —C(═O)O—CH2C≡CH (CH2C≡CH=propargyl).


Particularly preferred are moreover compounds (I) in which for a single compound R1, R6 and R8 are hydrogen, R2, R3, R4, R5 and R7 have one of the meanings as defined in a single line of table A and X—Y in combination stand for a ring of the formula (Z12), wherein # denotes the attachment point to the remainder of the molecule and Rx is —C(═O)OH.


Particularly preferred are moreover compounds (I) in which for a single compound R1, R6 and R8 are hydrogen, R2, R3, R4, R5 and R7 have one of the meanings as (Z12), wherein # denotes the attachment point to the remainder of the molecule and Rx is —C(═O)O—CH3.


Particularly preferred are moreover compounds (I) in which for a single compound R1, R6 and R8 are hydrogen, R2, R3, R4, R5 and R7 have one of the meanings as defined in a single line of table A and X—Y in combination stand for a ring of the formula (Z12), wherein # denotes the attachment point to the remainder of the molecule and Rx is —C(═O)O—CH2CH3.


Particularly preferred are moreover compounds (I) in which for a single compound R1, R6 and R8 are hydrogen, R2, R3, R4, R5 and R7 have one of the meanings as defined in a single line of table A and X—Y in combination stand for a ring of the formula (Z12), wherein # denotes the attachment point to the remainder of the molecule and Rx is —C(═O)O—CH(CH3)2.


Particularly preferred are moreover compounds (I) in which for a single compound R1, R6 and R8 are hydrogen, R2, R3, R4, R5 and R7 have one of the meanings as defined in a single line of table A and X—Y in combination stand for a ring of the formula (Z12), wherein # denotes the attachment point to the remainder of the molecule and Rx is —C(═O)O—CH2CN.


Particularly preferred are moreover compounds (I) in which for a single compound R1, R6 and R8 are hydrogen, R2, R3, R4, R5 and R7 have one of the meanings as defined in a single line of table A and X—Y in combination stand for a ring of the formula (Z12), wherein # denotes the attachment point to the remainder of the molecule and Rx is —C(═O)O-cyclobutyl.


Particularly preferred are moreover compounds (I) in which for a single compound R1, R6 and R8 are hydrogen, R2, R3, R4, R5 and R7 have one of the meanings as defined in a single line of table A and X—Y in combination stand for a ring of the formula (Z12), wherein # denotes the attachment point to the remainder of the molecule and Rx is —C(═O)O—CH2C6H5 (CH2C6H5=benzyl).


Particularly preferred are moreover compounds (I) in which for a single compound R1, R6 and R8 are hydrogen, R2, R3, R4, R5 and R7 have one of the meanings as defined in a single line of table A and X—Y in combination stand for a ring of the formula (Z12), wherein # denotes the attachment point to the remainder of the molecule and Rx is —C(═O)O—CH2C≡CH (CH2C≡CH=propargyl).


Particularly preferred are moreover compounds (I) in which for a single compound R1, R6 and R8 are hydrogen, R2, R3, R4, R5 and R7 have one of the meanings as defined in a single line of table A and X—Y in combination stand for a ring of the formula (Z13), wherein # denotes the attachment point to the remainder of the molecule and Rx is —C(═O)OH.


Particularly preferred are moreover compounds (I) in which for a single compound R1, R6 and R8 are hydrogen, R2, R3, R4, R5 and R7 have one of the meanings as defined in a single line of table A and X—Y in combination stand for a ring of the formula (Z13), wherein # denotes the attachment point to the remainder of the molecule and Rx is —C(═O)O—CH3.


Particularly preferred are moreover compounds (I) in which for a single compound R1, R6 and R8 are hydrogen, R2, R3, R4, R5 and R7 have one of the meanings as defined in a single line of table A and X—Y in combination stand for a ring of the formula (Z13), wherein # denotes the attachment point to the remainder of the molecule and Rx is —C(═O)O—CH2CH3.


Particularly preferred are moreover compounds (I) in which for a single compound R1, R6 and R8 are hydrogen, R2, R3, R4, R5 and R7 have one of the meanings as defined in a single line of table A and X—Y in combination stand for a ring of the formula (Z13), wherein # denotes the attachment point to the remainder of the molecule and Rx is —C(═O)O—CH(CH3)2.


Particularly preferred are moreover compounds (I) in which for a single compound R1, R6 and R8 are hydrogen, R2, R3, R4, R5 and R7 have one of the meanings as defined in a single line of table A and X—Y in combination stand for a ring of the formula (Z13), wherein # denotes the attachment point to the remainder of the molecule and Rx is —C(═O)O—CH2CN.


Particularly preferred are moreover compounds (I) in which for a single compound R1, R6 and R8 are hydrogen, R2, R3, R4, R5 and R7 have one of the meanings as defined in a single line of table A and X—Y in combination stand for a ring of the formula (Z13), wherein # denotes the attachment point to the remainder of the molecule and Rx is —C(═O)O-cyclobutyl.


Particularly preferred are moreover compounds (I) in which for a single compound R1, R6 and R8 are hydrogen, R2, R3, R4, R5 and R7 have one of the meanings as defined in a single line of table A and X—Y in combination stand for a ring of the formula (Z13), wherein # denotes the attachment point to the remainder of the molecule and Rx is —C(═O)O—CH2C6H5 (CH2C6H5=benzyl).


Particularly preferred are moreover compounds (I) in which for a single compound R1, R6 and R8 are hydrogen, R2, R3, R4, R5 and R7 have one of the meanings as defined in a single line of table A and X—Y in combination stand for a ring of the formula (Z13), wherein # denotes the attachment point to the remainder of the molecule and Rx is —C(═O)O—CH2C≡CH (CH2C≡CH=propargyl).


Particularly preferred are moreover compounds (I) in which for a single compound R1, R6 and R8 are hydrogen, R2, R3, R4, R5 and R7 have one of the meanings as defined in a single line of table A and X—Y in combination stand for a ring of the formula (Z14), wherein # denotes the attachment point to the remainder of the molecule and Rx is —C(═O)OH.


Particularly preferred are moreover compounds (I) in which for a single compound R1, R6 and R8 are hydrogen, R2, R3, R4, R5 and R7 have one of the meanings as defined in a single line of table A and X—Y in combination stand for a ring of the formula (Z14), wherein # denotes the attachment point to the remainder of the molecule and Rx is —C(═O)O—CH3.


Particularly preferred are moreover compounds (I) in which for a single compound R1, R6 and R8 are hydrogen, R2, R3, R4, R5 and R7 have one of the meanings as defined in a single line of table A and X—Y in combination stand for a ring of the formula (Z14), wherein # denotes the attachment point to the remainder of the molecule and Rx is —C(═O)O—CH2CH3.


Particularly preferred are moreover compounds (I) in which for a single compound R1, R6 and R8 are hydrogen, R2, R3, R4, R5 and R7 have one of the meanings as defined in a single line of table A and X—Y in combination stand for a ring of the formula (Z14), wherein # denotes the attachment point to the remainder of the molecule and Rx is —C(═O)O—CH(CH3)2.


Particularly preferred are moreover compounds (I) in which for a single compound R1, R6 and R8 are hydrogen, R2, R3, R4, R5 and R7 have one of the meanings as defined in a single line of table A and X—Y in combination stand for a ring of the formula (Z14), wherein # denotes the attachment point to the remainder of the molecule and Rx is —C(═O)O—CH2CN.


Particularly preferred are moreover compounds (I) in which for a single compound R1, R6 and R8 are hydrogen, R2, R3, R4, R5 and R7 have one of the meanings as defined in a single line of table A and X—Y in combination stand for a ring of the formula (Z14), wherein # denotes the attachment point to the remainder of the molecule and Rx is —C(═O)O-cyclobutyl.


Particularly preferred are moreover compounds (I) in which for a single compound R1, R6 and R8 are hydrogen, R2, R3, R4, R5 and R7 have one of the meanings as defined in a single line of table A and X—Y in combination stand for a ring of the formula (Z14), wherein # denotes the attachment point to the remainder of the molecule and Rx is —C(═O)O—CH2C6H5 (CH2C6H5=benzyl).


Particularly preferred are moreover compounds (I) in which for a single compound R1, R6 and R8 are hydrogen, R2, R3, R4, R5 and R7 have one of the meanings as defined in a single line of table A and X—Y in combination stand for a ring of the formula (Z14), wherein # denotes the attachment point to the remainder of the molecule and Rx is —C(═O)O—CH2C≡CH (CH2C≡CH=propargyl).


Particularly preferred are moreover compounds (I) in which for a single compound R1, R6 and R8 are hydrogen, R2, R3, R4, R5 and R7 have one of the meanings as (Z15), wherein # denotes the attachment point to the remainder of the molecule and Rx is —C(═O)OH.


Particularly preferred are moreover compounds (I) in which for a single compound R1, R6 and R8 are hydrogen, R2, R3, R4, R5 and R7 have one of the meanings as defined in a single line of table A and X—Y in combination stand for a ring of the formula (Z15), wherein # denotes the attachment point to the remainder of the molecule and Rx is —C(═O)O—CH3.


Particularly preferred are moreover compounds (I) in which for a single compound R1, R6 and R8 are hydrogen, R2, R3, R4, R5 and R7 have one of the meanings as defined in a single line of table A and X—Y in combination stand for a ring of the formula (Z15), wherein # denotes the attachment point to the remainder of the molecule and Rx is —C(═O)O—CH2CH3.


Particularly preferred are moreover compounds (I) in which for a single compound R1, R6 and R8 are hydrogen, R2, R3, R4, R5 and R7 have one of the meanings as defined in a single line of table A and X—Y in combination stand for a ring of the formula (Z15), wherein # denotes the attachment point to the remainder of the molecule and Rx is —C(═O)O—CH(CH3)2.


Particularly preferred are moreover compounds (I) in which for a single compound R1, R6 and R8 are hydrogen, R2, R3, R4, R5 and R7 have one of the meanings as defined in a single line of table A and X—Y in combination stand for a ring of the formula (Z15), wherein # denotes the attachment point to the remainder of the molecule and Rx is —C(═O)O—CH2CN.


Particularly preferred are moreover compounds (I) in which for a single compound R1, R6 and R8 are hydrogen, R2, R3, R4, R5 and R7 have one of the meanings as defined in a single line of table A and X—Y in combination stand for a ring of the formula (Z15), wherein # denotes the attachment point to the remainder of the molecule and Rx is —C(═O)O-cyclobutyl.


Particularly preferred are moreover compounds (I) in which for a single compound R1, R6 and R8 are hydrogen, R2, R3, R4, R5 and R7 have one of the meanings as defined in a single line of table A and X—Y in combination stand for a ring of the formula (Z15), wherein # denotes the attachment point to the remainder of the molecule and Rx is —C(═O)O—CH2C6H5 (CH2C6H5=benzyl).


Particularly preferred are moreover compounds (I) in which for a single compound R1, R6 and R8 are hydrogen, R2, R3, R4, R5 and R7 have one of the meanings as defined in a single line of table A and X—Y in combination stand for a ring of the formula (Z15), wherein # denotes the attachment point to the remainder of the molecule and Rx is —C(═O)O—CH2C≡CH (CH2C≡CH=propargyl).


Particularly preferred are moreover compounds (I) in which for a single compound R1, R6 and R8 are hydrogen, R2, R3, R4, R5 and R7 have one of the meanings as defined in a single line of table A and X—Y in combination stand for a ring of the formula (Z16), wherein # denotes the attachment point to the remainder of the molecule and Rx is —C(═O)OH.


Particularly preferred are moreover compounds (I) in which for a single compound R1, R6 and R8 are hydrogen, R2, R3, R4, R5 and R7 have one of the meanings as defined in a single line of table A and X—Y in combination stand for a ring of the formula (Z16), wherein # denotes the attachment point to the remainder of the molecule and Rx is —C(═O)O—CH3.


Particularly preferred are moreover compounds (I) in which for a single compound R1, R6 and R8 are hydrogen, R2, R3, R4, R5 and R7 have one of the meanings as defined in a single line of table A and X—Y in combination stand for a ring of the formula (Z16), wherein # denotes the attachment point to the remainder of the molecule and Rx is —C(═O)O—CH2CH3.


Particularly preferred are moreover compounds (I) in which for a single compound R1, R6 and R8 are hydrogen, R2, R3, R4, R5 and R7 have one of the meanings as defined in a single line of table A and X—Y in combination stand for a ring of the formula (Z16), wherein # denotes the attachment point to the remainder of the molecule and Rx is —C(═O)O—CH(CH3)2.


Particularly preferred are moreover compounds (I) in which for a single compound R1, R6 and R8 are hydrogen, R2, R3, R4, R5 and R7 have one of the meanings as defined in a single line of table A and X—Y in combination stand for a ring of the formula (Z16), wherein # denotes the attachment point to the remainder of the molecule and Rx is —C(═O)O—CH2CN.


Particularly preferred are moreover compounds (I) in which for a single compound R1, R6 and R8 are hydrogen, R2, R3, R4, R5 and R7 have one of the meanings as defined in a single line of table A and X—Y in combination stand for a ring of the formula (Z16), wherein # denotes the attachment point to the remainder of the molecule and Rx is —C(═O)O-cyclobutyl.


Particularly preferred are moreover compounds (I) in which for a single compound R1, R6 and R8 are hydrogen, R2, R3, R4, R5 and R7 have one of the meanings as defined in a single line of table A and X—Y in combination stand for a ring of the formula (Z16), wherein # denotes the attachment point to the remainder of the molecule and Rx is —C(═O)O—CH2C6H5 (CH2C6H5=benzyl).


Particularly preferred are moreover compounds (I) in which for a single compound R1, R6 and R8 are hydrogen, R2, R3, R4, R5 and R7 have one of the meanings as defined in a single line of table A and X—Y in combination stand for a ring of the formula (Z16), wherein # denotes the attachment point to the remainder of the molecule and Rx is —C(═O)O—CH2C≡CH (CH2C≡CH=propargyl).


Particularly preferred are moreover compounds (I) in which for a single compound R1, R6 and R8 are hydrogen, R2, R3, R4, R5 and R7 have one of the meanings as defined in a single line of table A and X—Y in combination stand for a ring of the formula (Z17), wherein # denotes the attachment point to the remainder of the molecule and Rx is —C(═O)OH.


Particularly preferred are moreover compounds (I) in which for a single compound R1, R6 and R8 are hydrogen, R2, R3, R4, R5 and R7 have one of the meanings as defined in a single line of table A and X—Y in combination stand for a ring of the formula (Z17), wherein # denotes the attachment point to the remainder of the molecule and Rx is —C(═O)O—CH3.


Particularly preferred are moreover compounds (I) in which for a single compound R1, R6 and R8 are hydrogen, R2, R3, R4, R5 and R7 have one of the meanings as defined in a single line of table A and X—Y in combination stand for a ring of the formula (Z17), wherein # denotes the attachment point to the remainder of the molecule and Rx is —C(═O)O—CH2CH3.


Particularly preferred are moreover compounds (I) in which for a single compound R1, R6 and R8 are hydrogen, R2, R3, R4, R5 and R7 have one of the meanings as defined in a single line of table A and X—Y in combination stand for a ring of the formula (Z17), wherein # denotes the attachment point to the remainder of the molecule and Rx is —C(═O)O—CH(CH3)2.


Particularly preferred are moreover compounds (I) in which for a single compound R1, R6 and R8 are hydrogen, R2, R3, R4, R5 and R7 have one of the meanings as defined in a single line of table A and X—Y in combination stand for a ring of the formula (Z17), wherein # denotes the attachment point to the remainder of the molecule and Rx is —C(═O)O—CH2CN.


Particularly preferred are moreover compounds (I) in which for a single compound R1, R6 and R8 are hydrogen, R2, R3, R4, R5 and R7 have one of the meanings as defined in a single line of table A and X—Y in combination stand for a ring of the formula (Z17), wherein # denotes the attachment point to the remainder of the molecule and Rx is —C(═O)O-cyclobutyl.


Particularly preferred are moreover compounds (I) in which for a single compound R1, R6 and R8 are hydrogen, R2, R3, R4, R5 and R7 have one of the meanings as defined in a single line of table A and X—Y in combination stand for a ring of the formula (Z17), wherein # denotes the attachment point to the remainder of the molecule and Rx is —C(═O)O—CH2C6H5 (CH2C6H5=benzyl).


Particularly preferred are moreover compounds (I) in which for a single compound R1, R6 and R8 are hydrogen, R2, R3, R4, R5 and R7 have one of the meanings as (Z17), wherein # denotes the attachment point to the remainder of the molecule and Rx is —C(═O)O—CH2C≡CH (CH2C≡CH=propargyl).


Particularly preferred are moreover compounds (I) in which for a single compound R1, R6 and R8 are hydrogen, R2, R3, R4, R5 and R7 have one of the meanings as defined in a single line of table A and X—Y in combination stand for a ring of the formula (Z18), wherein # denotes the attachment point to the remainder of the molecule and Rx is —C(═O)OH.


Particularly preferred are moreover compounds (I) in which for a single compound R1, R6 and R8 are hydrogen, R2, R3, R4, R5 and R7 have one of the meanings as defined in a single line of table A and X—Y in combination stand for a ring of the formula (Z18), wherein # denotes the attachment point to the remainder of the molecule and Rx is —C(═O)O—CH3.


Particularly preferred are moreover compounds (I) in which for a single compound R1, R6 and R8 are hydrogen, R2, R3, R4, R5 and R7 have one of the meanings as defined in a single line of table A and X—Y in combination stand for a ring of the formula (Z18), wherein # denotes the attachment point to the remainder of the molecule and Rx is —C(═O)O—CH2CH3.


Particularly preferred are moreover compounds (I) in which for a single compound R1, R6 and R8 are hydrogen, R2, R3, R4, R5 and R7 have one of the meanings as defined in a single line of table A and X—Y in combination stand for a ring of the formula (Z18), wherein # denotes the attachment point to the remainder of the molecule and Rx is —C(═O)O—CH(CH3)2.


Particularly preferred are moreover compounds (I) in which for a single compound R1, R6 and R8 are hydrogen, R2, R3, R4, R5 and R7 have one of the meanings as defined in a single line of table A and X—Y in combination stand for a ring of the formula (Z18), wherein # denotes the attachment point to the remainder of the molecule and Rx is —C(═O)O—CH2CN.


Particularly preferred are moreover compounds (I) in which for a single compound R1, R6 and R8 are hydrogen, R2, R3, R4, R5 and R7 have one of the meanings as defined in a single line of table A and X—Y in combination stand for a ring of the formula (Z18), wherein # denotes the attachment point to the remainder of the molecule and Rx is —C(═O)O-cyclobutyl.


Particularly preferred are moreover compounds (I) in which for a single compound R1, R6 and R8 are hydrogen, R2, R3, R4, R5 and R7 have one of the meanings as defined in a single line of table A and X—Y in combination stand for a ring of the formula (Z18), wherein # denotes the attachment point to the remainder of the molecule and Rx is —C(═O)O—CH2C6H5 (CH2C6H5=benzyl).


Particularly preferred are moreover compounds (I) in which for a single compound R1, R6 and R8 are hydrogen, R2, R3, R4, R5 and R7 have one of the meanings as defined in a single line of table A and X—Y in combination stand for a ring of the formula (Z18), wherein # denotes the attachment point to the remainder of the molecule and Rx is —C(═O)O—CH2C≡CH (CH2C≡CH=propargyl).


Particularly preferred are moreover compounds (I) in which for a single compound R1, R6 and R8 are hydrogen, R2, R3, R4, R5 and R7 have one of the meanings as defined in a single line of table A and X—Y in combination stand for a ring of the formula (Z19), wherein # denotes the attachment point to the remainder of the molecule and Rx is —C(═O)OH.


Particularly preferred are moreover compounds (I) in which for a single compound R1, R6 and R8 are hydrogen, R2, R3, R4, R5 and R7 have one of the meanings as defined in a single line of table A and X—Y in combination stand for a ring of the formula (Z19), wherein # denotes the attachment point to the remainder of the molecule and Rx is —C(═O)O—CH3.


Particularly preferred are moreover compounds (I) in which for a single compound R1, R6 and R8 are hydrogen, R2, R3, R4, R5 and R7 have one of the meanings as defined in a single line of table A and X—Y in combination stand for a ring of the formula (Z19), wherein # denotes the attachment point to the remainder of the molecule and Rx is —C(═O)O—CH2CH3.


Particularly preferred are moreover compounds (I) in which for a single compound R1, R6 and R8 are hydrogen, R2, R3, R4, R5 and R7 have one of the meanings as defined in a single line of table A and X—Y in combination stand for a ring of the formula (Z19), wherein # denotes the attachment point to the remainder of the molecule and Rx is —C(═O)O—CH(CH3)2.


Particularly preferred are moreover compounds (I) in which for a single compound R1, R6 and R8 are hydrogen, R2, R3, R4, R5 and R7 have one of the meanings as defined in a single line of table A and X—Y in combination stand for a ring of the formula (Z19), wherein # denotes the attachment point to the remainder of the molecule and Rx is —C(═O)O—CH2CN.


Particularly preferred are moreover compounds (I) in which for a single compound R1, R6 and R8 are hydrogen, R2, R3, R4, R5 and R7 have one of the meanings as defined in a single line of table A and X—Y in combination stand for a ring of the formula (Z19), wherein # denotes the attachment point to the remainder of the molecule and Rx is —C(═O)O-cyclobutyl.


Particularly preferred are moreover compounds (I) in which for a single compound R1, R6 and R8 are hydrogen, R2, R3, R4, R5 and R7 have one of the meanings as defined in a single line of table A and X—Y in combination stand for a ring of the formula (Z19), wherein # denotes the attachment point to the remainder of the molecule and Rx is —C(═O)O—CH2C6H5 (CH2C6H5=benzyl).


Particularly preferred are moreover compounds (I) in which for a single compound R1, R6 and R8 are hydrogen, R2, R3, R4, R5 and R7 have one of the meanings as defined in a single line of table A and X—Y in combination stand for a ring of the formula (Z19), wherein # denotes the attachment point to the remainder of the molecule and Rx is —C(═O)O—CH2C≡CH (CH2C≡CH=propargyl).


Particularly preferred are moreover compounds (I) in which for a single compound R1, R6 and R8 are hydrogen, R2, R3, R4, R5 and R7 have one of the meanings as defined in a single line of table A and X—Y in combination stand for a ring of the formula (Z20), wherein # denotes the attachment point to the remainder of the molecule and Rx is —C(═O)OH.


Particularly preferred are moreover compounds (I) in which for a single compound R1, R6 and R8 are hydrogen, R2, R3, R4, R5 and R7 have one of the meanings as defined in a single line of table A and X—Y in combination stand for a ring of the formula (Z20), wherein # denotes the attachment point to the remainder of the molecule and Rx is —C(═O)O—CH3.


Particularly preferred are moreover compounds (I) in which for a single compound R1, R6 and R8 are hydrogen, R2, R3, R4, R5 and R7 have one of the meanings as defined in a single line of table A and X—Y in combination stand for a ring of the formula (Z20), wherein # denotes the attachment point to the remainder of the molecule and Rx is —C(═O)O—CH2CH3.


Particularly preferred are moreover compounds (I) in which for a single compound R1, R6 and R8 are hydrogen, R2, R3, R4, R5 and R7 have one of the meanings as defined in a single line of table A and X—Y in combination stand for a ring of the formula (Z20), wherein # denotes the attachment point to the remainder of the molecule and Rx is —C(═O)O—CH(CH3)2.


Particularly preferred are moreover compounds (I) in which for a single compound R1, R6 and R8 are hydrogen, R2, R3, R4, R5 and R7 have one of the meanings as defined in a single line of table A and X—Y in combination stand for a ring of the formula (Z20), wherein # denotes the attachment point to the remainder of the molecule and Rx is —C(═O)O—CH2CN.


Particularly preferred are moreover compounds (I) in which for a single compound R1, R6 and R8 are hydrogen, R2, R3, R4, R5 and R7 have one of the meanings as defined in a single line of table A and X—Y in combination stand for a ring of the formula (Z20), wherein # denotes the attachment point to the remainder of the molecule and Rx is —C(═O)O-cyclobutyl.


Particularly preferred are moreover compounds (I) in which for a single compound R1, R6 and R8 are hydrogen, R2, R3, R4, R5 and R7 have one of the meanings as (Z20), wherein # denotes the attachment point to the remainder of the molecule and Rx is —C(═O)O—CH2C6H5 (CH2C6H5=benzyl).


Particularly preferred are moreover compounds (I) in which for a single compound R1, R6 and R8 are hydrogen, R2, R3, R4, R5 and R7 have one of the meanings as defined in a single line of table A and X—Y in combination stand for a ring of the formula (Z20), wherein # denotes the attachment point to the remainder of the molecule and Rx is —C(═O)O—CH2C≡CH (CH2C≡CH=propargyl).


Particularly preferred are moreover compounds (I) in which for a single compound R1, R6 and R8 are hydrogen, R2, R3, R4, R5 and R7 have one of the meanings as defined in a single line of table A and X—Y in combination stand for a ring of the formula (Z21), wherein # denotes the attachment point to the remainder of the molecule and Rx is —C(═O)OH.


Particularly preferred are moreover compounds (I) in which for a single compound R1, R6 and R8 are hydrogen, R2, R3, R4, R5 and R7 have one of the meanings as defined in a single line of table A and X—Y in combination stand for a ring of the formula (Z21), wherein # denotes the attachment point to the remainder of the molecule and Rx is —C(═O)O—CH3.


Particularly preferred are moreover compounds (I) in which for a single compound R1, R6 and R8 are hydrogen, R2, R3, R4, R5 and R7 have one of the meanings as defined in a single line of table A and X—Y in combination stand for a ring of the formula (Z21), wherein # denotes the attachment point to the remainder of the molecule and Rx is —C(═O)O—CH2CH3.


Particularly preferred are moreover compounds (I) in which for a single compound R1, R6 and R8 are hydrogen, R2, R3, R4, R5 and R7 have one of the meanings as defined in a single line of table A and X—Y in combination stand for a ring of the formula (Z21), wherein # denotes the attachment point to the remainder of the molecule and Rx is —C(═O)O—CH(CH3)2.


Particularly preferred are moreover compounds (I) in which for a single compound R1, R6 and R8 are hydrogen, R2, R3, R4, R5 and R7 have one of the meanings as defined in a single line of table A and X—Y in combination stand for a ring of the formula (Z21), wherein # denotes the attachment point to the remainder of the molecule and Rx is —C(═O)O—CH2CN.


Particularly preferred are moreover compounds (I) in which for a single compound R1, R6 and R8 are hydrogen, R2, R3, R4, R5 and R7 have one of the meanings as defined in a single line of table A and X—Y in combination stand for a ring of the formula (Z21), wherein # denotes the attachment point to the remainder of the molecule and Rx is —C(═O)O-cyclobutyl.


Particularly preferred are moreover compounds (I) in which for a single compound R1, R6 and R8 are hydrogen, R2, R3, R4, R5 and R7 have one of the meanings as defined in a single line of table A and X—Y in combination stand for a ring of the formula (Z21), wherein # denotes the attachment point to the remainder of the molecule and Rx is —C(═O)O—CH2C6H5 (CH2C6H5=benzyl).


Particularly preferred are moreover compounds (I) in which for a single compound R1, R6 and R8 are hydrogen, R2, R3, R4, R5 and R7 have one of the meanings as defined in a single line of table A and X—Y in combination stand for a ring of the formula (Z21), wherein # denotes the attachment point to the remainder of the molecule and Rx is —C(═O)O—CH2C≡CH (CH2C≡CH=propargyl).


Particularly preferred are moreover compounds (I) in which for a single compound R1, R6 and R8 are hydrogen, R2, R3, R4, R5 and R7 have one of the meanings as defined in a single line of table A and X—Y in combination stand for a ring of the formula (Z22), wherein # denotes the attachment point to the remainder of the molecule and Rx is —C(═O)OH.


Particularly preferred are moreover compounds (I) in which for a single compound R1, R6 and R8 are hydrogen, R2, R3, R4, R5 and R7 have one of the meanings as defined in a single line of table A and X—Y in combination stand for a ring of the formula (Z22), wherein # denotes the attachment point to the remainder of the molecule and Rx is —C(═O)O—CH3.


Particularly preferred are moreover compounds (I) in which for a single compound R1, R6 and R8 are hydrogen, R2, R3, R4, R5 and R7 have one of the meanings as defined in a single line of table A and X—Y in combination stand for a ring of the formula (Z22), wherein # denotes the attachment point to the remainder of the molecule and Rx is —C(═O)O—CH2CH3.


Particularly preferred are moreover compounds (I) in which for a single compound R1, R6 and R8 are hydrogen, R2, R3, R4, R5 and R7 have one of the meanings as defined in a single line of table A and X—Y in combination stand for a ring of the formula (Z22), wherein # denotes the attachment point to the remainder of the molecule and Rx is —C(═O)O—CH(CH3)2.


Particularly preferred are moreover compounds (I) in which for a single compound R1, R6 and R8 are hydrogen, R2, R3, R4, R5 and R7 have one of the meanings as defined in a single line of table A and X—Y in combination stand for a ring of the formula (Z22), wherein # denotes the attachment point to the remainder of the molecule and Rx is —C(═O)O—CH2CN.


Particularly preferred are moreover compounds (I) in which for a single compound R1, R6 and R8 are hydrogen, R2, R3, R4, R5 and R7 have one of the meanings as defined in a single line of table A and X—Y in combination stand for a ring of the formula (Z22), wherein # denotes the attachment point to the remainder of the molecule and Rx is —C(═O)O-cyclobutyl.


Particularly preferred are moreover compounds (I) in which for a single compound R1, R6 and R8 are hydrogen, R2, R3, R4, R5 and R7 have one of the meanings as defined in a single line of table A and X—Y in combination stand for a ring of the formula (Z22), wherein # denotes the attachment point to the remainder of the molecule and Rx is —C(═O)O—CH2C6H5 (CH2C6H5=benzyl).


Particularly preferred are moreover compounds (I) in which for a single compound R1, R6 and R8 are hydrogen, R2, R3, R4, R5 and R7 have one of the meanings as defined in a single line of table A and X—Y in combination stand for a ring of the formula (Z22), wherein # denotes the attachment point to the remainder of the molecule and Rx is —C(═O)O—CH2C≡CH (CH2C≡CH=propargyl).


Particularly preferred are moreover compounds (I) in which for a single compound R1, R6 and R8 are hydrogen, R2, R3, R4, R5 and R7 have one of the meanings as defined in a single line of table A and X—Y in combination stand for a ring of the formula (Z23), wherein # denotes the attachment point to the remainder of the molecule and Rx is —C(═O)OH.


Particularly preferred are moreover compounds (I) in which for a single compound R1, R6 and R8 are hydrogen, R2, R3, R4, R5 and R7 have one of the meanings as defined in a single line of table A and X—Y in combination stand for a ring of the formula (Z23), wherein # denotes the attachment point to the remainder of the molecule and Rx is —C(═O)O—CH3.


Particularly preferred are moreover compounds (I) in which for a single compound R1, R6 and R8 are hydrogen, R2, R3, R4, R5 and R7 have one of the meanings as defined in a single line of table A and X—Y in combination stand for a ring of the formula (Z23), wherein # denotes the attachment point to the remainder of the molecule and Rx is —C(═O)O—CH2CH3.


Particularly preferred are moreover compounds (I) in which for a single compound R1, R6 and R8 are hydrogen, R2, R3, R4, R5 and R7 have one of the meanings as defined in a single line of table A and X—Y in combination stand for a ring of the formula (Z23), wherein # denotes the attachment point to the remainder of the molecule and Rx is —C(═O)O—CH(CH3)2.


Particularly preferred are moreover compounds (I) in which for a single compound R1, R6 and R8 are hydrogen, R2, R3, R4, R5 and R7 have one of the meanings as defined in a single line of table A and X—Y in combination stand for a ring of the formula (Z23), wherein # denotes the attachment point to the remainder of the molecule and Rx is —C(═O)O—CH2CN.


Particularly preferred are moreover compounds (I) in which for a single compound R1, R6 and R8 are hydrogen, R2, R3, R4, R5 and R7 have one of the meanings as (Z23), wherein # denotes the attachment point to the remainder of the molecule and Rx is —C(═O)O-cyclobutyl.


Particularly preferred are moreover compounds (I) in which for a single compound R1, R6 and R8 are hydrogen, R2, R3, R4, R5 and R7 have one of the meanings as defined in a single line of table A and X—Y in combination stand for a ring of the formula (Z23), wherein # denotes the attachment point to the remainder of the molecule and Rx is —C(═O)O—CH2C6H5 (CH2C6H5=benzyl).


Particularly preferred are moreover compounds (I) in which for a single compound R1, R6 and R8 are hydrogen, R2, R3, R4, R5 and R7 have one of the meanings as defined in a single line of table A and X—Y in combination stand for a ring of the formula (Z23), wherein # denotes the attachment point to the remainder of the molecule and Rx is —C(═O)O—CH2C≡CH (CH2C≡CH=propargyl).


Particularly preferred are moreover compounds (I) in which for a single compound R1, R6 and R8 are hydrogen, R2, R3, R4, R5 and R7 have one of the meanings as defined in a single line of table A and X—Y in combination stand for a ring of the formula (Z24), wherein # denotes the attachment point to the remainder of the molecule and Rx is —C(═O)OH.


Particularly preferred are moreover compounds (I) in which for a single compound R1, R6 and R8 are hydrogen, R2, R3, R4, R5 and R7 have one of the meanings as defined in a single line of table A and X—Y in combination stand for a ring of the formula (Z24), wherein # denotes the attachment point to the remainder of the molecule and Rx is —C(═O)O—CH3.


Particularly preferred are moreover compounds (I) in which for a single compound R1, R6 and R8 are hydrogen, R2, R3, R4, R5 and R7 have one of the meanings as defined in a single line of table A and X—Y in combination stand for a ring of the formula (Z24), wherein # denotes the attachment point to the remainder of the molecule and Rx is —C(═O)O—CH2CH3.


Particularly preferred are moreover compounds (I) in which for a single compound R1, R6 and R8 are hydrogen, R2, R3, R4, R5 and R7 have one of the meanings as defined in a single line of table A and X—Y in combination stand for a ring of the formula (Z24), wherein # denotes the attachment point to the remainder of the molecule and Rx is —C(═O)O—CH(CH3)2.


Particularly preferred are moreover compounds (I) in which for a single compound R1, R6 and R8 are hydrogen, R2, R3, R4, R5 and R7 have one of the meanings as defined in a single line of table A and X—Y in combination stand for a ring of the formula (Z24), wherein # denotes the attachment point to the remainder of the molecule and Rx is —C(═O)O—CH2CN.


Particularly preferred are moreover compounds (I) in which for a single compound R1, R6 and R8 are hydrogen, R2, R3, R4, R5 and R7 have one of the meanings as defined in a single line of table A and X—Y in combination stand for a ring of the formula (Z24), wherein # denotes the attachment point to the remainder of the molecule and Rx is —C(═O)O-cyclobutyl.


Particularly preferred are moreover compounds (I) in which for a single compound R1, R6 and R8 are hydrogen, R2, R3, R4, R5 and R7 have one of the meanings as defined in a single line of table A and X—Y in combination stand for a ring of the formula (Z24), wherein # denotes the attachment point to the remainder of the molecule and Rx is —C(═O)O—CH2C6H5 (CH2C6H5=benzyl).


Particularly preferred are moreover compounds (I) in which for a single compound R1, R6 and R8 are hydrogen, R2, R3, R4, R5 and R7 have one of the meanings as defined in a single line of table A and X—Y in combination stand for a ring of the formula (Z24), wherein # denotes the attachment point to the remainder of the molecule and Rx is —C(═O)O—CH2C≡CH (CH2C≡CH=propargyl).


Particularly preferred are moreover compounds (I) in which for a single compound R1, R6 and R8 are hydrogen, R2, R3, R4, R5 and R7 have one of the meanings as defined in a single line of table A and X—Y in combination stand for a ring of the formula (Z25), wherein # denotes the attachment point to the remainder of the molecule and Rx is —C(═O)OH.


Particularly preferred are moreover compounds (I) in which for a single compound R1, R6 and R8 are hydrogen, R2, R3, R4, R5 and R7 have one of the meanings as defined in a single line of table A and X—Y in combination stand for a ring of the formula (Z25), wherein # denotes the attachment point to the remainder of the molecule and Rx is —C(═O)O—CH3.


Particularly preferred are moreover compounds (I) in which for a single compound R1, R6 and R8 are hydrogen, R2, R3, R4, R5 and R7 have one of the meanings as defined in a single line of table A and X—Y in combination stand for a ring of the formula (Z25), wherein # denotes the attachment point to the remainder of the molecule and Rx is —C(═O)O—CH2CH3.


Particularly preferred are moreover compounds (I) in which for a single compound R1, R6 and R8 are hydrogen, R2, R3, R4, R5 and R7 have one of the meanings as defined in a single line of table A and X—Y in combination stand for a ring of the formula (Z25), wherein # denotes the attachment point to the remainder of the molecule and Rx is —C(═O)O—CH(CH3)2.


Particularly preferred are moreover compounds (I) in which for a single compound R1, R6 and R8 are hydrogen, R2, R3, R4, R5 and R7 have one of the meanings as defined in a single line of table A and X—Y in combination stand for a ring of the formula (Z25), wherein # denotes the attachment point to the remainder of the molecule and Rx is —C(═O)O—CH2CN.


Particularly preferred are moreover compounds (I) in which for a single compound R1, R6 and R8 are hydrogen, R2, R3, R4, R5 and R7 have one of the meanings as defined in a single line of table A and X—Y in combination stand for a ring of the formula (Z25), wherein # denotes the attachment point to the remainder of the molecule and Rx is —C(═O)O-cyclobutyl.


Particularly preferred are moreover compounds (I) in which for a single compound R1, R6 and R8 are hydrogen, R2, R3, R4, R5 and R7 have one of the meanings as defined in a single line of table A and X—Y in combination stand for a ring of the formula (Z25), wherein # denotes the attachment point to the remainder of the molecule and Rx is —C(═O)O—CH2C6H5 (CH2C6H5=benzyl).


Particularly preferred are moreover compounds (I) in which for a single compound R1, R6 and R8 are hydrogen, R2, R3, R4, R5 and R7 have one of the meanings as defined in a single line of table A and X—Y in combination stand for a ring of the formula (Z25), wherein # denotes the attachment point to the remainder of the molecule and Rx is —C(═O)O—CH2C≡CH (CH2C≡CH=propargyl).


Particularly preferred are moreover compounds (I) in which for a single compound R1, R6 and R8 are hydrogen, R2, R3, R4, R5 and R7 have one of the meanings as defined in a single line of table A and X—Y in combination stand for a ring of the formula (Z26), wherein # denotes the attachment point to the remainder of the molecule and Rx is —C(═O)OH.


Particularly preferred are moreover compounds (I) in which for a single compound R1, R6 and R8 are hydrogen, R2, R3, R4, R5 and R7 have one of the meanings as defined in a single line of table A and X—Y in combination stand for a ring of the formula (Z26), wherein # denotes the attachment point to the remainder of the molecule and Rx is —C(═O)O—CH3.


Particularly preferred are moreover compounds (I) in which for a single compound R1, R6 and R8 are hydrogen, R2, R3, R4, R5 and R7 have one of the meanings as defined in a single line of table A and X—Y in combination stand for a ring of the formula (Z26), wherein # denotes the attachment point to the remainder of the molecule and Rx is —C(═O)O—CH2CH3.


Particularly preferred are moreover compounds (I) in which for a single compound R1, R6 and R8 are hydrogen, R2, R3, R4, R5 and R7 have one of the meanings as defined in a single line of table A and X—Y in combination stand for a ring of the formula (Z26), wherein # denotes the attachment point to the remainder of the molecule and Rx is —C(═O)O—CH(CH3)2.


Particularly preferred are moreover compounds (I) in which for a single compound R1, R6 and R8 are hydrogen, R2, R3, R4, R5 and R7 have one of the meanings as (Z26), wherein # denotes the attachment point to the remainder of the molecule and Rx is —C(═O)O—CH2CN.


Particularly preferred are moreover compounds (I) in which for a single compound R1, R6 and R8 are hydrogen, R2, R3, R4, R5 and R7 have one of the meanings as defined in a single line of table A and X—Y in combination stand for a ring of the formula (Z26), wherein # denotes the attachment point to the remainder of the molecule and Rx is —C(═O)O-cyclobutyl.


Particularly preferred are moreover compounds (I) in which for a single compound R1, R6 and R8 are hydrogen, R2, R3, R4, R5 and R7 have one of the meanings as defined in a single line of table A and X—Y in combination stand for a ring of the formula (Z26), wherein # denotes the attachment point to the remainder of the molecule and Rx is —C(═O)O—CH2C6H5 (CH2C6H5=benzyl).


Particularly preferred are moreover compounds (I) in which for a single compound R1, R6 and R8 are hydrogen, R2, R3, R4, R5 and R7 have one of the meanings as defined in a single line of table A and X—Y in combination stand for a ring of the formula (Z26), wherein # denotes the attachment point to the remainder of the molecule and Rx is —C(═O)O—CH2C≡CH (CH2C≡CH=propargyl).


Particularly preferred are moreover compounds (I) in which for a single compound R1, R6 and R8 are hydrogen, R2, R3, R4, R5 and R7 have one of the meanings as defined in a single line of table A and X—Y in combination stand for a ring of the formula (Z27), wherein # denotes the attachment point to the remainder of the molecule and Rx is —C(═O)OH.


Particularly preferred are moreover compounds (I) in which for a single compound R1, R6 and R8 are hydrogen, R2, R3, R4, R5 and R7 have one of the meanings as defined in a single line of table A and X—Y in combination stand for a ring of the formula (Z27), wherein # denotes the attachment point to the remainder of the molecule and Rx is —C(═O)O—CH3.


Particularly preferred are moreover compounds (I) in which for a single compound R1, R6 and R8 are hydrogen, R2, R3, R4, R5 and R7 have one of the meanings as defined in a single line of table A and X—Y in combination stand for a ring of the formula (Z27), wherein # denotes the attachment point to the remainder of the molecule and Rx is —C(═O)O—CH2CH3.


Particularly preferred are moreover compounds (I) in which for a single compound R1, R6 and R8 are hydrogen, R2, R3, R4, R5 and R7 have one of the meanings as defined in a single line of table A and X—Y in combination stand for a ring of the formula (Z27), wherein # denotes the attachment point to the remainder of the molecule and Rx is —C(═O)O—CH(CH3)2.


Particularly preferred are moreover compounds (I) in which for a single compound R1, R6 and R8 are hydrogen, R2, R3, R4, R5 and R7 have one of the meanings as defined in a single line of table A and X—Y in combination stand for a ring of the formula (Z27), wherein # denotes the attachment point to the remainder of the molecule and Rx is —C(═O)O—CH2CN.


Particularly preferred are moreover compounds (I) in which for a single compound R1, R6 and R8 are hydrogen, R2, R3, R4, R5 and R7 have one of the meanings as defined in a single line of table A and X—Y in combination stand for a ring of the formula (Z27), wherein # denotes the attachment point to the remainder of the molecule and Rx is —C(═O)O-cyclobutyl.


Particularly preferred are moreover compounds (I) in which for a single compound R1, R6 and R8 are hydrogen, R2, R3, R4, R5 and R7 have one of the meanings as defined in a single line of table A and X—Y in combination stand for a ring of the formula (Z27), wherein # denotes the attachment point to the remainder of the molecule and Rx is —C(═O)O—CH2C6H5 (CH2C6H5=benzyl).


Particularly preferred are moreover compounds (I) in which for a single compound R1, R6 and R8 are hydrogen, R2, R3, R4, R5 and R7 have one of the meanings as defined in a single line of table A and X—Y in combination stand for a ring of the formula (Z27), wherein # denotes the attachment point to the remainder of the molecule and Rx is —C(═O)O—CH2C≡CH (CH2C≡CH=propargyl).


Particularly preferred are moreover compounds (I) in which for a single compound R1, R6 and R8 are hydrogen, R2, R3, R4, R5 and R7 have one of the meanings as defined in a single line of table A and X—Y in combination stand for a ring of the formula (Z28), wherein # denotes the attachment point to the remainder of the molecule and Rx is —C(═O)OH.


Particularly preferred are moreover compounds (I) in which for a single compound R1, R6 and R8 are hydrogen, R2, R3, R4, R5 and R7 have one of the meanings as defined in a single line of table A and X—Y in combination stand for a ring of the formula (Z28), wherein # denotes the attachment point to the remainder of the molecule and Rx is —C(═O)O—CH3.


Particularly preferred are moreover compounds (I) in which for a single compound R1, R6 and R8 are hydrogen, R2, R3, R4, R5 and R7 have one of the meanings as defined in a single line of table A and X—Y in combination stand for a ring of the formula (Z28), wherein # denotes the attachment point to the remainder of the molecule and Rx is —C(═O)O—CH2CH3.


Particularly preferred are moreover compounds (I) in which for a single compound R1, R6 and R8 are hydrogen, R2, R3, R4, R5 and R7 have one of the meanings as defined in a single line of table A and X—Y in combination stand for a ring of the formula (Z28), wherein # denotes the attachment point to the remainder of the molecule and Rx is —C(═O)O—CH(CH3)2.


Particularly preferred are moreover compounds (I) in which for a single compound R1, R6 and R8 are hydrogen, R2, R3, R4, R5 and R7 have one of the meanings as defined in a single line of table A and X—Y in combination stand for a ring of the formula (Z28), wherein # denotes the attachment point to the remainder of the molecule and Rx is —C(═O)O—CH2CN.


Particularly preferred are moreover compounds (I) in which for a single compound R1, R6 and R8 are hydrogen, R2, R3, R4, R5 and R7 have one of the meanings as defined in a single line of table A and X—Y in combination stand for a ring of the formula (Z28), wherein # denotes the attachment point to the remainder of the molecule and Rx is —C(═O)O-cyclobutyl.


Particularly preferred are moreover compounds (I) in which for a single compound R1, R6 and R8 are hydrogen, R2, R3, R4, R5 and R7 have one of the meanings as defined in a single line of table A and X—Y in combination stand for a ring of the formula (Z28), wherein # denotes the attachment point to the remainder of the molecule and Rx is —C(═O)O—CH2C6H5 (CH2C6H5=benzyl).


Particularly preferred are moreover compounds (I) in which for a single compound R1, R6 and R8 are hydrogen, R2, R3, R4, R5 and R7 have one of the meanings as defined in a single line of table A and X—Y in combination stand for a ring of the formula (Z28), wherein # denotes the attachment point to the remainder of the molecule and Rx is —C(═O)O—CH2C≡CH (CH2C≡CH=propargyl).


Particularly preferred are moreover compounds (I) in which for a single compound R1, R6 and R8 are hydrogen, R2, R3, R4, R5 and R7 have one of the meanings as defined in a single line of table A and X—Y in combination stand for a ring of the formula (Z29), wherein # denotes the attachment point to the remainder of the molecule and Rx is —C(═O)OH.


Particularly preferred are moreover compounds (I) in which for a single compound R1, R6 and R8 are hydrogen, R2, R3, R4, R5 and R7 have one of the meanings as defined in a single line of table A and X—Y in combination stand for a ring of the formula (Z29), wherein # denotes the attachment point to the remainder of the molecule and Rx is —C(═O)O—CH3.


Particularly preferred are moreover compounds (I) in which for a single compound R1, R6 and R8 are hydrogen, R2, R3, R4, R5 and R7 have one of the meanings as defined in a single line of table A and X—Y in combination stand for a ring of the formula (Z29), wherein # denotes the attachment point to the remainder of the molecule and Rx is —C(═O)O—CH2CH3.


Particularly preferred are moreover compounds (I) in which for a single compound R1, R6 and R8 are hydrogen, R2, R3, R4, R5 and R7 have one of the meanings as (Z29), wherein # denotes the attachment point to the remainder of the molecule and Rx is —C(═O)O—CH(CH3)2.


Particularly preferred are moreover compounds (I) in which for a single compound R1, R6 and R8 are hydrogen, R2, R3, R4, R5 and R7 have one of the meanings as defined in a single line of table A and X—Y in combination stand for a ring of the formula (Z29), wherein # denotes the attachment point to the remainder of the molecule and Rx is —C(═O)O—CH2CN.


Particularly preferred are moreover compounds (I) in which for a single compound R1, R6 and R8 are hydrogen, R2, R3, R4, R5 and R7 have one of the meanings as defined in a single line of table A and X—Y in combination stand for a ring of the formula (Z29), wherein # denotes the attachment point to the remainder of the molecule and Rx is —C(═O)O-cyclobutyl.


Particularly preferred are moreover compounds (I) in which for a single compound R1, R6 and R8 are hydrogen, R2, R3, R4, R5 and R7 have one of the meanings as defined in a single line of table A and X—Y in combination stand for a ring of the formula (Z29), wherein # denotes the attachment point to the remainder of the molecule and Rx is —C(═O)O—CH2C6H5 (CH2C6H5=benzyl).


Particularly preferred are moreover compounds (I) in which for a single compound R1, R6 and R8 are hydrogen, R2, R3, R4, R5 and R7 have one of the meanings as defined in a single line of table A and X—Y in combination stand for a ring of the formula (Z29), wherein # denotes the attachment point to the remainder of the molecule and Rx is —C(═O)O—CH2C≡CH (CH2C≡CH=propargyl).


Particularly preferred are moreover compounds (I) in which for a single compound R1, R6 and R8 are hydrogen, R2, R3, R4, R5 and R7 have one of the meanings as defined in a single line of table A and X—Y in combination stand for a ring of the formula (Z30), wherein # denotes the attachment point to the remainder of the molecule and Rx is —C(═O)OH.


Particularly preferred are moreover compounds (I) in which for a single compound R1, R6 and R8 are hydrogen, R2, R3, R4, R5 and R7 have one of the meanings as defined in a single line of table A and X—Y in combination stand for a ring of the formula (Z30), wherein # denotes the attachment point to the remainder of the molecule and Rx is —C(═O)O—CH3.


Particularly preferred are moreover compounds (I) in which for a single compound R1, R6 and R8 are hydrogen, R2, R3, R4, R5 and R7 have one of the meanings as defined in a single line of table A and X—Y in combination stand for a ring of the formula (Z30), wherein # denotes the attachment point to the remainder of the molecule and Rx is —C(═O)O—CH2CH3.


Particularly preferred are moreover compounds (I) in which for a single compound R1, R6 and R8 are hydrogen, R2, R3, R4, R5 and R7 have one of the meanings as defined in a single line of table A and X—Y in combination stand for a ring of the formula (Z30), wherein # denotes the attachment point to the remainder of the molecule and Rx is —C(═O)O—CH(CH3)2.


Particularly preferred are moreover compounds (I) in which for a single compound R1, R6 and R8 are hydrogen, R2, R3, R4, R5 and R7 have one of the meanings as defined in a single line of table A and X—Y in combination stand for a ring of the formula (Z30), wherein # denotes the attachment point to the remainder of the molecule and Rx is —C(═O)O—CH2CN.


Particularly preferred are moreover compounds (I) in which for a single compound R1, R6 and R8 are hydrogen, R2, R3, R4, R5 and R7 have one of the meanings as defined in a single line of table A and X—Y in combination stand for a ring of the formula (Z30), wherein # denotes the attachment point to the remainder of the molecule and Rx is —C(═O)O-cyclobutyl.


Particularly preferred are moreover compounds (I) in which for a single compound R1, R6 and R8 are hydrogen, R2, R3, R4, R5 and R7 have one of the meanings as defined in a single line of table A and X—Y in combination stand for a ring of the formula (Z30), wherein # denotes the attachment point to the remainder of the molecule and Rx is —C(═O)O—CH2C6H5 (CH2C6H5=benzyl).


Particularly preferred are moreover compounds (I) in which for a single compound R1, R6 and R8 are hydrogen, R2, R3, R4, R5 and R7 have one of the meanings as defined in a single line of table A and X—Y in combination stand for a ring of the formula (Z30), wherein # denotes the attachment point to the remainder of the molecule and Rx is —C(═O)O—CH2C≡CH (CH2C≡CH=propargyl).


Particularly preferred are moreover compounds (I) in which for a single compound R1, R6 and R8 are hydrogen, R2, R3, R4, R5 and R7 have one of the meanings as defined in a single line of table A and X—Y in combination stand for a ring of the formula (Z31), wherein # denotes the attachment point to the remainder of the molecule and Rx is —C(═O)OH.


Particularly preferred are moreover compounds (I) in which for a single compound R1, R6 and R8 are hydrogen, R2, R3, R4, R5 and R7 have one of the meanings as defined in a single line of table A and X—Y in combination stand for a ring of the formula (Z31), wherein # denotes the attachment point to the remainder of the molecule and Rx is —C(═O)O—CH3.


Particularly preferred are moreover compounds (I) in which for a single compound R1, R6 and R8 are hydrogen, R2, R3, R4, R5 and R7 have one of the meanings as defined in a single line of table A and X—Y in combination stand for a ring of the formula (Z31), wherein # denotes the attachment point to the remainder of the molecule and Rx is —C(═O)O—CH2CH3.


Particularly preferred are moreover compounds (I) in which for a single compound R1, R6 and R8 are hydrogen, R2, R3, R4, R5 and R7 have one of the meanings as defined in a single line of table A and X—Y in combination stand for a ring of the formula (Z31), wherein # denotes the attachment point to the remainder of the molecule and Rx is —C(═O)O—CH(CH3)2.


Particularly preferred are moreover compounds (I) in which for a single compound R1, R6 and R8 are hydrogen, R2, R3, R4, R5 and R7 have one of the meanings as defined in a single line of table A and X—Y in combination stand for a ring of the formula (Z31), wherein # denotes the attachment point to the remainder of the molecule and Rx is —C(═O)O—CH2CN.


Particularly preferred are moreover compounds (I) in which for a single compound R1, R6 and R8 are hydrogen, R2, R3, R4, R5 and R7 have one of the meanings as defined in a single line of table A and X—Y in combination stand for a ring of the formula (Z31), wherein # denotes the attachment point to the remainder of the molecule and Rx is —C(═O)O-cyclobutyl.


Particularly preferred are moreover compounds (I) in which for a single compound R1, R6 and R8 are hydrogen, R2, R3, R4, R5 and R7 have one of the meanings as defined in a single line of table A and X—Y in combination stand for a ring of the formula (Z31), wherein # denotes the attachment point to the remainder of the molecule and Rx is —C(═O)O—CH2C6H5 (CH2C6H5=benzyl).


Particularly preferred are moreover compounds (I) in which for a single compound R1, R6 and R8 are hydrogen, R2, R3, R4, R5 and R7 have one of the meanings as defined in a single line of table A and X—Y in combination stand for a ring of the formula (Z31), wherein # denotes the attachment point to the remainder of the molecule and Rx is —C(═O)O—CH2C≡CH (CH2C≡CH=propargyl).


Particularly preferred are moreover compounds (I) in which for a single compound R1, R6 and R8 are hydrogen, R2, R3, R4, R5 and R7 have one of the meanings as defined in a single line of table A and X—Y in combination stand for a ring of the formula (Z32), wherein # denotes the attachment point to the remainder of the molecule and Rx is —C(═O)OH.


Particularly preferred are moreover compounds (I) in which for a single compound R1, R6 and R8 are hydrogen, R2, R3, R4, R5 and R7 have one of the meanings as defined in a single line of table A and X—Y in combination stand for a ring of the formula (Z32), wherein # denotes the attachment point to the remainder of the molecule and Rx is —C(═O)O—CH3.


Particularly preferred are moreover compounds (I) in which for a single compound R1, R6 and R8 are hydrogen, R2, R3, R4, R5 and R7 have one of the meanings as (Z32), wherein # denotes the attachment point to the remainder of the molecule and Rx is —C(═O)O—CH2CH3.


Particularly preferred are moreover compounds (I) in which for a single compound R1, R6 and R8 are hydrogen, R2, R3, R4, R5 and R7 have one of the meanings as defined in a single line of table A and X—Y in combination stand for a ring of the formula (Z32), wherein # denotes the attachment point to the remainder of the molecule and Rx is —C(═O)O—CH(CH3)2.


Particularly preferred are moreover compounds (I) in which for a single compound R1, R6 and R8 are hydrogen, R2, R3, R4, R5 and R7 have one of the meanings as defined in a single line of table A and X—Y in combination stand for a ring of the formula (Z32), wherein # denotes the attachment point to the remainder of the molecule and Rx is —C(═O)O—CH2CN.


Particularly preferred are moreover compounds (I) in which for a single compound R1, R6 and R8 are hydrogen, R2, R3, R4, R5 and R7 have one of the meanings as defined in a single line of table A and X—Y in combination stand for a ring of the formula (Z32), wherein # denotes the attachment point to the remainder of the molecule and Rx is —C(═O)O-cyclobutyl.


Particularly preferred are moreover compounds (I) in which for a single compound R1, R6 and R8 are hydrogen, R2, R3, R4, R5 and R7 have one of the meanings as defined in a single line of table A and X—Y in combination stand for a ring of the formula (Z32), wherein # denotes the attachment point to the remainder of the molecule and Rx is —C(═O)O—CH2C6H5 (CH2C6H5=benzyl).


Particularly preferred are moreover compounds (I) in which for a single compound R1, R6 and R8 are hydrogen, R2, R3, R4, R5 and R7 have one of the meanings as defined in a single line of table A and X—Y in combination stand for a ring of the formula (Z32), wherein # denotes the attachment point to the remainder of the molecule and Rx is —C(═O)O—CH2C≡CH (CH2C≡CH=propargyl).


Particularly preferred are moreover compounds (I) in which for a single compound R1, R6 and R8 are hydrogen, R2, R3, R4, R5 and R7 have one of the meanings as defined in a single line of table A and X—Y in combination stand for a ring of the formula (Z33), wherein # denotes the attachment point to the remainder of the molecule and Rx is —C(═O)OH.


Particularly preferred are moreover compounds (I) in which for a single compound R1, R6 and R8 are hydrogen, R2, R3, R4, R5 and R7 have one of the meanings as defined in a single line of table A and X—Y in combination stand for a ring of the formula (Z33), wherein # denotes the attachment point to the remainder of the molecule and Rx is —C(═O)O—CH3.


Particularly preferred are moreover compounds (I) in which for a single compound R1, R6 and R8 are hydrogen, R2, R3, R4, R5 and R7 have one of the meanings as defined in a single line of table A and X—Y in combination stand for a ring of the formula (Z33), wherein # denotes the attachment point to the remainder of the molecule and Rx is —C(═O)O—CH2CH3.


Particularly preferred are moreover compounds (I) in which for a single compound R1, R6 and R8 are hydrogen, R2, R3, R4, R5 and R7 have one of the meanings as defined in a single line of table A and X—Y in combination stand for a ring of the formula (Z33), wherein # denotes the attachment point to the remainder of the molecule and Rx is —C(═O)O—CH(CH3)2.


Particularly preferred are moreover compounds (I) in which for a single compound R1, R6 and R8 are hydrogen, R2, R3, R4, R5 and R7 have one of the meanings as defined in a single line of table A and X—Y in combination stand for a ring of the formula (Z33), wherein # denotes the attachment point to the remainder of the molecule and Rx is —C(═O)O—CH2CN.


Particularly preferred are moreover compounds (I) in which for a single compound R1, R6 and R8 are hydrogen, R2, R3, R4, R5 and R7 have one of the meanings as defined in a single line of table A and X—Y in combination stand for a ring of the formula (Z33), wherein # denotes the attachment point to the remainder of the molecule and Rx is —C(═O)O-cyclobutyl.


Particularly preferred are moreover compounds (I) in which for a single compound R1, R6 and R8 are hydrogen, R2, R3, R4, R5 and R7 have one of the meanings as defined in a single line of table A and X—Y in combination stand for a ring of the formula (Z33), wherein # denotes the attachment point to the remainder of the molecule and Rx is —C(═O)O—CH2C6H5 (CH2C6H5=benzyl).


Particularly preferred are moreover compounds (I) in which for a single compound R1, R6 and R8 are hydrogen, R2, R3, R4, R5 and R7 have one of the meanings as defined in a single line of table A and X—Y in combination stand for a ring of the formula (Z33), wherein # denotes the attachment point to the remainder of the molecule and Rx is —C(═O)O—CH2C≡CH (CH2C≡CH=propargyl).


Particularly preferred are moreover compounds (I) in which for a single compound R1, R6 and R8 are hydrogen, R2, R3, R4, R5 and R7 have one of the meanings as defined in a single line of table A and X—Y in combination stand for a ring of the formula (Z34), wherein # denotes the attachment point to the remainder of the molecule and Rx is —C(═O)OH.


Particularly preferred are moreover compounds (I) in which for a single compound R1, R6 and R8 are hydrogen, R2, R3, R4, R5 and R7 have one of the meanings as defined in a single line of table A and X—Y in combination stand for a ring of the formula (Z34), wherein # denotes the attachment point to the remainder of the molecule and Rx is —C(═O)O—CH3.


Particularly preferred are moreover compounds (I) in which for a single compound R1, R6 and R8 are hydrogen, R2, R3, R4, R5 and R7 have one of the meanings as defined in a single line of table A and X—Y in combination stand for a ring of the formula (Z34), wherein # denotes the attachment point to the remainder of the molecule and Rx is —C(═O)O—CH2CH3.


Particularly preferred are moreover compounds (I) in which for a single compound R1, R6 and R8 are hydrogen, R2, R3, R4, R5 and R7 have one of the meanings as defined in a single line of table A and X—Y in combination stand for a ring of the formula (Z34), wherein # denotes the attachment point to the remainder of the molecule and Rx is —C(═O)O—CH(CH3)2.


Particularly preferred are moreover compounds (I) in which for a single compound R1, R6 and R8 are hydrogen, R2, R3, R4, R5 and R7 have one of the meanings as defined in a single line of table A and X—Y in combination stand for a ring of the formula (Z34), wherein # denotes the attachment point to the remainder of the molecule and Rx is —C(═O)O—CH2CN.


Particularly preferred are moreover compounds (I) in which for a single compound R1, R6 and R8 are hydrogen, R2, R3, R4, R5 and R7 have one of the meanings as defined in a single line of table A and X—Y in combination stand for a ring of the formula (Z34), wherein # denotes the attachment point to the remainder of the molecule and Rx is —C(═O)O-cyclobutyl.


Particularly preferred are moreover compounds (I) in which for a single compound R1, R6 and R8 are hydrogen, R2, R3, R4, R5 and R7 have one of the meanings as defined in a single line of table A and X—Y in combination stand for a ring of the formula (Z34), wherein # denotes the attachment point to the remainder of the molecule and Rx is —C(═O)O—CH2C6H5 (CH2C6H5=benzyl).


Particularly preferred are moreover compounds (I) in which for a single compound R1, R6 and R8 are hydrogen, R2, R3, R4, R5 and R7 have one of the meanings as defined in a single line of table A and X—Y in combination stand for a ring of the formula (Z34), wherein # denotes the attachment point to the remainder of the molecule and Rx is —C(═O)O—CH2C≡CH (CH2C≡CH=propargyl).


Particularly preferred are moreover compounds (I) in which for a single compound R1, R6 and R8 are hydrogen, R2, R3, R4, R5 and R7 have one of the meanings as defined in a single line of table A and X—Y in combination stand for a ring of the formula (Z35), wherein # denotes the attachment point to the remainder of the molecule and Rx is —C(═O)OH.


Particularly preferred are moreover compounds (I) in which for a single compound R1, R6 and R8 are hydrogen, R2, R3, R4, R5 and R7 have one of the meanings as (Z35), wherein # denotes the attachment point to the remainder of the molecule and Rx is —C(═O)O—CH3.


Particularly preferred are moreover compounds (I) in which for a single compound R1, R6 and R8 are hydrogen, R2, R3, R4, R5 and R7 have one of the meanings as defined in a single line of table A and X—Y in combination stand for a ring of the formula (Z35), wherein # denotes the attachment point to the remainder of the molecule and Rx is —C(═O)O—CH2CH3.


Particularly preferred are moreover compounds (I) in which for a single compound R1, R6 and R8 are hydrogen, R2, R3, R4, R5 and R7 have one of the meanings as defined in a single line of table A and X—Y in combination stand for a ring of the formula (Z35), wherein # denotes the attachment point to the remainder of the molecule and Rx is —C(═O)O—CH(CH3)2.


Particularly preferred are moreover compounds (I) in which for a single compound R1, R6 and R8 are hydrogen, R2, R3, R4, R5 and R7 have one of the meanings as defined in a single line of table A and X—Y in combination stand for a ring of the formula (Z35), wherein # denotes the attachment point to the remainder of the molecule and Rx is —C(═O)O—CH2CN.


Particularly preferred are moreover compounds (I) in which for a single compound R1, R6 and R8 are hydrogen, R2, R3, R4, R5 and R7 have one of the meanings as defined in a single line of table A and X—Y in combination stand for a ring of the formula (Z35), wherein # denotes the attachment point to the remainder of the molecule and Rx is —C(═O)O-cyclobutyl.


Particularly preferred are moreover compounds (I) in which for a single compound R1, R6 and R8 are hydrogen, R2, R3, R4, R5 and R7 have one of the meanings as defined in a single line of table A and X—Y in combination stand for a ring of the formula (Z35), wherein # denotes the attachment point to the remainder of the molecule and Rx is —C(═O)O—CH2C6H5 (CH2C6H5=benzyl).


Particularly preferred are moreover compounds (I) in which for a single compound R1, R6 and R8 are hydrogen, R2, R3, R4, R5 and R7 have one of the meanings as defined in a single line of table A and X—Y in combination stand for a ring of the formula (Z35), wherein # denotes the attachment point to the remainder of the molecule and Rx is —C(═O)O—CH2C≡CH (CH2C≡CH=propargyl).


Particularly preferred are moreover compounds (I) in which for a single compound R1, R6 and R8 are hydrogen, R2, R3, R4, R5 and R7 have one of the meanings as defined in a single line of table A and X—Y in combination stand for a ring of the formula (Z36), wherein # denotes the attachment point to the remainder of the molecule and Rx is —C(═O)OH.


Particularly preferred are moreover compounds (I) in which for a single compound R1, R6 and R8 are hydrogen, R2, R3, R4, R5 and R7 have one of the meanings as defined in a single line of table A and X—Y in combination stand for a ring of the formula (Z36), wherein # denotes the attachment point to the remainder of the molecule and Rx is —C(═O)O—CH3.


Particularly preferred are moreover compounds (I) in which for a single compound R1, R6 and R8 are hydrogen, R2, R3, R4, R5 and R7 have one of the meanings as defined in a single line of table A and X—Y in combination stand for a ring of the formula (Z36), wherein # denotes the attachment point to the remainder of the molecule and Rx is —C(═O)O—CH2CH3.


Particularly preferred are moreover compounds (I) in which for a single compound R1, R6 and R8 are hydrogen, R2, R3, R4, R5 and R7 have one of the meanings as defined in a single line of table A and X—Y in combination stand for a ring of the formula (Z36), wherein # denotes the attachment point to the remainder of the molecule and Rx is —C(═O)O—CH(CH3)2.


Particularly preferred are moreover compounds (I) in which for a single compound R1, R6 and R8 are hydrogen, R2, R3, R4, R5 and R7 have one of the meanings as defined in a single line of table A and X—Y in combination stand for a ring of the formula (Z36), wherein # denotes the attachment point to the remainder of the molecule and Rx is —C(═O)O—CH2CN.


Particularly preferred are moreover compounds (I) in which for a single compound R1, R6 and R8 are hydrogen, R2, R3, R4, R5 and R7 have one of the meanings as defined in a single line of table A and X—Y in combination stand for a ring of the formula (Z36), wherein # denotes the attachment point to the remainder of the molecule and Rx is —C(═O)O-cyclobutyl.


Particularly preferred are moreover compounds (I) in which for a single compound R1, R6 and R8 are hydrogen, R2, R3, R4, R5 and R7 have one of the meanings as defined in a single line of table A and X—Y in combination stand for a ring of the formula (Z36), wherein # denotes the attachment point to the remainder of the molecule and Rx is —C(═O)O—CH2C6H5 (CH2C6H5=benzyl).


Particularly preferred are moreover compounds (I) in which for a single compound R1, R6 and R8 are hydrogen, R2, R3, R4, R5 and R7 have one of the meanings as defined in a single line of table A and X—Y in combination stand for a ring of the formula (Z36), wherein # denotes the attachment point to the remainder of the molecule and Rx is —C(═O)O—CH2C≡CH (CH2C≡CH=propargyl).




embedded image


embedded image


embedded image


embedded image


Among rings Z1 to Z36, particular preference is given to rings Z9.


The compounds of formula (I) according to the invention can be prepared by standard processes of organic chemistry, for example by the following processes:




embedded image


The compounds of formula (I) can be prepared according to methods or in analogy to methods that are described in the prior art. The synthesis takes advantage of starting materials that are commercially available or may be prepared according to conventional procedures starting from readily available compounds.


Compounds of the formula (I) can be prepared from the carboxylic acids (III) and commercially available amines (II) using an organic base and a coupling reagent. Thus, compounds of formula (I) can be synthesized from the corresponding carboxylic acids (1 eq.) using a coupling reagent (1-2 eq.), for example T3P (propanephosphonic acid anhydride) or HATU (O-(7-azabenzotriazole-1-yl)-N,N,N′,N′-tetramethyluronium-hexafluorphosphate), an organic base (1-3 eq.) and the amines (II) (1-3 eq.). The reaction is typically carried out in an organic solvent. Preferably an aprotic organic solvent is used. Most preferably tetrahydrofuran (THF), N,N-dimethylformamide (DMF) or acetonitrile (ACN) are used. The reaction is carried out at temperatures between 0° C. and reflux. Preferably the reaction is carried out at room temperature. Preferably the organic base is triethylamine or N,N-diisopropylethylamine.




embedded image


The carboxylic acids (III) are commercially available or can be prepared from the corresponding esters (IV) (wherein RP is alkyl or benzyl). If RP is alkyl, esters (IV) may be cleaved using aqueous alkali metal hydroxides. Preferably lithium hydroxide, sodium hydroxide or potassium hydroxide (1-2 eq.) are employed. The reaction is typically carried out in mixtures of water and an organic solvent. Preferably the organic solvent is THF, methanol or acetonitrile. The reaction is carried out at temperatures between 0° C. and 100° C. Preferably the reaction is carried at room temperature. If RP is benzyl in (IV), then the ester may be cleaved using palladium on charcoal (0.001-1 eq.) as catalyst and hydrogen gas at temperatures between 0° C. and reflux. Preferably the reaction is carried out at room temperature. Typically, an organic solvent is employed. Preferably THF, methanol or ethanol are employed.


Compounds of the formula (IV) are commercially available or can be prepared by known methods. For example, the esters (IV) can be prepared according to methods described in Organometallics 2001, 20(22), 4675-4682. For example, they can be prepared from the carboxylic acids (VI) and commercially available amines (V) using a base and a coupling reagent.




embedded image


Thus, compounds of formula (IV) can be synthesized from the corresponding carboxylic acids (1 eq.) using a coupling reagent (1-2 eq.), for example T3P (propanephosphonic acid anhydride) or HATU (O-(7-azabenzotriazole-1-yl)-N,N,N′,N′-tetramethyluronium-hexafluorphosphate), an organic base (1-3 eq.) and the amines (V) (1-3 eq.). The reaction is typically carried out in an organic solvent. Preferably an aprotic organic solvent is used. Most preferably tetrahydrofuran (THF), N,N-dimethylformamide (DMF) or acetonitrile (ACN) are used. The reaction is carried out at temperatures between 0° C. to refluxing temperatures. Preferably the reaction is carried out at room temperature. Preferably the organic base is triethylamine or N,N-diisopropylethylamine.




embedded image


Carboxylic acid (VI) may be prepared from the corresponding diester by selective cleavage of one ester group. If Rq is an alkyl ester, selective ester cleavage may be achieved using an aqueous base. Preferably an alkali metal hydroxide is used. Most preferably lithium hydroxide, sodium hydroxide or potassium hydroxide are used. The reaction is typically carried out in mixtures of water and an organic solvent. Preferably THF, methanol or acetonitrile are employed. The reaction is carried out at temperatures between 0° C. and 100° C., preferably at room temperature.


Alternatively, trimethyltin hydroxide (e.g. 1 eq.) in 1,2-dichlorethane at room temperature to reflux may be used (as described in Angew. Chem. Int. Ed, 2005, 44: 1378-1382), preferably at reflux. If Rq is benzyl in (VII), then the ester may be cleaved using palladium on charcoal (0.001-1 eq.) as catalyst and hydrogen gas at temperatures between 0° C. and reflux. Preferably the reaction is carried out at room temperature. Typically, an organic solvent is employed. Preferably THF, methanol or ethanol are employed.


The diesters (VII) are either commercially available or can be prepared by standard methods of organic chemistry.




embedded image


Amines of the formula (XIII) can be prepared from the lactames (XIV), which are either commercially available or may be prepared by alkylation as described in Org. Process Res. Dev. 2018, 22, 337-343, and commercially available alcohols (XV) using thionyl chloride (2 eq.) as described in Tetrahedron Lett. 2001, 42, 1347-1350. The reaction is typically carried out in the coupling alcohols (XV) as the solvent. The reaction is carried out at temperatures between 0° C. to refluxing temperatures. Preferably the reaction is carried out at room temperature.


To widen the spectrum of action, the compounds of formula (I) may be mixed with many representatives of other herbicidal or growth-regulating active ingredient groups and then applied concomitantly. Suitable components for combinations are, for example, herbicides from the classes of the acetamides, amides, aryloxyphenoxypropionates, benzamides, benzofuran, benzoic acids, benzothiadiazinones, bipyridylium, carbamates, chloroacetamides, chlorocarboxylic acids, cyclohexanediones, dinitroanilines, dinitrophenol, diphenyl ether, glycines, imidazolinones, isoxazoles, isoxazolidinones, nitriles, N-phenylphthalimides, oxadiazoles, oxazolidinediones, oxyacetamides, phenoxycarboxylic acids, phenylcarbamates, phenylpyrazoles, phenylpyrazolines, phenylpyridazines, phosphinic acids, phosphoroamidates, phosphorodithioates, phthalamates, pyrazoles, pyridazinones, pyridines, pyridinecarboxylic acids, pyridinecarboxamides, pyrimidinediones, pyrimidinyl(thio)benzoates, quinolinecarboxylic acids, semicarbazones, sulfonylaminocarbonyltriazolinones, sulfonylureas, tetrazolinones, thiadiazoles, thiocarbamates, triazines, triazinones, triazoles, triazolinones, triazolocarboxamides, triazolopyrimidines, triketones, uracils, ureas.


It may furthermore be beneficial to apply the compounds of formula (I) alone or in combination with other herbicides, or else in the form of a mixture with other crop protection agents, for example together with agents for controlling pests or phytopathogenic fungi or bacteria. Also of interest is the miscibility with mineral salt solutions, which are employed for treating nutritional and trace element deficiencies. Other additives such as non-phytotoxic oils and oil concentrates may also be added.


In one embodiment of the present invention the combinations according to the present invention comprise at least one compound of formula (I) (compound A or component A) and at least one further active compound selected from herbicides B (compound B), preferably herbicides B of class b1) to b15), and safeners C (compound C).


In another embodiment of the present invention the combinations according to the present invention comprise at least one compound of formula (I) and at least one further active compound B (herbicide B).


Examples of herbicides B which can be used in combination with the compounds A of formula (I) according to the present invention are:

    • b1) from the group of the lipid biosynthesis inhibitors:
    • ACC-herbicides such as alloxydim, alloxydim-sodium, butroxydim, clethodim, clodinafop, clodinafop-propargyl, cycloxydim, cyhalofop, cyhalofop-butyl, diclofop, di-clofop-methyl, fenoxaprop, fenoxaprop-ethyl, fenoxaprop-P, fenoxaprop-P-ethyl, fluazifop, fluazifop-butyl, fluazifop-P, fluazifop-P-butyl, haloxyfop, haloxyfop-methyl, halox-yfop-P, haloxyfop-P-methyl, metamifop, pinoxaden, profoxydim, propaquizafop, quizalofop, quizalofop-ethyl, quizalofop-tefuryl, quizalofop-P, quizalofop-P-ethyl, quizalofop-P-tefuryl, sethoxydim, tepraloxydim, tralkoxydim, 4-(4′-Chloro-4-cyclopropyl-2′-fluoro[1,1′-biphenyl]-3-yl)-5-hydroxy-2,2,6,6-tetramethyl-2H-pyran-3(6H)-one (CAS 1312337-72-6); 4-(2′,4′-Dichloro-4-cyclopropyl[1,1′-biphenyl]-3-yl)-5-hydroxy-2,2,6,6-tetramethyl-2H-pyran-3(6H)-one (CAS 1312337-45-3); 4-(4′-Chloro-4-ethyl-2′-fluoro[1,1′-biphenyl]-3-yl)-5-hydroxy-2,2,6,6-tetramethyl-2H-pyran-3(6H)-one (CAS 1033757-93-5); 4-(2′,4′-Dichloro-4-ethyl[1,1′-biphenyl]-3-yl)-2,2,6,6-tetramethyl-2H-pyran-3,5(4H,6H)-dione (CAS 1312340-84-3); 5-(Acetyloxy)-4-(4′-chloro-4-cyclopropyl-2′-fluoro[1,1′-biphenyl]-3-yl)-3,6-dihydro-2,2,6,6-tetramethyl-2H-pyran-3-one (CAS 1312337-48-6); 5-(Acetyloxy)-4-(2′,4′-dichloro-4-cyclopropyl-[1,1′-biphenyl]-3-yl)-3,6-dihydro-2,2,6,6-tetramethyl-2H-pyran-3-one; 5-(Acetyloxy)-4-(4′-chloro-4-ethyl-2′-fluoro[1,1′-biphenyl]-3-yl)-3,6-dihydro-2,2,6,6-tetramethyl-2H-pyran-3-one (CAS 1312340-82-1); 5-(Acetyloxy)-4-(2′,4′-dichloro-4-ethyl[1,1′-biphenyl]-3-yl)-3,6-dihydro-2,2,6,6-tetramethyl-2H-pyran-3-one (CAS 1033760-55-2); 4-(4′-Chloro-4-cyclopropyl-2′-fluoro[1,1′-biphenyl]-3-yl)-5,6-dihydro-2,2,6,6-tetramethyl-5-oxo-2H-pyran-3-yl carbonic acid methyl ester (CAS 1312337-51-1); 4-(2′,4′-Dichloro-4-cyclopropyl-[1,1′-biphenyl]-3-yl)-5,6-dihydro-2,2,6,6-tetramethyl-5-oxo-2H-pyran-3-yl carbonic acid methyl ester; 4-(4′-Chloro-4-ethyl-2′-fluoro[1,1′-biphenyl]-3-yl)-5,6-dihydro-2,2,6,6-tetramethyl-5-oxo-2H-pyran-3-yl carbonic acid methyl ester (CAS 1312340-83-2); 4-(2′,4′-Dichloro-4-ethyl[1,1′-biphenyl]-3-yl)-5,6-dihydro-2,2,6,6-tetramethyl-5-oxo-2H-pyran-3-yl carbonic acid methyl ester (CAS 1033760-58-5); and non ACC herbicides such as benfuresate, butylate, cycloate, dalapon, dimepiperate, EPTC, esprocarb, ethofumesate, flupro-panate, molinate, orbencarb, pebulate, prosulfocarb, TCA, thiobencarb, tiocarbazil, triallate and vernolate;
    • b2) from the group of the ALS inhibitors:
    • sulfonylureas such as amidosulfuron, azimsulfuron, bensulfuron, bensulfuron-methyl, chlorimuron, chlorimuron-ethyl, chlorsulfuron, cinosulfuron, cyclosulfamuron, ethametsulfuron, ethametsulfuron-methyl, ethoxysulfuron, flazasulfuron, flucetosulfuron, flupyrsulfuron, flupyrsulfuron-methyl-sodium, foramsulfuron, halosulfuron, halosulfuron-methyl, imazosulfuron, iodosulfuron, iodosulfuron-methyl-sodium, iofensulfuron, iofensulfuron-sodium, mesosulfuron, metazosulfuron, metsulfuron, metsulfuron-methyl, nicosulfuron, orthosulfamuron, oxasulfuron, primisulfuron, primisulfuron-methyl, propyrisulfuron, prosulfuron, pyrazosulfuron, pyrazosulfuron-ethyl, rimsulfuron, sulfometuron, sulfometuron-methyl, sulfosulfuron, thifensulfuron, thifensulfuron-methyl, triasulfuron, tribenuron, tribenuron-methyl, trifloxysulfuron, triflusulfuron, triflusulfuron-methyl and tritosulfuron, imidazolinones such as imazamethabenz, imazamethabenz-methyl, imazamox, imazapic, imazapyr, imazaquin and imazethapyr, triazolopyrimidine herbicides and sulfonanilides such as cloransulam, cloransulam-methyl, diclosulam, flumetsulam, florasulam, metosulam, penoxsulam, pyrimisulfan and pyroxsulam, pyrimidinylbenzoates such as bispyribac, bispyribac-sodium, pyribenzoxim, pyriftalid, pyriminobac, pyriminobac-methyl, pyrithiobac, pyrithiobac-sodium, 4-[[[2-[(4,6-dimethoxy-2-pyrimidinyl)oxy]phenyl]methyl]amino]-benzoic acid-1-methylethyl ester (CAS 420138-41-6), 4-[[[2-[(4,6-dimethoxy-2-pyrimidinyl)oxy]phenyl]methyl]amino]-benzoic acid propyl ester (CAS 420138-40-5), N-(4-bromophenyl)-2-[(4,6-dimethoxy-2-pyrimidinyl)oxy]benzenemethanamine (CAS 420138-01-8), sulfonylaminocarbonyl-triazolinone herbicides such as flucarbazone, flucarbazone-sodium, propoxycarbazone, propoxycarbazone-sodium, thiencarbazone and thiencarbazone-methyl; and triafamone;
    • among these, a preferred embodiment of the invention relates to those compositions comprising at least one imidazolinone herbicide;
    • b3) from the group of the photosynthesis inhibitors:
    • amicarbazone, inhibitors of the photosystem II, e.g. 1-(6-tert-butylpyrimidin-4-yl)-2-hydroxy-4-methoxy-3-methyl-2H-pyrrol-5-one (CAS 1654744-66-7), 1-(5-tert-butylisoxazol-3-yl)-2-hydroxy-4-methoxy-3-methyl-2H-pyrrol-5-one (CAS 1637455-12-9), 1-(5-tert-butylisoxazol-3-yl)-4-chloro-2-hydroxy-3-methyl-2H-pyrrol-5-one (CAS 1637453-94-1), 1-(5-tert-butyl-1-methyl-pyrazol-3-yl)-4-chloro-2-hydroxy-3-methyl-2H-pyrrol-5-one (CAS 1654057-29-0), 1-(5-tert-butyl-1-methyl-pyrazol-3-yl)-3-chloro-2-hydroxy-4-methyl-2H-pyrrol-5-one (CAS 1654747-80-4), 4-hydroxy-1-methoxy-5-methyl-3-[4-(trifluoromethyl)-2-pyridyl]imidazolidin-2-one; (CAS 2023785-78-4), 4-hydroxy-1,5-dimethyl-3-[4-(trifluoromethyl)-2-pyridyl]imidazolidin-2-one (CAS 2023785-79-5), 5-ethoxy-4-hydroxy-1-methyl-3-[4-(trifluoromethyl)-2-pyridyl]imidazolidin-2-one (CAS 1701416-69-4), 4-hydroxy-1-methyl-3-[4-(trifluoromethyl)-2-pyridyl]imidazolidin-2-one (CAS 1708087-22-2), 4-hydroxy-1,5-dimethyl-3-[1-methyl-5-(trifluoromethyl)pyrazol-3-yl]imidazolidin-2-one (CAS 2023785-80-8), 1-(5-tert-butylisoxazol-3-yl)-4-ethoxy-5-hydroxy-3-methyl-imidazolidin-2-one (CAS 1844836-64-1), triazine herbicides, including of chlorotriazine, triazinones, triazindiones, methylthiotriazines and pyridazinones such as ametryn, atrazine, chloridazone, cyanazine, desmetryn, dimethametryn, hexazinone, metribuzin, prometon, prometryn, propazine, simazine, simetryn, terbumeton, terbuthylazin, terbutryn and trietazin, aryl urea such as chlorobromuron, chlorotoluron, chloroxuron, dimefuron, diuron, fluometuron, isoproturon, isouron, linuron, metamitron, methabenzthiazuron, metobenzuron, metoxuron, monolinuron, neburon, siduron, tebuthiuron and thiadiazuron, phenyl carbamates such as desmedipham, karbutilat, phenmedipham, phenmedipham-ethyl, nitrile herbicides such as bromofenoxim, bromoxynil and its salts and esters, ioxynil and its salts and esters, uraciles such as bromacil, lenacil and terbacil, and bentazon and bentazon-sodium, pyridate, pyridafol, pentanochlor and propanil and inhibitors of the photosystem I such as diquat, diquat-dibromide, paraquat, paraquat-dichloride and paraquat-dimetilsulfate. Among these, a preferred embodiment of the invention relates to those compositions comprising at least one aryl urea herbicide. Among these, likewise a preferred embodiment of the invention relates to those compositions comprising at least one triazine herbicide. Among these, likewise a preferred embodiment of the invention relates to those compositions comprising at least one nitrile herbicide;
    • b4) from the group of the protoporphyrinogen-IX oxidase inhibitors:
    • acifluorfen, acifluorfen-sodium, azafenidin, bencarbazone, benzfendizone, bifenox, butafenacil, carfentrazone, carfentrazone-ethyl, chlomethoxyfen, chlorphthalim, cinidon-ethyl, cyclopyranil, fluazolate, flufenpyr, flufenpyr-ethyl, flumiclorac, flumiclorac-pentyl, flumioxazin, fluoroglycofen, fluoroglycofen-ethyl, fluthiacet, fluthiacet-methyl, fomesafen, halosafen, lactofen, oxadiargyl, oxadiazon, oxyfluorfen, pentoxazone, profluazol, pyraclonil, pyraflufen, pyraflufen-ethyl, saflufenacil, sulfentrazone, thidiazimin, tiafenacil, trifludimoxazin, ethyl [3-[2-chloro-4-fluoro-5-(1-methyl-6-trifluoromethyl-2,4-dioxo-1,2,3,4-tetrahydropyrimidin-3-yl)phenoxy]-2-pyridyloxy]acetate (CAS 353292-31-6; S-3100), N-ethyl-3-(2,6-dichloro-4-trifluoromethylphenoxy)-5-methyl-1H-pyrazole-1-carboxamide (CAS 452098-92-9), N-tetrahydrofurfuryl-3-(2,6-dichloro-4-trifluoromethylphenoxy)-5-methyl-1H-pyrazole-1-carboxamide (CAS 915396-43-9), N-ethyl-3-(2-chloro-6-fluoro-4-trifluoromethylphenoxy)-5-methyl-1H-pyrazole-1-carboxamide (CAS 452099-05-7), N-tetrahydrofurfuryl-3-(2-chloro-6-fluoro-4-trifluoro-methylphenoxy)-5-methyl-1H-pyrazole-1-carboxamide (CAS 452100-03-7), 3-[7-fluoro-3-oxo-4-(prop-2-ynyl)-3,4-dihydro-2H-benzo[1,4]oxazin-6-yl]-1,5-dimethyl-6-thioxo-[1,3,5]triazinan-2,4-dione (CAS 451484-50-7), 2-(2,2,7-trifluoro-3-oxo-4-prop-2-ynyl-3,4-dihydro-2H-benzo[1,4]oxazin-6-yl)-4,5,6,7-tetrahydro-isoindole-1,3-dione (CAS 1300118-96-0), 1-methyl-6-trifluoromethyl-3-(2,2,7-trifluoro-3-oxo-4-prop-2-ynyl-3,4-dihydro-2H-benzo[1,4]oxazin-6-yl)-1H-pyrimidine-2,4-dione (CAS 1304113-05-0), methyl (E)-4-[2-chloro-5-[4-chloro-5-(difluoromethoxy)-1H-methyl-pyrazol-3-yl]-4-fluoro-phenoxy]-3-methoxy-but-2-enoate (CAS 948893-00-3), and 3-[7-chloro-5-fluoro-2-(trifluoromethyl)-1H-benzimidazol-4-yl]-1-methyl-6-(trifluoromethyl)-1H-pyrimidine-2,4-dione (CAS 212754-02-4), 2-[2-chloro-5-[3-chloro-5-(trifluoromethyl)-2-pyridinyl]-4-fluorophenoxy]-2-methoxy-acetic acid methyl ester (CAS 1970221-16-9), 2-[2-[[3-chloro-6-[3,6-dihydro-3-methyl-2,6-dioxo-4-(trifluoromethyl)-1(2H)-pyrimidinyl]-5-fluoro-2-pyridinyl]oxy]phenoxy]-acetic acid methyl ester (CAS 2158274-96-3), 2-[2-[[3-chloro-6-[3,6-dihydro-3-methyl-2,6-dioxo-4-(trifluoromethyl)-1(2H)-pyrimidinyl]-5-fluoro-2-pyridinyl]oxy]phenoxy] acetic acid ethyl ester (CAS 158274-50-9), methyl 2-[[3-[2-chloro-5-[4-(difluoromethyl)-3-methyl-5-oxo-1,2,4-triazol-1-yl]-4-fluoro-phenoxy]-2-pyridyl]oxy]acetate (CAS 2271389-22-9), ethyl 2-[[3-[2-chloro-5-[4-(difluoromethyl)-3-methyl-5-oxo-1,2,4-triazol-1-yl]-4-fluoro-phenoxy]-2-pyridyl]oxy]acetate (CAS 2230679-62-4), 2-[[3-[[3-chloro-6-[3,6-dihydro-3-methyl-2,6-dioxo-4-(trifluoromethyl)-1(2H)-pyrimidinyl]-5-fluoro-2-pyridinyl]oxy]-2-pyridinyl]oxy]-acetic acid methyl ester (CAS 2158275-73-9), 2-[[3-[[3-chloro-6-[3,6-dihydro-3-methyl-2,6-dioxo-4-(trifluoromethyl)-1(2H)-pyrimidinyl]-5-fluoro-2-pyridinyl]oxy]-2-pyridinyl]oxy] acetic acid ethyl ester (CAS 2158274-56-5), 2-[2-[[3-chloro-6-[3,6-dihydro-3-methyl-2,6-dioxo-4-(trifluoromethyl)-1(2H)-pyrimidinyl]-5-fluoro-2-pyridinyl]oxy]phenoxy]-N-(methylsulfonyl)-acetamide (CAS 2158274-53-2), 2-[[3-[[3-chloro-6-[3,6-dihydro-3-methyl-2,6-dioxo-4-(trifluoromethyl)-1(2H)-pyrimidinyl]-5-fluoro-2-pyridinyl]oxy]-2-pyridinyl]oxy]-N-(methylsulfonyl)-acetamide (CAS 2158276-22-1);
    • b5) from the group of the bleacher herbicides:
    • PDS inhibitors: beflubutamid, diflufenican, fluridone, flurochloridone, flurtamone, norflurazon, picolinafen, and 4-(3-trifluoromethylphenoxy)-2-(4-trifluoromethylphenyl)-pyrimidine (CAS 180608-33-7), HPPD inhibitors: benzobicyclon, benzofenap, bicyclopyrone, clomazone, fenquinotrione, isoxaflutole, mesotrione, oxotrione (CAS 1486617-21-3), pyrasulfotole, pyrazolynate, pyrazoxyfen, sulcotrione, tefuryltrione, tembotrione, tolpyralate, topramezone, bleacher, unknown target: aclonifen, amitrole flumeturon 2-chloro-3-methylsulfanyl-N-(1-methyltetrazol-5-yl)-4-(trifluoromethyl)benzamide (CAS 1361139-71-0), bixlozone and 2-(2,5-dichlorophenyl)methyl-4,4-dimethyl-3-isoxazolidinone (CAS 81778-66-7);
    • b6) from the group of the EPSP synthase inhibitors:
    • glyphosate, glyphosate-isopropylammonium, glyposate-potassium and glyphosate-trimesium (sulfosate);
    • b7) from the group of the glutamine synthase inhibitors:
    • bilanaphos (bialaphos), bilanaphos-sodium, glufosinate, glufosinate-P and glufosinate-ammonium;
    • b8) from the group of the DHP synthase inhibitors:
    • asulam;
    • b9) from the group of the mitosis inhibitors:
    • compounds of group K1: dinitroanilines such as benfluralin, butralin, dinitramine, ethalfluralin, fluchloralin, oryzalin, pendimethalin, prodiamine and trifluralin, phosphoramidates such as amiprophos, amiprophos-methyl, and butamiphos, benzoic acid herbicides such as chlorthal, chlorthal-dimethyl, pyridines such as dithiopyr and thiazopyr, benzamides such as propyzamide and tebutam; compounds of group K2: carbetamide, chlorpropham, flamprop, flamprop-isopropyl, flamprop-methyl, flamprop-M-isopropyl, flamprop-M-methyl and propham; among these, compounds of group K1, in particular dinitroanilines are preferred;
    • b10) from the group of the VLCFA inhibitors:
    • chloroacetamides such as acetochlor, alachlor, amidochlor, butachlor, dimethachlor, dimethenamid, dimethenamid-P, metazachlor, metolachlor, metolachlor-S, pethoxamid, pretilachlor, propachlor, propisochlor and thenylchlor, oxyacetanilides such as flufe-nacet and mefenacet, acetanilides such as diphenamid, naproanilide, napropamide and napropamide-M, tetrazolinones such fentrazamide, and other herbicides such as anilofos, cafenstrole, fenoxasulfone, ipfencarbazone, piperophos, pyroxasulfone and isoxazoline compounds of the formulae II.1, II.2, II.3, II.4, II.5, II.6, II.7, II.8 and II.9




embedded image


embedded image






      • the isoxazoline compounds of the formula (II) are known in the art, e.g. from WO 2006/024820, WO 2006/037945, WO 2007/071900 and WO 2007/096576;

      • among the VLCFA inhibitors, preference is given to chloroacetamides and oxyacetamides;



    • b11) from the group of the cellulose biosynthesis inhibitors:

    • chlorthiamid, dichlobenil, flupoxam, indaziflam, isoxaben, triaziflam and 1-cyclohexyl-5-pentafluorphenyloxy-14-[1,2,4,6]thiatriazin-3-ylamine (CAS 175899-01-1);

    • b12) from the group of the decoupler herbicides:

    • dinoseb, dinoterb and DNOC and its salts;

    • b13) from the group of the auxinic herbicides:

    • 2,4-D and its salts and esters such as clacyfos, 2,4-DB and its salts and esters, aminocyclopyrachlor and its salts and esters, aminopyralid and its salts such as aminopyralid-dimethylammonium, aminopyralid-tris(2-hydroxypropyl)ammonium and its esters, benazolin, benazolin-ethyl, chloramben and its salts and esters, clomeprop, clopyralid and its salts and esters, dicamba and its salts and esters, dichlorprop and its salts and esters, dichlorprop-P and its salts and esters, flopyrauxifen, fluroxypyr, fluroxypyr-butometyl, fluroxypyr-meptyl, halauxifen and its salts and esters (CAS 943832-60-8); MCPA and its salts and esters, MCPA-thioethyl, MCPB and its salts and esters, mecoprop and its salts and esters, mecoprop-P and its salts and esters, picloram and its salts and esters, quinclorac, quinmerac, TBA (2,3,6) and its salts and esters, triclopyr and its salts and esters, florpyrauxifen, florpyrauxifen-benzyl (CAS 1390661-72-9) and 4-amino-3-chloro-5-fluoro-6-(7-fluoro-1H-indol-6-yl)picolinic acid (CAS 1629965-65-6);

    • b14) from the group of the auxin transport inhibitors: diflufenzopyr, diflufenzopyr-sodium, naptalam and naptalam-sodium;

    • b15) from the group of the other herbicides: bromobutide, chlorflurenol, chlorflurenol-methyl, cinmethylin, cumyluron, cyclopyrimorate (CAS 499223-49-3) and its salts and esters, dalapon, dazomet, difenzoquat, difenzoquat-metilsulfate, dimethipin, DSMA, dymron, endothal and its salts, etobenzanid, flurenol, flurenol-butyl, flurprimidol, fosamine, fosamine-ammonium, indanofan, maleic hydrazide, mefluidide, metam, methiozolin, methyl azide, methyl bromide, methyl-dymron, methyl iodide, MSMA, oleic acid, oxaziclomefone, pelargonic acid, pyributicarb, quinoclamine tetflupyrolimet, and tridiphane.





Moreover, it may be useful to apply the compounds of formula (I) in combination with safeners. Safeners are chemical compounds which prevent or reduce damage on useful plants without having a major impact on the herbicidal action of the compounds of the formula (I) towards undesired vegetation. They can be applied either before sowings (e.g. on seed treatments, shoots or seedlings) or in the pre-emergence application or post-emergence application of the useful plant. The safeners and the compounds of formula (I) and optionally the herbicides B can be applied simultaneously or in succession.


In another embodiment of the present invention the combinations according to the present invention comprise at least one compound of formula (I) and at least one safener C (component C).


Examples of safeners are e.g. (quinolin-8-oxy)acetic acids, 1-phenyl-5-haloalkyl-1H-1,2,4-triazol-3-carboxylic acids, 1-phenyl-4,5-dihydro-5-alkyl-1H-pyrazol-3,5-dicarboxylic acids, 4,5-dihydro-5,5-diaryl-3-isoxazol carboxylic acids, dichloroacetamides, alpha-oximinophenylacetonitriles, acetophenonoximes, 4,6-dihalo-2-phenylpyrimidines, N-[[4-(aminocarbonyl)phenyl]sulfonyl]-2-benzoic amides, 1,8-naphthalic anhydride, 2-halo-4-(haloalkyl)-5-thiazol carboxylic acids, phosphorthiolates and N-alkyl-O-phenylcarbamates and their agriculturally acceptable salts and their agriculturally acceptable derivatives such amides, esters, and thioesters, provided they have an acid group.


Examples of safener compounds C are benoxacor, cloquintocet, cyometrinil, cyprosulfamide, dichlormid, dicyclonon, dietholate, fenchlorazole, fenclorim, flurazole, fluxofenim, furilazole, isoxadifen, mefenpyr, mephenate, naphthalic anhydride, oxabetrinil, 4-(dichloroacetyl)-1-oxa-4-azaspiro[4.5]decane (MON4660, CAS 71526-07-3), 2,2,5-trimethyl-3-(dichloroacetyl)-1,3-oxazolidine (R-29148, CAS 52836-31-4), metcamifen and BPCMS (CAS 54091-06-4).


The active compounds B of groups b1) to b15) and the active compounds C are known herbicides and safeners, see, for example, The Compendium of Pesticide Common Names (http://www.alanwood.net/pesticides/); Farm Chemicals Handbook 2000 volume 86, Meister Publishing Company, 2000; B. Hock, C. Fedtke, R. R. Schmidt, Herbizide [Herbicides], Georg Thieme Verlag, Stuttgart 1995; W. H. Ahrens, Herbicide Handbook, 7th edition, Weed Science Society of America, 1994; and K. K. Hatzios, Herbicide Handbook, Supplement for the 7th edition, Weed Science Society of America, 1998. 2,2,5-Trimethyl-3-(dichloroacetyl)-1,3-oxazolidine [CAS No. 52836-31-4] is also referred to as R-29148. 4-(Dichloroacetyl)-1-oxa-4-azaspiro[4.5]decane [CAS No. 71526-07-3] is also referred to as AD-67 and MON 4660.


The assignment of the active compounds to the respective mechanisms of action is based on current knowledge. If several mechanisms of action apply to one active compound, this substance was only assigned to one mechanism of action.


The invention also relates to formulations comprising at least an auxiliary and at least one compound of formula (I) according to the invention.


A formulation comprises a pesticidally effective amount of a compound of formula (I). The term “effective amount” denotes an amount of the combination or of the compound of formula (I), which is sufficient for controlling undesired vegetation, especially for controlling undesired vegetation in crops (i.e. cultivated plants) and which does not result in a substantial damage to the treated crop plants. Such an amount can vary in a broad range and is dependent on various factors, such as the undesired vegetation to be controlled, the treated crop plants or material, the climatic conditions and the specific compound of formula (I) used.


The compounds of formula (I), their salts, amides, esters or thioesters can be converted into customary types of formulations, e. g. solutions, emulsions, suspensions, dusts, powders, pastes, granules, pressings, capsules, and mixtures thereof. Examples for formulation types are suspensions (e.g. SC, OD, FS), emulsifiable concentrates (e.g. EC), emulsions (e.g. EW, EO, ES, ME), capsules (e.g. CS, ZC), pastes, pastilles, wet-table powders or dusts (e.g. WP, SP, WS, DP, DS), pressings (e.g. BR, TB, DT), granules (e.g. WG, SG, GR, FG, GG, MG), insecticidal articles (e.g. LN), as well as gel formulations for the treatment of plant propagation materials such as seeds (e.g. GF). These and further formulation types are defined in the “Catalogue of pesticide formulation types and international coding system”, Technical Monograph No. 2, 6th Ed. May 2008, CropLife International.


The formulations are prepared in a known manner, such as described by Mollet and Grubemann, Formulation technology, Wiley VCH, Weinheim, 2001; or Knowles, New developments in crop protection product formulation, Agrow Reports DS243, T&F Informa, London, 2005.


Suitable auxiliaries are solvents, liquid carriers, solid carriers or fillers, surfactants, dispersants, emulsifiers, wetting agents, adjuvants, solubilizers, penetration enhancers, protective colloids, adhesion agents, thickeners, humectants, repellents, attractants, feeding stimulants, compatibilizers, bactericides, anti-freezing agents, anti-foaming agents, colorants, tackifiers and binders.


Suitable solvents and liquid carriers are water and organic solvents, such as mineral oil fractions of medium to high boiling point, e.g. kerosene, diesel oil; oils of vegetable or animal origin; aliphatic, cyclic and aromatic hydrocarbons, e. g. toluene, paraffin, tetra-hydronaphthalene, alkylated naphthalenes; alcohols, e.g. ethanol, propanol, butanol, benzylalcohol, cyclohexanol; glycols; DMSO; ketones, e.g. cyclohexanone; esters, e.g. lactates, carbonates, fatty acid esters, gamma-butyrolactone; fatty acids; phospho-nates; amines; amides, e.g. N-methylpyrrolidone, fatty acid dimethylamides; and mixtures thereof.


Suitable solid carriers or fillers are mineral earths, e.g. silicates, silica gels, talc, kao-lins, limestone, lime, chalk, clays, dolomite, diatomaceous earth, bentonite, calcium sulfate, magnesium sulfate, magnesium oxide; polysaccharides, e.g. cellulose, starch; fertilizers, e.g. ammonium sulfate, ammonium phosphate, ammonium nitrate, ureas; products of vegetable origin, e.g. cereal meal, tree bark meal, wood meal, nutshell meal, and mixtures thereof.


Suitable surfactants are surface-active compounds, such as anionic, cationic, nonionic and amphoteric surfactants, block polymers, polyelectrolytes, and mixtures thereof. Such surfactants can be used as emulsifier, dispersant, solubilizer, wetter, penetration enhancer, protective colloid, or adjuvant. Examples of surfactants are listed in McCutcheon's, Vol. 1: Emulsifiers & Detergents, McCutcheon's Directories, Glen Rock, USA, 2008 (International Ed. or North American Ed.).


Suitable anionic surfactants are alkali, alkaline earth or ammonium salts of sulfonates, sulfates, phosphates, carboxylates, and mixtures thereof. Examples of sulfonates are alkylarylsulfonates, diphenylsulfonates, alpha-olefin sulfonates, lignine sulfonates, sulfonates of fatty acids and oils, sulfonates of ethoxylated alkylphenols, sulfonates of alkoxylated arylphenols, sulfonates of condensed naphthalenes, sulfonates of dodecyl- and tridecylbenzenes, sulfonates of naphthalenes and alkylnaphthalenes, sulfosuccin-ates or sulfosuccinamates. Examples of sulfates are sulfates of fatty acids and oils, of ethoxylated alkylphenols, of alcohols, of ethoxylated alcohols, or of fatty acid esters. Examples of phosphates are phosphate esters. Examples of carboxylates are alkyl carboxylates, and carboxylated alcohol or alkylphenol ethoxylates.


Suitable nonionic surfactants are alkoxylates, N-substituted fatty acid amides, amine oxides, esters, sugar-based surfactants, polymeric surfactants, and mixtures thereof. Examples of alkoxylates are compounds such as alcohols, alkylphenols, amines, amides, arylphenols, fatty acids or fatty acid esters which have been alkoxylated with 1 to 50 equivalents. Ethylene oxide and/or propylene oxide may be employed for the alkoxylation, preferably ethylene oxide. Examples of N-substituted fatty acid amides are fatty acid glucamides or fatty acid alkanolamides. Examples of esters are fatty acid esters, glycerol esters or monoglycerides. Examples of sugar-based surfactants are sorbitans, ethoxylated sorbitans, sucrose and glucose esters or alkylpolyglucosides. Examples of polymeric surfactants are home- or copolymers of vinylpyrrolidone, vinyl-alcohols, or vinylacetate.


Suitable cationic surfactants are quaternary surfactants, for example quaternary ammonium compounds with one or two hydrophobic groups, or salts of long-chain primary amines. Suitable amphoteric surfactants are alkylbetains and imidazolines. Suitable block polymers are block polymers of the A-B or A-B-A type comprising blocks of poly-ethylene oxide and polypropylene oxide, or of the A-B—C type comprising alkanol, poly-ethylene oxide and polypropylene oxide. Suitable polyelectrolytes are polyacids or polybases. Examples of polyacids are alkali salts of polyacrylic acid or polyacid comb polymers. Examples of polybases are polyvinylamines or polyethyleneamines.


Suitable adjuvants are compounds, which have a neglectable or even no pesticidal activity themselves, and which improve the biological performance of the compounds of formula (I) on the target. Examples are surfactants, mineral or vegetable oils, and other auxiliaries. Further examples are listed by Knowles, Adjuvants and additives, Agrow Reports DS256, T&F Informa UK, 2006, chapter 5.


Suitable thickeners are polysaccharides (e.g. xanthan gum, carboxymethylcellulose), inorganic clays (organically modified or unmodified), polycarboxylates, and silicates.


Suitable bactericides are bronopol and isothiazolinone derivatives such as alkylisothia-zolinones and benzisothiazolinones.


Suitable anti-freezing agents are ethylene glycol, propylene glycol, urea and glycerin.


Suitable anti-foaming agents are silicones, long chain alcohols, and salts of fatty acids.


Suitable colorants (e.g. in red, blue, or green) are pigments of low water solubility and water-soluble dyes. Examples are inorganic colorants (e.g. iron oxide, titan oxide, iron hexacyanoferrate) and organic colorants (e.g. alizarin-, azo- and phthalocyanine colorants).


Suitable tackifiers or binders are polyvinylpyrrolidons, polyvinylacetates, polyvinyl alcohols, polyacrylates, biological or synthetic waxes, and cellulose ethers.


Examples for formulation types and their preparation are:


i) Water-Soluble Concentrates (SL, LS)

10-60 wt % of a compound of formula (I) or a combination comprising at least one compound of formula (I) (component A) and at least one further compound selected from the herbicidal compounds B (component B) and safeners C (component C) according to the invention and 5-15 wt % wetting agent (e.g. alcohol alkoxylates) are dissolved in water and/or in a water-soluble solvent (e.g. alcohols) ad 100 wt %. The active substance dissolves upon dilution with water.


ii) Dispersible Concentrates (DC)

5-25 wt % of a compound of formula (I) or a combination comprising at least one compound of formula (I) (component A) and at least one further compound selected from the herbicidal compounds B (component B) and safeners C (component C) according to the invention and 1-10 wt % dispersant (e. g. polyvinylpyrrolidone) are dissolved in organic solvent (e.g. cyclohexanone) ad 100 wt %. Dilution with water gives a dispersion.


iii) Emulsifiable Concentrates (EC)


15-70 wt % of compound of formula (I) or a combination comprising at least one compound of formula (I) (component A) and at least one further compound selected from the herbicidal compounds B (component B) and safeners C (component C) according to the invention and 5-10 wt % emulsifiers (e.g. calcium dodecylbenzenesulfonate and castor oil ethoxylate) are dissolved in water-insoluble organic solvent (e.g. aromatic hydrocarbon) ad 100 wt %. Dilution with water gives an emulsion.


iv) Emulsions (EW, EO, ES)

5-40 wt % of compound of formula (I) or a combination comprising at least one compound of formula (I) (component A) and at least one further compound selected from the herbicidal compounds B (component B) and safeners C (component C) according to the invention and 1-10 wt % emulsifiers (e.g. calcium dodecylbenzenesulfonate and castor oil ethoxylate) are dissolved in 20-40 wt % water-insoluble organic solvent (e.g. aromatic hydrocarbon). This mixture is introduced into water ad 100 wt % by means of an emulsifying machine and made into a homogeneous emulsion. Dilution with water gives an emulsion.


v) Suspensions (SC, OD, FS)

In an agitated ball mill, 20-60 wt % of a compound of formula (I) or a combination comprising at least one compound of formula (I) (component A) and at least one further compound selected from the herbicidal compounds B (component B) and safeners C (component C) according to the invention are comminuted with addition of 2-10 wt % dispersants and wetting agents (e.g. sodium lignosulfonate and alcohol ethoxylate), 0.1-2 wt % thickener (e.g. xanthan gum) and water ad 100 wt % to give a fine active substance suspension. Dilution with water gives a stable suspension of the active substance. For FS type formulation up to 40 wt % binder (e.g. polyvinylalcohol) is added.


vi) Water-Dispersible Granules and Water-Soluble Granules (WG, SG)

50-80 wt % of a compound of formula (I) or a combination comprising at least one compound of formula (I) (component A) and at least one further compound selected from the herbicidal compounds B (component B) and safeners C (component C) according to the invention are ground finely with addition of dispersants and wetting agents (e.g. sodium lignosulfonate and alcohol ethoxylate) ad 100 wt % and prepared as water-dispersible or water-soluble granules by means of technical appliances (e. g. extrusion, spray tower, fluidized bed). Dilution with water gives a stable dispersion or solution of the active substance.


vii) Water-Dispersible Powders and Water-Soluble Powders (WP, SP, WS)


50-80 wt % of a compound of formula (I) or a combination comprising at least one compound of formula (I) (component A) and at least one further compound selected from the herbicidal compounds B (component B) and safeners C (component C) according to the invention are ground in a rotor-stator mill with addition of 1-5 wt % dispersants (e.g. sodium lignosulfonate), 1-3 wt % wetting agents (e.g. alcohol ethoxylate) and solid carrier (e.g. silica gel) ad 100 wt %. Dilution with water gives a stable dispersion or solution of the active substance.


viii) Gel (GW, GF)


In an agitated ball mill, 5-25 wt % of a compound of formula (I) or a combination comprising at least one compound of formula (I) (component A) and at least one further compound selected from the herbicidal compounds B (component B) and safeners C (component C) according to the invention are comminuted with addition of 3-10 wt % dispersants (e.g. sodium lignosulfonate), 1-5 wt % thickener (e.g. carboxymethylcellulose) and water ad 100 wt % to give a fine suspension of the active substance. Dilution with water gives a stable suspension of the active substance.


iv) Microemulsion (ME)

5-20 wt % of a compound of formula (I) or a combination comprising at least one compound of formula (I) (component A) and at least one further compound selected from the herbicidal compounds B (component B) and safeners C (component C) according to the invention are added to 5-30 wt % organic solvent blend (e.g. fatty acid dimethyl-amide and cyclohexanone), 10-25 wt % surfactant blend (e.g. alcohol ethoxylate and arylphenol ethoxylate), and water ad 100%. This mixture is stirred for 1 h to produce spontaneously a thermodynamically stable microemulsion.


iv) Microcapsules (CS)

An oil phase comprising 5-50 wt % of a compound of formula (I) or a combination comprising at least one compound of formula (I) (component A) and at least one further compound selected from the herbicidal compounds B (component B) and safeners C (component C) according to the invention, 0-40 wt % water insoluble organic solvent (e.g. aromatic hydrocarbon), 2-15 wt % acrylic monomers (e.g. methylmethacrylate, methacrylic acid and a di- or triacrylate) are dispersed into an aqueous solution of a protective colloid (e.g. polyvinyl alcohol). Radical polymerization initiated by a radical initiator results in the formation of poly(meth)acrylate microcapsules. Alternatively, an oil phase comprising 5-50 wt % of a compound of formula (I) according to the invention, 0-40 wt % water insoluble organic solvent (e.g. aromatic hydrocarbon), and an isocya-nate monomer (e.g. diphenylmethene-4,4′-diisocyanate) are dispersed into an aqueous solution of a protective colloid (e.g. polyvinyl alcohol). The addition of a polyamine (e.g. hexamethylenediamine) results in the formation of polyurea microcapsules. The monomers amount to 1-10 wt %. The wt % relate to the total CS formulation.


ix) Dustable powders (DP, DS)


1-10 wt % of a compound of formula (I) or a combination comprising at least one compound of formula (I) (component A) and at least one further compound selected from the herbicidal compounds B (component B) and safeners C (component C) according to the invention are ground finely and mixed intimately with solid carrier (e.g. finely di-vided kaolin) ad 100 wt %.


x) Granules (GR, FG)

0.5-30 wt % of a compound of formula (I) or a combination comprising at least one compound of formula (I) (component A) and at least one further compound selected from the herbicidal compounds B (component B) and safeners C (component C) according to the invention is ground finely and associated with solid carrier (e.g. silicate) ad 100 wt %. Granulation is achieved by extrusion, spray-drying or the fluidized bed.


xi) Ultra-Low Volume Liquids (UL)

1-50 wt % of a compound of formula (I) or a combination comprising at least one compound of formula (I) (component A) and at least one further compound selected from the herbicidal compounds B (component B) and safeners C (component C) according to the invention are dissolved in organic solvent (e.g. aromatic hydrocarbon) ad 100 wt %.


The formulation types i) to xi) may optionally comprise further auxiliaries, such as 0.1-1 wt % bactericides, 5-15 wt % anti-freezing agents, 0.1-1 wt % anti-foaming agents, and 0.1-1 wt % colorants.


The formulations and/or combinations generally comprise between 0.01 and 95%, preferably between 0.1 and 90%, and in particular between 0.5 and 75%, by weight of the compounds of formula (I).


The compounds of formula (I) are employed in a purity of from 90% to 100%, preferably from 95% to 100% (according to NMR spectrum).


Solutions for seed treatment (LS), suspoemulsions (SE), flowable concentrates (FS), powders for dry treatment (DS), water-dispersible powders for slurry treatment (WS), water-soluble powders (SS), emulsions (ES), emulsifiable concentrates (EC) and gels (GF) are usually employed for the purposes of treatment of plant propagation materials, particularly seeds. The formulations in question give, after two-to-tenfold dilution, active substance concentrations of from 0.01 to 60% by weight, preferably from 0.1 to 40% by weight, in the ready-to-use preparations. (nach unten verschoben)


Methods for applying compounds of formula (I), formulations and/or combinations thereof, on to plant propagation material, especially seeds, include dressing, coating, pelleting, dusting, soaking and in-furrow application methods of the propagation material. Preferably, compounds of formula (I), formulations and/or combinations thereof, respectively, are applied on to the plant propagation material by a method such that germination is not induced, e. g. by seed dressing, pelleting, coating and dusting.


Various types of oils, wetting agents, adjuvants, fertilizer, or micronutrients, and further pesticides (e.g. herbicides, insecticides, fungicides, growth regulators, safeners) may be added to the compounds of formula (I), the formulations and/or the combinations comprising them as premix or, if appropriate not until immediately prior to use (tank mix). These agents can be admixed with the formulations according to the invention in a weight ratio of 1:100 to 100:1, preferably 1:10 to 10:1.


The user applies the compounds of formula (I) according to the invention, the formulations and/or the combinations comprising them usually from a pre-dosage device, a knapsack sprayer, a spray tank, a spray plane, or an irrigation system. Usually, the formulation is made up with water, buffer, and/or further auxiliaries to the desired application concentration and the ready-to-use spray liquor or the formulation according to the invention is thus obtained. Usually, 20 to 2000 liters, preferably 50 to 400 liters, of the ready-to-use spray liquor are applied per hectare of agricultural useful area.


According to one embodiment, either individual components of the formulation according to the invention or partially premixed components, e. g. components comprising compounds of formula (I) and optionally active substances from the groups B and/or C), may be mixed by the user in a spray tank and further auxiliaries and additives may be added, if appropriate.


In a further embodiment, individual components of the formulation according to the invention such as parts of a kit or parts of a binary or ternary mixture may be mixed by the user himself in a spray tank and further auxiliaries may be added, if appropriate.


In a further embodiment, either individual components of the formulation according to the invention or partially premixed components, e. g components comprising compounds of formula (I) and optionally active substances from the groups B and/or C), can be applied jointly (e.g. after tank mix) or consecutively.


The compounds of formula (I), are suitable as herbicides. They are suitable as such, as an appropriate formulation or in combination with at least one further compound selected from the herbicidal active compounds B (component B) and safeners C (component C).


The compounds of formula (I), or the formulations and/or combinations comprising the compounds of formula (I), control undesired vegetation on non-crop areas very efficiently, especially at high rates of application. They act against broad-leaved weeds and grass weeds in crops such as wheat, rice, maize, soya and cotton without causing any significant damage to the crop plants. This effect is mainly observed at low rates of application.


The compounds of the invention are useful for controlling for example following weeds: Abutilon theophrasti (ABUTH), Alopercurus myosuroides (ALOMY), Amaranthus retroflexus (AMARE), Apera spica-venti(APESV), Avena fatua (AVEFA), Digitaria sanguinalis (DIGSA), Echinocloa crus-galli(ECHCG), Lolium multiforum (LOLMU), Setaria faberi(SETFA), Setaria viridis (SETVI), to name just a few representative examples.


The compounds of formula (I), or the formulations and/or the combinations comprising them, are applied to the plants mainly by spraying the leaves. Here, the application can be carried out using, for example, water as carrier by customary spraying techniques using spray liquor amounts of from about 100 to 1000 l/ha (for example from 300 to 400 l/ha). The compounds of formula (I), or the formulations and/or the combinations comprising them, may also be applied by the low-volume or the ultra-low-volume method, or in the form of microgranules.


Application of the compounds of formula (I), or the formulations and/or the combinations comprising them, can be done before, during and/or after, preferably during and/or after, the emergence of the undesired vegetation.


Application of the compounds of formula (I), or the formulations and/or the combinations can be carried out before or during sowing.


The compounds of formula (I), or the formulations and/or the combinations comprising them, can be applied pre-, post-emergence or pre-plant, or together with the seed of a crop plant. It is also possible to apply the compounds of formula (I), or the formulations and/or the combinations comprising them, by applying seed, pretreated with the compounds of formula (I), or the formulations and/or the combinations comprising them, of a crop plant. If the active ingredients are less well tolerated by certain crop plants, application techniques may be used in which the combinations are sprayed, with the aid of the spraying equipment, in such a way that as far as possible they do not come into contact with the leaves of the sensitive crop plants, while the active ingredients reach the leaves of undesired vegetation growing underneath, or the bare soil surface (post-directed, lay-by).


In a further embodiment, the compounds of formula (I), or the formulations and/or the combinations comprising them, can be applied by treating seed. The treatment of seeds comprises essentially all procedures familiar to the person skilled in the art (seed dressing, seed coating, seed dusting, seed soaking, seed film coating, seed multilayer coating, seed encrusting, seed dripping and seed pelleting) based on the compounds of formula (I), or the formulations and/or the combinations prepared therefrom. Here, the combinations can be applied diluted or undiluted.


The term “seed” comprises seed of all types, such as, for example, corns, seeds, fruits, tubers, seedlings and similar forms. Here, preferably, the term seed describes corns and seeds. The seed used can be seed of the crop plants mentioned above, but also the seed of transgenic plants or plants obtained by customary breeding methods.


When employed in plant protection, the amounts of active substances applied, i.e. the compounds of formula (I), component B and, if appropriate, component C without formulation auxiliaries, are, depending on the kind of effect desired, from 0.001 to 2 kg per ha, preferably from 0.005 to 2 kg per ha, more preferably from 0.05 to 0.9 kg per ha and in particular from 0.1 to 0.75 kg per ha.


In another embodiment of the invention, the application rate of the compounds of formula (I), component B and, if appropriate, component C, is from 0.001 to 3 kg/ha, preferably from 0.005 to 2.5 kg/ha and in particular from 0.01 to 2 kg/ha of active substance (a.s.).


In another preferred embodiment of the invention, the rates of application of the compounds of formula (I) according to the present invention (total amount of compounds of formula (I)) are from 0.1 g/ha to 3000 g/ha, preferably 10 g/ha to 1000 g/ha, depending on the control target, the season, the target plants and the growth stage.


In another preferred embodiment of the invention, the application rates of the compounds of formula (I) are in the range from 0.1 g/ha to 5000 g/ha and preferably in the range from 1 g/ha to 2500 g/ha or from 5 g/ha to 2000 g/ha.


In another preferred embodiment of the invention, the application rate of the compounds of formula (I) is 0.1 to 1000 g/ha, preferably 1 to 750 g/ha, more preferably 5 to 500 g/ha.


The required application rates of herbicidal compounds B are generally in the range of from 0.0005 kg/ha to 2.5 kg/ha and preferably in the range of from 0.005 kg/ha to 2 kg/ha or 0.01 kg/ha to 1.5 kg/h of a.s.


The required application rates of safeners C are generally in the range of from 0.0005 kg/ha to 2.5 kg/ha and preferably in the range of from 0.005 kg/ha to 2 kg/ha or 0.01 kg/ha to 1.5 kg/h of a.s.


In treatment of plant propagation materials such as seeds, e. g. by dusting, coating or drenching seed, amounts of active substance of from 0.1 to 1000 g, preferably from 1 to 1000 g, more preferably from 1 to 100 g and most preferably from 5 to 100 g, per 100 kilogram of plant propagation material (preferably seeds) are generally required.


In another embodiment of the invention, to treat the seed, the amounts of active substances applied, i.e. the compounds of formula (I), component B and, if appropriate, component C are generally employed in amounts of from 0.001 to 10 kg per 100 kg of seed.


When used in the protection of materials or stored products, the amount of active substance applied depends on the kind of application area and on the desired effect.


Amounts customarily applied in the protection of materials are 0.001 g to 2 kg, preferably 0.005 g to 1 kg, of active substance per cubic meter of treated material.


In case of combinations according to the present invention it is immaterial whether the compounds of formula (I), and the further component B and/or the component C are formulated and applied jointly or separately.


In the case of separate application, it is of minor importance, in which order the application takes place. It is only necessary, that the compounds of formula (I), and the further component B and/or the component C are applied in a time frame that allows simulta-neous action of the active ingredients on the plants, preferably within a time-frame of at most 14 days, in particular at most 7 days.


Depending on the application method in question, the compounds of formula (I), or the formulations and/or combinations comprising them, can additionally be employed in a further number of crop plants for eliminating undesired vegetation. Examples of suitable crops are the following:



Allium cepa, Ananas comosus, Arachis hypogaea, Asparagus officinalis, Avena sativa, Beta vulgaris spec. altissima, Beta vulgaris spec. rapa, Brassica napus var. napus, Brassica napus var. napobrassica, Brassica rapa var. silvestris, Brassica oleracea, Brassica nigra, Camellia sinensis, Carthamus tinctorius, Carya illinoinensis, Citrus limon, Citrus sinensis, Coffea arabica (Coffea canephora, Coffea liberica), Cucumis sativus, Cynodon dactylon, Daucus carota, Elaeis guineensis, Fragaria vesca, Glycine max, Gossypium hirsutum, (Gossypium arboreum, Gossypium herbaceum, Gossypium vitifolium), Helianthus annuus, Hevea brasiliensis, Hordeum vulgare, Humulus lupulus, Ipomoea batatas, Juglans regia, Lens culinaris, Linum usitatissimum, Lycopersicon lycopersicum, Malus spec., Manihot esculenta, Medicago sativa, Musa spec., Nicotiana tabacum (N. rustica), Olea europaea, Oryza sativa, Phaseolus lunatus, Phaseolus vulgaris, Picea abies, Pinus spec., Pistacia vera, Pisum sativum, Prunus avium, Prunus persica, Pyrus communis, Prunus armeniaca, Prunus cerasus, Prunus dulcis and Prunus domestica, Ribes sylvestre, Ricinus communis, Saccharum officinarum, Secale cereale, Sinapis alba, Solanum tuberosum, Sorghum bicolor (s. vulgare), Theobroma cacao, Trifolium pratense, Triticum aestivum, Triticale, Triticum durum, Vicia faba, Vitis vinifera and Zea mays.


Preferred crops are Arachis hypogaea, Beta vulgaris spec. altissima, Brassica napus var. napus, Brassica oleracea, Citrus limon, Citrus sinensis, Coffea arabica (Coffea canephora, Coffea liberica), Cynodon dactylon, Glycine max, Gossypium hirsutum, (Gossypium arboreum, Gossypium herbaceum, Gossypium vitifolium), Helianthus annuus, Hordeum vulgare, Juglans regia, Lens culinaris, Linum usitatissimum, Lycopersicon lycopersicum, Malus spec., Medicago sativa, Nicotiana tabacum (N. rustica), Olea europaea, Oryza sativa, Phaseolus lunatus, Phaseolus vulgaris, Pistacia vera, Pisum sativum, Prunus dulcis, Saccharum officinarum, Secale cereale, Solanum tuberosum, Sorghum bicolor (s. vulgare), Triticale, Triticum aestivum, Triticum durum, Vlcia faba, Vtis vinifera and Zea mays.


Especially preferred crops are crops of cereals, corn, soybeans, rice, oilseed rape, cotton, potatoes, peanuts or permanent crops.


The compounds of formula (I) according to the invention, or the formulations and/or combinations comprising them, can also be used in crops which have been modified by mutagenesis or genetic engineering in order to provide a new trait to a plant or to modify an already present trait.


The term “crops” as used herein includes also (crop) plants which have been modified by mutagenesis or genetic engineering in order to provide a new trait to a plant or to modify an already present trait.


Mutagenesis includes techniques of random mutagenesis using X-rays or mutagen-ic chemicals, but also techniques of targeted mutagenesis, in order to create mutations at a specific locus of a plant genome. Targeted mutagenesis techniques frequently use oligonucleotides or proteins like CRISPRJCas, zinc-finger nucleases, TALENs or me-ganucleases to achieve the targeting effect.


Genetic engineering usually uses recombinant DNA techniques to create modifications in a plant genome which under natural circumstances cannot readily be obtained by cross breeding, mutagenesis or natural recombination. Typically, one or more genes are integrated into the genome of a plant in order to add a trait or improve a trait. These integrated genes are also referred to as transgenes in the art, while plant comprising such transgenes are referred to as transgenic plants. The process of plant transformation usually produces several transformation events, which differ in the genomic locus in which a transgene has been integrated. Plants comprising a specific transgene on a specific genomic locus are usually described as comprising a specific “event”, which is referred to by a specific event name. Traits which have been introduced in plants or have been modified include in particular herbicide tolerance, insect resistance, increased yield and tolerance to abiotic conditions, like drought.


Herbicide tolerance has been created by using mutagenesis as well as using genetic engineering. Plants which have been rendered tolerant to acetolactate synthase (ALS) inhibitor herbicides by conventional methods of mutagenesis and breeding comprise plant varieties commercially available under the name Clearfield®. However, most of the herbicide tolerance traits have been created via the use of transgenes.


Herbicide tolerance has been created to glyphosate, glufosinate, 2,4-D, dicamba, oxynil herbicides, like bromoxynil and ioxynil, sulfonylurea herbicides, ALS inhibitor herbicides and 4-hydroxyphenylpyruvate dioxygenase (HPPD) inhibitors, like isoxaflutole and mesotrione.


Transgenes which have been used to provide herbicide tolerance traits comprise: for tolerance to glyphosate: cp4 epsps, epsps grg23ace5, mepsps, 2mepsps, gat4601, gat4621 and goxv247, for tolerance to glufosinate: pat and bar, for tolerance to 2,4-D: aad-1 and aad-12, for tolerance to dicamba: dmo, for tolerance to oxynil herbicies: bxn, for tolerance to sulfonylurea herbicides: zm-hra, csr1-2, gm-hra, S4-HrA, for tolerance to ALS inhibitor herbicides: csr1-2, for tolerance to HPPD inhibitor herbicides: hppdPF, W336 and avhppd-03.


Transgenic corn events comprising herbicide tolerance genes are for example, but not excluding others, DAS40278, MON801, MON802, MON809, MON810, MON832, MON87411, MON87419, MON87427, MON88017, MON89034, NK603, GA21, MZHGOJG, HCEM485, VCO-01981-5, 676, 678, 680, 33121, 4114, 59122, 98140, Bt10, Bt176, CBH-351, DBT418, DLL25, MS3, MS6, MZIR098, T25, TC1507 and TC6275.


Transgenic soybean events comprising herbicide tolerance genes are for example, but not excluding others, GTS 40-3-2, MON87705, MON87708, MON87712, MON87769, MON89788, A2704-12, A2704-21, A5547-127, A5547-35, DP356043, DAS44406-6, DAS68416-4, DAS-81419-2, GU262, SYHTØH2, W62, W98, FG72 and CV127.


Transgenic cotton events comprising herbicide tolerance genes are for example, but not excluding others, 19-51a, 31707, 42317, 81910, 281-24-236, 3006-210-23, BXN10211, BXN10215, BXN10222, BXN10224, MON1445, MON1698, MON88701, MON88913, GHB119, GHB614, LLCotton25, T303-3 and T304-40.


Transgenic canola events comprising herbicide tolerance genes are for example, but not excluding others, MON88302, HCR-1, HCN10, HCN28, HCN92, MS1, MS8, PHY14, PHY23, PHY35, PHY36, RF1, RF2 and RF3.


Insect resistance has mainly been created by transferring bacterial genes for insecticidal proteins to plants. Transgenes which have most frequently been used are toxin genes of Bacillus spec. and synthetic variants thereof, like cry1A, cry1Ab, cry1Ab-Ac, cry1Ac, cry1A.105, cry1F, cry1Fa2, cry2Ab2, cry2Ae, mcry3A, ecry3.1Ab, cry3Bb1, cry34Ab1, cry35Ab1, cry9C, vip3A(a), vip3Aa20. However, also genes of plant origin have been transferred to other plants. In particular genes coding for protease inhibitors, like CpTI and pinII. A further approach uses transgenes in order to produce double stranded RNA in plants to target and downregulate insect genes. An example for such a transgene is dvsnf7.


Transgenic corn events comprising genes for insecticidal proteins or double stranded RNA are for example, but not excluding others, Bt10, Bt11, Bt176, MON801, MON802, MON809, MON810, MON863, MON87411, MON88017, MON89034, 33121, 4114, 5307, 59122, TC1507, TC6275, CBH-351, MIR162, DBT418 and MZIR098.


Transgenic soybean events comprising genes for insecticidal proteins are for example, but not excluding others, MON87701, MON87751 and DAS-81419.


Transgenic cotton events comprising genes for insecticidal proteins are for example, but not excluding others, SGK321, MON531, MON757, MON1076, MON15985, 31707, 31803, 31807, 31808, 42317, BNLA-601, Event1, COT67B, COT102, T303-3, T304-40, GFM Cry1A, GK12, MLS 9124, 281-24-236, 3006-210-23, GHB119 and SGK321. Increased yield has been created by increasing ear biomass using the transgene athb17, being present in corn event MON87403, or by enhancing photosynthesis using the transgene bbx32, being present in the soybean event MON87712.


Crops comprising a modified oil content have been created by using the transgenes: gm-fad2-1, Pj.D6D, Nc.Fad3, fad2-1A and fatb1-A. Soybean events comprising at least one of these genes are: 260-05, MON87705 and MON87769.


Tolerance to abiotic conditions, in particular to tolerance to drought, has been created by using the transgene cspB, comprised by the corn event MON87460 and by using the transgene Hahb-4, comprised by soybean event IND-00410-5.


Traits are frequently combined by combining genes in a transformation event or by combining different events during the breeding process. Preferred combination of traits are herbicide tolerance to different groups of herbicides, insect tolerance to different kind of insects, in particular tolerance to lepidopteran and coleopteran insects, herbicide tolerance with one or several types of insect resistance, herbicide tolerance with increased yield as well as a combination of herbicide tolerance and tolerance to abiotic conditions.


Plants comprising singular or stacked traits as well as the genes and events providing these traits are well known in the art. For example, detailed information as to the muta-genized or integrated genes and the respective events are available from websites of the organizations “International Service for the Acquisition of Agri-biotech Applications (ISAAA)” (http://www.isaaa.org/gmapprovaldatabase) and the “Center for Environmen-tal Risk Assessment (CERA)” (http://cera-gmc.org/GMCropDatabase), as well as in patent applications, like EP3028573 and WO2017/011288.


The use of the compounds of formula (I) or formulations or combinations comprising them according to the invention on crops may result in effects which are specific to a crop comprising a certain gene or event. These effects might involve changes in growth behavior or changed resistance to biotic or abiotic stress factors. Such effects may in particular comprise enhanced yield, enhanced resistance or tolerance to insects, nematodes, fungal, bacterial, mycoplasma, viral or viroid pathogens as well as early vigor, early or delayed ripening, cold or heat tolerance as well as changed amino acid or fatty acid spectrum or content.


Furthermore, plants are also covered that contain by the use of recombinant DNA techniques a modified amount of ingredients or new ingredients, specifically to improve raw material production, e.g., potatoes that produce increased amounts of amylopectin (e.g. Amflora® potato, BASF SE, Germany).


Furthermore, it has been found that the compounds of formula (I) according to the invention, or the formulations and/or combinations comprising them, are also suitable for the defoliation and/or desiccation of plant parts of crops such as cotton, potato, oilseed rape, sunflower, soybean or field beans, in particular cotton. In this regard, formulations and/or combinations for the desiccation and/or defoliation of crops, processes for preparing these formulations and/or combinations and methods for desiccating and/or defoliating plants using the compounds of formula (I) have been found.


As desiccants, the compounds of formula (I) are particularly suitable for desiccating the above-ground parts of crop plants such as potato, oilseed rape, sunflower and soybean, but also cereals. This makes possible the fully mechanical harvesting of these important crop plants.


Also of economic interest is to facilitate harvesting, which is made possible by concentrating within a certain period of time the dehiscence, or reduction of adhesion to the tree, in citrus fruit, olives and other species and varieties of pernicious fruit, stone fruit and nuts. The same mechanism, i.e. the promotion of the development of abscission tissue between fruit part or leaf part and shoot part of the plants is also essential for the controlled defoliation of useful plants, in particular cotton.


Moreover, a shortening of the time interval in which the individual cotton plants mature leads to an increased fiber quality after harvesting.


A SYNTHESIS EXAMPLES

Chemical bonds, drawn as bars in chemical formulae, indicate the relative stereochemistry on the ring system.


Example 1: Synthesis of ethyl (3S)-3-[[3-(3,5-difluoroanilino)-2-methyl-3-oxo-propanoyl]amino]butanoate (compound I.31 in Table 1)



embedded image


1.1 Lithium 3-ethoxy-2-methyl-3-oxo-propanoate



embedded image


A solution of lithium hydroxide in water was added dropwise to mixture of diethyl 2-methylpropanedioate (100.0 g, 574 mmol), THF (200 ml) and water (200 ml) and the reaction mixture was stirred at room temperature overnight. The THF was evaporated in vacuo and the remainder washed with methyl t-butyl ether. The aqueous solution was concentrated in vacuo and the remainder dried to give the product (51.8 g, 59% yield).



1H NMR: (400 MHz, D2O) δ=4.2 (t, 2H), 3.35 (q, 1H), 1.35-1.20 (m, 6H).


1.2 Ethyl 3-(3,5-difluoroanilino)-2-methyl-3-oxo-propanoate



embedded image


A mixture of 3,5-difluoroaniline (61.1 g, 473 mmol), the lithium salt of 3-ethoxy-2-methyl-3-oxo-propanoic acid (60.0 g, 395 mmol) and triethylamine (164 mL, 3 equiv.) in THF (500 mL) was treated with n-propane-phosphonic acid anhydride (427 g, 671 mmol, 50% solution in ethyl acetate), (T3P, CAS [68957-94-8]), and stirred overnight at room temperature. Water was added and the reaction mixture extracted with ethyl acetate; the organic layers were washed with aqueous hydrochloric acid solution (1M) and water, dried over sodium sulfate and concentrated in vacuo. The remainder was triturated with di-isopropyl ether and filtered. The residue consists of the product (72.1 g, 71% yield).



1H NMR: (400 MHz, CDCl3) δ=9.9 (br s, 1H), 7.20-7.10 (m, 2), 6.60 (m, 1H), 4.25 (q, 2H), 3.40 (q, 1H), 1.55 (d, 3H), 1.30 (t, 3H).


1.3 3-(3,5-Difluoroanilino)-2-methyl-3-oxo-propanoic acid



embedded image


A solution of ethyl 3-(3,5-difluoroanilino)-2-methyl-3-oxo-propanoate (3.00 g, 11.7 mmol) in THF (25 ml) was treated with a solution of potassium hydroxide (654 mg, 11.7 mmol) in water (25 ml) and stirred for a few hours. The THF was evaporated in vacuum and the remaining aqueous phase washed with tert-butyl methyl ether (2×20 ml). Hydrochloric acid (1 M, 20 ml) was added and the resulting precipitate separated by filtration. Drying yielded 1.6 g (60%) of the product 3-(3,5-difluoroanilino)-2-methyl-3-oxo-propanoic acid.



1H NMR: (400 MHz, CDCl3) δα=8.65 (1H), 7.4 (2H), 6.65 (1H), 4.45 (1H), 3.75 (3H).


1.4 Ethyl (3S)-3-[[3-(3,5-difluoroanilino)-2-methyl-3-oxo-propanoyl]amino]butanoate



embedded image


To a solution of 3-(3,5-difluoroanilino)-2-methyl-3-oxo-propanoic acid (5.60 g, 21.8 mmol) in dimethylformamide (DMF, 60 ml) methyl (3S)-3-aminobutanoate (S-homoalanine) hydrochloride (3.66 g, 23.8 mmol) was added. To the resulting solution was added HATU (2-(7-aza-1H-benzotriazole-1-yl)-1,1,3,3-tetramethyluronium hexafluorophosphate, CAS [148893-10-1]), (9.07 g, 83 mmol) and then diisopropylethylamine (14.4 ml). The resulting reaction mixture was stirred at room temperature for a few hours. To the reaction mixture water and sodium bicarbonate solution were added, extracted with ethyl acetate, washed with water, dried (sodium sulfate) and the solvent evaporated under reduced pressure. The resulting crude product of methyl (3S)-3-[[3-(3,5-difluoroanilino)-2-methyl-3-oxo-propanoyl]amino]butanoate was dissolved in THF (50 ml) treated with a solution of potassium hydroxide (1.35 g) in water (50 ml) for 3 hours. The THF was evaporated in vacuum and the remaining aqueous phase washed with di-isopropyl ether. Hydrochloric acid (1 M, 30 ml) was added and the resulting precipitate separated by filtration and washed with water. Drying yielded 5.8 g of the crude product.


An aliquot of 200 mg (0.64 mmol) was dissolved in THF (10 ml) and treated with one drop of DMF and oxalyl dichloride (162 mg, 1.27 mmol) and stirred for one hour. 5 ml of absolute ethanol were added and stirring continued for an additional hour. Water was added and the mixture extracted with ethyl acetate. The crude product was purified by chromatography to yield 87 mg (40%) of the product ethyl (3S)-3-[[3-(3,5-difluoroanilino)-2-methyl-3-oxo-propanoyl]amino]butanoate as a 1.1 mixture of two diastereomers.



1H NMR: (400 MHz, deutero-THF) δ=10.0 and 9.8 (2×br s, 1H, N—H of diastereomers), 7.5 (1H), 7.3 (2H), 6.6 (1H), 4.25 (1H), 4.05 (2H), 3.15 (1H), 2.45 (2H), 1.4 (3H), 1.2 (6H).


Example 2: Synthesis of methyl (1S,4R)-4-[2-[(3,5-dichlorophenyl)carbamoyl]butanoylamino]cyclopent-2-ene-1-carboxylate (compound I.90 in Table 1)



embedded image


2.1 Potassium 2-ethoxycarbonylbutanoate



embedded image


The diethyl 2-ethylpropanedioate (200 g, 1063 mmol) were treated with potassium hydroxide solution (1 M in ethanol, 1.07 I, 1.07 mol) dropwise over 20 minutes (slightly exothermic). Stirring was continued for at room temperature for 4 hours. Evaporation of ethanol yielded the crude product (213 g).



1H NMR: (500 MHz, D2O) δ 4.2 (t, 2H), 3.2 (t, 1H), 1.8 (m, 2H), 1.3 (t, 3H), 0.9 (t, 3H).


2.2 Ethyl 2-[(3,5-dichlorophenyl)carbamoyl]butanoate



embedded image


A mixture of 3,5-dichloroaniline (10.8 g, 66.6 mmol), the crude product of the potassium salt of diethyl 2-ethylpropanedioate (12.0 g, 60.5 mmol) and triethylamine (18.4 g, 181.8 mmol) in THF (120 mL) was treated with n-propane phosphonic acid anhydride (65.5 g, 103 mmol, 50% solution in ethyl acetate), (T3P, CAS [68957-94-8]), and stirred 7 hours at room temperature. Water was added and stirring continued overnight. The mixture was transferred to a separating funnel and allowed to separate. The aqueous phase was extracted two times with ethyl acetate. The combined organic layers were washed with aqueous hydrochloric acid solution (1M) and brine, dried over sodium sulfate and concentrated in vacuo. The remainder was triturated for a few hours with di-isopropyl ether and separated by filtration. The residue was dried to yield the product ethyl 2-[(3,5-dichlorophenyl)carbamoyl]butanoate (9.2 g).



1H NMR: (500 MHz, THF-deuterated) δ 9.5 (s, 1H), 7.65 (s, 2H), 7.1 (s, 1H), 4.15 (m, 2H), 3.2 (t, 1H), 1.9 (m, 2H), 1.2 (t, 3H), 0.95 (t, 3H).


2.3 2-[(3,5-Dichlorophenyl)carbamoyl]butanoic acid



embedded image


A solution of potassium hydroxide (15 mL, 1 mol/L in methanol) was added dropwise to a solution of ethyl 2-[(3,5-dichlorophenyl)carbamoyl]butanoate (4.0 g 14 mmol) in methanol (10 ml) and the reaction mixture stirred at room temperature for 6 hours. The methanol was evaporated in vacuo and the remainder washed with 2×30 mL di-isopropyl ether. The aqueous phase was adjusted from alkaline to pH 1.5 with addition of aqueous hydrochloric acid solution (1 mol/1) at room temperature to yield a precipitate which was separated by filtration, washed with water and dried to give the product as an off-white solid (3.3 g, 87% yield).



1H NMR: (500 MHz, THF-deuterated) δ 9.5 (s, 1H), 7.65 (s, 2H), 7.1 (s, 1H), 3.2 (m, 1H), 1.9 (m, 2H), 0.95 (t, 3H).


2.4 Methyl (1S,4R)-4-[2-[(3,5-dichlorophenyl)carbamoyl]butanoylamino]cyclopent-2-ene-1-carboxylate



embedded image


A solution 2-[(3,5-dichlorophenyl)carbamoyl]butanoic acid (500 mg, 1.81 mmol), methyl (1S,4R)-4-aminocyclopent-2-ene-1-carboxylate;hydrochloride (370 mg, 2.08 mmol) and HATU (2-(7-aza-1H-benzotriazole-1-yl)-1,1,3,3-tetramethyluronium hexafluorophosphate, CAS [148893-10-1]), (792 mg, 2.08 mmol) in DMF (3 ml) was added diisopropylethylamine (1.26 mL). The mixture was stirred at room temperature for 2.5 hours. Water and ethyl acetate were added. The ethyl acetate phase was washed with saturated sodium chloride solution and the solvent evaporated under reduced pressure. The crude product was purified by reversed phase chromatography using acetoni-trile/water as eluent. This gave 544 mg (75%) of the product as 1:1 mixture of diastereomers.



1H NMR: (400M Hz, deutero-THF) δ 9.5 (2 br s, 1H), 7.7 (m, 3H), 7.1 (s, 1H), 5.9 (m, 1H), 5.8 (m, 1H), 5.0 (m, 1H), 3.6 (s, 3H), 3.5 (m, 1H), 3.0 (m, 1H), 2.5 (1H), 1.8-2.0 (m, 3H), 0.95 (t, 3H)


In analogy to the examples described above, the following compounds of formula (I), wherein R1, R6 and R8 are hydrogen and R2, R3, R4, R5, R7 and X—Y (depicted together with the nitrogen atom to which —X—Y is bound to show the stereochemistry) are com-piled in Table 1, were prepared, starting from commercially available diesters and using commercially available amines:




embedded image
















TABLE 1





No.
R2
R3
R4
R5
R7
N*-X-Y
LC-MS






















1.1.
H
Cl
H
Cl
CH3


embedded image


360.8





1.2.
H
Cl
H
Cl
CH2CH3


embedded image


374.8





1.3.
H
Cl
H
Cl
cPr


embedded image


387.0





1.4.
H
Cl
H
H
CH3


embedded image


350.8





1.5.
H
CF3
H
H
CH3


embedded image


385.0





1.6.
H
F
H
OCH3
CH3


embedded image


365.0





1.7.
H
F
H
Cl
CH3


embedded image


369.0





1.8.
H
H
Cl
H
CH3


embedded image


350.8





1.9.
Cl
H
Cl
H
CH3


embedded image


384.7





1.10.
H
Cl
Cl
H
CH3


embedded image


384.9





1.11.
H
F
H
CH3
CH3


embedded image


401.1





1.12.
H
F
H
CH3
CH3


embedded image


339.0





1.13.
H
F
H
CH3
CH3


embedded image


353.1





1.14.
H
F
H
CH3
CH3


embedded image


402.1





1.15.
H
F
H
CH3
CH3


embedded image


349.0





1.16.
H
F
H
CH3
CH3


embedded image


325.0





1.17.
H
F
H
CH3
CH3


embedded image


349.2





1.18.
H
F
H
F
CH3


embedded image


352.9





1.19.
H
Cl
H
Cl
CH3


embedded image


384.8





1.20.
H
Cl
H
Cl
CH3


embedded image


437.1





1.21.
H
F
H
F
CH3


embedded image


405.2





1.22.
H
F
H
CH3
CH3


embedded image


416.0





1.23.
H
F
H
CH3
CH3


embedded image


441.9





1.24.
H
F
H
CH3
CH3


embedded image


350.2





1.25.
H
F
H
Cl
CH3


embedded image


368.9





1.26.
H
F
H
H
CH3


embedded image


334.9





1.27.
H
F
H
F
CH3


embedded image


353.9





1.28.
H
Cl
H
Cl
CH3


embedded image


385.9





1.29.
H
Cl
H
F
CH3


embedded image


369.9





1.30.
H
F
H
H
CH3


embedded image


335.9





1.31.
H
F
H
F
CH3


embedded image


343.2





1.32.
H
Cl
H
Cl
CH3


embedded image


375.1





1.33.
H
Cl
H
F
CH3


embedded image


359.1





1.34.
H
F
H
H
CH3


embedded image


325.2





1.35.
H
Cl
H
F
CH3


embedded image


421.9





1.36.
H
Cl
H
F
CH3


embedded image


435.9





1.37.
H
F
H
F
CH3


embedded image


356.9





1.38.
H
Cl
H
Cl
CH3


embedded image


388.9





1.39.
H
Cl
H
F
CH3


embedded image


372.9





1.40.
H
F
H
H
CH3


embedded image


339.0





1.41.
H
Cl
H
F
CH3


embedded image


421.0





1.42.
H
F
H
H
CH3


embedded image


387.0





1.43.
H
Cl
H
F
CH3


embedded image


345.0





1.44.
H
CF3
H
H
CH3


embedded image


360.8





1.45.
H
Cl
Cl
H
CH3


embedded image


360.7





1.46.
Cl
H
Cl
H
CH3


embedded image


360.7





1.47.
H
OCH3
H
F
CH3


embedded image


341.0





1.48.
H
H
Cl
H
CH3


embedded image


326.7





1.49.
H
F
H
H
CH3


embedded image


334.8





1.50.
H
Cl
H
H
CH3


embedded image


327.0





1.51.
H
F
H
H
CH3


embedded image


387.9





1.52.
H
F
H
H
CH3


embedded image


401.9





1.53.
H
Cl
H
F
CH3


embedded image


408.2





1.54.
H
Cl
H
Cl
CH3


embedded image


424.1





1.55.
H
F
H
F
CH3


embedded image


391.5





1.56.
H
F
H
H
CH3


embedded image


310.8





1.57.
H
Cl
H
Cl
CH3


embedded image


438.2





1.58.
H
Cl
H
Cl
CH3


embedded image


452.2





1.59.
H
Cl
H
Cl
CH3


embedded image


478.1





1.60.
H
F
H
F
CH3


embedded image


420.2





1.61.
H
F
H
F
CH3


embedded image


406.2





1.62.
H
Cl
H
F
CH3


embedded image


462.1





1.63.
H
F
H
H
CH3


embedded image


427.9





1.64.
H
F
H
F
CH3


embedded image


445.9





1.65.
H
F
H
H
CH3


embedded image


373.9





1.66.
H
Cl
H
Cl
CH3


embedded image


493.0





1.67.
H
F
H
F
CH3


embedded image


461.3





1.68.
H
Cl
H
Cl
CH3


embedded image


328.9





1.69.
H
F
H
F
CH3


embedded image


435.3





1.70.
H
F
H
F
CH3


embedded image


483.3





1.71.
H
Cl
H
F
CH3


embedded image


360.2





1.72.
H
Cl
H
Cl
CH3


embedded image


475.9





1.73.
H
Cl
H
Cl
CH3


embedded image


495.0





1.74.
H
F
H
F
CH3


embedded image


421.2





1.75.
H
CH3
H
F
CH3


embedded image


340.2





1.76.
H
Cl
H
H
CH3


embedded image


326.0





1.77.
H
Cl
H
Cl
CH3


embedded image


452.9





1.78.
H
Cl
H
Cl
CH3


embedded image


375.9





1.79.
H
F
H
F
CH3


embedded image


343.9





1.80.
H
F
H
H
CH3


embedded image


325.0





1.81.
H
CH3
H
F
CH3


embedded image


339.0





1.82.
H
Cl
H
H
CH3


embedded image


341.0





1.83.
Cl
H
Cl
H
CH3


embedded image


375.0





1.84.
H
Cl
Cl
H
CH3


embedded image


374.9





1.85.
H
CF3
H
H
CH3


embedded image


375.0





1.86.
H
OCH3
H
F
CH3


embedded image


355.0





1.87.
H
Cl
H
F
CH3


embedded image


359.0





1.88.
H
H
Cl
H
CH3


embedded image


341.0





1.89.
H
CH3
H
F
CH3


embedded image


335.0





1.90.
H
Cl
H
Cl
CH2CH3


embedded image


398.9





1.91.
H
Cl
H
Cl
CH2CH3


embedded image


388.9





1.92.
H
Cl
H
H
CH2CH3


embedded image


341.0





1.93.
H
Cl
H
H
CH2CH3


embedded image


364.9





1.94.
H
Cl
H
H
CH2CH3


embedded image


355.0





1.95.
H
F
H
F
CH2CH3


embedded image


343.0





1.96.
H
F
H
F
CH2CH3


embedded image


366.9





1.97.
H
F
H
F
CH2CH3


embedded image


357.1





1.98.
H
F
H
H
CH2CH3


embedded image


325.1





1.99.
H
F
H
H
CH2CH3


embedded image


349.2





1.100.
H
F
H
H
CH2CH3


embedded image


339.1





1.101.
H
Cl
H
F
CH2CH3


embedded image


358.9





1.102.
H
Cl
H
F
CH2CH3


embedded image


382.9





1.103.
H
Cl
H
F
CH2CH3


embedded image


373.2





1.104.
H
CH3
H
F
CH2CH3


embedded image


339.1





1.105.
H
CH3
H
F
CH2CH3


embedded image


363.1





1.106.
H
CH3
H
F
CH2CH3


embedded image


353.3





1.107.
H
OCF3
H
H
CH2CH3


embedded image


391.2





1.108.
H
OCF3
H
H
CH2CH3


embedded image


415.2





1.109.
H
OCF3
H
H
CH2CH3


embedded image


405.2





1.110.
H
I
H
H
CH2CH3


embedded image


433.1





1.111.
H
I
H
H
CH2CH3


embedded image


457.1





1.112.
H
I
H
H
CH2CH3


embedded image


447.1





1.113.
H
Et
H
H
CH2CH3


embedded image


335.2





1.114.
H
Et
H
H
CH2CH3


embedded image


359.3





1.115.
H
Et
H
H
CH2CH3


embedded image


349.2





1.116.
H
OCF3
H
H
CH2CH3


embedded image


405.3





1.117.
H
Et
H
H
CH2CH3


embedded image


349.4





1.118.
H
I
H
H
CH2CH3


embedded image


447.1





1.119.
H
Cl
H
Cl
CH2CH3


embedded image


389.0





1.120.
H
Cl
H
H
CH2CH3


embedded image


355.0





1.121.
H
F
H
F
CH2CH3


embedded image


357.1





1.122.
H
F
H
H
CH2CH3


embedded image


339.2





1.123.
H
Cl
H
F
CH2CH3


embedded image


373.2





1.124.
H
F
H
Me
CH2CH3


embedded image


353.2





1.125.
H
Cl
H
Cl
CH2CH3


embedded image


385.3





1.126.
H
Cl
H
H
CH2CH3


embedded image


350.9





1.127.
H
F
H
F
CH2CH3


embedded image


353.0





1.128.
H
OCF3
H
H
CH2CH3


embedded image


390.6





1.129.
H
I
H
H
CH2CH3


embedded image


432.8





1.130.
H
Et
H
H
CH2CH3


embedded image


335.0





1.131.
H
Et
H
H
CH2CH3


embedded image


345.3





1.132.
H
Cl
H
Cl
CH2CH3


embedded image


375.2





1.133.
H
Cl
H
H
CH2CH3


embedded image


341.2





1.134.
H
F
H
H
CH2CH3


embedded image


325.2





1.135.
H
Cl
H
F
CH2CH3


embedded image


359.2





1.136.
H
F
H
Me
CH2CH3


embedded image


339.3





1.137.
H
F
H
F
CH2CH3


embedded image


343.2





1.138.
H
F
H
H
CH2CH3


embedded image


335.0





1.139.
H
Cl
H
F
CH2CH3


embedded image


368.9





1.140.
H
F
H
Me
CH2CH3


embedded image


349.0





1.141.
H
OCF3
H
H
CH2CH3


embedded image


400.9





1.142.
H
I
H
H
CH2CH3


embedded image


442.8





1.143.
H
Cl
H
H
CH2CH3


embedded image


327.2





1.144.
H
F
H
F
CH2CH3


embedded image


329.1





1.145.
H
F
H
Me
CH2CH3


embedded image


325.2





1.146.
H
OCF3
H
H
CH2CH3


embedded image


377.2





1.147.
H
I
H
H
CH2CH3


embedded image


419.1





1.148.
H
F
H
H
CH2CH3


embedded image


311.2





1.149.
H
Cl
H
F
CH2CH3


embedded image


345.1





1.150.
H
OCF3
H
F
CH2CH3


embedded image


391.2





1.151.
H
Et
H
H
CH2CH3


embedded image


335.3





1.152.
H
Cl
H
Cl
CH3


embedded image


385.0





1.153.
H
F
H
F
CH3


embedded image


353.1





1.154.
H
F
H
F
CH3


embedded image


343.1





1.155.
H
Cl
H
Cl
CH3


embedded image


376.0





1.156.
H
OCF3
H
H
CH2CH3


embedded image


455.1





1.157.
H
I
H
H
CH2CH3


embedded image


471.1





1.158.
H
OCF3
H
H
CH2CH3


embedded image


429.2





1.159.
H
OCF3
H
H
CH2CH3


embedded image


443.3





1.160.
H
I
H
H
CH2CH3


embedded image


485.1





1.161.
H
I
H
H
CH2CH3


embedded image


497.2





1.162.
H
I
H
H
CH2CH3


embedded image


482.1





1.163.
H
OCF3
H
H
CH2CH3


embedded image


440.2





1.164.
H
I
H
H
CH2CH3


embedded image


481.1





1.165.
H
OCF3
H
H
CH2CH3


embedded image


439.2





1.166.
H
I
H
H
CH2CH3


embedded image


533.2





1.167.
H
OCF3
H
H
CH2CH3


embedded image


491.2





cPr cyclopropyl


Et ethyl


Me methyl






B BIOLOGICAL EXAMPLES

The herbicidal activity of the compounds of formula (I) was demonstrated by the following greenhouse experiments:


The culture containers used were plastic flowerpots containing loamy sand with approximately 3.0% of humus as the substrate. The seeds of the test plants were sown separately for each species.


For the pre-emergence treatment, the active ingredients, which had been suspended or emulsified in water, were applied directly after sowing by means of finely distributing nozzles. The containers were irrigated gently to promote germination and growth and subsequently covered with transparent plastic hoods until the test plants had rooted.


This cover caused uniform germination of the test plants, unless this had been impaired by the active ingredients.


For the post-emergence treatment, the test plants were first grown to a height of 3 to 15 cm, depending on the plant habit, and only then treated with the active ingredients which had been suspended or emulsified in water. For this purpose, the test plants were either sown directly and grown in the same containers, or they were first grown separately as seedlings and transplanted into the test containers a few days prior to treatment.


Depending on the species, the test plants were kept at 10-25° C. or 20-35° C., respectively.


The test period extended over 2 to 4 weeks. During this time, the test plants were tended, and their response to the individual treatments was evaluated.


Evaluation was carried out using a scale from 0 to 100. 100 means no emergence of the test plants, or complete destruction of at least the aerial moieties, and 0 means no damage, or normal course of growth. A good herbicidal activity is given at values of 70 to <90 and a very good herbicidal activity is given at values of 90 to 100.


The test plants used in the greenhouse experiments were of the following species:
















Bayer code
Scientific name









ABUTH

Abutilon theophrasti




ALOMY

Alopercurus myosuroides




AMARE

Amaranthus retroflexus




APESV

Apera spica-venti




AVEFA

Avena fatua




DIGSA

Digitaria sanguinalis




ECHCG

Echinocloa crus-galli




LOLMU

Lolium multiflorum




SETFA

Setaria faberi




SETVI

Setaria viridis











At an application rate of 0.125 kg/ha, applied by the pre-emergence method:

    • compound I.79 showed good herbicidal activity against ABUTH
    • compound I.14 showed very good herbicidal activity against AMARE
    • compound I.117 showed very good herbicidal activity against APESV
    • compounds I.79, I.85 showed good herbicidal activity against APESV
    • compound I.14 showed good herbicidal activity against ECHCG
    • compound I.90 showed good herbicidal activity against SETFA


At an application rate of 0.125 kg/ha, applied by the post-emergence method:

    • compounds I.39, I.90 showed very good herbicidal activity against ABUTH
    • compounds I.66, I.85 showed good herbicidal activity against ABUTH
    • compounds I.42, I.85, I.90 showed good herbicidal activity against ALOMY
    • compounds I.39, I.66, I.85, I.117 showed good herbicidal activity against AVEFA
    • compounds I.90, I.91 showed good herbicidal activity against ECHCG


At an application rate of 0.250 kg/ha, applied by the pre-emergence method:

    • compounds I.13, I.22 showed very good herbicidal activity against ABUTH
    • compounds I.11, I.99 showed good herbicidal activity against ABUTH
    • compounds I.6, I.7, I.12, I.16, I.28, I.78, I.108, I.116 showed very good herbicidal activity against AMARE
    • compounds I.15, I.18, I.93, I.167 showed good herbicidal activity against AMARE
    • compounds I.4, I.5, I.6, I.7, I.10, I.17, I.49, I.93, I.96, I.102, I.105, I.108, I.111, I.116, I.118 showed very good herbicidal activity against APESV
    • compounds I.13, I.15, I.18, I.19, I.20, I.21, I.53, I.56, I.57, I.67, I.68, I.74, I.75, I.80, I.81, I.82, I.92, I.99, I.104, I.107 showed good herbicidal activity against APESV
    • compounds I.153, I.156, I.158, I.159 showed very good herbicidal activity against DIGSA
    • compounds I.152, I.163 showed good herbicidal activity against DIGSA
    • compounds I.4, I.6, I.96, I.108 showed very good herbicidal activity against ECHCG
    • compounds I.5, I.17, I.19, I.49, I.116 showed good herbicidal activity against ECHCG
    • compounds I.153, I.154 showed very good herbicidal activity against LOLMU
    • compounds I.152, I.156, I.159, I.163 showed good herbicidal activity against LOLMU
    • compounds I.93, I.96, I.103 showed very good herbicidal activity against SETFA
    • compounds I.16, I.17, I.120, I.121, I.123 showed good herbicidal activity against SETFA
    • compound I.153 showed very good herbicidal activity against SETVI
    • compounds I.152, I.158, I.159, I.163 showed good herbicidal activity against SETVI


At an application rate of 0.250 kg/ha, applied by the post-emergence method:

    • compounds I.7, I.49, I.81, I.82, I.102, I.108, I.111, I.118 showed very good herbicidal activity against ABUTH
    • compounds I.5, I.6, I.8, I.67, I.77, I.92, I.105, I.107, I.120, I.122, I.123, I.124 showed good herbicidal activity against ABUTH
    • compounds I.5, I.6, I.10, I.17, I.50, I.56, I.82, I.152, I.153, I.163, I.165 showed very good herbicidal activity against ALOMY
    • compounds I.8, I.11, I.12, I.15, I.16, I.18, I.20, I.27, I.29, I.31, I.33, I.41, I.43, I.80, I.81, I.107, I.111, I.154, I.164 showed good herbicidal activity against ALOMY
    • compounds I.4, I.19, I.21, I.82, I.93, I.96, I.99, I.116, I.118, I.156, I.158, I.159, I.160, I.161 showed very good herbicidal activity against AMARE
    • compounds I.22, I.27, I.48, I.53, I.57, I.76, I.77, I.121, I.122, I.123, I.154, I.157, I.162, I.163, I.164, I.165, I.166, I.167 showed good herbicidal activity against AMARE
    • compounds I.4, I.5, I.6, I.7, I.10, I.17, I.19, I.20, I.43, I.49, I.50, I.74, I.77, I.80, I.82, I.108, I.118, I.152, I.153, I.154, I.156, I.157, I.159, I.160, I.161, I.166 showed very good herbicidal activity against AVEFA
    • compounds I.11, I.12, I.15, I.16, I.18, I.20, I.25, I.27, I.29, I.31, I.33, I.41, I.56, I.57, I.78, I.81, I.84, I.86, I.95, I.98, I.101, I.110, I.120, I.122, I.158, I.162, I.167 showed good herbicidal activity against AVEFA
    • compounds I.49, I.93, I.96, I.99, I.102, I.105, I.108, I.111, I.116, I.152, I.153, I.157, I.158, I.159, I.160, I.161, I.163 showed very good herbicidal activity against ECHCG
    • compounds I.121, I.162, I.164, I.165, I.166, I.167 showed good herbicidal activity against ECHCG
    • compounds I.4, I.7, I.17, I.80, I.93, I.96, I.99, I.102, I.116, I.156 showed very good herbicidal activity against SETVI
    • compounds I.15, I.92, I.101, I.105, I.107, I.120, I.121, I.123 showed good herbicidal activity against SETVI


At an application rate of 0.500 kg/ha, applied by the pre-emergence method:

    • compounds I.1 showed good herbicidal activity against AMARE


At an application rate of 0.500 kg/ha, applied by the post-emergence method:

    • compounds I.2, I.3 showed good herbicidal activity against ALOMY
    • compounds I.1, I.2, I.3 showed very good herbicidal activity against AMARE
    • compounds I.1, I.2 showed good herbicidal activity against AVEFA
    • compounds I.3 showed good herbicidal activity against ECHCG


At an application rate of 1.000 kg/ha, applied by the pre-emergence method:

    • compounds I.126, I.127 showed good herbicidal activity against ABUTH
    • compound I.128 showed very good herbicidal activity against AMARE
    • compounds I.133, I.134, I.135 showed good herbicidal activity against AMARE
    • compounds I.141, I.142, I.144, I.146 showed very good herbicidal activity against DIGSA
    • compound I.138 showed good herbicidal activity against DIGSA
    • compounds I.126, I.128, I.133, I.134 showed very good herbicidal activity against ECHCG
    • compounds I.127, I.135 showed good herbicidal activity against ECHCG
    • compounds I.141, I.144, I.146 showed very good herbicidal activity against LOLMU
    • compound I.138 showed good herbicidal activity against LOLMU
    • compound I.128, I.133, I.135 showed very good herbicidal activity against SETFA
    • compounds I.126, I.127, I.137 showed good herbicidal activity against SETFA
    • compounds I.138, I.141 showed good herbicidal activity against SETVI


At an application rate of 1.000 kg/ha, applied by the post-emergence method:

    • compounds I.126, I.128, I.134, I.135, I.137 showed very good herbicidal activity against ABUTH
    • compounds I.125, I.127, I.129, I.131, I.136 showed good herbicidal activity against ABUTH
    • compounds I.141, I.149 showed very good herbicidal activity against ALOMY
    • compounds I.125, I.140, I.144, I.146, I.147 showed good herbicidal activity against ALOMY
    • compounds I.126, I.127, I.128, I.129, I.133, I.134, I.135, I.137, I.138, I.139, I.141, I.142, I.146 showed very good herbicidal activity against AMARE
    • compounds I.144 showed good herbicidal activity against AMARE
    • compounds I.138, I.140, I.142 showed very good herbicidal activity against AVEFA
    • compounds I.136, I.139, I.143, I.144, I.146, I.147, I.149 showed good herbicidal activity against AVEFA
    • compounds I.126, I.127, I.128, I.138, I.139, I.141, I.142 showed very good herbicidal activity against ECHCG
    • compounds I.125, I.129, I.131, I.133, I.140 showed good herbicidal activity against ECHCG
    • compounds I.133, I.134, I.135, I.137 showed very good herbicidal activity against SETVI
    • compound I.136 showed good herbicidal activity against SETVI

Claims
  • 1. A compound of formula (I)
  • 2. The compound as claimed in claim 1, wherein one, two, three, or all four of the following conditions (a), (b), (c) and (d) apply: (a) R1 is hydrogen; and R8 is hydrogen;(b) R2 is hydrogen, halogen, or (C1-C3)-alkyl; and R6 is hydrogen, halogen, or (C1-C3)-alkyl;(c) R3 is hydrogen, halogen, (C1-C3)-alkyl, (C1-C3)-haloalkyl, (C1-C3)-alkoxy or (C1-C3)-haloalkoxy; and R5 is hydrogen, halogen, (C1-C3)-alkyl, (C1-C3)-haloalkyl, (C1-C3)-alkoxy or (C1-C3)-haloalkoxy; where preferably R3 and R5, independently of each other, are hydrogen or halogen;(d) R4 is hydrogen or halogen.
  • 3. The compound as claimed in claim 2, wherein one, two, three, or all four of the following conditions (a), (b), (c) and (d) apply: (a) R1 is hydrogen; and R8 is hydrogen;(b) R2 is hydrogen or halogen and R6 is hydrogen;(c) R3 is hydrogen, halogen, (C1-C3)-alkyl, (C1-C3)-haloalkyl, (C1-C3)-alkoxy, or (C1-C3)-haloalkoxy; and R5 is hydrogen, halogen, (C1-C3)-alkyl, (C1-C3)-haloalkyl, (C1-C3)-alkoxy, or (C1-C3)-haloalkoxy;(d) R4 is hydrogen or halogen.
  • 4. The compound as claimed in claim 1, wherein: R7 is (C1-C6)-alkyl, (C3-C6)-cycloalkyl, or (C2-C6)-alkenyl.
  • 5. The compound as claimed in claim 4, wherein: R7 is (C1-C6)-alkyl or (C3-C6)-cycloalkyl, preferably (C1-C6)-alkyl.
  • 6. The compound as claimed in claim 1, wherein the substituents have the following meaning: X is a bond; andY is Z;where Z is a three-, four-, five-, or six-membered saturated, partly unsaturated or fully unsaturated carbocyclic ring, except phenyl, which is substituted by p radicals selected from the group consisting of CO2Re, CONRbRh, S(O)nRa, SO2NRbRd, SO2NRbCORe, CORb, CONReS(O)Ra, CONReSO2Ra, CONRb1SO2NRb2Rb3, NRbRe, NRbCORe, NRbCONReRe, NRbCO2Re, NRbSO2Re, NRb1SO2NRb2Re, OCONRbRe, OCSNRbRe, PORfRf, and C(Rb)═NORe, and where the carbon ring atoms bear n oxo groups; orwhere Z is a three-, four-, five-, or six-membered saturated, partly unsaturated or fully unsaturated heterocyclic ring containing one or two oxygen atoms as ring members, where the ring is substituted by p radicals selected from the group consisting of CO2Re, CONRbRh, S(O)nRa, SO2NRbRd, SO2NRbCORe, CORb, CONReS(O)Ra, CONReSO2Ra, CONRb1SO2NRb2Rb3, NRbRe, NRbCORe, NRbCONReRe, NRbCO2Re, NRbSO2Re, NRb1SO2NRb2Re, OCONRbRe, OCSNRbRe, PORfRf, and C(Rb)═NORe, and where the carbon ring atoms bear n oxo groups.
  • 7. The compound as claimed in claim 6, where Z is a five- or six-membered saturated or partly unsaturated carbocyclic ring which is substituted by p radicals CO2Re, where Re is hydrogen, (C1-C6)-alkyl which optionally has a cyano group; phenyl-(C1-C2)-alkyl or (C3-C6)-cycloalkyl.
  • 8. The compound as claimed in claim 7, where Z is a five-membered partly unsaturated carbocyclic ring which is substituted by p radicals CO2Re, where R e is hydrogen, (C1-C6)-alkyl which optionally has a cyano group; phenyl-(C1-C2)-alkyl or (C3-C6)-cycloalkyl.
  • 9. The compound as claimed in claim 1, wherein the substituents have the following meanings: X is a divalent unit (X1), where R10 and R11 are as defined in claim 1;Y is (C1-C8)-alkyl which is substituted by p radicals selected from the group consisting of CO2Re, CONRbRh, S(O)nRa, SO2NRbRd, SO2NRbCORe, CORb, CONReS(O)Ra, CONReSO2Ra, CONRb1SO2NRb2Rb3, NRbRe, NRbCORe, NRbCONReRe, NRbCO2Re, NRbSO2Re, NRb1SO2NRb2Re, OCONRbRe, OCSNRbRe, PORfRf, and C(Rb)═NORe.
  • 10. The compound as claimed in claim 9, wherein the substituents have the following meanings: X is a divalent unit (X1), where R10 is hydrogen and R11 is methyl;Y is (C1-C4)-alkyl which is substituted by p radicals selected from the group consisting of CO2Re, CONRbRh, CONReS(O)Ra, CONReSO2Ra, and CONRb1SO2NRb2Rb3, where Ra, Rb, Rb1, Rb2, Rb3, Re and Rh are as defined in claim 1.
  • 11. The compound as claimed in claim 1, wherein p is 1 or 2.
  • 12. The compound as claimed in claim 1, wherein the substituents have the following meaning: R1 is hydrogen;R2 is hydrogen or halogen;R3 is hydrogen, halogen, (C1-C3)-alkyl, (C1-C3)-haloalkyl, (C1-C3)-alkoxy, or (C1-C3)-haloalkoxy;R4 is hydrogen or halogen;R5 is hydrogen, halogen, (C1-C3)-alkyl, (C1-C3)-haloalkyl, (C1-C3)-alkoxy, or (C1-C3)-haloalkoxy;R6 is hydrogen;R7 is (C1-C6)-alkyl or (C3-C6)-cycloalkyl;R8 hydrogen; andX is a bond; and Y is Z; where Z is a five- or six-membered saturated or partly unsaturated carbocyclic ring which is substituted by p radicals CO2Re, where Re is hydrogen, (C1-C6)-alkyl, (C1-C6)-alkyl which carries a cyano group, phenyl-(C1-C2)-alkyl, or (C3-C6)-cycloalkyl; orX is a divalent unit (X1), where R10 and R11 are independently of each other hydrogen or (C1-C6)-alkyl; and Y is (C1-C4)-alkyl which is substituted by p radicals selected from the group consisting of CO2Re, CONRbRh, CONReS(O)Ra, CONReSO2Ra, and CONRb1SO2NRb2Rb3, whereRe in CO2Re is hydrogen, (C1-C6)-alkyl which optionally has a phenyl ring or a cyano group; or (C2-C4)-alkynyl;Rb in CONRbRh is hydrogen or (C1-C3)-alkyl;Rh in CONRbRh is (C1-C3)-alkoxy;Re in CONReS(O)Ra is hydrogen or (C1-C3)-alkyl;Ra in CONReS(O)Ra is (C1-C6)-alkyl or (C1-C3)-haloalkyl;Re in CONReSO2Ra is hydrogen or (C1-C3)-alkyl;Ra in CONReSO2Ra is (C1-C6)-alkyl or (C1-C3)-haloalkyl;Rb1 in CONRb1SO2NRb2Rb3 is hydrogen or (C1-C3)-alkyl;Rb2 in CONRb1SO2NRb2Rb3 is hydrogen or (C1-C3)-alkyl;Rb3 in CONRb1SO2NRb2Rb3 is (C1-C6)-alkyl; orRb2 and Rb3, together with the nitrogen atom they are bound to, form a saturated 5- or 6-membered N-bound heterocyclic ring; andp is 1 or 2.
  • 13. The compound as claimed in claim 12, wherein the substituents have the following meaning: R1 is hydrogen;R2 is hydrogen;R3 is hydrogen, halogen, (C1-C3)-alkyl, (C1-C3)-haloalkyl, (C1-C3)-alkoxy, or (C1-C3)-haloalkoxy;R4 is hydrogen or halogen;R5 is hydrogen, halogen, (C1-C3)-alkyl, (C1-C3)-haloalkyl, (C1-C3)-alkoxy, or (C1-C3)-haloalkoxy;R6 is hydrogen;R7 is (C1-C4)-alkyl or (C3-C4)-cycloalkyl;R8 hydrogen; andX is a bond; and Y is Z; where Z is a five-membered partly unsaturated carbocyclic ring which is substituted by p radicals CO2Re, where Re is hydrogen, (C1-C6)-alkyl, (C1-C2)-alkyl which carries a cyano group, benzyl, or (C3-C6)-cycloalkyl; orX is a divalent unit (X1), where R10 is hydrogen and R11 is methyl; and Y is (C1-C4)-alkyl which is substituted by p radicals selected from the group consisting of CO2Re, CONRbRh, CONReSO2Ra, and CONRb1SO2NRb2Rb3, whereRe in CO2Re is hydrogen, (C1-C6)-alkyl, (C1-C2)-alkyl which carries a cyano group, benzyl, or (C2-C4)-alkynyl;Rb in CONRbRh is hydrogen;Rh in CONRbRh is (C1-C3)-alkoxy;Re in CONReSO2Ra is hydrogen;Ra in CONReSO2Ra is (C1-C6)-alkyl;Rb1 in CONRb1SO2NRb2Rb3 is hydrogen;Rb2 in CONRb1SO2NRb2Rb3 is hydrogen or (C1-C3)-alkyl;Rb3 in CONRb1SO2NRb2Rb3 is (C1-C6)-alkyl; orRb2 and Rb3, together with the nitrogen atom they are bound to, form a saturated 6-membered N-bound heterocyclic ring; andp is 1.
  • 14. The compound as claimed in claim 1, wherein —X—Y form together a group of the formula (XY1) or (XY2)
  • 15. The compound as claimed in claim 14, where in XY1 RA is hydrogen or methyl; andRB, RC and RD are hydrogen;in XY2 RA is hydrogen or methyl; andRB, RC, RD, RE, and RF are hydrogen; orin XY2 RA and RE, together with the carbon atoms they are bound to, form a 5- or 6-membered saturated or partly unsaturated carbocyclic ring; andRB, RC, RD, and RF are hydrogen; orin XY2 RA and RE, together with the carbon atoms they are bound to, form a 5- or 6-membered saturated or partly unsaturated heterocyclic ring containing one oxygen atom as ring member; andRB, RC, RD, and RF are hydrogenandRe is hydrogen, (C1-C6)-alkyl, (C1-C2)-alkyl which carries a CN substituent, benzyl, (C2-C4)-alkynyl or (C3-C6)-cycloalkyl; and is preferably (C1-C4)-alkyl.
  • 16. The compound as claimed in claim 15, where in XY1 RA is methyl; andRB, RC, and RD are hydrogen;in XY2 RA is methyl; andRB, RC, RD, RE, and RF are hydrogen; orin XY2 RA and RE, together with the carbon atoms they are bound to, form a 5-membered partly unsaturated carbocyclic ring; andRB, RC, RD, and RF are hydrogen;andRe is hydrogen, (C1-C6)-alkyl, (C1-C2)-alkyl which carries a CN substituent, benzyl, (C2-C4)-alkynyl or (C3-C6)-cycloalkyl.
  • 17. A composition comprising at least one compound as claimed in claim 1, and at least one auxiliary, which is customary for formulating crop protection compounds.
  • 18. The composition as claimed in claim 17, comprising a further herbicide.
  • 19. (canceled)
  • 20. A method for controlling unwanted vegetation comprising contacting an herbicidally effective amount of at least one compound as claimed in claim 1 with a plant, its seed and/or its habitat.
Priority Claims (1)
Number Date Country Kind
21193037.5 Aug 2021 EP regional
PCT Information
Filing Document Filing Date Country Kind
PCT/EP2022/073598 8/24/2022 WO